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During the last decades, cancer diseases have increased all over the world. The 
low quality of food and strong pollution of environment are the main 
prerequisites for carcinogenesis. The main problem for scientists is to find strategy 
for prevention of cancer diseases. Therefore, the information about models for 
studying carcinogenesis and mutagens which appear during cooking, 
environmental pollutants, and tests for specific detection of carcinogens is 
particularly important. 
The book “Carcinogen” contains a collection of reviews and original papers which 
illustrate: 
Models of Carcinogenesis - a review focused on the role of stem cells as target to 
carcinogenesis 
Tests for Detection of Carcinogens - one of the reviews describes different methods for 
analyzing nucleic acid adducts, while the other describes the Ty1 retrotransposition 
short-term test, which can be used to study carcinogenicity of chemicals, including 
such applied in agriculture, nutrition and pharmacy. The test is highly sensitive, 
selective to carcinogenic substances, and can be used to control environmental 
pollution. 
Food and Carcinogens - one of the reviews gives general information about 
mycotoxins. Some of them have biological effect on human health, the others, 
however, are carcinogenic according to their mechanism of action. The quality of 
food depends on the heat treatment during cooking process, which may cause the 
formation of mutagenic and carcinogenic compounds. Food industry has to monitor 
and control food technology to ultimately reduce food born carcinogens. 
Environmental Carcinogenesis - four reviews are closely focused on environmental 
pollution with carcinogens and their effect on human health - the risk of leukemia 
arising from formaldehyde exposure, the effects of bisphenol A (BPA) exposure to 
cancer risk, the consumption of high amount of water containing humic acid, and 
genome instability caused by ionizing radiation. The book “Carcinogen” is intended 
 
for biologists, researchers, students in medical sciences and professionals interested in 
associated areas.  
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The New Model of Carcinogenesis: 
The Cancer Stem Cell Hypothesis  
Brenda Loaiza, Emilio Rojas and Mahara Valverde 
Universidad Nacional Autónoma de México, Instituto de Investigaciones Biomédicas 
México 
1. Introduction 
Cancer has long been seen as a disease that arises from mutations and epigenetic alterations 
that impair the capacity of any cell within the organism to deregulation its proliferation, 
avoid apoptosis and metastasis, giving rise to malignant transformation. Progressively, 
these early cancer cells lead to different generations of daughter cells that accumulate 
additional mutations, acting in concert to drive the full neoplastic phenotype. Adult stem 
cells are found in numerous tissues of the body and play an important role in tissue 
development, replacement and repair. In addition, these cells show long-term replicative 
potential, together with the capacities of self-renewal and multi-lineage differentiation. 
These stem cell properties are tightly regulated in normal development, therefore their 
alteration may be a critical issue for tumorigenesis. The Cancer Stem Cell (CSC) theory 
arises from the poor probability of short-lived differentiated progenitors or terminally 
differentiated cells to accumulate mutations that become cancer. On the other side, the 
normal tissue stem cells or early progenitors that already possess the most important 
characteristics of cancer are an easy target for the accumulation of genetic aberrations which 
lead to cancer formation. The new defining model for carcinogenesis, the "cancer stem cell 
theory" was put forward since 1997, when John Dick and coworkers started a series of 
pioneering investigations to understand whether the functional hierarchy observed in 
normal hematopoiesis was conserved in blood tumors (Bonnet & Dick, 1997). According to 
this model cancer is a stem cell disease that places malignant stem cells at the centre of its 
tumorigenic activity. Cancer stem cells give rise to undifferentiated cells and terminally 
differentiated cells, as happens in normal tissue renewal, but the major difference between 
cancer growth and normal tissue renewal is that whereas normal transit amplifying cells 
usually differentiate and die, at various levels of differentiation, the cancer transit-
amplifying cells fail to differentiate normally and instead accumulate (ie, they undergo 
maturation arrest), resulting in cancer growth. 
Cancer stem cells may be caused by transforming mutations and/or epigenetic events to 
gain the self-renewal activity and lose some features of differentiation occurring in multi-
potential stem cells, tissue-specific stem cells, progenitor cells, mature cells and cancer cells. 
This theory has been functionally supported by the observation that among all cancer cells 
within a particular tumor, only a minute cell fraction has the exclusive potential to 
regenerate the entire tumor cell population. Many groups have extrapolated the cancer stem 
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cell theory from the haematopoietic system to solid cancers, where using in vitro culture 
techniques and in vivo transplant models have established evidence of cancer stem cells in 
colon, pancreas, prostate, brain and breast cancers. Some tumor stem cells, like breast, have 
upregulated genes which include Notch. Notch signaling has been highlighted as a pathway 
involved in the development of the breast and is frequently deregulated in invasive breast 
cancer, as well as other oncogenic pathways like Wnt, Hh and NF-κB. Also studies on 
haematopoietic cancers show that these important signaling pathways for normal 
haematopoiesis, are oncogenic, thereby potentially involved in cancer stem cell regulation. 
On the other side, the degree of differentiation of a carcinoma depends on the proportion of 
undifferentiated tumor stem cells. The cancer-derived differentiated cells are not normal, 
moreover they don't have the potential to develop cancer, so it could be attempt to direct 
normal differentiation of malignant stem cells and serve as an alternative to cytotoxic 
therapy. Differentiation therapies are currently underway. To be maximally effective, 
therapy of cancer must be directed against both the resting stem cells and the proliferating 
cells of the cancer. Conventional radiation treatment and chemotherapy only kill the actively 
proliferating cells of the cancer. Successful therapies could be reached if specific stem cell 
signals are inhibited using gene therapy, while at the same time attacking proliferating cells 
by conventional radiation treatment or chemotherapy. However, the chemoresistant 
phenotype of CSCs makes it difficult to increase their sensitivity to anticancer drugs and to 
decrease the rate of cancer recurrence in patients that is the one of major causes of death all 
over the world. 
This review will focus on the role of stem cell as a target to carcinogenesis, the major 
oncogenic pathways and finally provides an update of the major chemoresistance related 
mechanisms of cancer stem cells. 
2. The raise of the stem cells  
At the dawn of the 20th century, we had recognized that chemicals cause cancer, but we had 
not yet identified individual cancer-causing molecules, nor did we know their cellular 
targets. What we lacked was knowledge of the mechanisms by which chemicals cause 
cancer and the molecular changes that characterize tumor progression. We now are early in 
a century in which cancer is being investigated at the molecular level, and we have 
developed technologies that afford unprecedented power to delineate and manipulate 
altered pathways in cancer cells (Loeb & Harris, 2008). However we still been confronted 
with the same old kind of questions and realities, Can we harness new insights and 
technologies to prevent or obliterate human cancers or delay their progression? Can we give 
more specific molecular-based therapeutic options to a cancer patient? Can we identify the 
origin of the carcinogenesis process?, defining these questions is a critical step to a complete 
understanding of carcinogenesis.  
In the last 15 years a great advance has been performed trying to understand the 
mechanisms underlying the origin of the carcinogenesis process. With the concept of stem 
cells the cancer scenario suffers an extraordinary expansion. Nowadays with the discovery 
that almost all tissues in the body are able to renovate owing to the presence of Stem Cells 
(SCs), most of medical research about regeneration therapy involve the study of these cells. 
Indeed when looking for stem cells in Pubmed there are more than 150,000 papers. Since 
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1961 with Till and McCulloch initial work, lot of researchers have dealt of isolating and 
identify stem cells in all tissues (Till & McCulloch, 1961).  
Stem Cells are defined principally by its genuine capacity of self-renewal, as a matter of fact 
in assays for identification of stemness is necessary to demonstrate this property. Some of 
most popular assays to evaluate functionally are, in the case of hematopoietic stem cells 
(HSC), the long term repopulating of the entire hematopoietic system of myeloablated 
animals in vivo. These studies have been done by transplanting murine HSC into irradiated, 
SCID (severe combined immunodeficient) and NOD/SCID (non-obese diabetic/severe 
combined immunodeficiency) mice (Jordan & Lemishka, 1990; Kamel-Reid & Dick J, 1988). 
Immunophenotypic analysis and functionally in vitro are, also, carry out to identify stem 
cells, for example, HSC are defined by their capacity to initiate and sustain long-term 
hematopoiesis in liquid cultures in presence of an adherent cell layer formed by stromal 
elements (Sutherland et al., 1990).  
As responsible of the tissue renovation, SCs have an extraordinary expansion potential and 
an important capacity of differentiation, giving rise to a heterogeneous hierarchical progeny 
of cells (Mayani, 2003). To produce differentiated cells and at the same time preserve the 
stem cell pool, stem cells undergo asymmetric or symmetric cell divisions. Asymmetry 
division refers to two different daughter cells; a stem cell and a progenitor cell capable of 
differentiating, meanwhile, symmetric cell divisions contribute to regulate cell pool size 
giving rise to two identical stem cells, or two progenitor cells. In certain cases such as in 
hematopoiesis, it is likely that both mechanisms operate to preserve the SCs pool and give 
rise to all the different lineages and maturation stages (Mayani et al., 1993).  
SCs types generated during development are the fertilized egg, or zygote, which is by 
definition the “Totipotent” stem cell capable of produce all the different cells of an 
organism, including those that do not form part of the embryo, such as placenta cells 
(Alberts et al., 1994, Wobus, 2010). Totipotent stem cells are up to morula (8-cell) stage, each 
cell produced is identical to the zygote. Then the embryo becomes blastocyst, in which each 
cell that forms part of the inner cell mass is capable of producing all cells of the embryo 
itself, but not extraembryonic structures produced only by trophoblast cells that then 
become placenta. At blastocyst stage, each cell is a “Pluripotent” Embryonic Stem Cell (ESC) 
with an unlimited proliferation potential (Williams, 1988). Three types of pluripotent stem 
cells lines with self-renewal capacity and the potential to differentiate into cell types of all 
three primary germ layers were derived from embryos and fetal stages of mice: embryonic 
stem (ES) cells were isolated from blastomeres of the early mouse embryo from the 8-cell up 
to the blastocyst stage (Evans & Kaufman, 1981, Wobus et al., 1991); embryonic germ (EG) 
cells were isolated from primordial germ cells, the precursor cells of germ cells from 9.5- to 
12.5-day fetal stages (Resnick et al., 1992); and embryonic carcinoma (EC) cells have been 
established from the stem cell population of teratocarcinomas (Figure 1). These three cell 
types share typical characteristics, such as expression of alkaline phosphatase, the 
embryonic antigen SSEA-1 (Solter & Knowles, 1978) and the germline-specific transcription 
factor Oct-4 (Scholer at al., 1989), a short G1 phase of the cell cycle (Rohwedel et al., 1996) 
and high telomerase activity (Thomson et al., 1998).  
A novel source of stem cells is induced pluripotent stem cells (iPSC) and adult multipotent 
stem cells. iPSC cells were first derived from murine fibroblasts by ectopic expression of 
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Oct4, Sox2, Klf4 and c-Myc transcription factors, demonstrating that the specialized somatic 
cells can be reversed into a pluripotent state in vitro (Takahasi & Yamanaka, 2006). Like 
embryonic stem (ES) cells, iPSC cells are able to self-renew indefinitely and to differentiate 
into all types of cells in the body. iPSC hold great promise for regenerative medicine, 
because iPSC avoid immunological rejection but also get away from ethical issues (Chen & 
Liu, 2009). Since the first report on the derivation of iPSC in 2006, many laboratories all over 
the world started research on iPSC cells and have made significant progress. 
In the other hand, Till and McCulloch (1961) were the first to detect spleen-colony forming 
units in mouse bone marrow and to realize that these were a kind of stem cell, since that 
time, stem cell for a number of other adult tissues have been identified. The fundamental 
role of adult stem cells in a living organism involves maintaining the somatic cell 
population in tissues in response to cellular injuring or stress, and thus such stem cells are 
important in maintaining tissue homeostasis in the organism. Adult stem cells are 
multipotent differentiating into a few cell types, usually limited to the tissue from which 
they arise, however, a few reports have suggest that have the potential to differentiate to 
cells other than their tissue of origin (Charbod, 2010; D´lppolito et al., 2004; Jiang et al., 
2002) (Figure 1). 
 
Embryogenesis starts with the fertilized oocyte, zygote (totipotent stem cell), which develops into 
embryonic stem cell (pluripotent stem cell). Somatic and germ line cells represent the multipotent stem 
cells. CNS: Central Nervous System. 
Fig. 1. General Types of Stem Cells.  
Zygote 
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Stem cells develop within specific microenvironments called “niches” consisting of different 
cell types and their products, these external elements provide signals that control stem cell 
behavior by modulating expression and activity of the nuclear transcription factors, gene 
expression, molecular regulators of cell cycle, epigenetic regulation, etc., (Oh & Kwon, 2010). 
To avoid aberrant growth or tissue loss, the balance between stem cell proliferation and 
differentiation must be perfect. In natural conditions, stem cells are found in quiescence and 
their frequency is very low (Orford & Scadden, 2008). For example in bone marrow, where 
are located  the vast majority of HSC,  there are 1 HSC per 1–2 x 104 bone marrow cells (i.e., 
0.01–0.005% of total bone marrow cells) (Szilvassy & Hoffman, 1995; Thomas et al., 1999), 
and as we have mentioned previously, the location of HSC within the bone marrow is not 
random. Most HSC are located within the endosteal region, whereas lineage-committed 
progenitors and mature cells are distributed away from this region, predominantly in the 
central marrow region, close to the central marrow vessels (Nilsson et al., 2001). 
In the elegant manuscript of the hallmarks of cancer, Hanahan and Weinberg (2011) 
described a set of events necessary to reach a transformation condition, it was worth-noting 
for a lot of researchers that some of these events are present in stem cells, because these cells 
can undergo extensively cell division and has the potential to give rise to both stem cells and 
cell differentiate into specialized cells, opening the possibility of the participation of stem 
cells in cancer process. The still unresolved question is how stem cells, which stay in very 
well maintained niches, interacts with environmental factors that provide them the damage 
that will became an irreversible deregulated self-renewal? How oncogenes and/or tumor 
suppressors genes can be compromised in cancer stem cell process?  
2.1 Stem cells as target of mutations and transformation 
Target cells of transforming mutations is unknown, even in cancer; however there is 
considerable evidence that certain types of leukemia arise from mutations that accumulate 
HSC. This proposal is sustained in the fact that cells capable of initiating human Acute 
Myeloid Leukemia (AML) have a CD34+CD38- phenotype in most AML subtypes and thus 
have similar phenotype to normal HSC. Conversely, CD34+CD38+ leukemia cells cannot 
transfer disease, despite the fact that they exhibit leukemic blast phenotype. This suggests 
that normal HSC rather than committed progenitors are target for leukemic transformation 
(Reya el at., 2001).  
In a work of Miyamoto an colleges (2000), done on HSC from patients in remission, AML1-
ETO transcripts which result of the most frequent chromosomal translocation 8;21 were 
found in a fraction of normal HSC in the marrow. These prospectively isolated HSC and 
their progeny were not leukemic, indicating that translocation occurred originally in normal 
HSC and that additional mutation in a subset of these HSC or their progeny subsequently 
lead to leukemia. Other evidences where clonotypic leukemia-associated chromosomal 
rearrangements have also been found in CD34+CD38- lymphoid (George et al., 2001) and 
chronic myeloid leukemias (Mauro & Druker, 2001). 
Although SCs are often target of genetic events that trigger malignant transformation, in 
other cases restricted progenitors or even differentiated cells may become transformed. 
Mouse model in which myeloid leukemia arises from restricted progenitors was created by 
targeting the expression of transgenes specifically to restricted myeloid progenitors using 
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Oct4, Sox2, Klf4 and c-Myc transcription factors, demonstrating that the specialized somatic 
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In the other hand, Till and McCulloch (1961) were the first to detect spleen-colony forming 
units in mouse bone marrow and to realize that these were a kind of stem cell, since that 
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Embryogenesis starts with the fertilized oocyte, zygote (totipotent stem cell), which develops into 
embryonic stem cell (pluripotent stem cell). Somatic and germ line cells represent the multipotent stem 
cells. CNS: Central Nervous System. 
Fig. 1. General Types of Stem Cells.  
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the hMRP-8 promoter, this model of leukemia resemble human leukemias in many respects. 
The enforced expression of anti-apoptotic gene bcl-2 in the myeloid linage leads to a disease 
that is similar to human chronic myelomonocytic leukemia, including monocytosis, 
splenomegaly and neutropenia, as the mice age, but rarely these mice develop acute 
malignancies. To test whether additional mutations are required to synergize with bcl-2 to 
promote AML, hMRP8-bcl-2 transgenic mice were bred with lpr/lpr Fas-deficient mice. 
Remarkably, the loss of these two distinct apoptosis pathways led to the development of 
AML in 15% of the mice (Traver et al., 1998). These mice have an expansion of myeloblast in 
all haematopoietic tissues, with substantially lowered number of granulocytes in the 
marrow and blood. As previously described, in the case of spontaneously arising human 
leukemias it is likely that stem cells accumulate the mutations that are necessary for 
neoplastic proliferation; however these mutations are expressed in restricted progenitors. 
That is, mutations that accumulate in stem cells may lead to neoplastic proliferation of 
primitive progenitors downstream of stem cells. Perhaps the reason why only 15% of mice 
progress to AML expressing Bcl-2 and lacking Fas is that the progenitors in these mice also 
must acquire an additional mutation that cause deregulated self-renewal. If a single 
additional mutation causes transforming events is probably a gain-of-function mutation, 
such as one that promotes constitutive self-renewal. Due that stabilized -catenin promote 
self-renewal of HSCs and other progenitors, Reya and colleges (2001) propose that gain-of-
function mutations in -catenin may, transform deathless pre-malignant cells to cancer cells 
by promoting proliferation.  
2.2 Evidences about the existence of Cancer Stem Cells (CSC) 
The first’s evidences about the existence of Cancer Stem Cells were documented for 
leukemia and multiple myeloma reporting that only small subset of cancer cells is capable of 
extensive proliferation. When leukemic cells were transplanted in vivo, only 1-4% of cells 
could form spleen colonies (Bruce & Van der Gaag, 1963; Wodinsky et al., 1967). Even when 
mouse myeloma cells were obtained from ascites, separated from normal hematopoietic 
cells and put in clonal in vitro colony forming assay, only 1 in 10,000 to 1 in 100 cancer cells 
were able to form colonies (Park et al., 1971). The clonogenic leukemic cells were described 
as leukemic stem cells because the differences in clonogenicity among the leukemia cells 
mirrored the differences among normal haematopoietic cells. Bonnet and Dick (1997) show 
that human Acute Myeloid Leukemia (AML) stem cells could be identified prospectively 
and purified as CD34+CD38- cells form patient samples. Despite the fact that these cells 
represent only 0.2% of variable proportion of AML cells, they were the only cells with the 
capacity of transferring AML from human patients to NOD/SCID (non-obese 
diabetic/severe combined immunodeficiency) mice in the vast majority of cases. For solid 
tumors, also has been shown that the cells are phenotypically heterogeneous and that only a 
small proportion of cells are clonogenic in vivo and in culture; for example, in lung cancer, 
only 1 in 1000 to 1 in 5000; ovarian cancer and neuroblastoma cells were found to form 
colonies in soft agar. Only in terms of leukemic stem cells, these findings led to the 
hypothesis that only a few cancer cells are actually tumorigenic and that these tumorigenic 
cells could be considered as cancer stem cells (CSC). 
In most human breast cancer, only a very small fraction of the tumor clone defined as 
CD44+,CD24neg/low and representing 11-35% of total cancer cells, is able to sustain tumor 
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grow when xenografted in NOD/SCID mice (Al-Hajj et al., 2003). The CSC working model 
has also been proved in brain tumors, Galli et al., (2004) succeeded to isolate and propagated 
neurospheres from human glioblastoma, which are highly enriched in long-term cell 
renewing multi-linage-differentiating and tumor-initiating cells. Another example for 
demonstrating the existence of CSC was found in rapidly renewing intestinal cells (small 
intestine and colon). This epithelium is full with normal stem cells localized at the bottom of 
the crypts and expressing the Wnt target gene Lgr5. Stem cells that were disrupted of the 
APC (Adenomatous Polyposis Coli) gene were leading to constitutive activation of the Wnt 
pathway, a well known initiation step in intestinal cancer. The result was the formation of 
microscopic adenomas, a first step in malignant transformation of the intestine. 
Interestingly, when the APC gene was deleted in more differentiated and short-lived 
progenitors, microadenoma could be observed that however lacked growth potential and 
did hardly result in microscopic adenoma formation (Lapham et al., 2009). 
2.3 Theory of cancer stem cell 
In cancer biology has long recognized that tumor is complex collections of aberrant cells, 
each of which ultimately derives from a single antecessor, the cell of origin that describes 
their clonal source. The process by which the cell of origin develops into an ever-expanding, 
heterogeneous tumor that retains many features of its parent tissue remains mysterious. In 
this classical carcinogenesis model, a somatic differentiated cell had to be reprogrammed or 
“dedifferentiated” to regain immortalization properties of cancer. The limited life span and 
proliferation capacity of the differentiated cell should be induced to an irreversible change 
that enables the cell to get the ability to have unlimited proliferation (Trosko, 2009); then 
after, this initiated cell have to survive long enough to acquire the hallmarks of cancer. 
Recently the cancer stem cell theory has re-emerged as a compelling model to explain both 
the clonality and some of the heterogeneity of tumors. It postulate that each tumor contains 
a subset of cells, cancer stem cells, that are unique responsible for tumor growth, 
heterogeneity and metastasis. These cells specialized; possess important features, self-
renewal and differentiation potential, that together pointing out them from the remainder of 
the tumor cells (Rothenberg and Clarke, 2009). 
The cancer stem cell theory proposes that tumors have a cellular hierarchy that is a 
caricature of their normal tissue counterpart because they reflect the pluripotency of the 
originally transformed cell. 
Two observations lead to this theory, first most tumors arise from a single cell, but not all 
the cells in a tumor are identical this is also known as tumor heterogeneity (Park et al., 1971). 
A widely held belief in cancer biology is that all cellular heterogeneity found in tumors may 
be attributed to genomic instability and the selection for cells that can adapt to the tumor 
microenvironment. However recent evidence strongly supports that CSC also plays a major 
role in tumor heterogeneity (Lobo et al., 2007). 
The second observation was build came from studies that demonstrated that a large number 
of cancer cells were required to growth a tumor (Bruce & Van der Gaag, 1963; Hamburger & 
Salmon, 1977). Two formal possibilities could explain this observation: either all cancer cells 
had a low probability of proliferating extensively or most cancer cells were unable to 
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the hMRP-8 promoter, this model of leukemia resemble human leukemias in many respects. 
The enforced expression of anti-apoptotic gene bcl-2 in the myeloid linage leads to a disease 
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leukemias it is likely that stem cells accumulate the mutations that are necessary for 
neoplastic proliferation; however these mutations are expressed in restricted progenitors. 
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proliferate extensively and only a small, definable subset of cells was consistently 
clonogenic. 
In both cases, some of the cancer cell heterogeneity would arise a result of environmental 
differences within the tumor and continuing mutagenesis. The essential difference between 
these possibilities is the prediction, according to the second possibility that whatever the 
environment or mutational status of the cells, only a small phenotipically distinct subset of 
cancer cells has the ability to proliferate extensively or form a new tumor. 
The cancer stem theory postulate that only some tumor cells, cancer stem cells, are 
tumorigenic. When they divide, these malignant cells self-renew, and also give rise to the 
non-self-renewing cells that go on to elaborate the heterogeneous cells within a cancer. In 
this sense, CSC´s both drive tumor growth, and also initiate the execution of a 
developmental program. Cancer stem cells thus utilize pre-existing developmental 
hierarchies, and give rise to some of the cellular heterogeneity seen in such tumors. 
After proposal of cancer stem theory, the term “cancer stem cell” is an operative definition 
that does not necessarily connote a developmental relationship to normal stem cells; instead, 
it merely states that a subset of cells within a tumor can self-renew and elaborate tumor 
heterogeneity. Recently, the definition depends on the assay of self-renewal and 
tumorigenicity. Also, the cancer stem cell theory does not imply what percentage of cells 
within a tumor are cancer stem cells. Some very aggressive tumors may have a high 
percentage of CSC´s (Kelly et al., 2007, Kennedy et al., 2007), and chemotherapeutic 
treatments may increase the frequency of CSC´s in a tumor (Dylla et al., 2008); however 
neither of these observations affects the operative definition. Is important to mention that 
stochastic model and the cancer stem are not mutually exclusive. Since they are malignant 
cells, CSC´s likely exhibit genomic instability, and have a mutator phenotype (Hannahan & 
Weinberg, 2000). Thus, as they divide and give rise to both tumorigenic and non-
tumorigenic progeny subclones of CSC´s may develop. 
2.4 Proposal of cancer stem cell model integration into the stochastic model 
It is believed that the initiation step is caused by a mutation or any other irreversible event, 
in which the single normal cell acquire an advantage proliferation capacity and/or to avoid 
apoptosis. Given the natural characteristics of stem cells, the initiation process could be 
more easily carry out if the cell has per se the capacity of self-renewal, then to complete the 
step, only the deregulation of these mechanisms would be needed, a good example of this is 
the aberrant activation of the Wnt signaling pathway in many cancer types and especially 
those of the gastrointestinal tract. Indeed, Wnt signaling activity was shown to designate 
colon CSCs (de Sousa et al., 2011).  
On the other side, promoting conditions can be wound healing, surgery, cell death, 
inflammatory agents, growth factor hormones, and mutagenic or non-mutagenic chemicals 
that stimulate proliferation, then, the initiated cell must be clonally expanded, process which 
also can be facilitated by self-renewal and great proliferation properties of stem cells. It is 
important to highlight that in most of the tumors it has been seen blocked differentiation, so 
the initiated cell would not terminally differentiate and neither die by apoptosis (Piscaglia et 
al., 2007). Indeed, if we begin the transformation with a stem cell rather than with a 
differentiated cell, the block of differentiation process would be easier that reprogramming 
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or “dedifferentiation, consequently, in promotion step the adult stem cells inhibits its ability 
to complete differentiation under normal conditions and the symmetric division is 
preferred, meanwhile any other normal stem cell would divide preferentially in the 
asymmetric way to favor differentiation, and could die by apoptosis or suffer senescence if 
any damage is not resolved (Reviewed in Trosko, 2009)(Figure 2). 
 
Fig. 2. Integration of the Cancer Stem Cell model into the stochastic model of carcinogenesis.  
The stochastic model of carcinogenesis process consists of 3 principal steps. The first one is 
the initiation process, which had to irreversibly convert a normal somatic differentiated cell 
to a premalignant state. The second step is the promotion stage, where the single initiated 
cell is clonally expanded by a mitogenic process, and is unable to die, even if the 
microenvironmental conditions favorite apoptosis. The last step, the progression, has 
traditionally seen as the process when the tumor completes its malignant transformation 
and become metastatic. Cancer stem cells may be caused by transforming mutations and/or 
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epigenetic events, to gain the self-renewal activity and lose some features of differentiation 
occurring in multi-potential stem cells, or progenitor cells. This model has been functionally 
supported by the observation that among all cancer cells within a particular tumor, only a 
minute cell fraction has the exclusive potential to regenerate the entire tumor cell 
population. Many groups have extrapolated the cancer stem cell model from the 
hematopoietic system to solid cancers, using in vitro culture techniques and in vivo 
transplant models; they have established evidence of cancer stem cells in colon, spleen, 
prostate, brain and breast cancers. 
Finally, when the expanded initiated cells accrue sufficient alterations to become growth 
stimulus independent, and resistant to growth inhibitors and apoptosis, to have unlimited 
replicative potential and invasive and metastatic phenotypes, then the progression phase 
has been achieved (Trosko et al., 2004). About stem cells, some of these have per se the 
properties unlimited replicative potential, as wells as the homing capacity, passing 
inadvertently all over the organism, and also plasticity, to change their phenotype (Figure 
2). Given is well known these processes also, enable metastasis, a program involved in 
various steps of embryonic morphogenesis and wound healing called ‘‘epithelial-
mesenchymal transition’’ (EMT), has been recently implicated in metastases. Cells which 
suffer EMT acquire stem cells phenotype and the abilities to invade, to resist apoptosis, and 
to disseminate. 
2.5 Evidences that not all cancer cells are tumorigenic 
Under the CSC´s model, only a subset of cells is capable to self-renew and generate at least 
part of a tumor´s developmental heterogeneity, other malignant cells within the tumor 
should be non-tumorigenic. A number of independent observations, both in the clinic and 
basic research level needs to take in account to be clear that tumor are heterogeneous cell 
populations.  
The most startling experiments in cancer biology are of Southam and Brunschwig in 1966. 
At that time, physicians had realized that malignant cells could be found circulating in the 
blood or lymphatic of cancer patients, but only small percentage of these seemed to give rise 
to metastatic tumors. Southam and Brunschwig sought to test this observation directly by 
harvesting tumor cells of patients with various disseminated or unresectable cancer, 
dissociating tumor fragments into single cell suspensions, and then subcutaneously 
autotransplanting varying number of cells to roughly determine how many tumor cells 
were needed to generate a new tumor (Southam et al., 1966). In spite of the deep ethical and 
methodological flaws, this study did suggest that, using their methods, only a subset of cells 
within a tumor is tumorigenic. Similar findings have being documented in different cancer 
patients, patients with malignant ascites, breast cancer (Braun et al., 2005, Riethdorf et al., 
2008), and liver cancer. In the case of cancer patients with malignant ascites who have 
implantation of peritoneo as procedure which help alleviate abdominal distention, but also 
has the unavoidable effect of shunting huge number of tumor cells into systemic circulation, 
disseminated cancer is a rare event (Campioni et al., 1986, Tarin et al., 1984). A related 
clinical example is the recognition that viable breast cancer cells have been found in the 
bone marrow of a large percentage of patients. Although in many patients the presence of 
these cells correlates with an increased probability of overt metastasis and a worse overall 
prognosis, the vast majority of these cells either remain dormant for years or are simply not 
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tumorigenic (Braun et al., 2005; Riethdorf et al., 2008). Another supportive example is the 
observation that percutaneous biopsy of breast and liver tumors frequently leads to the 
disruption of the tumor and the deposition of thousands of malignant cells along the biopsy 
track, yet even with large bore needles, the rate of tumor seeding of the biopsy track is 
relatively low (Ryd et al., 1993; Eriksson etal., 1984; Smith, 1984; Diaz et al., 1999). Several 
possibilities could explain this discrepancy, including the idea that only a fraction of the 
tumor cells are tumorigenic. 
Along these lines, in many different animal models of cancer (both with hematologic 
malignancies and solid tumors) a large number of tumor cells must be transplanted into a 
recipient animal in order to generate a tumor. Similarly, only a minority of tumors cells is 
able to proliferate in vitro and generate colonies (Hamburger & Salmon, 1977a; Hill and 
Milas, 1989; Cho et al., 2008). 
2.6 Return of some tumorigenic cells to nonmalignant cells 
The Cancer Stem Cells theory implies that tumor heterogeneity is, at least in part, due to the 
execution of a developmental program in the progeny of cancer stem cells. As defined, 
cancer stem cells should be immature, multipotent, and able to give raises both tumorigenic 
and non-tumorigenic cells. This has been shown in the case of mouse teratocarcinoma, a 
malignant germ cell tumor that can give rise to differentiated cell types of all three germ 
layers. When this tumor develops, it will metastasize and kill the host within a matter of 
weeks. Single cells, when injected subcutaneously into recipient mice, cause tumor to form. 
However, when single genetically-marked teratocarcinoma cells are isolated and injected 
into a normal mouse blastocyst, the progeny of the teratocarcinoma cells contribute 
functioning terminally-differentiated post-mitotic cells to multiple different tissues without 
inducing more tumors (Mintz & Illmensee, 1975). Importantly, among cancer, 
teratocarcinomas are not unique in their ability to execute a program of differentiation. 
Experiments with a transplantable squamous cell cancer in rats showed that tumor growth 
is driven mainly by immature, proliferating cells that subsequently develop into 
differentiated cells that, when transplanted, lose their tumorigenicity (Pierce & Wallace, 
1971). Also, supportive data in humans comes from the genetic analysis of leukemic clone 
can also be seen in mature, well-differentiated cells of various lineages. This suggests that 
the cancer is driven by immature hematopoietic cells that retain the capability of generating 
mature, noncancerous progeny (Fialkow, 1972; Fialkow et al., 1977). 
3. Pathways involved in stem cell deregulation 
Cell signaling involved in cancer had been extensively studied in the last decades; several 
pathways had been involved in this process. Many of the molecular mechanisms underlying 
tumorigenesis in cancer and self renewal in stem cells have been elucidated in the past 
decade, but with the introduction of the cancer stem cell theory, the carcinogenesis field 
began to change the form to look at the pathways involved in this process.  
A subtle change in the conceptualization of the illness had been developed in the last years, 
from our first cancer definition as a cell proliferation problem to an acquirement of stem-like 
phenotype passing through a dead incapacity problem, the form to deal with this process 
had been change enormously. Cancer cells have the ability to divide indefinitely and spread 
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epigenetic events, to gain the self-renewal activity and lose some features of differentiation 
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tumorigenic (Braun et al., 2005; Riethdorf et al., 2008). Another supportive example is the 
observation that percutaneous biopsy of breast and liver tumors frequently leads to the 
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malignancies and solid tumors) a large number of tumor cells must be transplanted into a 
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able to proliferate in vitro and generate colonies (Hamburger & Salmon, 1977a; Hill and 
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2.6 Return of some tumorigenic cells to nonmalignant cells 
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and non-tumorigenic cells. This has been shown in the case of mouse teratocarcinoma, a 
malignant germ cell tumor that can give rise to differentiated cell types of all three germ 
layers. When this tumor develops, it will metastasize and kill the host within a matter of 
weeks. Single cells, when injected subcutaneously into recipient mice, cause tumor to form. 
However, when single genetically-marked teratocarcinoma cells are isolated and injected 
into a normal mouse blastocyst, the progeny of the teratocarcinoma cells contribute 
functioning terminally-differentiated post-mitotic cells to multiple different tissues without 
inducing more tumors (Mintz & Illmensee, 1975). Importantly, among cancer, 
teratocarcinomas are not unique in their ability to execute a program of differentiation. 
Experiments with a transplantable squamous cell cancer in rats showed that tumor growth 
is driven mainly by immature, proliferating cells that subsequently develop into 
differentiated cells that, when transplanted, lose their tumorigenicity (Pierce & Wallace, 
1971). Also, supportive data in humans comes from the genetic analysis of leukemic clone 
can also be seen in mature, well-differentiated cells of various lineages. This suggests that 
the cancer is driven by immature hematopoietic cells that retain the capability of generating 
mature, noncancerous progeny (Fialkow, 1972; Fialkow et al., 1977). 
3. Pathways involved in stem cell deregulation 
Cell signaling involved in cancer had been extensively studied in the last decades; several 
pathways had been involved in this process. Many of the molecular mechanisms underlying 
tumorigenesis in cancer and self renewal in stem cells have been elucidated in the past 
decade, but with the introduction of the cancer stem cell theory, the carcinogenesis field 
began to change the form to look at the pathways involved in this process.  
A subtle change in the conceptualization of the illness had been developed in the last years, 
from our first cancer definition as a cell proliferation problem to an acquirement of stem-like 
phenotype passing through a dead incapacity problem, the form to deal with this process 
had been change enormously. Cancer cells have the ability to divide indefinitely and spread 
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to different parts of the body during metastasis. At the other hand embryonic stem cells can 
self renew and, through differentiation to somatic cells, provide the building blocks of the 
human body (Dressen & Brinvanlou, 2007). Then it is possible to hypothesizer that certain 
highly conserved genes may contain evolutionary-conserved self-renewal machinery, and 
this machinery (at least in part), must be present in both normal and cancer stem cells. Day 
by day, the study of stemnes genes take relevance in the understanding the circuitry of 
cancer cells. 
Among of the pathways that have been involved in the stemnes phenotype, seven of them 
seem to be constantly present: cascades of signaling involve Signal Transducers and 
Activators of Transcription (STAT), Fibroblast Growth Factor (FGF), Tumor Growth Factor 
(TGF), WNT, Phosphatidylinositol 3-kinase PI3K/AKT, Notch and Hedgehog signaling 
pathways. Furthermore, the stemnes phenotype is the result of a very well orchestrated and 
unique gene expression pattern characterized by the activation of some genes and the 
repression of others. Then, elucidation of the stemnes phenotype is based primarily on the 
identification of the transcription factors involved in regulating gene expression of the 
stemnes state (Cavaleri & Schöler, 2009). Among them Oct-4, Sox2, Nanog, NF-kB and 
recently miRNAs has been involved in this process, for that, in the present section we will 
discuss their role in carcinogenesis. 
3.1 Jak/STAT signaling 
Cells can communicate with each other through the secretion of cytokines. After binding 
their receptors, receptor-associated Janus Kinases (JAKS), as well as interacting Signal 
Transducers and Activators of Transcription (STATs) through tyrosine phosphorylation 
form homodimers, shuttle to the nucleus and participate in transcriptional regulation of a 
variety of genes (Darnell, 2002, 2005). STATs are also activated in response to growth 
promoting factors such as Epidermal Growth Factor (EGF) or Platelet-Derived Growth 
Factor (PDGF). Identification of STAT3 as a determinant of ES renewal came from Smith´s 
and Yokota´s laboratories at the end of 90’s, where demonstrated that STAT3 docking sites 
are essential in mediating transmission of the signal in self-renewing ES cells. Thus, the 
JAK/STAT pathway plays an important role in mediating cell fates, such as apoptosis, 
differentiation and proliferation, in response to growth promoting factors and cytokines 
(Matsuda et al., 1999; Smith, 2001). 
Deregulated JAK/STAT signaling can contribute directly and indirectly to tumorigenesis. 
Mutations, fusions, and/or amplification of JAK/STAT signaling components, such as the 
HER2/neu- in mammary and stomach carcinomas, or Epidermal Growth Factor-Receptor 
(EGF-R) in breast, brain and stomach tumors, can confer hypersensitivity to mitogenic 
signals and promote proliferation (Slamon, et al., 1987; Yarden, & Ullrich, 1988).  
Additionally, STAT3 is constitutively activated in several major human carcinomas. Also, 
STAT3 is persistently active in over 50% of lung and breast tumors and more than 95% of 
head and neck cancers (Darnell, 2005). 
3.2 FGF signaling 
Twenty-two FGF family orthologs are conserved among mammalian genomes. FGF 
dimmers bind to FGF receptors with extracellular immunoglobulin-like domain and 
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cytoplasmic tyrosine kinase domain. FGF signals are transduced through FGF receptors to 
activated PKC signaling cascade and the Ca2+- mediated NFAT signaling cascade. FGF signals 
are also transduced through FGF receptors and FRS2/FSR3-SHP2-GRB2 docking protein to 
the SOS-RAS-RAF-MEK-ERK signaling cascade and GAB1/GAB2-PI3K-PKD-AKT signaling 
cascade. The RAS-ERK had been implicated in cell growth, differentiation and cancer, while 
PI3K-AKT signaling cascade in the cell survival, cell fate determination and also in cancer. 
3.3 TGF signaling 
The TGF superfamily includes nearly 30 proteins in mammals, e.g. TGF, activins, nodal 
GDF, and BMPs. Smad 1/5/8 transduce signals from Bmps, and GDFs ligands, whereas 
Smad 2/3 transduce signals from TGF, activins and nodal. Upon activation by 
phosphorylation and association with a common Smad4, the receptor-activated Smads 
translocate to the nucleus to regulate gene expression in concert with other transcription 
factors (Cavaleri and Schöler, 2009). It has long been appreciated that the TGF-β pathway 
plays a crucial role during embryonic development. Several lines of evidence suggest that 
TGF-β signaling is also involved in sustaining the undifferentiated state in hESC. Activin / 
Nodal branch of TGF-β signaling is necessary to sustain pluripotency. In contrast the BMP 
branch of TGF-β signaling appears to play the opposite role (Dressen & Brivanlou, 2007). In 
conclusion, extensive studies established the TGF-β signaling pathway as a major regulator 
during embryonic development. Mutations or downregulation of TGF-β receptors, 
inactivation of SMAD4 or p15INK4B can be found in a variety of cancers. BMP2 is 
dramatically overexpressed in 98% of lung carcinomas (Langenfeld et al., 2003; Langenfeld 
et al., 2006). TGF-β signaling can also enhance malignancy of epithelial tumors by 
stimulating metastasis (Hartwell et al., 2006; Yang et al., 2004; Zavadil & Bottinger, 2005). 
3.4 WNT signaling 
WNT/- catenin pathway, is associated with many kind of cancers, secreted Wnt ligands 
bind to frizzled receptors and activate a cascade important in development. WNT signaling 
increases the expression of HoxB4 and Notch-1 genes. Both of these proteins are implicated 
in the specification and /or self-renewal of HSCs (Reya et al., 2003). In addition, the Wnt/-
catenin pathway is involved in the maintenance of the normal epithelial cells and in 
regenerative responses during tissue repair (Reguart et al., 2005). 
Wnt signaling has been implicated in blood diseases and colon carcinoma. Activating 
mutations of -catenin or inactivating mutations of the adenomatosis polyposis coli (APC) 
gene, which targets -catenin for degradation, occur in a large percentage of colon cancers 
(Kolligs et al., 1999). In CML, -catenin accumulates in granulocyte-macrophage progenitor 
cells when CML progresses to blast crisis (Jamieson et al., 2004). -catenin accumulation has 
also been associated with breast cancer, melanoma, sarcoma, myeloid leukemia, multiple 
myeloma, brain tumors and in the other hand, mutations in -catenin are also observed in 
endometrial, prostate and hepatocellular carcinomas (Reguart et al, 2005). 
3.5 PI3K/AKT signaling  
Phosphatidylinositol 3-kinase/AKT (PI3K/AKT) pathway responds to a variety signals, like 
hormonal receptors, transmembrane tyrosine kinase-linked receptors (RTK) and 
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cytoplasmic tyrosine kinase domain. FGF signals are transduced through FGF receptors to 
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the SOS-RAS-RAF-MEK-ERK signaling cascade and GAB1/GAB2-PI3K-PKD-AKT signaling 
cascade. The RAS-ERK had been implicated in cell growth, differentiation and cancer, while 
PI3K-AKT signaling cascade in the cell survival, cell fate determination and also in cancer. 
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The TGF superfamily includes nearly 30 proteins in mammals, e.g. TGF, activins, nodal 
GDF, and BMPs. Smad 1/5/8 transduce signals from Bmps, and GDFs ligands, whereas 
Smad 2/3 transduce signals from TGF, activins and nodal. Upon activation by 
phosphorylation and association with a common Smad4, the receptor-activated Smads 
translocate to the nucleus to regulate gene expression in concert with other transcription 
factors (Cavaleri and Schöler, 2009). It has long been appreciated that the TGF-β pathway 
plays a crucial role during embryonic development. Several lines of evidence suggest that 
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Nodal branch of TGF-β signaling is necessary to sustain pluripotency. In contrast the BMP 
branch of TGF-β signaling appears to play the opposite role (Dressen & Brivanlou, 2007). In 
conclusion, extensive studies established the TGF-β signaling pathway as a major regulator 
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inactivation of SMAD4 or p15INK4B can be found in a variety of cancers. BMP2 is 
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WNT/- catenin pathway, is associated with many kind of cancers, secreted Wnt ligands 
bind to frizzled receptors and activate a cascade important in development. WNT signaling 
increases the expression of HoxB4 and Notch-1 genes. Both of these proteins are implicated 
in the specification and /or self-renewal of HSCs (Reya et al., 2003). In addition, the Wnt/-
catenin pathway is involved in the maintenance of the normal epithelial cells and in 
regenerative responses during tissue repair (Reguart et al., 2005). 
Wnt signaling has been implicated in blood diseases and colon carcinoma. Activating 
mutations of -catenin or inactivating mutations of the adenomatosis polyposis coli (APC) 
gene, which targets -catenin for degradation, occur in a large percentage of colon cancers 
(Kolligs et al., 1999). In CML, -catenin accumulates in granulocyte-macrophage progenitor 
cells when CML progresses to blast crisis (Jamieson et al., 2004). -catenin accumulation has 
also been associated with breast cancer, melanoma, sarcoma, myeloid leukemia, multiple 
myeloma, brain tumors and in the other hand, mutations in -catenin are also observed in 
endometrial, prostate and hepatocellular carcinomas (Reguart et al, 2005). 
3.5 PI3K/AKT signaling  
Phosphatidylinositol 3-kinase/AKT (PI3K/AKT) pathway responds to a variety signals, like 
hormonal receptors, transmembrane tyrosine kinase-linked receptors (RTK) and 
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intracellular factors and has been implicated in the regulation of several processes such as 
cellular proliferation, cell death and cytoskeletal rearrangements (Hennessy et al., 2005). 
Activation of PI3K occurs through interaction with various activating proteins such as 
protein kinase C (PKC), RHO, RAC, mutated RAS, SRC and leads to activation of 
phosphatidylinositol-3,4,5-biphosphate (PIP3). PI3K/AKT signaling is counteracted by 
PTEN (and SHIP1, SHIP2), which dephosphorylates PIP3. In the other hand AKT protein 
kinase interacts with Phophoinositide Kinase 1 (PDK1), and regulates directly or indirectly a 
number of downstream targets, such as NF-κB, BAD, pro-caspase 9, MDM2, p53 and GSK3. 
Deregulated PI3K/AKT signaling has been observed in various cancers. Mutations in the 
PI3K/AKT pathway inhibitor and tumor suppressor PTEN has been found in glioblastomas, 
lung carcinomas and melanomas whereas AKT overexpression or overactivation has been 
found in breast, ovarian, thyroid and a variety of other cancers (Vivanco & Sawyers, 2002). 
3.6 Notch signaling pathway 
DLL and Jag families are transmembrane-type ligands for the Notch family receptors 
(Radtke & Raj, 2003). Ligand binding induces the cleavage of the Notch family members by 
metalloprotease and secretase to release Notch intracellular domain (NICD) for the 
interaction with CSL or NF-kB transcription factors. 
Notch signals are transduced to the canonical CSL-NICD signaling cascade and the non-
canonical NICD-NF-kB signaling cascade. HES1, HES5, HEY1 and 2 and HEYL genes, 
encoding transcriptional repressor with bHLH and orange domains, are target genes of the 
canonical Notch signaling cascade. The notch signaling activation have been implicated in 
gastric cancer resulting in the maintenance of stem or progenitor cells through the inhibition 
of epithelial differentiation (Katoh, 2007). 
3.7 Hedgehog signaling pathway  
Sonic hedgehog (SSh), Indian hedgehog (IHh) and Desert hedgehog (DHh) are members of 
the hedgehog (Hh) family of secreted signaling proteins having diverse function during 
vertebrate development. Hh signaling also functions postembryonically in tissue 
homeostasis through effects on stem or progenitors cells. Inappropriate activity of the Hh 
pathway have been linked in pancreatic, skin, brain and gastric cancer and  tumor types that 
arise sporadically  or in genetically  predisposed individuals. SHh signaling is launched by 
binding with the transmembrane protein Patched (PTCH) resulting in the loss of the PTCH 
activity and consequent phosphorylation and post-transcriptional stabilization of 
smoothened (SMO) protein. Pathway activation via SMO thus can occur either by Hh 
protein stimulation or through loss of PTCH activity (Ruiz et al., 2002; Tang et al., 2011).  
3.8 Regulation factors involved in cancer stem cells gene expression 
3.8.1 Oct-4 
The Oct3/4 gene, a POU family transcription factor Oct3/4 or Oct4, (also referred to as 
Pou5f1), was first found in ovulated oocytes, mouse pre-implantation embryos, ectoderm of 
the gastrula (but not in other germ layers) and primordial germ cells, as well as in 
embryonic stem cells but not in their differentiated daughters (Rosner et al., 1990). 
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Nowadays is well known that Oct-4 is also expressed in Adult Stem Cells, where it normally 
start the terminal differentiation process and when Oct4 gene activity is down-regulated, 
differentiation of both stem cells and embryonal carcinoma cells occurred (Tai et al., 2004). 
In addition, it has been shown, that the success or failure of cloning depends on expression 
of this gene, during reprogramming of the genome of a nucleus transferred to an enucleated 
oocyte (Boiani et al., 2002). Seemingly in contrast, the Oct4 gene has also been shown to be 
expressed in some human tumor cells but not in normal somatic tissues. 
Also, Oct-4 provides adult stem cells the property to sell-renew and proliferate, so when 
differentiation process takes place the Oct-4 expression is lost. In Tai´s work (2004), when 
the human breast epithelial, spleen and liver stem cells were induced to differentiate, Oct4 
expression markedly diminished, but when a stem cell is initiated by up-regulation of Oct-4, 
the cell is able to differentiate and maintain the transcription factor expression and 
consequently the ability to self-renew occurred. Using antibodies and PCR primers against 
Oct-4, the group of Trosko, tested human breast, liver, spleen, kidney, mesenchyme and 
gastric stem cells, as wells as, the cancer cell lines HeLa and MCF-7 and human, dog and rat 
tumors for evidencing the Oct4 expression. They found that adult human stem cells, 
immortalized non-tumorigenic cells and all tumor cells tested express Oct-4, but not the 
differentiated cells (Tai et al., 2005). In addition, with these results, they conclude that adult 
cells expressing the Oct4 gene could be the target cells for initiation of the carcinogenic 
process, because they were able to isolate non-tumorigenic, but immortalized clones that 
exhibited phenotypic markers similar to the original stem cell and, after X-ray irradiation, 
they could also isolate weakly tumorigenic clones which could be rendered highly 
tumorigenic after transfection with the c-erb B-2/neu oncogene. 
3.8.2 Sox2 
Sox2 belongs to the Sry-related HMG box-containing family of proteins that binds to the 
minor groove of –DNA through the 79 amino-acid HMG domain. Sox2 is a major stemness 
factor. Indeed, it is a critical transcription regulator of the normal stem cell phenotype of 
ESCs, with a restricted number of partners, including Oct-4 and Nanog. It controls self-
renewal and differentiation processes through coordinated transcriptional programs. As 
forced Oct4 expression induces pluripotency in Sox2-null cells, a group of researchers 
concluded that the primary role of Sox2 in induced pluripotent stem cells is controlling Oct4 
expression, and they perpetuate their own expression when expressed concurrently. More 
recent studies indicated that Sox2 exits in the nuclei of ES cells and acts as a transcriptional 
factor to maintain the unique characters such as clonogenicity, pluripotency, and self-
renewal of them (Masui et al., 2007).  
A number of links were recently found between Sox2 and cancer; it has been intensively 
investigated and was found to contribute to the establishment of lung, prostate and spleen 
cancer (Saigusa et al., 2009, Sanada et al., 2006, Rodriguez-Pinilla et al., 2007).  
3.8.3 Nanog 
In 2003 Chambers and Mitsui reported the identification of Nanog as a new member of the 
embryonic stem cell stage. Nanog is a gene expressed in ESCs and is a key factor in 
maintaining pluripotency. Nanog is thought to function in concert with other factors such as 
pou5f1 and Sox2 to establish ESC identity. Oct4 and Sox32 control Nanog transcription by 
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intracellular factors and has been implicated in the regulation of several processes such as 
cellular proliferation, cell death and cytoskeletal rearrangements (Hennessy et al., 2005). 
Activation of PI3K occurs through interaction with various activating proteins such as 
protein kinase C (PKC), RHO, RAC, mutated RAS, SRC and leads to activation of 
phosphatidylinositol-3,4,5-biphosphate (PIP3). PI3K/AKT signaling is counteracted by 
PTEN (and SHIP1, SHIP2), which dephosphorylates PIP3. In the other hand AKT protein 
kinase interacts with Phophoinositide Kinase 1 (PDK1), and regulates directly or indirectly a 
number of downstream targets, such as NF-κB, BAD, pro-caspase 9, MDM2, p53 and GSK3. 
Deregulated PI3K/AKT signaling has been observed in various cancers. Mutations in the 
PI3K/AKT pathway inhibitor and tumor suppressor PTEN has been found in glioblastomas, 
lung carcinomas and melanomas whereas AKT overexpression or overactivation has been 
found in breast, ovarian, thyroid and a variety of other cancers (Vivanco & Sawyers, 2002). 
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DLL and Jag families are transmembrane-type ligands for the Notch family receptors 
(Radtke & Raj, 2003). Ligand binding induces the cleavage of the Notch family members by 
metalloprotease and secretase to release Notch intracellular domain (NICD) for the 
interaction with CSL or NF-kB transcription factors. 
Notch signals are transduced to the canonical CSL-NICD signaling cascade and the non-
canonical NICD-NF-kB signaling cascade. HES1, HES5, HEY1 and 2 and HEYL genes, 
encoding transcriptional repressor with bHLH and orange domains, are target genes of the 
canonical Notch signaling cascade. The notch signaling activation have been implicated in 
gastric cancer resulting in the maintenance of stem or progenitor cells through the inhibition 
of epithelial differentiation (Katoh, 2007). 
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Sonic hedgehog (SSh), Indian hedgehog (IHh) and Desert hedgehog (DHh) are members of 
the hedgehog (Hh) family of secreted signaling proteins having diverse function during 
vertebrate development. Hh signaling also functions postembryonically in tissue 
homeostasis through effects on stem or progenitors cells. Inappropriate activity of the Hh 
pathway have been linked in pancreatic, skin, brain and gastric cancer and  tumor types that 
arise sporadically  or in genetically  predisposed individuals. SHh signaling is launched by 
binding with the transmembrane protein Patched (PTCH) resulting in the loss of the PTCH 
activity and consequent phosphorylation and post-transcriptional stabilization of 
smoothened (SMO) protein. Pathway activation via SMO thus can occur either by Hh 
protein stimulation or through loss of PTCH activity (Ruiz et al., 2002; Tang et al., 2011).  
3.8 Regulation factors involved in cancer stem cells gene expression 
3.8.1 Oct-4 
The Oct3/4 gene, a POU family transcription factor Oct3/4 or Oct4, (also referred to as 
Pou5f1), was first found in ovulated oocytes, mouse pre-implantation embryos, ectoderm of 
the gastrula (but not in other germ layers) and primordial germ cells, as well as in 
embryonic stem cells but not in their differentiated daughters (Rosner et al., 1990). 
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Nowadays is well known that Oct-4 is also expressed in Adult Stem Cells, where it normally 
start the terminal differentiation process and when Oct4 gene activity is down-regulated, 
differentiation of both stem cells and embryonal carcinoma cells occurred (Tai et al., 2004). 
In addition, it has been shown, that the success or failure of cloning depends on expression 
of this gene, during reprogramming of the genome of a nucleus transferred to an enucleated 
oocyte (Boiani et al., 2002). Seemingly in contrast, the Oct4 gene has also been shown to be 
expressed in some human tumor cells but not in normal somatic tissues. 
Also, Oct-4 provides adult stem cells the property to sell-renew and proliferate, so when 
differentiation process takes place the Oct-4 expression is lost. In Tai´s work (2004), when 
the human breast epithelial, spleen and liver stem cells were induced to differentiate, Oct4 
expression markedly diminished, but when a stem cell is initiated by up-regulation of Oct-4, 
the cell is able to differentiate and maintain the transcription factor expression and 
consequently the ability to self-renew occurred. Using antibodies and PCR primers against 
Oct-4, the group of Trosko, tested human breast, liver, spleen, kidney, mesenchyme and 
gastric stem cells, as wells as, the cancer cell lines HeLa and MCF-7 and human, dog and rat 
tumors for evidencing the Oct4 expression. They found that adult human stem cells, 
immortalized non-tumorigenic cells and all tumor cells tested express Oct-4, but not the 
differentiated cells (Tai et al., 2005). In addition, with these results, they conclude that adult 
cells expressing the Oct4 gene could be the target cells for initiation of the carcinogenic 
process, because they were able to isolate non-tumorigenic, but immortalized clones that 
exhibited phenotypic markers similar to the original stem cell and, after X-ray irradiation, 
they could also isolate weakly tumorigenic clones which could be rendered highly 
tumorigenic after transfection with the c-erb B-2/neu oncogene. 
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Sox2 belongs to the Sry-related HMG box-containing family of proteins that binds to the 
minor groove of –DNA through the 79 amino-acid HMG domain. Sox2 is a major stemness 
factor. Indeed, it is a critical transcription regulator of the normal stem cell phenotype of 
ESCs, with a restricted number of partners, including Oct-4 and Nanog. It controls self-
renewal and differentiation processes through coordinated transcriptional programs. As 
forced Oct4 expression induces pluripotency in Sox2-null cells, a group of researchers 
concluded that the primary role of Sox2 in induced pluripotent stem cells is controlling Oct4 
expression, and they perpetuate their own expression when expressed concurrently. More 
recent studies indicated that Sox2 exits in the nuclei of ES cells and acts as a transcriptional 
factor to maintain the unique characters such as clonogenicity, pluripotency, and self-
renewal of them (Masui et al., 2007).  
A number of links were recently found between Sox2 and cancer; it has been intensively 
investigated and was found to contribute to the establishment of lung, prostate and spleen 
cancer (Saigusa et al., 2009, Sanada et al., 2006, Rodriguez-Pinilla et al., 2007).  
3.8.3 Nanog 
In 2003 Chambers and Mitsui reported the identification of Nanog as a new member of the 
embryonic stem cell stage. Nanog is a gene expressed in ESCs and is a key factor in 
maintaining pluripotency. Nanog is thought to function in concert with other factors such as 
pou5f1 and Sox2 to establish ESC identity. Oct4 and Sox32 control Nanog transcription by 
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binding to this element in both mouse and human ES cells. Overexpression of Nanog in 
mouse embryonic stem cells causes them to self-renew in the absence of leukemia inhibitory 
factor. In the absence of Nanog, mouse embryonic stem cells differentiate into 
visceral/parietal endoderm (Chambers et al., 2003, Mitsui et al., 2003). Loss of Nanog 
function causes differentiation of mouse embryonic stem cells into other cell types (Lin et al., 
2005). Gene knockdown of Nanog promotes differentiation, thereby demonstrating a role for 
these factors in human embryonic stem cell self-renewal (Zaehres et al., 2005). 
Somatic cells respond to DNA damage by activating p53, which causes cell cycle arrest or 
apoptosis. ES cells, under high levels of DNA damage, lack the p53 dependent G1 arrest and 
cells undergo apoptosis. However, at low levels of DNA damage, it has been shown that p53 
binds to the promoter of Nanog and suppresses its expression in mouse embryonic stem 
cells. p53 can thus induce differentiation of embryonic stem cells into other cell types which 
undergo efficient p53-dependent cell-cycle arrest and apoptosis (Lin et al., 2005). Nanog 
protein has been implicated in several types of cancer such as: bladder, colorectal, gastric, 
prostate and oral squamous cell carcinoma (Chiou et al., 2008). 
3.8.4 NF-kB  
Nuclear factor of kB (NF-kB) is a transcription factor involved in the inflammatory and 
innate immune responses (Lin & Karin, 2007). The activation of NF-kB occurs as it is 
transported from the cytoplasm to the nucleus upon degradation of the inhibitory subunit. 
In the nucleus, it binds to specific kB sites on the DNA and mediates the expression of 
mostly genes involved in the cellular response to stress (Ghosh & Karin, 2002). The REL 
family proteins of NF-kB form various homo and heterodimers, and their activity is 
regulated by two main pathways. The canonical NF-kB activation applies to dimers that are 
composed of RELA, c-REL, and p50, which are held captive in the cytoplasm by specific 
inhibitors that are known as the inhibitor of kB (IkB) proteins. This pathway is normally 
triggered in response to microbial and viral infections and exposure to proinflammatory 
cytokines and physical and chemical stresses. Cellular stresses such as ionizing radiation 
and chemotherapeutic agents also activate NF-kB (Karin & Ben-Neriah, 2000).  
The first link between NF-κB and cancer was when the subunit p50 was identified as a 
member of the REL family, which is also the family of the famous oncoprotein v-Rel, of the 
REL retrovirus (REV-T) (Gilmore et al., 2004). Activation of NF-kB is a tightly regulated 
event, in tumor cells, different types of molecular alterations may result in an impaired 
regulation of NF-kB activation. In such cases, NF-kB becomes constitutively activated, 
which leads to deregulated expression of NF-kB controlled genes. According to Hanahan 
and Weinberg in the hallmarks of cancer NF-kB is able to induce all of cellular alterations 
that become cancer (Hanahan & Weinberg, 2011). 
3.8.5 MiRNA Regulation  
Micro RNAs are small, 19−22 nucleotide (nt) long, non-coding RNAs that inhibit gene 
expression at the posttranscriptional level. The mRNA/miRNA duplex then inhibits 
translation either through a (mRNA 5') cap-dependent mechanism affecting initiation or 
through increased degradation of the mRNA. Given the frequency with which miRNA 
target motifs are conserved within 3'UTRs, it is estimated that 20 to 30% of all human genes 
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are targets of miRNAs, and that for each miRNA hundreds of genes exist that carry 
conserved sequence motifs within the 3'UTR (Peter, 2009). 
miRNAs have been shown to regulate embryonic development (Stefani and Slack, 2008). 
Upregulation of miRNAs is required for various differentiation processes in fact, little is 
known with respect to mechanisms by which miRNA function in controlling the 
developmental potential of ES cells. However, it is still largely unknown how ES cell-specific 
transcription factors and miRNAs work together (Bar et al., 2008; Calabrese et al., 2007; 
Mineno et al., 2006). 
A strong link between miRNA deregulation and human cancer has been established. A 
comparison of miRNA expression in normal and tumor tissues demonstrated global 
changes in miRNA expression in various human malignancies. In addition, mapping of 186 
human miRNA genes has revealed that they are frequently located at fragile sites and other 
cancer associated chromosomal regions. Consequently miRNAs have been demonstrated to 
act either as oncogenes or tumor suppressors (He et al., 2007; Akao et al., 2006; Zhang et al., 
2006; Calin et al., 2004). 
4. Cancer stem cells as a target for chemotherapy: The problem of resistance 
Despite all the new knowledge and advances in treatment, cancer remains one of the most 
common causes of death all over the world. Failure in treatment is the principal cause of the 
mortality, and it could be due to the cancer ability to recur and spread after initial therapies. 
Relapses may be caused in part to the existence of CSCs. Thus, CSCs are regarded as the 
root of cancer origin and recurrence. New therapeutic approaches targeting these malignant 
cells have become the topic of ongoing research. However, the chemoresistant phenotype of 
CSCs makes difficult to increase their sensitivity to anticancer drugs and to decrease the rate 
of cancer recurrence in patients.  
4.1 Mechanisms of resistance to traditional chemotherapy 
The trouble of chemotherapy resistance has been present since 1945, when Gilman and co-
workers introduced chemotherapy into clinical practice at the end of the Second World War. 
They used nitrogen mustard to treat a patient with advanced malignant lymphoma, after an 
initial regression of the disease, a second course of therapy was given, however a lesser 
therapeutic effect was observed and after the third treatment, the tumor no longer 
responded to the agent (Goodman et al., 1946). 
The drug resistance can be due to diverse factors: pharmacokinetics, such as  inadequate 
access of the drug to the tumor, inadequate infusion rate and inadequate route of delivery 
(Garattini, 2007). Another important factor is drug metabolism which can inactivate and 
efflux the drug. The cytochrome P450 enzymes, a multigene family of constitutive and 
inducible haemo-containing oxidative enzymes from the liver, play an important role in the 
metabolism of a diverse range of xenobiotics and are often over expressed in a variety of 
solid tumors, in which they can contribute to drug resistance. The third factor are the 
membrane proteins such as solute carriers channels and ATP-binding cassette (ABC) 
transporters; they can facilitate the drug efflux from the cell, in fact colon and liver cancer 
have an intrinsic drug resistance, due to the function of these type of transporters, which are 
already highly expressed in the healthy tissues (Gottesman et al., 2002, 2006). 
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binding to this element in both mouse and human ES cells. Overexpression of Nanog in 
mouse embryonic stem cells causes them to self-renew in the absence of leukemia inhibitory 
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prostate and oral squamous cell carcinoma (Chiou et al., 2008). 
3.8.4 NF-kB  
Nuclear factor of kB (NF-kB) is a transcription factor involved in the inflammatory and 
innate immune responses (Lin & Karin, 2007). The activation of NF-kB occurs as it is 
transported from the cytoplasm to the nucleus upon degradation of the inhibitory subunit. 
In the nucleus, it binds to specific kB sites on the DNA and mediates the expression of 
mostly genes involved in the cellular response to stress (Ghosh & Karin, 2002). The REL 
family proteins of NF-kB form various homo and heterodimers, and their activity is 
regulated by two main pathways. The canonical NF-kB activation applies to dimers that are 
composed of RELA, c-REL, and p50, which are held captive in the cytoplasm by specific 
inhibitors that are known as the inhibitor of kB (IkB) proteins. This pathway is normally 
triggered in response to microbial and viral infections and exposure to proinflammatory 
cytokines and physical and chemical stresses. Cellular stresses such as ionizing radiation 
and chemotherapeutic agents also activate NF-kB (Karin & Ben-Neriah, 2000).  
The first link between NF-κB and cancer was when the subunit p50 was identified as a 
member of the REL family, which is also the family of the famous oncoprotein v-Rel, of the 
REL retrovirus (REV-T) (Gilmore et al., 2004). Activation of NF-kB is a tightly regulated 
event, in tumor cells, different types of molecular alterations may result in an impaired 
regulation of NF-kB activation. In such cases, NF-kB becomes constitutively activated, 
which leads to deregulated expression of NF-kB controlled genes. According to Hanahan 
and Weinberg in the hallmarks of cancer NF-kB is able to induce all of cellular alterations 
that become cancer (Hanahan & Weinberg, 2011). 
3.8.5 MiRNA Regulation  
Micro RNAs are small, 19−22 nucleotide (nt) long, non-coding RNAs that inhibit gene 
expression at the posttranscriptional level. The mRNA/miRNA duplex then inhibits 
translation either through a (mRNA 5') cap-dependent mechanism affecting initiation or 
through increased degradation of the mRNA. Given the frequency with which miRNA 
target motifs are conserved within 3'UTRs, it is estimated that 20 to 30% of all human genes 
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are targets of miRNAs, and that for each miRNA hundreds of genes exist that carry 
conserved sequence motifs within the 3'UTR (Peter, 2009). 
miRNAs have been shown to regulate embryonic development (Stefani and Slack, 2008). 
Upregulation of miRNAs is required for various differentiation processes in fact, little is 
known with respect to mechanisms by which miRNA function in controlling the 
developmental potential of ES cells. However, it is still largely unknown how ES cell-specific 
transcription factors and miRNAs work together (Bar et al., 2008; Calabrese et al., 2007; 
Mineno et al., 2006). 
A strong link between miRNA deregulation and human cancer has been established. A 
comparison of miRNA expression in normal and tumor tissues demonstrated global 
changes in miRNA expression in various human malignancies. In addition, mapping of 186 
human miRNA genes has revealed that they are frequently located at fragile sites and other 
cancer associated chromosomal regions. Consequently miRNAs have been demonstrated to 
act either as oncogenes or tumor suppressors (He et al., 2007; Akao et al., 2006; Zhang et al., 
2006; Calin et al., 2004). 
4. Cancer stem cells as a target for chemotherapy: The problem of resistance 
Despite all the new knowledge and advances in treatment, cancer remains one of the most 
common causes of death all over the world. Failure in treatment is the principal cause of the 
mortality, and it could be due to the cancer ability to recur and spread after initial therapies. 
Relapses may be caused in part to the existence of CSCs. Thus, CSCs are regarded as the 
root of cancer origin and recurrence. New therapeutic approaches targeting these malignant 
cells have become the topic of ongoing research. However, the chemoresistant phenotype of 
CSCs makes difficult to increase their sensitivity to anticancer drugs and to decrease the rate 
of cancer recurrence in patients.  
4.1 Mechanisms of resistance to traditional chemotherapy 
The trouble of chemotherapy resistance has been present since 1945, when Gilman and co-
workers introduced chemotherapy into clinical practice at the end of the Second World War. 
They used nitrogen mustard to treat a patient with advanced malignant lymphoma, after an 
initial regression of the disease, a second course of therapy was given, however a lesser 
therapeutic effect was observed and after the third treatment, the tumor no longer 
responded to the agent (Goodman et al., 1946). 
The drug resistance can be due to diverse factors: pharmacokinetics, such as  inadequate 
access of the drug to the tumor, inadequate infusion rate and inadequate route of delivery 
(Garattini, 2007). Another important factor is drug metabolism which can inactivate and 
efflux the drug. The cytochrome P450 enzymes, a multigene family of constitutive and 
inducible haemo-containing oxidative enzymes from the liver, play an important role in the 
metabolism of a diverse range of xenobiotics and are often over expressed in a variety of 
solid tumors, in which they can contribute to drug resistance. The third factor are the 
membrane proteins such as solute carriers channels and ATP-binding cassette (ABC) 
transporters; they can facilitate the drug efflux from the cell, in fact colon and liver cancer 
have an intrinsic drug resistance, due to the function of these type of transporters, which are 
already highly expressed in the healthy tissues (Gottesman et al., 2002, 2006). 
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Mutation or over expression of the drug’s target is another mechanism of resistance, for 
example the case of protein BCR-ABL in CML. The chimaeric BCR-ABL protein is a 
constitutively active protein tyrosine kinase with an important role in the regulation of cell 
growth (Melo & Barnes, 2007). Imatinib mesylate (formerly STI571; Gleevec, Novartis, Basel, 
Switzerland) is a potent and highly specific competitive inhibitor of the BCR-ABL tyrosine 
kinase. Initially, it had a high rate of cytogenetic and hematologic responses in patients with 
chronic-phase CML, in whom previous therapy had failed, and actually, its use has 
revolutionized the management and clinical expectations of CML patients. Unfortunately, 
not long after its initial use, resistance to Imatinib was demonstrated in CML patients.  
Approximately 50% of imatinib-resistant CML patients carry a resistance-associated point 
mutation in BCR-ABL, which interferes with imatinib binding, and more than 50 different 
resistance-associated point mutations in BCR-ABL have been seen (Gorre et al., 2001). Also 
BCR-ABL gene amplification or over expression at the mRNA and protein levels has been 
detected in clinical samples (Hochhaus et al., 2002). The BCR–ABL fusion oncogene has also 
been implicated in NF-kB activation, cell survival, and tumorigenesis in human leukemias 
(Reuther et al., 1998). 
As mentioned above, resistance appears not only to traditional chemotherapy but also to 
targeted therapies such as tamoxifen, which targets the estrogen receptor (ER) in breast 
cancer (Ali & Coombes, 2002); Imatinib, which targets the constitutively active kinase BCR-
ABL important role in the regulation of cell growth (Melo & Barnes, 2007) in CML.  
In addition to p53 mutations which inactive the tumor suppressor, p53 pathway can also be 
inactivated in wild-type p53- carrying tumors, via indirect mechanisms such as 
MDM2/MDMX amplification. In fact, most wild-type p53 types of cancer harbor alternative 
genetic alterations such as mutations in APC in colon cancer, BRCA1 and BRCA2 in breast 
cancer, and B-RAF in melanoma (Soussi & Wiman, 2007). 
4.2 The cancer stem cell and drug resistance 
The failure to eradicate cancer may be as fundamental as a misidentification of the target. 
Antitumor treatments designed and selected for broad cytotoxic activity may kill mostly of 
cancer cells and induce regression of the tumor; however according to the CSC model, 
cancer stem cells will re-establish tumor growth and cause relapse from therapy. In other 
words, therapeutic approaches that do not eradicate the CSC compartment are likely to 
achieve little success (Reya et al., 2001). In fact, the whole drug resistance concept has been 
revised incorporating the CSC paradigm, and recognizing of stem cells in different tissues, 
can help to distinguish the degree of damage tolerance and multipotentiality and then 
translate it into differential drug susceptibilities depending on the tissue of origin 
(Donnenberg & Donnenberg, 2005).  
 Current views favor the model that cancer stem cells are innately resistant to chemotherapy 
through their relative quiescence, their enhanced capacity for DNA repair, decreased entry 
into apoptosis, and ABC transporters expression. The inherently slow cycling rate of CSCs 
has been hypothesized to provide them inherent defense against most traditional 
chemotherapeutic regents, which are antiproliferative and most effectively target the fastest 
dividing cancer cells (Graham et al., 2002). On the other side, the problem of resistance can 
be more complex, the expression and activity of ABC transporters is one of the most 
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important markers for stem cells and cancer stem cells, they have high multidrug resistance 
(MDR) pump activity associated with high expression of the ATP-binding cassette family of 
proteins such as ABCB1 (P-glycoprotein) and/or ABCG2 (Breast Cancer Resistance Protein-
1, BCRP1) (Wu & Alman, 2008). 
The well-known, side-population (SP) phenotype is due to the expression of ABCG2 and has 
been detected in both normal and AML hematopoietic stem cells. In fact, expression of 
ABCG2 and Hoechst 33342 effluxes are two of the best markers of these cells, interestingly 
that expression is often turned off during differentiation to progenitor and mature blood 
cells (Kim et al., 2002). Imatinib is both an ABCG2 substrate, and inhibitor, making it 
susceptible to efflux by stem cells that express this transporter (Burguer et al., 2004; 
Houghton et al., 2004).  
Imatinib and Gefitinib are, also, both direct and downstream inactivators of ABCG2 and, 
therefore, serve as candidates to reverse cancer stem cell chemoresistance and potentially 
target cancer stem cells (An & Ongkeko, 2009). Nevertheless, the level of contribution of 
ABC efflux chemoresistance and their inhibition remains controversial in clinical trials 
(Leonard et al., 2003). Unfortunately, there are lots of reasons that make, the ABC 
transporters, an incomplete and dangerous targeted to finish with the chemotherapy 
resistance. The expression of ABCG2 by microvessel endothelium of the brain suggests that 
ABCG2 plays an important role in maintaining the Blood Brain Barrier BBB. Thus, anti-
ABCG2 therapy that successfully eliminates ABCG2+ CSCs may lead to adverse neurotoxic 
effects (Cooray et al., 2002). On the other side, it has been proposed that selective pressure 
imposed by chemotherapy leads to both mutation and secondary genetic changes, including 
MDR upregulation in the bulky tumor (Donnenberg, & Donnenberg, 2005). 
The redundancy of the individual transporters within the MDR phenotype together with 
several other resistance-related proteins expressed in solid tumors (eg, glutathione S-
transferase, metallothionin, O6-alkylguanine-DNA-alkyltransferase, thymidylate synthase, 
dihydrofolate reductase, heat shock proteins), may contribute to the failure when inhibiting 
only the MDR proteins. 
4.3 Novel targets against cancer stem cells 
In a very recent work for characterization of cancer stem cells in CML, it has been 
demonstrated that TKI (tyrosine kinase inhibitors) don't function with CSC of CML. First, 
efflux Hoechst dye, express CD34, lack CD38 and cytokine-non-responsive cells were 
isolated, and then these cells had been shown to regenerate bcr-abl-positive haemopoiesis in 
immunocompromised mice upon transplantation. CML stem cells express very high levels 
of functional wild-type bcr-abl; however, no kinase domain mutations were detected in the 
stem cell population. FTIs (farnesyl transferase inhibitors) have activity against CML. BMS-
214662 was the most effective of these and induced apoptosis of phenotypically and 
functionally defined CML stem cells in vitro, as a single agent and in combination with IM 
or Dasatinib. In association with apoptosis, there was activation of caspase 8 and caspase 3, 
inhibition of the MAPK pathway, IAP-1 (inhibitor of apoptosis protein-1), NF-kB and iNOS 
(inducible nitric oxide synthase) (Jorgensen & Holyoake, 2011). Fumitremorgin C (FTC) is 
derived from the fermentation broth of Aspergillus fumigates and was the first specific 
ABCG2 inhibitor. FTC is a potent inhibitor of ABCG2 and has been shown to reverse 
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translate it into differential drug susceptibilities depending on the tissue of origin 
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through their relative quiescence, their enhanced capacity for DNA repair, decreased entry 
into apoptosis, and ABC transporters expression. The inherently slow cycling rate of CSCs 
has been hypothesized to provide them inherent defense against most traditional 
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important markers for stem cells and cancer stem cells, they have high multidrug resistance 
(MDR) pump activity associated with high expression of the ATP-binding cassette family of 
proteins such as ABCB1 (P-glycoprotein) and/or ABCG2 (Breast Cancer Resistance Protein-
1, BCRP1) (Wu & Alman, 2008). 
The well-known, side-population (SP) phenotype is due to the expression of ABCG2 and has 
been detected in both normal and AML hematopoietic stem cells. In fact, expression of 
ABCG2 and Hoechst 33342 effluxes are two of the best markers of these cells, interestingly 
that expression is often turned off during differentiation to progenitor and mature blood 
cells (Kim et al., 2002). Imatinib is both an ABCG2 substrate, and inhibitor, making it 
susceptible to efflux by stem cells that express this transporter (Burguer et al., 2004; 
Houghton et al., 2004).  
Imatinib and Gefitinib are, also, both direct and downstream inactivators of ABCG2 and, 
therefore, serve as candidates to reverse cancer stem cell chemoresistance and potentially 
target cancer stem cells (An & Ongkeko, 2009). Nevertheless, the level of contribution of 
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(inducible nitric oxide synthase) (Jorgensen & Holyoake, 2011). Fumitremorgin C (FTC) is 
derived from the fermentation broth of Aspergillus fumigates and was the first specific 
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mitoxantrone-resistance in selected cancer cell lines (NeRabindran et al., 1998). Moreover, 
neurotoxicity has precluded the clinical use of FTC. Inhibitors of ABCB1 are already in 
clinical use, some of these compounds also effectively target ABCG2, including Elacridar 
(GF120918) and Tariquidar (XR9576) (Robey et al., 2004, 2007).  
Another field of research in the resistance is directed at the identification of pathways 
known to be involved in the regulation of growth and self-renewal properties of CSCs, such 
as the Wnt, Notch and Hedgehog (Hombach-Klonisch et al., 2008).  
4.4 Role of NF-kB in chemotherapy resistance 
The role of the canonical NF-κB pathway in mammary tumorigenesis was investigated 
using a transgenic (TG) mouse expressing a dominant-negative inhibitor of kappaB 
(IkappaB alpha(SR (S32A/S36A))). TG and control mice were subjected to a chemical 
carcinogenesis protocol. Hyperkeratinized squamous metaplasias, were found in both TG 
and control mice. p65/RelA- and NF-κB DNA-binding activity were detected in mammary 
luminal lesions, but rarely in squamous metaplasias. Analysis of NF-κB family proteins and 
target genes using microarray data from a cohort of human mammary tumors revealed the 
expression of a canonical NF-κB pathway, but not non-canonical pathway proteins in 
HER2+ luminal cancers. HER2+ tumors also showed differential regulation of specific NF-
κB target genes relative to basal and ER+ luminal cancers. Isolation of mammary cell 
populations enriched for stem and progenitor cells by fluorescence-activated cell sorting and 
with the help of an NF-κB-EGFP reporter mouse, demonstrated that luminal progenitors 
contain activated NF-κB whereas the mammary stem cell-enriched population does not. 
Together these data suggest that the canonical NF-κB pathway is active in normal luminal 
progenitor cells before transformation and is required for the formation of mammary 
luminal-type epithelial neoplasias (Pratt et al., 2009). 
As we have reviewed in this study, the NF-κB pathway is a major source of pro-
inflammatory cytokines, which may contribute to cancer chemoresistance. Constitutive NF-
κB activity has been observed in ovarian cancer stem cells (OCSCs). Leizar and coworkers 
used Eriocalyxin B (EriB) for the inhibition of NfκB and induction of cell death. OCSCs and 
mature ovarian cancer cells (mOCCs) were treated with increasing concentrations of EriB, and 
then, cell viability was measured, caspase activity and cytokine levels were quantified. EriB 
decreased the percent of viable cells in all cultures tested with GI(50) of 0.5-1 μm after 48 hrs of 
treatment and induced cell death by inhibition of NF-κB activity, EriB produced decreased 
cytokine levels and activation of caspases, too. Down-regulation of XIAP and sensitizing of 
OCSCs to TNFα and FasL-mediated cell death were others effects of EriB (Leizer et al., 2011). 
In a very recent work, with the fact that Disulfiram is a specific inhibitor of ALDHs and, 
therefore, it may also be an inhibitor of Breast Cancer  Stem Cells (BCSCs), Wang's group 
used Disulfiram (DS)/copper and inhibited BCSCs and enhanced cytotoxicity of paclitaxel 
(PAC) in Breast Cancer (BC) cell lines: MCF7, MDA-MB-231 and T47D. The constitutive NF-
kB activity in BC cell lines was inhibited by DS/Cu. Combination index isobologram 
analysis demonstrated a synergistic effect between DS/Cu and PAC. The increased Bax and 
Bcl2 protein expression ratio indicated that intrinsic apoptotic pathway may be involved in 
DS/Cu-induced apoptosis, and this may be caused by simultaneous induction of ROS and 
inhibition of NF-kB (Yamamoto, et al., 2011). 
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4.5 Novel cytotoxic compounds for CSCs through the inhibition of NF-kB pathway and 
its effectors 
Actually series of compounds have been tested as inhibitors of Cancer Stem Cells growth 
and their potent cytotoxic effects on these cells. Exploring the mechanism of action, most of 
these compounds target the NF-kB pathway or some of the genes regulated by the 
transcription factor.  
 CDF (difluorinated-curcumin), a novel analog of the dietary ingredient of curcumin, was 
examined in combination with 5-fluorouracil and oxaliplatin (5-FU + Ox), the mainstay of 
colon cancer chemotherapeutic, as a treatment for eliminating colon CSCs. Through multiple 
and simply methodologies that include real-time RT-PCR, Western blot, MTT assay, 
caspase-3 activity, colonosphere formation, Hoechst-33342 dye exclusion and NF-κB-ELISA, 
it was observed that CDF together with 5-FU + Ox were more potent than curcumin in 
reducing CD44 and CD166 in chemo-resistant colon cancer cells, accompanied by inhibition 
of growth, induction of apoptosis and disintegration of colonospheres. These changes were 
associated with down-regulation of the membrane transporter ABCG2 and attenuation of 
EGFR, IGF-1R, and NF-κB signaling consistent with inactivation of β-catenin, COX-2, c-Myc 
and Bcl-xL and activation of the pro-apoptotic Bax (Kanwar et al., 2011).  
Emerging evidence suggests that highly treatment-resistant tumor-initiating cells (TICs) 
play a central role in the pathogenesis of pancreatic cancer. Tumor necrosis factor-Related 
Apoptosis-Inducing Ligand (TRAIL) is considered to be a novel anticancer agent; however, 
recent studies have shown that many pancreatic cancer cells are resistant to apoptosis 
induction by TRAIL due to NF-kB signalling. Several chemopreventive agents are able to 
inhibit NF-kB, for example the broccoli compound sulforaphane. This compound prevents 
metastasis in clinical studies. Kallifatidis G and coworkers isolated TICs (CD44(+)/CD24(-), 
CD44(+)/CD24(+) or CD44(+)/CD133(+)) and grew in immunodeficient mice. Specific 
binding of transcriptionally active cRel-containing NF-kB complexes in TICs was observed. 
Sulforaphane prevented NF-kB binding, downregulated apoptosis inhibitors and induced 
apoptosis, together with prevention of clonogenicity. In a xenograft model, sulforaphane 
strongly blocked tumor growth and angiogenesis, while combination with TRAIL had an 
additive effect without cytotoxicity in normal cells (Kallifatidis et al., 2009).  
5. Conclusions 
One of the most important functions in stem cell biology is the regulation of self-renewal. 
Self-renewal is required by stem cells so that they may last a lifetime, and all stem cells must 
self-renew and regulate the balance between self-renewal and differentiation. Many 
pathways that were primarily described in cancer may also regulate normal stem cell 
development. Among them Oct4 and Nanog, are essential regulators of early development 
and ES identity. Disruption of either of these factors causes loss of pluripotency. The HMG-
box transcription factor, Sox2, heterodimerize with Oct4 in ES cells and regulates expression 
of Oct4. Each binds to its own promoter and to the promoter of the other two genes. In ES 
cells Oct4, Sox2 and Nanog act in concert to maintain the pluripotent state. These three 
transcription factors co-occupy promoters of hundreds of genes, activating some genes and 
silencing others, in a coordinated fashion, that together promote ES cell self-renewal, 
however a deregulation of this well orchestrated regulation could generate special 
conditions that favorites the cancer establishment. 
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Then there is a very tiny line that differentiates Stem cells and Cancer Stem Cells. However 
in terms of ill- understanding process our conception of cancer, through the cancer stem 
cells theory, is changing very fast. The acquisition of stemness like phenotype seems to be 
involved in several steps of carcinogenesis, then the knowledge generated behind this 
phenotype could benefits several areas from cell biology to clinical application. Promotion 
of survival and drug resistance, are the most relevant aspects for a clinical treatment 
succeed. Gaining a better insight into the mechanisms of stem cell resistance to 
chemotherapy and the develop of new therapeutic strategies at the molecular level will lead 
to an effective treatment strategy for preventing the emergence of chemo-resistant cancer 
cells by eliminating CSCs.  
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1. Introduction 
Formaldehyde (CH2O), the most simple and reactive aldehyde, is a colorless, reactive and 
readily polymerizing gas at room temperature (National Toxicology Program [NTP], 
2005). It has a pungent suffocating odor that is recognized by most human subjects at 
concentrations below 1 ppm (International Agency for Research on Cancer [IARC], 2006).  
Aleksandr Butlerov synthesized the chemical in 1859, but it was August Wilhelm von 
Hofmann who identified it as the product formed from passing methanol and air over a 
heated platinum spiral in 1867. This method is still the basis for the industrial production of 
formaldehyde today, in which methanol is oxidized using a metal catalyst. By the early 20th 
century, with the explosion of knowledge in chemistry and physics, coupled with demands 
for more innovative synthetic products, the scene was set for the birth of a new material–
plastics (Zhang et al., 2009). 
According to the Report on Carcinogens, formaldehyde ranks 25th in the overall U.S. 
chemical production, with more than 5 million tons produced each year (NTP, 2005). 
Formaldehyde annual production rises up to 21 million tons worldwide and it has increased 
in China with 7.5 million tons produced in 2007. Given its economic importance and 
widespread use, many people are exposed to formaldehyde environmentally and/or 
occupationally (Nazaroff et al., 2006). 
Commercially, formaldehyde is manufactured as an aqueous solution called formalin, 
usually containing 37% by weight of dissolved formaldehyde.  
This chemical is present in all regions of the atmosphere arising from the oxidation of 
biogenic and anthropogenic hydrocarbons (International Programme on Chemical Safety 
[IPCS] 1991; Granby et al., 1997). Formaldehyde concentration levels range typically from 
2 to 45 ppbV (parts per billion in a given volume) in urban settings that are mainly 
governed by primary emissions and secondary formation (Chen et al., 2002; Naya & 
Nakanishi, 2005). 
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chemical production, with more than 5 million tons produced each year (NTP, 2005). 
Formaldehyde annual production rises up to 21 million tons worldwide and it has increased 
in China with 7.5 million tons produced in 2007. Given its economic importance and 
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occupationally (Nazaroff et al., 2006). 
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This chemical is present in all regions of the atmosphere arising from the oxidation of 
biogenic and anthropogenic hydrocarbons (International Programme on Chemical Safety 
[IPCS] 1991; Granby et al., 1997). Formaldehyde concentration levels range typically from 
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Primary formaldehyde is emitted from motor vehicles and fugitive industrial emissions, 
while secondary formaldehyde is produced by the photochemical oxidation of volatile 
organic compounds (VOCs) as the result of intense sunlight, especially during summer 
months (Odabasi & Seyfioglu, 2005). In addition, it has been postulated that formaldehyde 
can be produced by reactions involving anthropogenic and naturally occurring alkenes 
(Chen et al., 2002). 
Removal of formaldehyde from the atmosphere can occur by chemical transformations, rain 
and snow scavenging of vapours and particles, by dry deposition of particles, and by 
vapour exchange across the air–water interface. Particle/gas phase distribution of 
formaldehyde is an important factor in determining its atmospheric fate, transport, and 
transformation (Odabasi & Seyfioglu, 2005).  
Considering indoor air presence, homes containing large amounts of pressed wood 
products such as hard plywood wall paneling, particleboard, fiberboard, and Urea-
Formaldehyde Foam Insulation (UFFI) often have elevated levels of formaldehyde 
emissions exceeding 0.3 ppm (U. S. Environmental Protection Agency [USEPA], 2007). Since 
1985, the Department of Housing and Urban Development has only allowed the use of 
plywood particleboard that conforms to the 0.4 ppm formaldehyde emission limit in the 
construction of prefabricated and mobile homes (USEPA, 2007). Formaldehyde emission 
levels generally decrease as products age. In older homes without UFFI, concentrations of 
formaldehyde emissions are generally far below 0.1 ppm (USEPA, 2007). This value is close 
to the indoor limit, 0.1 mg/m3 (0.08 ppm), recommended by the World Health Organization 
(World Health Organization - Regional Office of Europe [WHO-ROE], 2006), the limit 
followed by many other countries including the UK (Committee on the Medical Effects of 
Air Pollutants [COMEAP], 2004), and China (Standardization Administration of China 
[SAC], 2002).  
Moreover, some studies have reported that seasonal variations resulted in higher indoor 
formaldehyde concentrations during the summer due to increased off gassing promoted by 
the higher temperatures (Kinney et al., 2002; Ohura et al., 2006; Yao & Wang., 2005). It seems 
that besides the type of materials used and home age also the season (warmer temperatures) 
influence formaldehyde concentrations in indoor settings (Viegas & Prista, 2010; Zhang et 
al., 2009). 
Small amounts of formaldehyde are naturally produced in most organisms, including 
humans, as a metabolic byproduct (IARC, 2006; NTP, 2005), and are physiologically present 
in all body fluids, cells and tissues. The endogenous concentration in the blood of humans, 
monkeys and rats is approximately 2–3 mg/L (0.1 mM) (Casanova et al., 1988; Heck et al., 
1985). Formaldehyde is also found in foods, either naturally or as a result of contamination 
(IARC, 2006). Therefore, everyone is continually exposed to small amounts of formaldehyde, 
environmentally present in the air, our homes and endogenously in our own bodies (Zhang 
et al., 2009). 
Taking into account occupational settings, exposure involves not only workers in direct 
production of formaldehyde and products containing it, but also in industries utilizing these 
products, such as those related with construction and household (Zhang et al., 2009). The 
most extensive use of formaldehyde is in production of resins with urea, phenol and 
melamine, and also polyacetal resins. These products are used as adhesives in manufacture 
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of particle-board, plywood, furniture and other wood products (IARC, 2006). Formaldehyde 
is also used in cosmetics composition and has an important application as a disinfectant and 
preservative, reason why relevant workplace exposure may also occur in pathology and 
anatomy laboratories and in mortuaries (Goyer et al., 2004; IARC, 2006; Zhang et al., 2009).  
The exposed workers, commonly found in resin production, textiles or other industrial 
settings, inhale formaldehyde as a gas or absorb the liquid through their skin. Other 
exposed workers include health-care professionals, medical-lab specialists, morticians and 
embalmers, all of whom routinely handle bodies or biological specimens preserved with 
formaldehyde (IARC, 2006; Vincent & Jandel, 2006; Zhang et al., 2009). 
Concerning exposure limits in occupational settings, Occupational Safety and Health 
Administration (OSHA) has established the following standards that have remained the 
same since 1992: the permissible exposure limit (PEL) is 0.75 ppm (parts per million) in air 
as an 8-h time-weighted average (TWA8h) and the short-term (15 min) exposure limit (STEL) 
is 2 ppm. American Conference of Governmental Industrial Hygienists (ACGIH) 
recommended threshold limit value (TLV) is 0.3 ppm as a ceiling value. The National 
Institute of Occupational Safety and Health (NIOSH) recommends much lower exposure 
limits of 0.016 ppm (TWA8h) and 0.1 ppm (STEL), above which individuals are advised to 
use respirators if working under such conditions. In Portugal, the Portuguese Norm (NP 
1796 - 2007) points also 0.3 ppm as a ceiling value.  
The primary metabolite of formaldehyde is formate which is not as reactive as formaldehyde 
itself and can either enter into the one-carbon metabolic pool for incorporation into other 
cellular components, be excreted as a salt in the urine, or further metabolized to carbon 
dioxide (Agency for Toxic Substances and Disease Registry [ATSDR], 1999). The metabolic 
pathway to formate production is catalyzed by cytosolic glutathione (GSH)- dependent 
formaldehyde dehydrogenase (FDH). The reaction of formaldehyde with GSH yields (S)-
hydroxymethylglutathione which, in the presence of NAD+ and FDH, forms the thiol ester of 
formic acid via the action of (S)-formyl glutathione hydrolase (SFGH) (Pyatt et al., 2008). 
There is  scientific evidence conclusively demonstrating that inhaled formaldehyde does not 
enter the systemic circulation to modify normally present endogenous levels (ATSDR, 1999; 
Heck & Casanova, 2004). This is likely due to the high water solubility of formaldehyde and 
its rapid metabolism. The lack of systemic distribution is evidenced by a variety of studies in 
rodents, monkeys and humans (Pyatt et al., 2008). 
It seems clear that as long as inhaled levels of formaldehyde are below concentrations that 
can be rapidly metabolized by tissue formaldehyde dehydrogenase and other highly 
efficient detoxification enzymes, normal endogenous concentrations (0.1 mM) of 
formaldehyde in the blood do not increase (ATSDR, 1999; Heck & Casanova, 2004).  
Human studies have shown that chronic exposure to formaldehyde by inhalation is 
associated with eye, nose and throat irritation (Arts et al., 2008). Sensory irritation leads to 
reflex responses such as sneezing, lacrimation, rhinorrhea, coughing, vasodilatation and 
changes in the rate and depth of respiration. The latter results are a decrease in the total 
amount of inhaled material resulting in a protective effect to the individual. Trigeminus 
stimulation is not necessarily an indication of cell or tissue damage. At higher 
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irritation is a localized pathophysiological response to a chemical, involving local redness, 
swelling, or itching (Arts et al., 2006). 
Formaldehyde was long considered as a probable human carcinogen (Group 2A chemical) 
based on experimental animal studies and limited evidence of human carcinogenicity. More 
recently, several studies report a carcinogenic effect in humans after chronic exposure to 
formaldehyde, in particular an increased risk for nasopharyngeal cancer (Armstrong et al., 
2000; Coggon et al., 2003; Hildesheim et al., 2001; Lubin et al., 2004; Vaughan et al., 2000). 
Since 2006, IARC classifies formaldehyde as carcinogenic to humans (Group 1), based on 
sufficient evidence in humans and in experimental animals (IARC, 2006). IARC also 
concluded that there is a “strong but not sufficient evidence for a causal association between 
leukemia and occupational exposure to formaldehyde”.  
The ‘‘strong’’ evidence for a causal relationship between formaldehyde exposure and 
leukaemia comes from recent updates of two of the three major industrial cohort studies of 
formaldehyde-exposed workers (Hauptmann et al., 2003; Pinkerton et al., 2004). These data 
have strengthened a potential causal association between leukemia and occupational 
exposure to formaldehyde, especially for myeloid leukemia (Zhang et al., 2009). 
Nevertheless, some authors have argued that it is biologically implausible for formaldehyde 
to cause leukaemia (Cole & Axten, 2004; Marsh & Youk, 2004). Their primary arguments 
against the human leukemogenicity of formaldehyde are: (1) it is unlikely to reach the bone 
marrow and cause toxicity due to its highly reactive nature; (2) there is no evidence that it 
can damage the stem and progenitor cells, the target cells for leukemogenesis; and (3) there 
is no credible experimental animal model for formaldehyde-induced leukaemia. This led 
Pyatt et al., (2008) to recently comment that ‘‘the notion that formaldehyde can cause any 
lymphohematopoietic malignancy is not supported with either epidemiologic data or 
current understanding of differing etiologies and risk factors for the various hematopoietic 
and lymphoproliferative malignancies’’. Indeed, IARC itself concluded that ‘‘based on the 
data available at this time, it was not possible to identify a mechanism for the induction of 
myeloid leukaemia in humans’’ and stated that ‘‘this is an area needing more research’’ 
(IARC, 2006; Cogliano et al., 2005; Zhang et al., 2009). 
However, recently, IARC reaffirmed the classification of formaldehyde in Group I, based on 
sufficient evidence in humans of nasopharyngeal cancer. Considering the possible 
association with leukemia the epidemiological evidence has become stronger and IARC has 
concluded that there is sufficient evidence for leukaemia, particularly myeloid leukaemia 
(Baan et al., 2009; Hauptmann et al., 2009; IARC, 2006). 
Moreover, in 2010 Schwilk and colleagues performed an up-dated meta-analyses focusing in 
higher exposure groups and myeloid leukemia and included two large recent studies and 
conclude that formaldehyde exposure is associated with increased risks of leukemia, 
particularly myeloide leukemia and highlight the importance of focusing on high-exposure 
groups and myeloid leukemia when evaluating the human carcinogenicity of formaldehyde 
(Schwilk et al., 2010). 
In the case of formaldehyde exposure assessment and considering that health effects seems 
to be mainly related with the high concentration peaks than with long time exposure at low 
levels, the strategy to perform exposure assessment in occupational settings must be based 
on the determination of ceilings concentrations. This option might be the best to evaluate 
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exposures and to obtain data for risk assessment development (Hauptmann et al., 2009; 
IARC, 2006). 
Manifold in vitro studies clearly indicated that formaldehyde can induce genotoxic effects in 
proliferating cultured mammalian cells (IARC, 2006). Furthermore, some in vivo studies 
detected changes in epithelial cells (oral and nasal) and in peripheral lymphocytes related to 
formaldehyde exposure (Speit & Schmid, 2006; Suruda et al., 1993).  
Frequency of micronucleus (MN) in buccal and/or nasal mucosa cells is being used to 
investigate local genotoxicity. According to reports concerning experimental genotoxicity 
studies, MN are the most sensitive genetic endpoints for detection of formaldehyde induced 
genotoxicity (Merck & Speit, 1998). Thus, MN test with exfoliated cells could be a powerful 
tool for detection of local genotoxic effects in humans, which is fundamental for hazard 
identification and risk estimation (Speit & Schmid, 2006). 
MN in peripheral blood lymphocytes has been extensively used to evaluate the presence 
and extend of chromosome damage in human populations exposed to genotoxic agents. As 
advantages, this MN test provides a reliable measure of chromosomal breakage and loss at 
lower cost and more easily than chromosomal aberrations. Moreover, the availability of 
cytokinesis-block technique eliminates potential background caused by effects on cell 
division kinetics (Bonassi et al., 2001). 
Research work has been developed to know occupational exposure to formaldehyde in two 
different occupational settings (resins production and in pathology and anatomy 
laboratories) from Portugal and, also, study eventual health effects related with exposure. 
The objective of this chapter is to describe the work developed and discuss the obtained 
results. 
2. Research developed 
2.1 Materials and methods 
2.1.1 Subjects 
This study was carried out in Portugal, in 80 workers occupationally exposed to 
formaldehyde vapours: 30 workers from formaldehyde and formaldehyde-based resins 
production factory and 50 from 10 pathology and anatomy laboratories. A control group of 
85 non-exposed subjects was considered. All subjects were provided with the protocol and 
with the consent form, which they read and signed.  
Health conditions, medical history, medication and lifestyle factors for all studied 
individuals, as well as information related to working practices (such as years of 
employment) were obtained through a standard questionnaire. 
2.1.2 Exposure assessment 
Two different exposure assessment methods were, simultaneously, applied in the 10 
anatomy and pathology laboratories in Portuguese hospitals and in the formaldehyde and 
formaldehyde-based resins production factory, in order to assess formaldehyde 
occupational exposure. Environmental monitoring was performed between the period of 
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In these two occupational settings were identified different exposure groups. In laboratories 
were defined three, namely pathologists, technicians and technical assistant. Also, in the 
factory were define three groups – production of resins, impregnation and quality control. 
These definitions were based essentially on activities similarity. 
2.1.3 Methods 
Method 1 
In one of the methods 30 environmental samples were obtained by personal air sampling 
with low flow rate (0.01 to 0.10 L/min) pumps (Zambelli) during a typical working day. The 
sorbent tubes used were impregnated with 10% (2-hydroxymethyl)piperidine. Sampling 
time was 6 to 7 hours. Two to three samples were collected in each laboratory by the use of 
electric flow pumps which were placed in a worker of each exposure group. 
Formaldehyde levels were measured by Gas Chromatography (GC). Capillary column: 
Supelcowax10 - 30 m x 0.32 mm x 0.5 µm; analyte: oxazolidine derivative of formaldehyde; 
desorption: 1 mL toluene; 60 min ultrasonic; injection volume: 1 μL splitless; split vent time 
30 sec; temperature: injector: 250 °C, detector: 300 °C, column: 70 °C for 1 min; 15 °C/min; 
hold at 240 °C for 10 min; carrier gas: He – 1.5 mL/min; calibration: formalin solution spiked 
on sorbent – 4.7 µg/mL, 6.0 µg/mL, 13.0 µg/mL, 25.0 µg/mL, 40.0 µg/mL, 50.0 µg/mL, 
100.0 µg/mL e 200.0 µg/mL; calibration curve: y=0.008522x – 0.008109 r2 = 0.999968, LOD: 
1μg/sample . Analysis and time-weighted average (TWA8h) estimated according to the 
National Institute of Occupational Safety and Health method - NIOSH 2541 (National 
Institute of Occupational Safety and Health [NIOSH], 1994).  
Method 2 
Ceiling values for formaldehyde exposure were obtained using Photo Ionization Detection 
(PID) direct-reading equipment (with an 11.7 eV lamp) designated by First-Check, from Ion 
Science. This equipment accurately detects formaldehyde from 1 ppb to 10,000 ppm and 
performs automatically data log readings from the sensor on a second basis. Measurements 
were performed in each task and readings were stored in instrument internal memory with 
a date and time stamp. At the same time it was performed video recording and 
synchronized with real-time exposure data obtained with PID equipment followed by 
combination of the exposure profile with the video image of worker activity. 
With this method it was possible to establish a relation between worker activities and ceiling 
values, and to determine principal emission sources.  
Eighty three activities were studied in the 10 laboratories and three activities in the factory. 
All tasks were studied in normal conditions, namely using ventilation dispositive and, as 
usual, none of the workers was using masks to protect from formaldehyde vapours. 
In both methods sampling/measures were performed near workers respiratory system. 
Data obtained from NIOSH 2451 method was compared with reference value from OSHA 
(TLV-TWA=0.75 ppm) because there is no reference in Portugal for this exposure metric. 
The ceiling values obtained from PID method were compared with reference value from 
Portuguese Norm 1796-2007 (0.3 ppm). 
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2.1.4 Biological monitoring 
To evaluate the effects of the occupational exposure, the study of effect biomarkers was 
conducted. The biomarkers of effect studied were specifically genotoxicity biomarkers, 
namely micronuclei in two different biological matrixes – peripheral blood lymphocytes and 
buccal exfoliated cells.  
The protocol used to measure the MN in peripheral blood lymphocytes was the fully validated 
cytokinesis-blocked micronucleus assay (CBMN), developed by Fenech [20], where it is used 
citochalasin B to block the cytokinesis in order to lymphocytes had a binucleated appearance. 
Heparinized blood samples were obtained by venipuncture from all subjects and freshly 
collected blood was directly used for the MN test. Lymphocytes were isolated using Ficoll-
Paque gradient and placed in RPMI 1640 culture medium with L-glutamine and red phenol 
added with 10% inactivated fetal calf serum, 50 ug/ml streptomycin + 50U/mL penicillin, and 
10 ug/mL phytohaemagglutinin. Duplicate cultures from each subject were incubated at 37ºC 
in a humidified 5% CO2 incubator for 44h, and cytochalasin-b 6 ug/mL was added to the 
cultures in order to prevent cytokinesis. After 28h incubation, cells were spun onto microscope 
slides using a cytocentrifuge. Smears were air-dried and double stained with May-Grünwald-
Giemsa and mounted with Entellan. The frequencies of binucleated cells with MN were 
determined analyzing 1000 lymphocytes from two slides for each subject.  
The optimal protocol of MN test for buccal exfoliated cells was performed after many 
experiments. In order to reach the optimal protocol, different techniques of collecting the 
cells and the staining were done. 
Concerning to the sample collection, it was considered that the best way of obtaining the 
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The staining protocols selected were based on the affinity of the stains with the nucleus: 
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The reliable results were achieved with Feulgen without counterstain (Nersesyan et al., 
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2.1.4 Biological monitoring 
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Table 1. Characterization of the studied population 
None of the individuals presented relevant information about health conditions, medical 
history, medication and lifestyle factors that could influence the results of MN test. 
2.2.2 Exposure assessment 
Formaldehyde exposure values were determined using the above described methods: 
NIOSH 2541 for average concentrations (TWA8h) and PID method to obtain ceiling 
concentrations (Tables 2 and 3).  
 












A Technical Assistant 0.27 2.51 1.05 – 2.51 1.78 
Pathologist <LOD 3.19 0.34 – 3.19 1.04 
Technician 0.16 NM --------  
B Technical Assistant 0.15 0.62 0.62 ------ 
Pathologist 0.24 2.71 1.49 – 3.36 2.23 
Technician 0.16 3.36 1.91 – 3.36 2.31 
C Technical Assistant 0.12 0.53 0.53 ----- 
Pathologist 0.47 2.93 1.53 – 2.93 2.18 
Technician 0.51 2.28 2.22 – 2.28 2.25 
D Technical Assistant < LOD NM ------  
Pathologist 0.07 2.31 2.09 – 2.31 2.21 
Technician 0.11 0.85 0.85 ------ 
E Technical Assistant < LOD NM ------ ------ 
Pathologist 0.06 1.10 0.95 – 1.10 1.03 
Technician 0.07 0.85 0.85 ----- 
F Technical Assistant 0.09 NM ------ ----- 
Pathologist 0.23 0.34 0.22 – 0.34 0.28 
Technician 0.12 0.28 0.28 ----- 
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G Technical Assistant 0.16 0.71 0.64 – 1.71 0.67 
Pathologist 0.05 2.81 0.18 – 2.81 0.56 
Technician 0.04 1.26 1.26 ----- 
H Technical Assistant 0.25 0.68 0.68 ---- 
Pathologist 0.11 2.08 1.21 – 2.08 1.65 
Technician 0.25 0.68 0.68 ---- 
I Technical Assistant 0.05 0.95 0.95 ---- 
Pathologist < LOD 0.47 0.21 – 0.47 0.34 
Technician 0.06 NM ---- ---- 
J Technical Assistant NM NM ---- ---- 
Pathologist 0.13 5.02 1.15 – 5.02 3.24 
Technician 0.08 4.32 4.32 ---- 
* Higher values for each exposure group  
< LOD – Below the Detection limit 
FA-formaldehyde 
NM – Not measured 
Table 2. Formaldehyde  exposure results in laboratories 
 

















NM Collecting a sample of the reactor 
1.02 
0.01 – 1.02 0.15 
Impregnation < LOD Operation of impregnation machine
1.04 
0.00 – 1.04 0.21 
Quality control 
 
< LOD analyze a resin sample  
0.52 
0.01 – 0.52 0.08 
* Higher values for each exposure group 
< LOD – Below the Detection limit 
NM – Not measured 
FA -formaldehyde 
Table 3. Formaldehyde  exposure results in the factory 
All of the results for time-weighted average concentrations (TWA8h) not exceeded OSHA 
reference value (0.75 ppm), with the majority of values falling below the method detection 
limited. 
On the opposite, for ceiling concentrations all the higher results obtained for each exposure 
group in each occupational setting exceeded the reference value (0.3 ppm). In laboratories, 
values lied between 0.18 ppm and 5.02 ppm, with a mean of 2.52 ppm. In the factory the 
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The three activities studied in the factory have result above the reference value for ceiling 
concentrations (0.3 ppm). 
In production of resins the higher concentration value was obtained during the collection of 
a sampling in resins reactor performed by a production operator. In this case and during 
operation of impregnation machine there were not local exhaust ventilation dispositive. 
Only in the “quality control” exposure group there was a small hotte that is not normally 
used to perform quality analysis of resins. 
In the case of laboratories, all of them had, at least, one task with a higher result than the 
reference value (0.3 ppm) (Figure 1). 
 
 
Fig. 1. Higher ceiling value obtained in each laboratory 
Considering all of the 83 tasks studied in the laboratories (Table 4), 93% of the results were 
higher than the reference value for ceiling concentrations (0.3 ppm). 
Highest exposure level was observed during “macroscopic examination” of formaldehyde-
preserved specimens. This task is developed in a macroscopic bench with local exhaust 
ventilation. In all the laboratories studied was verified that ventilation was functioning 
normally.  
The task “data registration” showed also a high formaldehyde concentration value, being 
important to note that this task occurs during macroscopic examination (Table 4).  
Concerning the 69 macroscopic examinations, the most frequent task develop in this 
laboratories, it was possible to verify that near 93% of formaldehyde concentration values 
were higher than 0.3 ppm. 
In this occupational setting, highest score for ceiling values was identified in the results of 
the exposure group "Pathologists” and the highest mean was obtained for the “Technicians” 
group (Table 5). 
It is important to consider that none of the workers of the two occupational settings were 
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Macroscopic examination 69 5.02 Pathologist 
Disposal of specimen and used 
solutions 




2 2.51 Technical Assistant 
Data registration 3 4.32 Technicians 
Specimen wash 
 
2 2.28 Technicians 
Biopsy 2 1.91 Technicians 










Technical Assistant 9 0.28 – 2.51 0.86 0.58 
Pathologist 65 0.21 – 5.02 1.42 1.07 
Technician 14 0.68 – 4.32 2.04 0.95 
* some activities involved the simultaneously exposure of two groups  
Table 5. Ceiling results for each exposure group 
2.2.3 Biological monitoring 
Table 6 showed that the frequency of MN in occupationally exposed workers was 
significantly higher in comparison with the control group, both in peripheral blood 
lymphocytes (p<0.001) and in epithelial buccal cells (p<0.001). 
 
 Controls Exposed 
 Factory Pathology and anatomy 
laboratories 
Total 
MN PBL 1 





















1 Peripheral Blood Lymphocytes  
2 Epithelial Buccal Cells 
Table 6. Frequency of MN in the studied population 
When analyzing each occupational setting separately, we found significant differences in 
MN frequencies in peripheral blood lymphocytes (p < 0.001) and in epithelial buccal cells 
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Table 6. Frequency of MN in the studied population 
When analyzing each occupational setting separately, we found significant differences in 
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significant differences in MN frequencies were only detected in epithelial buccal cells 
(p<0.001). 
Finally, it was compared MN frequencies between the two exposed groups and found that 
MN frequency in peripheral blood lymphocytes was significantly higher in the laboratories 
group (p<0.005), but respecting to epithelial buccal cells there was no significant difference 
between them (p=0.108). 
In what concern to the three exposure groups studied in the pathology anatomy 
laboratories, the pathologists group has higher MN mean in lymphocytes and the technician 
had higher MN mean in buccal cells (Table 7). 
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Table 7. Frequency of MN in the exposure groups of laboratories 
Factory results reveal quality control group with higher MN mean in lymphocytes and also 
in buccal cells (Table 8). 
 
 Factory 
Resins Production Impregnation Quality control 
MN PBL 















Table 8. Frequency of MN in the exposure groups of factory 
2.3 Discussion  
As indicated by several studies (IARC, 2006; Orsière et al., 2006; Shaham et al., 2003) 
exposure assessment in present investigation demonstrates that both occupational settings 
studied involve exposure to high peak formaldehyde concentrations. 
The importance of this consideration lies in the fact that health effects (cancer) linked to 
formaldehyde exposure are more related with peaks of high concentrations than with long 
time exposure at low levels (IARC, 2006; Pyatt et al., 2008). Moreover, the choice of exposure 
metric should be based on the most biologically relevant exposure measure in order to 
diminish misclassification of exposure, thus leading to attenuated exposure–response 
relationships (Preller et al., 2004). Furthermore, high exposures of short duration (peaks) are 
of special concern, because they can produce an elevated dose rate at target tissues and 
organs, potentially altering metabolism, overloading protective and repair mechanisms and 
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amplifying tissue responses (Preller et al., 2004; Smith, 2001). In addition, Pyatt et al. (2008) 
pointed out, as a limitation in most epidemiological studies, the lack of data about exposure 
to peak concentrations. Therefore, in those studies, health effects resulting from 
occupational exposure to formaldehyde are associated to exposure exclusively based on 
time-weighted average concentrations (Pyatt et al., 2008). Until 2004 only two studies 
concerning the association between exposure to formaldehyde and nasopharyngeal cancer 
that presented data on exposure to ceiling concentrations obtained higher relative risk 
values compared with the other studies (Hauptmann et al., 2004; Pinkerton et al., 2004; 
Zhang et al., 2009). 
Recently Hauptmann and colleagues have found that mortality rate from leukemia 
increased significantly not just with number of years of activity, in this case embalming, 
but also with increasing peak formaldehyde exposure (Dreyfuss, 2010; Hauptmann et al., 
2009).  
Results in laboratories indicate “macroscopic examination” as the task involving the highest 
exposure. This is probably because precision and very good visibility is needed and, 
therefore, pathologists must lean over the specimen with consequent increase of proximity 
to formaldehyde emission sources. Studies developed by Goyer et al., (2004) and Orsière et 
al., (2006) support that proximity to impregnated specimens promotes higher exposure to 
formaldehyde. “Pathologist” is normally the exposure group that performs this task. 
However, the “Technician” group obtained, simultaneously, higher TWA8h and higher 
mean of ceiling values. This can be due to the fact that this is the group envolved in more 
tasks related with formaldehyde exposure, during the working day. 
In the case of the factory, the task “collecting a sample of the reactor” involved a manual 
process. Probably the proximity and reactor open promote exposure. 
It is important to refer that these type of information (exposure determinants, emission 
sources and exposed workers) was only possible to obtain because video recording could be 
performed simultaneously with concentration measurements. 
This resource gives opportunity to directly relate performance with exposure (Mcglothlin, 
2005; Ryan et al., 2003; Rosén et al., 2005). Additionally, real-time measurements are useful 
also for evaluating engineering controls and their efficacy (Yokel & MacPhail, 2011). 
In addition, and in agreement with other studies (Kromouht, 2002; Meijster et al., 2008; Susi 
& Schneider, 1995), it is possible to conclude that TWA8h measurements give poor 
information and is of less utility in the identification of tasks that should be targeted for 
control. 
Long exposures to formaldehyde, as those to which some workers are subjected for 
occupational reasons, are suspected to be associated with genotoxic effects that can be 
evaluated by biomarkers (Conaway et al., 1996; IARC, 2006; Viegas & Prista, 2007). In this 
study, the results suggest that workers in pathological anatomy laboratories are exposed to 
formaldehyde levels that exceed recommended exposure criteria and a statistically 
significant association was found between formaldehyde exposure and biomarkers of 
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Chromosome damage and effects upon lymphocytes arise because formaldehyde escapes 
from sites of direct contact, such as mouth, originating nuclear alterations in lymphocytes of 
those exposed (He & Jin, 1998; Orsière et al., 2006; Ye et al., 2005; Zhang et al., 2009).  
Our results corroborate previous reports (Ye et al., 2005) that lymphocytes can be 
compromised by long term exposures. Moreover, the changes in peripheral lymphocytes 
can be a sign that the cytogenetic effects triggered by formaldehyde can reach tissues 
faraway from the site of initial contact (Suruda et al., 1993). Long term exposures to high 
concentrations of formaldehyde indeed appear to have a potential for generalized DNA 
damage. In experimental studies with animals, local genotoxic effects following 
formaldehyde exposure have been previously demonstrated to give rise to DNA-protein 
cross links, structural chromosomal aberrations, and aberrant cells (IARC, 2006). In our 
research work the MN frequency in peripheral blood lymphocytes was significantly higher 
in the laboratories group in comparison with the factory, probably because the years of 
exposure are higher in the first group. 
In humans, formaldehyde exposure is associated with an increase in the frequency of MN in 
buccal epithelium cells (Burgaz et al., 2002; Speit et al., 2007) as corroborated by the results 
presented here.  
Suruda el al. (1993) claims that although changes in oral and nasal epithelial cells and 
peripheral blood cells do not indicate a direct mechanism leading to carcinogenesis, they do 
indicate that DNA alterations took place. It thus appears reasonable to conclude that 
formaldehyde is a risk factor for those that are occupationally exposed in these two 
occupational settings (IARC, 2006). 
In human biomonitoring studies it is important to assess the influence of major confounding 
factors such as gender, age and smoking habits in the endpoints studied. However, in ours 
results no significant differences were obtained in MN frequencies between women and 
men (both in peripheral blood lymphocytes and epithelial buccal cells). However, in other 
studies an increase in MN frequencies in women was found. Current knowledge on the 
effect of gender on genetic damage determines a 1.5-fold greater MN frequency in females 
than in males (Fenech et al., 2003; Wojda et al., 2007), witch can be explained by preferential 
aneugenic events involving the X-chromossome. Surralés et al. (1996) reported an excessive 
overrepresentation of this chromosome in micronucleic lymphocytes cultured from women.  
Tobacco smoke contains a high number of mutagenic and carcinogenic substances and is 
causally linked to an elevated incidence of several forms of cancers (IARC, 1985). Hence, 
smoking is an important variable to consider in biomonitoring studies and, particularly in 
this study since formaldehyde is present in tobacco smoke (IARC, 2006). The effect of 
tobacco smoking on MN frequency in human cells has been object of study. In most reports 
the results were unexpected, as in many instance smokers had lower frequencies of MN 
than non-smokers (Bonassi et. 2003; Orsière et al., 2006). In the present study no significant 
differences were found in MN (peripheral blood lymphocytes and epithelial buccal cells) 
between smokers and non-smokers. These findings are similar to results obtained in the 
study of Bonassi et al., (2003). These authors recommend that quantitative data about 
smoking habit should be collected because the sub-group of heavy smokers (30 cigarettes 
per day) can influence the results. For notice, the questionnaire results of this study revealed 
no heavy smokers in these two workers groups.  
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3. Conclusion  
Some preventive measures can be applied to reduce exposure to formaldehyde in these two 
occupational settings. In the case of anatomy and pathology laboratories exposure reduction 
can be achieved by the use of adequate local exhausts ventilation, relocation of the specimen 
containers to areas with isolated ventilation and using hooded enclosures over such 
containers. 
For the factory, preventive measures must consider automating some processes like 
sampling in reactors and, additionally, promote the use of the existing located ventilation 
dispositive.  
Exposure assessment methods applied in the research developed permitted to conclude that 
TWA8h measurements give poor information concerning to preventive measures priority 
and CBMN assay applied to assess genotoxic effects is a screening technique that can be 
used for clinical prevention and management of workers under occupational carcinogenic 
risks, namely exposure to a genotoxic agent such as formaldehyde.  
The most recent studies suggest that future research is warranted to more effectively assess 
the risk of leukemia arising from formaldehyde exposure and to better explain some 
inconsistencies in mode of action and, also, to understand the role of short-term peak 
exposures.  
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1. Introduction 
Radiation contamination of several regions of Belarus was analyzed. As a part of analysis, 
statistical data on cancer cases was compared to the predicted data. Ecological situation due 
to chemical impact of industrial facilities' atmospheric releases was studied. For a biological 
model, an experimental study was carried out to investigate combined impact of radiation 
and chemical factors.  
Complex assessment of radiation and chemical state was performed for 6 districts of Gomel 
region and 4 districts of Mohilev region. As the result of the assessment, model values for 
radiation and chemical risks were obtained. 
In the relocation zone of Chernobyl Nuclear Power Plant (NPP), biological consequences of 
ecological factors (including radiation) combined impact were studied in a series of 
experiments. Laboratory mice of Af line (line of mice with high spontaneous frequency of 
lung tumors) were exposed in the relocation zone. The influence of exposure and natural 
background radiation level on the spontaneous and chemically induced process of lungs 
tumor development process was studied. 
Linear risk assessment methodology proposed by the International Commission on 
Radiological Protection (ICRP) was used to analyze radiation risk. The US Environmental 
Protection Agency (EPA) methodology (with adjustments to local conditions) was used to 
analyze chemical risks. 
2. Radiation risk assessment for Belarus regions which were most affected 
by Chernobyl accident 
To assess health detriment of population of these regions, value of radiation induced 
injuries (probabilities of stochastic effects, which newly formed malignancies being the most 
dangerous) was used. Data on radiation risk assessment, as calculated according to linear 
non–threshold "Dose–effect" model, is presented in Table 1 for the Belarus territories most 
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induced cancers was used (5%/Sv, as suggested by ICRP Recommendations, 1990). The values 
of doses used for risk assessment were taken from Compendium of Exposition Doses of Belarus 
Population (1992). Therefore, the assessments presented determine possible cancers due to 
exposure at that period of time, and do not consider thyroid cancers induced by radiation 




R, ×10–5 N nр  nр 
Brahin City 2.5 12.5 5635 0.704 2.1 
District 1.5 7.5 18083 1.356 
Vetka City 3.1 15.5 9714 1.506 3.3 
District 2.1 10.5 16904 1.775 
Korma City 2.0 10.0 6424 0.642 1.9 
District 1.7 8.5 15140 1.287 
Narovlya City 2.3 11.5 11166 1.284 2.7 
District 3.4 17.0 8294 1.410 
Hoyniki City 0.9 4.5 15813 0.712 2.5 
District 2.1 10.5 17015 1.787 
Chechersk City 2.9 14.5 8915 1.293 2.8 
District 2.1 10.5 13986 1.469 
* – here, AEED is Annual Effective Equivalent Dose, R – risk, N – population, nр – calculated values of 
found newly formed malignancies for a particular location,  nр – sum of np 
Table 1. Radiattion risk assessment for Gomel region. 
3. Carcinogenic risk analysis of environmental chemical contamination 
impact for Belarus regions which were most affected by Chernobyl accident 
Quantitative connection between probability of sickness and dose of an individual is 
exposed is determined, when assessing risk from carcinogens. The value of risk may be 
presented in one of the following ways: as normalized risk per unit dose, as concentration 
risk corresponding to the given risk level, as individual risk, and as risk for a group of 
people. Knowing the values of individual risk allows predicting risk of cancer development 
at particular exposure values. Values of carcinogenic risks for the substances proven to be 
carcinogens at the locations in study are presented in Table 2. Calculated values of 
carcinogenic risk due to chemical contamination of the environment are presented in Tables 
3 – 4 for two districts of Belarus. 
 






Table 2. Additional lifelong cancer risk for a person weighting 70kg due to inhaling 1µg/m3 
of a chemical compound during 70 years of life. 
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Region Substance С* R, ×10–5 n per 105 people N nр 
Brahin Manganese 0.32 1.82 1.8 23718 0.4 
Vetka Manganese 0.24 1.37 1.4 26618 0.4 
Korma Manganese 0.5 2.85 2.9 21564 0.6 







0.1 19460 0.1 







6.9 32828 2.4 
Chechersk Manganese 0.09 0.51 0.5 22901 0.1 
* – concentration as fraction of Maximum Permissible Concentration (MPC) 
Table 3. Calculated values of carcinogenic risk due to chemical contamination of the 
environment (Gomel district). 
Predicted carcinogenic risk (both radiation and chemical) values were compares to eh 
statistical data on cancer sickness. In our work it is shown, that combined radiation and 
chemical contamination cannot be the source of detectable (above the background) 
carcinogenic risk. Impartial assessment of ecological risk can be developed only with the 
help of combined multifactor theoretical and experimental modeling. 
 
Region Substance С* R n per 105 people N nр 
















































* – concentration as fraction of Maximum Permissible Concentration (MPC) 
Table 4. Calculated values of carcinogenic risk due to chemical contamination of the 
environment (Mogilev district). 
It is obvious that the obtained estimates of additional sicknesses number (Tables 3 – 4) are 
maximal, as required by the general "ideology" of risk assessment. 
4. Study of tumor formation in animals and their progeny when exposed to 
combined influence of ecological factors of different nature 
Radiation effects may result not only from action of artificial radio nuclides, but from 
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Radiation effects may result not only from action of artificial radio nuclides, but from 





widely distributed, are accumulated in elevated amounts in organs of people, which live in 
goiter endemic regions of Belarus. Significant amount of enriched uranium from the 
wrecked unit of Chernobyl NPP got into the environment. So far, the issue of possible 
contribution of uranium and other naturally occurring radio nuclides to progeny inheritance 
of genetic system damages induced by radiation particularly or in the process of evolution 
have not been considered. However, this aspect of the issue has both a fundamental 
importance in analysis of natural radioactivity role and especial relevance for population of 
regions suffered from radiation damage, because total increased background radiation level 
has become a global ecological factor. 
Discussed further, is a series of studies aimed on investigation of biological effects of joint 
influences of ecological factors. 
Belarus population, which suffered from Chernobyl NPP accident and is now living on 
radiation–contaminated territory, form a group exposed to an increased risk of developing 
stochastic and genetic effects related to exposure (Spiridonov et al., 2007, Lorimore et al., 
2005). One of the fundamental aspects of this problem is still to estimate stability of cells' 
genetic apparatus functioning, because damages to genome may become basis to immune 
system impairment, carcinogenesis, and decrease in life expectancy (Suskov et al., 2006). 
Biological effects of joint influences of ecological factors, including radiation, can be most 
profoundly studied in the Chernobyl NPP relocation zone. Chernobyl NPP relocation zone 
is a unique place, where radiation is the dominating ecological factor, which is caused by the 
environment contamination level. The Polessky Radiation–Ecology Reserve (PRER) was 
created on this territory in 1988. Various radiobiological studies are carried out in PRER 
(Konoplya et al., 2011). 
Series of studies were carried out in PRER to evaluate influence of: 
1. Exposure on laboratory animals; and 
2. Natural radioactivity on spontaneous and chemically induced tumor process in lungs 
(adenomas) of mice of Af line and their progeny (first generation – F1). 
Usage of a biological model "lungs adenomas" as an accelerated test for Af-line mice to 
determine carcinogenicity of chemical substances is based on responsiveness in adenomas 
development under the action of various carcinogenic agents (Turusov and Parfenov, 1986). 
Mice used in the experiment are of "highly carcinogenic" Af-line, characterized by high 
sensitivity of lung tissue to blastomogenic effect of urethane and genetic predisposition to 
formation of tumors in lungs. Previously, urethane was widely used in pediatrics as a 
sedative measure. However, it was experimentally established that urethane causes a wide 
spectrum of embryonic disorders and tumors of different localization, independent of the 
way it was injected into body (Porubova, 2000). 
Influence of exposure duration (1 and 4 months) in the Chernobyl NPP relocation zone on 
spontaneous and chemically induced mutagenesis and tumor formation in lungs of mice (Af 
line) and their progeny (first one – F1) was studied. The procedure of experiments was the 
following: male and female laboratory mice (3 month old) were delivered to the relocation 
zone in May 2007. Dose rate of 3.29±0.10 µGy/hr was detected at the ground level where the 
mice were placed. After one month mice were split into the following groups: one part was 
relocated from the contaminated area to read background indicators, while the other part 
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was allowed to copulate. Later pregnant females were relocated to vivarium in Minsk to get 
progeny F1. In 24 hours after being relocated from the contaminated area, the animals were 
injected with urethane (1 mg/g, in the form of 10% sterilized solution with crystalline 
urethane – ethyl-carbonate, (C3H7NO2) – Sigma - Aldrich). Animals were removed from the 
experiment after 72 hours after relocation from the contaminated area. 3–month old progeny 
F1 from parents, which were in the Chernobyl NPP relocation zone for 1 month, were 
injected with urethane (1 mg/g). Control was performed with the help of progeny F1 of the 
same age from Minsk vivarium. The same procedure was followed for laboratory animals 
after 4–month exposure in Chernobyl NPP relocation zone (PRER). 
For parents and progeny, tumor process was assessed according to the number 
adenomas/mouse after 20 weeks of urethane injection. Influence of mice's uranium 
intoxication on sensitivity of the progeny to combined impact of exposure and urethane was 
studied by testing lungs adenomas. In this study, 3 weeks old immature male and female 
mice of Af line who were drinking solution of nitro–acid uranium (UО2(NO3)2*6 H2O) in 
concentrations 180 mg/liter during the next 3.5 months, were used. (Novikov, 1974). After 
3.5 months from the start of drinking, a part of animals, as well as control, were relocated for 
7 – 10 days for copulation. Urethane (1 mg/g of body mass) was injected peritoneally to a 
part of immature animals 3.5 months after uranium intoxication as well as to intacted 
animals of the same age; adenomas were recorder after 20 weeks. Progeny of the intacted 
animals and 8– to 10–weeks old mice after uranium intoxication were exposed to 0.35 Gy 
gamma–rays (1 Gy/hr dose rate, 60Co source), injected with urethane (1 mg/g), and exposed 
to combined radiation of the same dose and urethane concentration. Control was injected 
with the same amount of physiological solution. Tumor process was estimated by tumor 
rate (% of mice with adenomas) and adenomas/mouse number after 20 weeks according to 
the process described by Turusov and Parfenov (1986). 
Experimental data were processed statistically using Student's criteria. An interaction 
coefficient Kw was used to describe quantitatively results of joint influence of factors of 
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was allowed to copulate. Later pregnant females were relocated to vivarium in Minsk to get 
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control. Interaction coefficient Kw was found to be 2.4 and 1.1 for mice exposed in the 
relocation zone during 1 and 4 months respectively. This signifies that joint effect of 
relocation zone factors and carcinogen (urethane) is synergetic, which decreases with 
exposure period in zone along with the increase in radiation contribution from 4.8 to 9.6%. 
 


















39 0.31 ± 0.09 – 27 0.26 ± 0.06 – 
Urethane (Minsk 
vivarium) 





0.37 ± 0.02 – 22 0.77 ± 0.17* – 
Chernobyl NPP 
relocation zone + 
urethane 
24 7.67 ± 2.08*8 2.4 21 8.05 ± 1.00* 1.1 
* – Statistically significant difference from control-group, p < 0.05; ** – statistically significant difference 
from urethane control-group, p < 0.05. 
Table 5. Number of induced adenomas/mouse in animals exposed in Chernobyl NPP 
relocation zone during 1 and 4 months. 
Genome damages caused by the environment of Chernobyl NPP relocation zone are 
inherited by progeny. Originally, research of consequences of ionizing radiation influence 
for mammals was developing as studies of radiation effects for progeny of one exposed and 
one un-exposed parents. Thus, progeny was formed and developed from one exposed and 
one intact sex cell. However, since ionizing radiation became a global ecological factor, 
studies of radiation effects for progeny of parents who had been both exposed have become 
relevant. Studies of this problem have both fundamental and practical importance, because 
it has been neither unambiguously accepted, nor scientifically proven as to what dose to use 
to calculate genetic risk for progeny of both exposed parents (Nefedov et al., 2003). 
Results of spontaneously and chemically induced carcinogenesis in lungs of F1 progeny of 
Af-line mice, both intact and exposed in PRER zone during 1 – 4 months, are presented in 
Table 6. 
Evaluation of late effects showed that spontaneous occurrence of lungs adenomas had risen 
significantly (more than 5 times) for F1-mice progeny, that had been contained in Chernobyl 
NPP relocation zone during 1 month, as compared to the number of adenomas in lungs of 
progeny of intact mice. 
Urethane injection to progeny of mice exposed in Chernobyl NPP relocation zone 
statistically significantly increases number of induced adenomas/mouse as compared to 
control-group (intact progeny of mice intoxicated with urethane). 
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Groups Exposure period of mice–parents 


















25 6.10 ± 0.81* – 26 6.38 ± 0.68* – 




20 1.75 ± 0.61* – 14 1.14 ± 0.36* – 
F1 progeny of 
parents from 
Chernobyl NPP 
relocation zone + 
urethane 
14 10.28 ± 1.40* 1.38 14 8.85 ± 1.08* 1.22 
* - Statistically significant difference from control-group, p  0.05. 
Table 6. Number of induced adenomas/mouse in F1 mice progeny that were exposed in 
Chernobyl NPP relocation zone during 1 and 4 months and/or were injected with urethane. 
For F1-mice progeny which were exposed during 4 months in Chernobyl NPP relocation 
zone, the number of spontaneous tumors exceeded that for intact F1-mice progeny more 
than 4.9 times. Injection of urethane to F1-mice progeny, that had been previously exposed 
in Chernobyl NPP during 4 months, increased number of induced tumors by 7.76 times as 
compared to that of progeny of mice from Chernobyl NPP relocation zone (Kw = 1.22). It is 
important to notice an increased sensitivity of progeny of mice that had been exposed in 
Chernobyl NPP relocation zone, compared to their parents. This was pronounced in higher 
values of interaction coefficient Kw, namely, 1.38 – 1.22 with simultaneous decrease of 
radiation contribution from 17 to 12%. 
A more pronounced difference in the level of induced tumor process occurred in the group 
of originally immature mice 6 months after stopping drinking uranium solution 
(adenomas/mouse number exceeded that of control-group more than 1.6 times). This 
signifies importance of age as a factor of animals' responsiveness to radiological and 
toxicological action. 
Differences in responsiveness between intact animals and mice, which had been intoxicated 
with uranium, was also revealed while studying occurrences of tumors among animals after 
separate and joint uranium and urethane action, see Fig. 1. 
Adenomas/mouse number increased statistically significantly after urethane action as 
compared to control-group (p < 0.05). Maximal value of tumor effect was observed among 
animals, which had been subjected to joint uranium and urethane action. This value 
exceeded level of urethane carcinogenesis more than by 10%, and reflects effect of 
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Fig. 1. Tumor formation among mice intoxicated with uranium (3.5 months) and being 
injected with urethane. 
Apart from this, uranium intoxication as well as influence of low levels of various toxicants 
changes the responsiveness (sensitivity) of cells to the further action of different genotoxic 
factors. These changes manifest themselves in the form of a modifying effect, the exhibited 
level of the latter being determined by the level an organism is "familiar" with it. 
Transgenetic transfer of sex cells; genome damages induced by uranium was also studied on 
Af-line mice. The results of studies are shown in Fig. 2. 
 
- F1 progeny of intact parents 
- F1 progeny of parents intoxicates with uranium 
Fig. 2. Tumor formation and sensitivity of progeny (F1) of intact and intoxicated with 
uranium mice to exposure and chemical carcinogen. 
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Comparison of level in spontaneous tumor formations within progeny F1 of intact and 
intoxicated with uranium mice indicates a significant increase in adenomas/mouse number 
(more than by 63%) for progeny (F1) of mice that received nitric acid uranium (0.22  0.09 
and 0.36  0.12 adenomas/mouse, respectively). Of a non-lesser importance is the difference 
in progeny sensitivity to the influence of additional agents. Urethane injection into progeny 
(F1) of uranium mice lead to statistically significant almost doubled (8.78  1.17) increase in 
adenomas/mouse number that was observed within progeny of intact mice (4.77  0.58). 
However, progeny responsiveness to exposure was somewhat different. In fact, the was 
almost no difference in number of induced adenomas/mouse between exposed progeny of 
uranium mice and that of exposed progeny of intact mice (0.72 and 0.66 adenomas/mouse) 
respectively. Subjecting to a joint effect of gamma-radiation and urethane group of progeny 
F1 of uranium mice, lead to the maximal (10.7  1.52 adenomas/mouse) and statistically 
significantly exceeded the same indicator for a subjected to the joint effect of gamma-
radiation and urethane group of progeny F1 of intact mice (7.05  1.00 adenomas/mouse). 
It follows from the obtained data, that: 
1. Damages are induced in the genetic system of sex cells as a result of uranium 
intoxication; 
2. These damages are transferred to progeny and manifest themselves as an increase in 
sensitivity of progeny to transformation under additional influence of genotoxic factors 
(i.e. genetic instability is induced). 
Genetic instability may be one of the contributors to the formation mechanism of genetic 
burden. 
4.1 Mathematical modeling of the consequences of the joint effect of the factors of 
radiation and non–radiation nature on the organism 
Principles of the risk evaluation, used today for the population, residing on the territories, 
contaminated after the disaster at the Chernobyl NPP, are based mainly on the radiation 
influence analysis. However, results of the radiation risk assessment come into collision 
with the actually established changes in the quantity of the stochastic effects (officially 
published annual statistics), requiring an elaboration of new criteria of analysis that would 
be based on a multifactor influence. 
In the framework of one of the problems of the present work, an attempt has been made to 
introduce a mathematical model of the synergic interaction of the factors of the radiation 
and non–radiation (on the example of a chemical carcinogen) nature and the damage 
manifestation as a result of such an interaction. A biological experiment has been carried out 
in the Radiation–Toxicological Ecology Laboratory of the Institute for Radio–Ecological 
Problems, National Academy of Sciences, Belarus (Malenchenko et al., 2001). 
A hypothesis is proposed to create a mathematical model able to describe effects under a 
combined interaction, based on the assumption that a formation of additional effective 
damages takes place due to the interaction of subdamages, induced by each agent and not 
effective under a separate influence of each factors, both under combined and joint effect of 
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Mathematical modeling of the consequences of the joint effect, based upon the above 
described method, turned out to be especially successful for a dose of 0.35 Gy owing to a 
monotonic character of the dependence "Number of the revealed damages" – "Time of the 
urethane introduction after the exposure to radiation". In accordance with the foregoing: 
 N = N1 + PN1, (1) 
 where 
N – total value of damages; 
N1 – amount of damages from the direct affect of the hazard factor (in our case – this is 
radiation); 
P – share of "sub–damages", that are not revealed under a single radiation influence but 
reveal with addition of the second hazard factor (here – urethane). 
Model (1) is stationary. If the sub–damages are not revealed under isolated influence of a 
single factor (radiation), then they will relax with time in the direction of the undamaged 
condition. We will consider this process as a purely probabilistic one with a constant relative 
rate (as in the case of the radioactive decay); i.e. the constant ratio of recoveries from the 
sub–damages rehabilitates per unit time. Then: 
N0 – amount of the damages from radiation; 
PN0 – amount of the sub–damages from radiation; 
PN0exp(– t / ) – decreasing in the amount of sub–damages with time t and  being 
"sub–damages lifetime". 
Thus, we can find the amount of damages at any instant after irradiation under the urethane 
incorporation to be: 
 N(t) = N0 + PN0exp(– t / ), (2) 
where the second term of the sum is the amount of the sub–damages at the moment t, 
revealed as damages due to incorporation of the second hazardous factor (urethane). 
On the basis of the experimental data, we are able to find average values of the parameters P 
and , corresponding to the experimental data with minimum error  at the whole range of 
values: 
P = 5.8  0.6 (  10%);  = 16  3 days (  20%) 
Hence, as for the dose of 0.35 Gy we get the following dependence of damages on time of 
the urethane incorporation after irradiation: 
 N(t) = 1.3 + 7.4exp(– t /16) (3) 
The modeled values shown in Fig. 3 were obtained in accordance with Eq. (3) and quite well 
correspond to the experimental values. This indicates a good fit of the model (2) to the 
experimental data in case of a monotonic character of dependence of the amount of damages 
on time. 
Difficulty in getting an estimate for the tumor genesis process appraisal under combined 
action of radiation and chemical carcinogen is not only limited by the time period between 
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interactions of carcinogens. Genesis of the radiation–induced tumor depends both on the 
dose and on its time distribution – the dose rate. 
 
Fig. 3. Calculations according to model and experimental data. 
Technical possibilities and latest experimental data allow revealing specific contribution of 
the radiation factor in the real ecological conditions and distinguishing single–factor risk 
due to radiation only. However, the attempt to extrapolate the findings for the current 
ecological conditions is connected with considerable difficulties that can mislead or show 
failure of the performed calculations. This was clearly pronounced in discrepancies between 
the predictions and the actual data on thyroid gland cancer occurrences among children in 
Belarus after the Chernobyl accident. In the view of this, we state that there is an obvious 
necessity to develop new methodological principles of the sanitary and ecological 
evaluation of the environmental quality under the conditions of joint effect of the ionizing 
radiation and factors of the non–radiation origin on human the organism. 
5. Discussion 
Currently, a special attention is paid to the issue of genome instability, which is caused by 
ionizing radiation. The main reason for this is that this issue is immediately related to 
understanding mechanisms of such important radiobiological phenomena as radiation 
mutagenesis, carcinogenesis, ageing, which are all remote consequences of ionizing 
radiation effects (Pelevina et al., 2003). Within concept of genome mutability, the 
phenomenon of genome instability induced by radiation is interpreted as a transition of 
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experimental data in case of a monotonic character of dependence of the amount of damages 
on time. 
Difficulty in getting an estimate for the tumor genesis process appraisal under combined 
action of radiation and chemical carcinogen is not only limited by the time period between 
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interactions of carcinogens. Genesis of the radiation–induced tumor depends both on the 
dose and on its time distribution – the dose rate. 
 
Fig. 3. Calculations according to model and experimental data. 
Technical possibilities and latest experimental data allow revealing specific contribution of 
the radiation factor in the real ecological conditions and distinguishing single–factor risk 
due to radiation only. However, the attempt to extrapolate the findings for the current 
ecological conditions is connected with considerable difficulties that can mislead or show 
failure of the performed calculations. This was clearly pronounced in discrepancies between 
the predictions and the actual data on thyroid gland cancer occurrences among children in 
Belarus after the Chernobyl accident. In the view of this, we state that there is an obvious 
necessity to develop new methodological principles of the sanitary and ecological 
evaluation of the environmental quality under the conditions of joint effect of the ionizing 
radiation and factors of the non–radiation origin on human the organism. 
5. Discussion 
Currently, a special attention is paid to the issue of genome instability, which is caused by 
ionizing radiation. The main reason for this is that this issue is immediately related to 
understanding mechanisms of such important radiobiological phenomena as radiation 
mutagenesis, carcinogenesis, ageing, which are all remote consequences of ionizing 
radiation effects (Pelevina et al., 2003). Within concept of genome mutability, the 
phenomenon of genome instability induced by radiation is interpreted as a transition of 





two outcomes: 1) adaptation to new conditions with a gradual normalization of cell systems 
and their functions by repairing and eliminating defective cells; or 2) transition to a 
modified state by means of preserved instability of genome; this can be accompanied by an 
occurrence of a malignant phenotype (Mazurik and Mikhaylov, 2001). 
Obtained experimental data within out studies indicate that a combination of ecological 
factors present in Chernobyl NPP relocation zone induced damages in the sex cells genome 
of parents and promotes transgeneration transfer of these damages to the progeny. 
Obviously, similar process are occurring in organisms of animals and people that leave in 
contaminated areas that are close to Chernobyl NPP relocation zone. That's why, an increase 
of child sicknesses, that has been detected in recent years, may be not only a consequence of 
the current ecological situation, but also be a result of their parents being subjected to 
harmful to health effects after Chernobyl accident and accompanying adverse socio-
economical and ecological factors (including naturally occurring radiation). These data 
pronounce an increase in the rate of genetic burden formation in organisms, subjected to the 
elevated radiation background level and influence of toxic factors. Such conditions are 
characteristic of territories suffered as the result of Chernobyl accident. Therefore, an 
impartial assessment of an ecological risk can be elaborates only be methods of combined 
multifactor theoretical and experimental modeling. 
6. Conclusions 
1. The radiation contamination due to Chernobyl accident cannot be the source of 
detectable carcinogenic risk on the territory of Belarus. 
2. Current ideas about carcinogenic danger due to chemical contamination of the 
environment cannot be used for satisfactory explanation of the observed stochastic 
effects. Impartial assessment of ecological risk can be developed only with the help of 
combined multifactor theoretical and experimental modeling. 
3. Combined-impact coefficient of interaction shows the mutually enhanced pattern of 
carcinogenic factors impact. The studied ecological factors induce damages to genome 
of parents' reproductive cells and its transgeneration transfer to the progeny. 
4. Strategic aim of ecological risk studies is to solve the general problem: to establish specific 
features and outputs of negative consequences (e.g. cancers) for human exposed to the specific 
combinations of technogenic and natural contamination. 
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1. Introduction 
Bisphenol A (BPA) is a ubiquitous chemical found in many consumer products. Despite the 
growing link between BPA and several diseases, including various cancers, it remains 
unregulated in many countries (like the USA). 
BPA has a high industrial production-volume that started in the USA in 1957, but by 2001 
was estimated to be globally approximately 2.5 million tons. It is widely used mainly in the 
production of polycarbonate (PC), plastics and epoxy resins, but also for many other 
applications (see Fig.1.) (Pfeiffer et al., 1997). Over 95% of BPA world consumption in 2009 
was for those two purposes. 
The PC applications include adhesives, compact disks, dental prosthesis and sealants, 
electrical and electronic parts, returnable empties, refillable water bottles and items for food 
such as sport bottles, baby bottles, pitchers, tumblers, home food containers and flatware. 
The epoxy applications include the protective coatings for the interiors and exteriors of food 
and beverage containers, as well as dental materials. BPA is also present in recycled and 
thermal paper (Keri et al., 2007; Ishido et al., 2004; Loffredo et al., 2010). 
Because of those uses, consumers of canned food or infants being bottle fed are particularly 
exposed to BPA through their diet, though many other sources (environmental and 
occupational) of human exposure are proposed today by researchers. 
BPA has drawn much discussion about its safety, due to its persistence in our environment 
(water, air, dust, waste sludge, food etc.) (Huang & Leung, 2009). 
A variety of studies are available on BPA concentration in food (from food surveys) and 
BPA migration from contact with food including via baby bottles and dental materials, and 
BPA concentration in air, dust and water. There are also a limited number of studies 
available on BPA concentration in paper (FAO-WHO, 2010; Reuben, 2010). 
A number of studies have involved BPA as a potential “endocrine disrupter,” primarily on 
the basis of the results of in vitro exposure, that, however, have not been unequivocally 
confirmed in vivo. 
Studies on the effects of BPA on health have focused on its oestrogenic activity, but some 
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disrupted pancreatic β-cell function , thyroid hormone disruption and obesity-promoting 
effects (Karim & Husain, 2010; Keri et al., 2007). 
 
Fig. 1. European applications of BPA 
BPA alters the cycle of the epithelial cells of the mammary gland in experimental mice and 
in human cells (in vitro) (Colerangle & Roy, 1997). It has received considerable media 
coverage, thus the problem is well known by the Western population, so much so that 
consumers have shown concern about BPA’s oestrogenic effects.  
All levels of government, from global to local, work to protect people from diseases through 
rigorous regulation of environmental pollutants (Dekant & Völkel, 2008; FAO-WHO, 2010). 
In the light of today’s uncertainties about the possibility of the adverse human health effects 
at low doses of BPA exposure (especially on reproduction, the nervous system and 
behavioural development) and considering the relatively higher exposure of very young 
children compared with adults, the Food and Agriculture Organization of the United 
Nations (FAO) and the World Health Organization (WHO) jointly organised an expert 
meeting to assess the safety of BPA (FAO-WHO, 2010). 
2. Bisphenol A  
BPA, or 4,49-(1-methylethylethylidene) bisphenol, was first synthesised in 1905 (Fig. 2). It is 
obtained by condensation of phenol with acetone in the presence of a strongly acidic jelly-
like ion-exchange resin as a catalyst. 
Bisphenol A is a moderately water-soluble compound (300 mg/L at room temperature) and 
it dissociates in an alkaline environment (pKa 9.9–11.3). It shows a weak acute toxicity for 
aquatic biota (Yamamoto et al., 2001). 
It is used as a component of plastics, e.g. polyvinyl chloride, and as an antioxidant in glues, 
epoxy resins and ink. 
 




Fig. 2. Bisphenol A 
Epoxy resins, in particular, are used as protective linings for a multitude of canned foods 
and beverages, and as a coating on metal lids for glass jars and bottles, including containers 
used for infant formula.  
Materials containing BPA have been used for many applications in other packaging used for 
storage of food products, beverages and pharmaceuticals. 
PC has been commonly used also for production of components of medical equipment (for 
dialysis and blood oxygenation), of returnable bottles for soft drinks, of infant feeding 
bottles, of kitchen dishes, toys, water pipes and polyethylene terephthalates or PET (Cobellis 
et al., 2009; Keri et al., 2007; Rykowska & Wasiak, 2006). 
The wide use of polycarbonates arises mainly from their particular properties: light weight, 
durable, high tensile strength, very good elasticity, high melting point and high vitrification 
temperature (Rykowska & Wasiak, 2006). 
2.1 Exposure routes to BPA 
It is important to note that the border line between occupational and environmental 
contaminants is very fine and often difficult to demarcate with accuracy.  
Many known or suspected carcinogens, in fact, were first identified by studying industrial 
and agricultural occupational exposures, while later they were found in the environment 
and in numerous consumer products. 
Human exposure to BPA may arise, then, also out of BPA leaching from those materials into 
the saliva or may occur through skin contact (Cobellis et al., 2009; Keri et al., 2007; Takahashi 
et al., 2001). 
Generally, higher doses are found in small groups due to exposure in their workplace, 
whereas environmental exposures are found at lower doses but in large populations. 
Very few studies have been done on the environmental occurrence of BPA. Recently, the 
Environment Agency of Japan reported that environmental pollution by BPA is widespread 
in Japan. BPA has been, in fact, also found in sediments and fish (Yamamoto et al., 2001). 
Many studies show that levels detected in beverages are lower than levels in food, levels in 
fruits are lower than in vegetables, while levels in fatty foods are higher than levels in all 
other foods. Data also exist on BPA levels in tap water and bottled water (FAO-WHO, 2010). 
BPA concentrations in air and dust are widely distributed and there is no difference 
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Few studies have been carried out on BPA in paper packaging, paper treatment water and 
thermal paper. BPA levels were detected higher in recycled paper than in virgin paper, 
therefore, additional studies on BPA migration from paper packaging to food are needed 
(FAO-WHO, 2010). 
When waste plastics containing BPA are buried in a landfill a hydrolytic or leaching process 
may occur to release the BPA from waste to leachate. Landfill leachates are therefore also an 
important source of environmental BPA (Yamamoto et al., 2001). 
As BPA can arise out of those sources, human exposure to this compound occurs especially 
in urbanised and industrialised areas. 
EFSA in 2006 set the Tolerable Daily Intake (TDI) at 0.05 mg BPA/kg body weight 
(b.w.)/day. 
In 2008, EFSA, following more recent studies, reaffirmed the same TDI (EFSA, 2010). 
Small amounts of BPA can potentially leach out from food containers into foodstuffs and 
beverages, and therefore be ingested; as a consequence, in the European Union (EU), BPA is 
permitted in plastics for food only if the specific migration limit of 0.6 mg/kg of food is 
respected (see Directive 2002/72/EC relating to plastic materials and plastic materials 
intended to come into contact with food).  
The use of BPA in food contact materials is also authorised in other countries like the USA 
and Japan. 
The new EU implementing Regulation No 321/2011, has replaced Directive 2002/72/EC, 
making it clear that BPA is "not to be used for the manufacture of polycarbonate baby 
bottles for feeding infants". 
Although FDA and EFSA ruled in 2008 that BPA is safe even for infants, in the same year 
Canada took a precautionary approach classifying BPA as ‘‘toxic’’ under the Canadian 
Environment Protection Act and it has banned its use in baby bottles and infant formula 
cans. More than 20 states in the USA are following suit with proposed or enacted BPA bans. 
In January 2010, FAO acknowledged that there is concern about BPA’s effects, but 
concluded that there was insufficient scientific evidence to support a product ban or even a 
requirement to label BPA-containing products. 
Endocrine disruptors (EDs) represent a major toxicological and public health issue. 
Endocrine disruptors are an extensive group of natural or anthropogenic organic molecules 
that act as hormone-like substances; they are widely dispersed in the environment and are 
capable of mimicking the action of steroidal oestrogens (Keri et al., 2007; Ishido et al., 2004; 
Loffredo et al., 2010). 
Among endocrine disruptors BPA is a known xenoestrogen (Ishido et al., 2004). 
Studies in vivo have shown that BPA can mimic 17β-estradiol in stimulating prolactin 
secretion, inducing growth and differentiation and exhibiting uterotrophic activity in rats 
and mice (Ishido et al., 2004), however, BPA oestrogenicity in vitro has been observed to be 
15,000 times less active than 17β-estradiol. 
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It is important to highlight that oestrogens are important in the maintenance of human 
pregnancy and the placenta is its major site. BPA is capable of potentially reducing 
oestrogen synthesis by down-regulating CYP of placental cells (Huang & Leung ,2009). 
Studies of prenatal exposure to BPA have shown in mice changes of the gross ovarian 
anatomy (a reduction in the number of corpora lutea and an increase in unilateral or 
bilateral ovarian bursae). Others have reported that BPA exposure increases aneuploidy and 
this has been linked to miscarriages also in humans (Huang & Leung, 2009). 
2.1.1 Environmental exposures to BPA 
Assessing health hazards due to drinking water contamination is difficult, since it is usually 
challenging to estimate the levels and timing of exposures, and the specific chemicals 
involved. It can also be difficult to clearly define exposed populations. Furthermore, it is 
often not possible to identify the cause of observed health effects when there are multiple 
exposures or to link specific health effects with an individual chemical that occurs in 
mixtures (FAO-WHO, 2010; Reuben 2010; Sciacca & Oliveri Conti, 2009). 
Many bottled water users assume that it is cleaner than tap water, but BPA can leach from 
the bottle itself into the water it contains (Reuben, 2010). 
Due to the low BPA vapour pressure, inhalation exposure of the general population will 
likely have only a minor contribution compared to the overall exposure. Inhalation of 
household dust containing BPA is unlikely to result in significant uptake of BPA from the 
lung because the large particles typically encountered in household dust do not penetrate 
into the low lung. However, house dust may be trapped in the mucociliary layer and may be 
swallowed resulting in additional oral exposure. 
Indirect ingestion (dust, soil and toys) is considered to be approximately 0.03 μg/kg bw per 
day in infants and approximately 0.0001 μg/kg bw per day in children and adults (FAO-
WHO, 2010). 
Non-occupational dermal exposures to BPA are considered as rare events, moreover, 
systemic bioavailability of BPA after dermal application is limited to only 10%. 
The mean exposure from inhalation of free BPA (concentrations in indoor and outdoor air) 
is approximately 0.003 μg/kg bw per day for the general population (FAO-WHO, 2010). 
Based on this evidence, several government organisations have concluded that oral 
exposure through food is the major source for BPA exposure in all age groups of non-
occupationally exposed human subjects (Reuben, 2010).  
Some additional oral exposure to BPA may also result from using BPA-based resins in 
dentistry, but this is restricted to a short period after treatment with BPA-based dental 
sealants or composites. 
Due to the wide range of applications of BPA in food cans and materials for packaging for 
food commodities, food may significantly contribute to human BPA exposure. 
The EU estimated daily exposures to BPA from a minimum of 0.02 μg/kg bw/day to 59 
μg/kg bw/day in adults. The EFSA estimated intakes of BPA through food from 0.2 μg/kg 
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month old infant fed with polycarbonate bottles and commercial food). Exposures to BPA 
based on direct food analysis and food consumption patterns generally resulted in estimates 
of low daily human exposure ranging from 0.005 to 0.37 μg/kg bw/day (Dekant & Völkel, 
2008; EFSA, 2010; FAO-WHO, 2010; Reuben, 2010). 
2.1.2 Foetal exposure to BPA 
Recent data from epidemiological studies have suggested that perturbations in the foetal 
environment may predispose individuals to disease and/or organ dysfunction, that 
becomes apparent in adulthood. 
This theory on the foetal origins of adult diseases has prompted scientists to hypothesise 
that foetal exposure to environmental oestrogens has increased incidence of uterine 
leiomyoma, testicular cancer and breast cancer as observed in European and US populations 
over the last 50 years.  
Exposure of rodents to low doses of BPA during foetal development has been shown to alter 
a variety of biological endpoints including early vaginal opening, early onset of puberty, 
disrupted oestrous cyclicity and decreased levels of luteinising hormone after ovariectomy. 
These results give strong credence to the supposition that there is a link between foetal 
exposure to BPA and the development of neoplasias in the adult mammary gland.  
These neoplasias may have their origin in the altered morphogenesis that occurs in the foetus 
during the period of BPA exposure (FAO-WHO, 2010; Murray et al., 2007; Reuben, 2010). 
Emerging evidence is that BPA affects the developing brain in the foetus, leading to severe 
behavioural alterations. Therefore, the hypothesis that BPA might also contribute to the 
incidence of neurodevelopmental disorders such as attention deficit, hyperactivity disorder 
and autism has been posited (Ishido et al., 2004). 
However, for EFSA, the foetal exposure and also the exposure to total BPA through lactation 
appear to be limited (EFSA, 2010). 
The recent final report of the US National Toxicology Program (NTP) stated that "there is 
currently insufficient evidence to conclude that Bisphenol A exposure during development 
predisposes laboratory animals to develop obesity or metabolic diseases such as diabetes, later in life..." 
(EFSA, 2010; Reuben; 2010). 
2.1.3 Potential dietary exposure for infants aged 0 to 3  
The estimated maximum BPA migration from PC baby bottles is 15 μg/kg. This intake is 
considered to be safe for consumers. 
Infants fed with canned liquid formula in PC bottles, were exposed to 4.5 μg/kg bw per day 
with a mean of 2.4 μg/kg bw per day, whereas infants fed with powdered formula 
(prepared when needed) were exposed to lower levels (2.7 μg/kg bw per day with a mean 
of 2.0 μg/kg bw).  
When infants were fed with canned liquid formula in PC-free bottles, the estimates were 0.5 
μg/kg bw per day at the mean and 1.9 μg/kg bw per day at the 95th percentile, whereas the 
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estimates were lower, 0.01 and 0.1 μg/kg bw per day, respectively, for infants fed with 
powdered formula.  
Therefore, the difference between canned liquid and powdered formula is mainly caused by 
the migration of BPA from the epoxy resin coating the cans in which liquid formula is 
packaged. 
Hence, it has been estimated that the major sources of exposure in this age group are: 
• migration of BPA from PC bottles (81%),  
• infant liquid formula packaged in PC containers or metal cans with epoxy linings (19%),  
• epoxy resin in contact with powdered milk formula (1%). 
For children aged 3 and older, the main source of exposure is instead migration from canned 
food that contributes to 94% of the total exposure (FAO-WHO, 2010). 
3. Metabolism and toxicokinetics  
BPA is well absorbed from the gastrointestinal tract with conversion to Bispenol A –
glucuronides  and Bispenol A-sulphate; this phase is critical but not very important because 
unlike the aglycone-BPA (i.e. free or unconjugated) BPA- glucuronides does not bind to the 
oestrogen receptor (see Fig.3). Aglycone-BPA does not accumulate in the body.  
Glucuronide-BPA is subjected to biliary excretion, enterohepatic recirculation and 
principally to faecal excretion; humans excrete conjugated forms of BPA in the urine within 
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4. Mutagenicity and genotoxicity of BPA 
Nitrosylation reactions have been associated with the production of several carcinogens, 
many of which elicit cancers in humans and animals. 
Several mutagens have been found by nitrosation of phenol derivatives present in several 
foodstuffs, including soy sauce, smoked foods, etc. 
It has been proven that BPA can be activated into a mutagenic species through nitrosylation 
reactions, raising the possibility that migration of BPA from polycarbonate or epoxy-lined 
containers into nitrite-containing foodstuffs could lead to the formation of mutagenic 
compounds. There is also the possibility that ingestion of BPA in addition to a nitrite-rich 
diet could lead to the production of mutagens. However, this contribution of nitrosylated-
BPA is a new hypothesis of carcinogenesis that is still speculative. 
No epidemiological studies have found that BPA is correlated with cancer incidence in the 
human population, especially with gastric or oesophageal cancers that can be indicative of 
dietary exposure to nitrosylated mutagens. 
The native BPA is non-mutagenic, however the incubation of BPA with sodium nitrite in an 
acidic environment activates the BPA into a direct-acting frameshift type and base pair mutagen 
in a variety of sites of nucleic acid in the Ames Salmonella assay (Schrader et al., 2002).  
It has been stated that BPA is not likely to pose a genotoxic hazard to humans (FAO-WHO 
2010; Keri et al., 2007), although there is only limited data available on the genotoxicity of 
BPA in human cells (Takahashi et al., 2001).  
5. Carcinogenicity of BPA  
There are no human epidemiology studies in the existing literature that have produced 
relevant data for the assessment of the carcinogenic potential of BPA (Haighton et al., 2002). 
BPA may be associated with increased cancers of the haematopoietic system, breast and a 
significant increase in interstitial-cell tumours of the testes. DNA adducts generally are 
formed in target mammary cells. Although DNA adducts do not necessarily evolve into 
tumours or other chronic degenerative diseases, the formation of these molecular lesions in 
target mammary cells may have relevance for the potential involvement of BPA in breast 
carcinogenesis (Izzotti et al., 2009). In addition to forming DNA adducts itself, BPA may act 
indirectly by unbalancing oestrogen metabolism; these effects could be additive, increasing 
even further the risk of BPA to initiate cancer (Cavalieri & Rogan, 2010). 
BPA alters microtubule function and can induce aneuploidy in some cells and tissues. It has 
been speculated that the ability of BPA to induce aneuploidy may play a role in the 
development of cancer (Takahashi et al., 2001) but also low doses of BPA generate reactive 
oxygen species (ROS) by decreasing the activities of antioxidant enzymes and increasing lipid 
peroxidation, thereby causing oxidative stress in the liver of rats (Bindhumol et al., 2003). 
Extensive research has revealed that the oxidative stress can lead to chronic inflammation, 
which in turn could mediate most chronic diseases including cancer, diabetes and 
cardiovascular, neurological and pulmonary diseases. The oxidative stress activates the 
inflammatory pathways leading to transformation of a normal cell to tumour cell (Kamp et 
al., 2011; Reuter et al., 2010). 
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Early life exposure to BPA may induce or predispose to preneoplastic lesions of the 
mammary gland and prostate gland in adult mice, but this is not yet demonstrated in 
humans; also prenatal exposure to environmental doses of BPA alters the mammary gland 
development in mice, increasing the endpoints considered markers of breast cancer risk in 
humans. Investigators funded by the US National Institutes of Health (NIH) concluded that 
a strong correlation is found between the above-named exposure, cancer and early puberty. 
Several studies aimed at demonstrating the increases of some tumour types after BPA 
exposure were considered not to provide convincing evidence for carcinogenicity. 
BPA exposure during the perinatal period is important because it has been hypothesised 
that it could alter the prostate and mammary gland development, predisposing to neoplastic 
or preneoplastic conditions (see section 2.1.2) (EFSA; 2010; FAO-WHO, 2010). 
In any case the European Commission, in addition to known carcinogens, includes BPA in 
the lists of chemicals that are “of concern". 
6. Reproductive and developmental toxicity of BPA in mammalian species  
Emerging evidence has proposed a putative role for ubiquitous environmental 
contaminants in the occurrence of endometriosis. The mechanism of action may be carried 
out through the interaction with steroidal receptors, mimicking an oestrogenic effect 
(Cobellis et al., 2009). 
Bisphenol A has been proven to have oestrogenic activity, even at concentrations below 1 
ng/L. A study on mice revealed that a concentration of BPA as low as 20 ppm in drinking 
water is sufficient to bring about genetic changes in mice foetuses. The changes are a result 
of disturbance of the distribution of chromosomes in the daughter cells (Rykowska & Wasiak, 
2006). The US Center for the Evaluation of Risks to Human Reproduction concluded in 2008 
that there is “some concern for effects on the brain, behaviour, and prostate gland in foetuses, 
infants, and children at current human exposures to bisphenol A”. 
Several governing agencies, recently, have identified an oral reproductive and 
developmental NOAEL of 50 mg/kg bw per day (FAO-WHO, 2010). 
7. Conclusions 
Much remains to be learned about the effects of BPA environmental exposure on cancer risk. 
Based on what is known, however, there is much that governments and industry can do 
now to address or prevent environmental cancer risk. 
At the same time, individuals can take important steps in choices of lifestyle to reduce their 
exposure to environmental elements that increase risk of cancer and other severe diseases. 
Furthermore, the individual’s small actions, if considered collectively, can drastically reduce 
the number and levels of environmental contaminants. 
Some alternatives to BPA-containing materials for PC bottles and containers, and epoxy can 
linings are available on the world's market or proposed for domestic use. The functionality 
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However, as it appears that it will not be possible to identify a single replacement for all 
uses of BPA, particularly for can coatings, the problem is still open. 
Due to the gaps in the current literature, it is premature to conclude that BPA is certainly a 
carcinogenic, however, the evidence suggests that BPA increases cancer susceptibility 
through developmental reprogramming and changes in target organ morphogenesis as a 
result of epigenetic alterations. It is important to underscore that studies examining changes 
in carcinogenic susceptibility have only focused on the mammary and prostate glands, two 
obvious targets of potential endocrine disruption, but it is necessary to include vagina, 
uterus, ovary and testes. 
Usually, the main exposure route for humans to low environmental doses of BPA is orally. 
There is no doubt that BPA is an environmental pollutant, although it is not yet considered a 
carcinogen, therefore the ALARA (As Low As Reasonably Achievable) concept should be 
employed for protection of consumers and the general population. 
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1. Introduction 
A number of breakdowns in human’s health including cancer have been attributed to the 
exposure of environmental pollutants, and it became imperative to check the potential 
toxicity, mutagenicity or carcinogenicity of a number of chemicals. The tests designed for 
such studies are divided into long-term and short-term assays. 
Long-term tests are bioassays for carcinogenicity using animals (mainly rats or mice) as 
testers. Targets of the carcinogenic action are either organs or the whole body of the tester 
animal studied by dissection and histochemical analysis. These bioassays are not suitable for 
the study of a large number of substances because they are time consuming, expensive, 
require special facilities and qualified personal. A full long-term assay is completed in an 
average period of two years which stimulated the development of medium-term bioassays 
(Ito et al. 1998). These assays determine formation of neoplasms in various tissues of rats or 
mice within a period of 12-18 months. However, the existence of thousands genotoxins with 
potential carcinogenic effect requires the application of much faster assays and short-term 
tests have been developed and widely used. According to the timeframe required to obtain 
results in an assay, the transgenic mouse systems are intermediate between long-term and 
short-term tests. Although designated as “short-term bioassays” (Tennant et al. 1995) results 
from these tests are obtained in 4-6 months. The modified genes of transgenic animals cause 
them to respond rapidly to carcinogens (Cannon et al. 1997). Transgenic mouse systems are 
statistically reliable in vivo assays and the positive results obtained in the tests are highly 
predictive of rodent carcinogenicity. 
1.1 Advantages of short-term tests  
Short-term tests identify genotoxic agents by detecting the three major end-points associated 
with human cancer diseases: gene mutation, clastogenicity and aneuploidy. The main value 
of the short-term tests lies in their ability to identify chemicals that may cause cancer under 
certain exposure conditions. More than 200 in vitro and in vivo short-term assays have been 
developed using bacteria, yeast, cultured mammalian cells and insects as testers. Most of the 
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testers are engineered to detect one genetic end-point, such as mutations, deletions, genome 
rearrangements, loss of chromosomal fragment or whole chromosome.  Tester strains were 
also constructed for simultaneous detection of several end-points. Typical example is the 
Saccharomyces cerevisiae D7 tester strain (Zimmermann et al. 1975) for detection of mitotic 
crossingover, gene conversion and reverse mutation. The current status of short-term tests 
for evaluation of genotoxicity, mutagenicity and carcinogenicity of chemicals and 
environmental pollutants has been recently reviewed (Bajpayee et al. 2005).  
Generally, the short-term tests are rapid, inexpensive and easy to perform: results from 
bacterial tests are obtained in 3-4 days, and mammalian cell based assays are accomplished 
in about 10 days. Some bacterial cell-based assays are commercially available with results 
obtained in few hours. However, the advantage of having a fast procedure is compensated 
by the high unspecificity of the positive response: these tests detect all kind of DNA-
damaging agents. Together with the possibility to analyze several samples simultaneously, 
these mentioned characteristics seem to be the main advantage of short-term tests. The 
mouse lymphoma assay and Chinese hamster ovary assay (Clive et al. 1979; Li et al. 1987) 
can detects genetic damages in viable cells capable of forming colonies, which permits the 
automatization of the methods. Cultured mammalian cells (in vitro) or bone marrow cells of 
rodents (in vivo) have been developed to study clastogenic response by analyses of 
chromosomal aberrations in metaphase cells or micronucleus formation. The micronucleus 
test (Neri et al. 2003) can be used along with kinetochore and centromeric staining to 
categorize the test compound as a clastogen or aneugen (Parry et al. 2002). Recently, the 
single cell gel electrophoresis (comet) assay gained popularity due to its rapidity and low 
cost (Singh et al. 1991). This assay can be performed both in vivo and in vitro to detect 
substantial DNA damages leading to fragmentation of the target DNA. 
A significant advance was the development of cell transformation assays for a specific 
detection of carcinogens or to study the process of neoplastic transformation. The Syrian 
hamster embryo cell system (Le Boeuf et al, 1999) detects carcinogens within 10 days and 
has the advantage to be the only transformation system that employs normal diploid cells 
capable of metabolizing a wide spectrum of pro-carcinogens to their active form. The 
BALB/c3T3 mice cell system is based on a spontaneously immortalized cell line showing 
high sensitivity to transformation. Improvements of the assay showed a concordance of 
73.5% with long-term bioassay (Kajiwara et al., 1997). 
In conclusion, results from several appropriately selected short-term tests is now considered 
equivalent to the predictive value of a long-term bioassay. Short-term tests not only save 
time and expenses but also cut down the animal experimentation. 
1.2 Disadvantages of short-term tests 
The results of collaborative studies and the data accumulated, evidence that at present no 
single short-term assay can detect all genotoxic substances and discriminate 
noncarcinogenic mutagens from carcinogens. It is now accepted that batteries of tests have 
to be used in the study of mutagenic and/or carcinogenic properties of each potential 
genotoxin. Recommendations were made for strategies in testing which include several 
stages (usually three), each one consisting of 2 to 4 different assays and some of the tests 
(like the Salmonella mutagenicity test) have to be performed with 3-5 tester strains (Bajpayee 
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et al. 2005; Eastmond et al. 2009). The necessity to perform a number of assays depreciates 
the main advantage of short-term tests – their rapidity and low cost. Short-term assays are 
used to study toxicity, mutagenicity and carcinogenicity of substances, however, the deep 
concern in such studies is mainly the presence of carcinogenic properties in pesticides, 
drugs, industrial wastages as well as pollutants of environment. Therefore, the need of 
having a short-term test for detection of carcinogenic activity in the start of testing for 
chemical risk assessment still exists. The cell transformation assays use the induction of 
certain phenotypic alterations that are related directly to neoplasia. The disadvantages of the 
assays seem to be the instability of the cell cultures used. Special precautions should be 
made to avoid culture and cell variations from different embryos and to maintain cells with 
the original karyotype. Therefore, the cell transformation assays can be successfully 
performed only in specialized laboratories by well trained personnel.  
The in vitro mammalian cell assays detect a number of DNA damages in well characterized 
genes used as markers. However a correlation between the positive results and 
carcinogenicity is not always foolproof. There is increasing evidence that carcinogens acting 
through nongenotoxic mechanisms are not detected in these assays (Bajpayee et al. 2005). 
The interpretation of results from other assays may be also difficult. Thus, the chromosomal 
aberration in vitro assay is affected by artifacts due to cytotoxic doses of the studied 
compound, extreme pH values and metabolic activation that give false-positive results 
(Galloway 2000; Scott et al. 1991). The in vivo chromosomal aberration assay (Johnson et al. 
1998) is used mainly for diagnosis, development and spread of tumors, rather than for 
screening studies (Szeles 2002). False-positive results can also be obtained with sister 
chromatide exchange measuring assays, since the majority of them do not represent genuine 
mutational events and are due to exchanges occurring in nonhomologous loci (Rodriguez-
Reyes & Morales-Ramirez 2003).  
The induction of micronuclei is related to dysfunction of spindle apparatus or formation of 
acentric fragments. Carcinogens give rise to these lesions during G1 to S phase transition of 
the cell cycle. The formation of micronuclei takes place in subsequent cell cycles and 
therefore one cell cycle is allowed between treatment and harvesting of cells. At shorter 
sample intervals micronuclei are not detected and at longer sampling time micronuclei are 
diluted and difficult for detection. Thus, results in the micronucleus test are greatly 
influenced by the time of treatment and sampling in relation to the cell cycle.  
Some disadvantages of the comet assay have also been found. The main are: variations of 
results obtained because of the small cell sample, rate limiting of results due to the analysis 
of single cells, different interpretation of results due to variability in technical performance 
and cells utilized. Beside, the comet assay detects significant damages that result in DNA 
fragmentation and degradation usually associated with cell death (Split & Hartmann, 2005). 
Therefore this assay is less suitable for monitoring mutagenicity and clastogenicity of 
genotoxins.  
In conclusion, most of the short-term tests have one genetic end-point associated with the 
activity of some, but not all carcinogens in the multistage process of differentiation the 
normal into malignant cells. Because of this, no one short-term test can detect all carcinogens 
and the usage of batteries of assays is recommended, which compromises the main 
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having the process of neoplastic differentiation as an end-point are high tech methods 
requiring well equipped and specialized laboratories. 
2. The Ty1 retrotransposon of saccharomyces cerevisiae is very similar to 
oncogenic retroviruses 
Transposons are mobile DNA elements that replicate independently of the cellular genome 
and transpose the new copy into different places of nuclear DNA by nonhomologous 
recombination. They are ubiquitous from bacteria to human cells with a clear tendency to 
increase their copy number in higher eukaryotes: 45% of human DNA represents 
transposons and their remnants. Mobile elements that transpose to new sites in the genome 
via RNA intermediate are called retrotransposons because in many aspects they are 
analogous to the retroviruses, such as equine anemia virus, human immunodeficiency virus 
type 1 (HIV-1), yeast Ty1 transposon ect. (Garfinkel et al. 2006). Retroelements have been 
extensively studied in the yeast S. cerevisiae. Five distinct families of retrotransposons exists 
in this organism, named Ty1 to Ty5. Ty1 elements are the most abundant (33 copies per 
haploid genome), most highly expressed and most transpositionally active.  
The structures of Ty1 retrotransposons and oncogenic retroviruses are very similar and 
consist of long terminal repeats (LTR) flanking a central coding domain including gag and 
pol genes (Figure 1). In the case of infectious retroviruses, an env gene is also present. The 
gag gene encodes structural proteins that form the retrotransposon virus-like particles 
(VLP), or the retroviral core particles, while the pol gene encodes the enzymes protease (PR), 
reverse transcriptase (RT) and integrase (IN). LTR retrotransposons and retroviruses are 
transcribed by RNA polymerase II from LTR to LTR to form a terminally redundant RNA 
molecule which is translated and packaged into the virion core particle or VLP. 
Translation of Ty1 mRNA initiates close to its 5’end (Figure1). Like retroviruses, Ty1 
elements employ translational frameshifting at the beginning of pol gene to regulate the 
expression of gag and pol gene products. The two open reading frames are overlapping and 
separated by a +1 frameshift occurring within a highly conserved sequence. The primary 
translation products are Gag-p49 and GagPol-p199 that are cleaved by PR to form mature 
Gag-p45, PR-p20, IN-p71 and RT-p63. The endogenous protease PR of Ty1 and retroviruses 
employs an aspartic residue in its catalytic centre. Finally, the processed subunits are 
assembled in VLPs where Ty1mRNA is used by RT as a template to generate double 
stranded Ty1 copyDNA that can be integrated by IN at new sites within the genome. The 
integration of the new Ty1 copy is often accompanied by the appearance of mutations, 
deletions, insertions, gene conversions, inversions or large genome rearrangements which 
labilize the structure of the host genome and may cause partial or complete loss of 
chromosomes (Garfinkel 2005). It should be noted that similar labilization of genome 
structure accompanied with chromosome loss occurred frequently during neoplastic 
differentiation of mammalian cells (Jeronimo et al. 2001). 
The analysis of large variety of target sites has shown that 5’ flanking regions of tRNA genes 
are the preferred target sites for Ty1 transposition (Mewes et al. 1997). Since the upstream 
regions of tRNA genes do not contain any special DNA sequences, the region-specific 
integration may be due to specific interactions of Ty1 integrase with the genome structure 
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formed over the promoter elements of the tRNA gene (Nyswaner et al. 2008). Thus, Ty1 
integration does not involve specific nucleotide sequence but a particular chromatine 
structure has the dominant role. 
 
Fig. 1. Expression of Ty1 retrotransposon 
Despite the high levels of Ty1 mRNA, transposition occurs at low level (10-5-10-
7/cell/generation), cells contain low amount of mature Ty1 proteins and few VLPs are 
present. The balance needed between the level of de novo transposition and the Ty1 activity 
that can be tolerated by host yeast cell is reached by (1) a mechanism of transposition to 
specific target sites (upstream of tRNA genes), which are less hazardous for the cell because 
are devoid of protein coding function and, (2) regulatory mechanisms, that restrict Ty1 
transposition to a low level. Both of these mechanisms lead to a decrease of successful Ty1 
transpositions, thus saving the host from dangerous damages of DNA that may appear in 
the target site and result in labilizing the integrity of the genome.  
The mobility of Ty1 retrotransposons is restricted by a large collection of proteins that 
preserve the integrity of the genome. Most of these repressors of transposition (Rtt) are 
ortologs of mammalian retroviral restriction factors (Curcio et al. 2007). The Rtt integrity 
factors inhibit transposition at posttranscriptional steps resulting in low level of Ty1 
copyDNA. Two checkpoint pathways, the replication stress pathway and the DNA damage 
pathway, are involved in this type of Ty1 regulation in a cell-cycle dependent manner. 
Earlier studies (Staleva & Venkov 2001) also evidenced the dependence of Ty1 transposition 
upon transit through the cell cycle and RAD9 gene product, which is a member of DNA 
damage signal transduction pathway. The protein product of RAD9 checkpoint gene is the 
yeast functional counterpart of the human oncogene suppressor protein p53, which has 
among its functions monitoring the integrity of the genome and the delay of DNA 
replication until repair has been completed (Bertram 2001). These data suggest the existence 
of similarities in certain steps in regulation of Ty1 transposition and the neoplastic cells.  
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The analogy between Ty1 retrotransposons and retroviruses was recently confirmed in 
studies dealing with details in the mechanisms of their replication. The human APOBEC3G 
protein is similar to the APOBEC proteins of other eukaryotes and has been shown to inhibit 
the replication of Ty1 retrotransposon and retrooncoviruses. In all studied retroelements this 
inhibition represents a deamination of cytosines to uracils in copyDNA, which leads to 
degradation of the retroelement genome. An absolute requirement for a glutamate (E250Q) 
in the catalytic center of the different APOBEC proteins was found evidencing that DNA 
cytosine deamination is part of a mechanism, that restricts successful replication of Ty1 
retrotransposons and retroviruses (Schumacher et al., 2008).  
The surprising similarities between Ty1 retroelements and retroviruses become more 
understandable by the results obtained in phylogenetic studies (Llorens et al. 2009). The 
usage of combined graph and phylogenetic analysis based on genome sequencing data 
made possible the evolutionary history of LTR retroelements to be traced as a time-evolving 
network. The results obtained show that the Ty1 family represents the oldest pattern in this 
network and that diverse retroviruses evolve from LTR retrotransposons. 
Mobile elements has a significant influence on evolution. Sequencing of diverse genomes 
reveals, that about half the spontaneous mutations in Drosophila result from insertions of 
mobile elements. In mammals mobile elements cause a smaller proportion of spontaneous 
mutations – 10% in mice and 0.2% in humans. It is presumed that mobile genetic elements 
have contributed to the evolution by promoting the creation of new genes with mutations 
favoring the adaptation (Garfinkel 2005). Thus, mobile genetic elements are probably one of 
the most powerful endogenous factors driving the evolution of all forms of life on earth.  
In conclusion: according to genome structure, gene expression, life cycle, regulation of gene 
expression and evolutionary history, Ty1 retrotransposons are very similar to the oncogenic 
retroviruses, except for the absence of an infectious extracellular phase in their life cycle. 
3. The Ty1 transposition test 
Stress conditions, such as exposure to UV light (Rolfe & Banks 1986), low temperature 
treatment (Paquin & Williams 1984; Stamenova et al. 2008), severe adenine starvation 
(Ribero-dos-Santos et al. 1997) increase Ty1 transposition frequency. Chemical carcinogens 
can also increase transposition rate (Bradshow & McEntee 1989; Staleva & Venkov 2001). 
This, and the similarity in structure, gene expression and regulation reaching full analogy at 
certain points between Ty1 retrotransposons and oncogenic retroviruses suggested that the 
carcinogen-induced Ty1 transposition may be used for detection of carcinogenic genotoxins 
and substantiated the development of the Ty1 short-term test. 
3.1 Construction of the tester strain 
Two features have been considered important in the construction of the tester strain: (1) easy 
phenotypic detection of retrotransposition events and (2) increased permeability of tester 
yeast cells to carcinogens. 
The indicator gene HIS3AI developed by Curcio & Garfinkel (1991) fulfills the first 
requirement. This reporter gene represents the S. cerevisiae HIS3 gene interrupted by an 
artificial intron (AI) in the antisense orientation. The HIS3AI construction was inserted into a 
 
The Ty1 Retrotransposition Short-Term Test for Selective Detection of Carcinogenic Genotoxins 
 
89 
Ty1 element with the intron on the sense strand of Ty1 and the marked Ty1 retrotransposon is 
integrated into the genome of a S. cerevisiae strain with deleted HIS3 gene (Curcio & Garfinkel 
1991). Thus, a successful transposition of the marked Ty1 element requires transcription, 
splicing the artificial intron, encapsulation in VLPs where Ty1 mRNA is reverse transcribed to 
give Ty1 copyDNA with functional HIS3 gene. Every integration of this Ty1 copyDNA gives 
rise to one His+ colony on selective medium lacking histidine. In contrast to other methods for 
determination of Ty1 transposition only in specific target loci (Ribeiro-dos-Santos et al., 1997), 
the usage of HIS3AI indicator gene permits tracing the Ty1 transposition in the genome as a 
whole. Another advantage of HIS3AI construction is that it allows direct selection of Ty1 
transposition events in a single-step test. Since the number of His+ transposants correlates 
directly with the number of transposition events for the marked Ty1 element, the usage of 
HIS3AI construction allows a quantitative determination of the transposition events. We used 
HIS3AI indicator gene for constructing the tester strain of Ty1 short-term test.  
Yeast cells have been used to develop a variety of systems monitoring mutagens and 
carcinogens. Few of these tests, however, have an application in laboratory or 
environmental studies. The main reason seems to be the lower response of yeast cells as an 
indicator organism, due to limited uptake of genotoxins (Parry 1976), because of low 
permeability of S. cerevisiae cells (Morita et al. 1989). We overcome the natural inertness of 
yeast cells to mutagens and carcinogens by constructing a tester strain with increased 
cellular permeability. Previous studies revealed that a temperature-sensitive mutation, 
initially designated ts1, causes an increased cellular permeability of S. cerevisiae to different 
substances, including mutagens and carcinogens (Staleva et al. 1996). Cloning and 
sequencing showed that the TS1 gene is the previously isolated SEC53 gene and the ts1/sec53 
mutant allele represents a change of CCA to CTA (proline to leucine) at the 5’end of the 
gene (Staleva 1998). The essential SEC53 gene codes for phosphomannomutase required in 
an early step in the pathway of O- and N-linked mannosylation (Kepes & Schekman 1988). 
Since the permeability barrier of S. cerevisiae is determined by the most superficial layer of 
the cell wall composed of highly glycosylated mannoproteins (Zlotnik et al. 1989), the 
impairment of protein glycosylation in sec53 mutant cells results in formation of a 
permeability barrier with insufficient functions.  
 
Strain Cell wall porosity after cultivation at: 
23°C 30°C 
550 (SEC53) 25.58 ± 3.47 23.96 ± 4.86 
551 (sec53) 29.25 ± 5.83 93.85 ± 7.22 
 Transformation with plasmid DNA 
(transformants per 1μg DNA) 
 +LiAc -LiAc 
23°C 30°C 23°C 30°C 
550 (SEC53) 1820 ± 43 2024 ± 18 0 0 
551 (sec53) 1682 ± 67 2120 ± 31 2 ± 1 172 ± 44 
LiAc –Lithium Acetate 
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Average values ± SD of 6 experiments. The porosity of cell wall was calculated as 
percentages following the recommendations of the authors (DeNobel & Barnett, 1991). The 
transformation procedure (Ito et al., 1983) with YCP50 plasmid DNA was used to obtain 
Ura+ transformants.  
The replacement of SEC53 gene in the tester strain with the sec53 mutant allele was 
performed by means of the two-step gene replacement method (Sherman et al. 2001). 
Briefly, the sec53 allele was cloned in an integrative URA3-marked vector, restricted in the 
unique AlfII site of the SEC53 gene and tester cells were transformed to give Ura+ 
integrative transformants. Strains having the sec53 allele instead of the SEC53 wild type gene 
were selected (Pesheva et al. 2005), one of the selected transformants was named S. cerevisiae 
551 and used as a tester strain in the Ty1 assay. Its genotype is: MATα ura3 his3∆200 
TymHIS3AI sec53, rho+. The S. cerevisiae 551 strain is deposited with №8719 into the National 
Bank for Industrial Microorganisms and Cell Cultures (Sofia, Bulgaria). 
The temperature of 37°C is nonpermissive for both, Ty1 transposition (Paquin & Williams, 
1984) and the growth of cells having the sec53 temperature sensitive mutant allele. 
Cultivated at the semirestrictive temperature of 30°C, tester cells are growing exponentially 
with generation time of about 150 min in YEPD liquid medium and partial expression of the 
sec53 phenotype. Significantly lower survival rates due to increased uptake of genotoxic 
substances were obtained for S. cerevisiae 551 cells grown at 30°C and treated with a variety 
of genotoxins compared to the isogenic SEC53 harboring cells at equal concentrations of the 
chemicals. Direct evidence for increased permeability of yeast cells were obtained using the 
porosity test (DeNobel & Barnett 1991) and the transformation procedure with plasmid 
DNA (Ito et al., 1983). A fourfold increase in porosity was found only for S. cerevisiae 551 
cells cultivated at 30°C (Table1). The porosity of the isogenic S. cerevisiae 550 cells (having 
the wild type SEC53 gene) remained identical after cultivation at 23°C or 30°C. The 
increased permeability of S. cerevisiae 551 cells was also confirmed by their transformability 
with plasmid DNA. Wild type yeast cells are not permeable for plasmid DNA and in order 
to be transformed, the permeability of intact S. cerevisiae cells is increased by treatment with 
lithium acetate (Ito et al. 1983) or the cells are converted to spheroplasts. We obtained 
relatively high frequency of transformation (5-6%) for intact 551 cells grown at 30°C and not 
treated with lithium acetate (Pesheva et al. 2005). Transformants were not obtained from 550 
cells without lithium acetate treatment either at 23°C or at 30°C, as expected. All these 
results evidence an increased cellular permeability of S. cerevisiae 551 cells at 30°C due to the 
sec53 mutation and supported the usage of S. cerevisiae 551 as a tester strain in the Ty1 short-
term assay. 
3.2 The Ty1 transposition test: A laboratory protocol 
1. S. cerevisiae 551 cells are cultivated at 30°C in water bath shaker in YEPD liquid medium 
(the recipes of used media are given in Sherman et al. 2001) to a density of 5-
7x107cells/ml. 
2. The culture is divided into samples of 4ml and appropriate concentrations of the 
studied genotoxins added. Water insoluble substances are dissolved in 
dimethylsulfoxide (Me2SO) or ethanol and used in volumes not exceeding a final 
concentration of 5% of Me2SO or ethanol. The control samples are treated with the same 
volume of the solvent. 
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3. Samples are cultivated at 30°C for 30 min in water bath shaker; cells are washed with 
YEPD liquid medium by centrifugation and suspended in 4ml fresh YEPD medium. 
4. Cells are cultivated at 20°C in water bath shaker for 24h to complete initiated Ty1 
transposition events. As it will be shown later on the cultivation at 20°C results in about 
5 fold higher rate of successful transpositions relative to cultivation at 30°C. 
5. Appropriate dilutions (usually 10-4-10-5) are made in sterile water and 0.1ml is plated on 
each YEPD plate. Use at least five YEPD plates to determine cell titer of survivals for 
control and for each concentration of the genotoxin. 
6. The remaining part of each sample is centrifuged; cells are washed twice with sterile 
water and suspended in 3.9ml of water. Ten SC-His plates are plated with 0.2ml 
suspension per plate to determine the number of His+ transformants for controls and 
for each concentration of the genotoxin. 
7. Plates are incubated at 30°C for 3 days (YEPD plates) or 5 days (SC-His plates) and 
colonies are counted. 
8. Median transposition rates are determined by the equation: 
Fold Increase = Fts/Ftc, where 
Number of His transposansof treatedcultureFts
Number of survivorsdevidedby fold dilutionof treatedculture

  
Number of His transposansof controlcultureFtc
Number of survivorsdevidedby fold dilutionof controlculture

  
Results can also be presented as “fold increase” of Ty1 transposition rates relative to the rate 
of transposition in the control sample taken as a fold increase of 1.0. A fold increase equal or 
higher than 2.0 is considered as a positive response of the Ty1 short-term test. 
Note: When metabolic activation is needed to convert pre-mutagens and pre-carcinogens to 
their active forms, S9 mix is added to samples 60 min before the treatment with genotoxins. 
S. cerevisiae cells have cytochrom P450 and P488 required for the metabolic activation of pre-
genotoxins. The activation of this intrinsic metabolic system can be achieved by switching 
cells growing in low dextrose (0.2%) to high dextrose (10%) YEPD liquid medium (Kelly & 
Perry 1983). After 3-4 generations in the high dextrose medium cells can be used in the Ty1 
test without addition of an exogenous S9 mix and the presence of S9 mix does not change 
the results obtained. The change from low to high dextrose medium is made in a very early 
exponential growth phase (about 2x107cells/ml) to allow for several generations before the 
treatment with pre-genotoxins. 
4. Response of Ty1 test to laboratory genotoxins 
Laboratory genotoxins with different structure and mode of action have been used to study 
the main characteristics of the Ty1 short-term test.  
4.1 Increased sensitivity of Ty1 test 
Benzo(a)pyrene [B(a)P] although being a very active agent in the Salmonella system, does not 
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3. Samples are cultivated at 30°C for 30 min in water bath shaker; cells are washed with 
YEPD liquid medium by centrifugation and suspended in 4ml fresh YEPD medium. 
4. Cells are cultivated at 20°C in water bath shaker for 24h to complete initiated Ty1 
transposition events. As it will be shown later on the cultivation at 20°C results in about 
5 fold higher rate of successful transpositions relative to cultivation at 30°C. 
5. Appropriate dilutions (usually 10-4-10-5) are made in sterile water and 0.1ml is plated on 
each YEPD plate. Use at least five YEPD plates to determine cell titer of survivals for 
control and for each concentration of the genotoxin. 
6. The remaining part of each sample is centrifuged; cells are washed twice with sterile 
water and suspended in 3.9ml of water. Ten SC-His plates are plated with 0.2ml 
suspension per plate to determine the number of His+ transformants for controls and 
for each concentration of the genotoxin. 
7. Plates are incubated at 30°C for 3 days (YEPD plates) or 5 days (SC-His plates) and 
colonies are counted. 
8. Median transposition rates are determined by the equation: 
Fold Increase = Fts/Ftc, where 
Number of His transposansof treatedcultureFts
Number of survivorsdevidedby fold dilutionof treatedculture

  
Number of His transposansof controlcultureFtc
Number of survivorsdevidedby fold dilutionof controlculture

  
Results can also be presented as “fold increase” of Ty1 transposition rates relative to the rate 
of transposition in the control sample taken as a fold increase of 1.0. A fold increase equal or 
higher than 2.0 is considered as a positive response of the Ty1 short-term test. 
Note: When metabolic activation is needed to convert pre-mutagens and pre-carcinogens to 
their active forms, S9 mix is added to samples 60 min before the treatment with genotoxins. 
S. cerevisiae cells have cytochrom P450 and P488 required for the metabolic activation of pre-
genotoxins. The activation of this intrinsic metabolic system can be achieved by switching 
cells growing in low dextrose (0.2%) to high dextrose (10%) YEPD liquid medium (Kelly & 
Perry 1983). After 3-4 generations in the high dextrose medium cells can be used in the Ty1 
test without addition of an exogenous S9 mix and the presence of S9 mix does not change 
the results obtained. The change from low to high dextrose medium is made in a very early 
exponential growth phase (about 2x107cells/ml) to allow for several generations before the 
treatment with pre-genotoxins. 
4. Response of Ty1 test to laboratory genotoxins 
Laboratory genotoxins with different structure and mode of action have been used to study 
the main characteristics of the Ty1 short-term test.  
4.1 Increased sensitivity of Ty1 test 
Benzo(a)pyrene [B(a)P] although being a very active agent in the Salmonella system, does not 





taken up by yeasts due to the limited permeability of cells. The results obtained in the Ty1 
test (Table 2) show that this is true when S. cerevisiae 550 cells with wild type of SEC53 gene 
are used as testers. However, if S. cerevisiae 551 (sec53) strain was used, the Ty1 test responds 
to increased concentrations of B(a)P with enhanced rate of Ty1 transposition. The positive 
answer of the test appears at low concentrations of B(a)P having negligible effect on cell - 
survival and the fold increase of Ty1 transposition rates enhanced in a concentration 










551 (sec53) 0 - 100 1.00 0.048 
 0 + 100 1.00 0.054 
 0.08 - 105 0.71 0.045 
 0.08 + 91 4.87 0.581 
 0.16 - 85 1.41 0.080 
 0.16 + 80 9.18 1.221 
 0.32 - 63 2.00 0.080 
 0.32 + 56 18.41 2.450 
551+NaN2b) 0.15 - 38 1.22 0.063 
550 (SEC53) 0 - 100 1.00 0.040 
 0 + 100 1.00 0.045 
 0.08 - 98 1.27 0.061 
 0.08 + 102 1.18 0.082 
 0.16 - 105 1.85 0.062 
 0.16 + 95 2.00 0.079 
 0.32 - 88 1.67 0.055 
 0.32 + 82 2.50 0.121 
550+NaN2b) 0.15 - 52 1.25 0.068 
Typical results from one out of six identical experiments 
a) Amount of superoxide anion (O2·-) in pM per one cell determined by the method described in 
Stamenova et al. (2008) 
b) Cells treated only with NaN2 
Table 2. Increased sensitivity of Ty1 test to metabolically activated B(a)P 
Similar increase in the values of Ty1 transposition rates was also found in kinetic 
experiments where cells were treated for periods of 15 to 90 minutes. The positive answer of 
Ty1 test is not due to the stress conditions generated by the increased cellular toxicity at 
higher concentrations of B(a)P, since treatment with NaN3, a powerful cell poison, had no 
effect on Ty1 transposition. Similar positive responses of the Ty1 test were found in 
concentration dependent and kinetic experiments with a number of carcinogenic genotoxins 
showing low response in tests based on wild type of yeast cells (Dimitrov et al., 2011; 
Pesheva et al., 2005; 2008; Staleva & Venkov 2001). 
4.2 The Ty1 test responds positively only to active carcinogens 
B(a)P is a pre-carcinogen which has to be metabolically activated in order to produce its 
effect in the cell. The Ty1 test used with the highly permeable 551 strain as tester cells did 
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not respond positively after treatment with B(a)P in absence of S9 mix (Table 2). The 
percentage of cells that survived this treatment decreases with increasing B(a)P 
concentration suggesting that ones inside cells the pre-carcinogen has a toxic effect which 
however is not an inducer of Ty1 transposition. The Ty1 test was positive with B(a)P and 
different other pre-carcinogens only in presence of S9 metabolizing mix (Dimitrov et al. 
2011; Pesheva et al. 2005; 2008). These results evidence that the sec53 mutation in S. cerevisiae 
551 tester strain increases the sensitivity of Ty1 test due to increased permeability of cells. In 
addition, the positive response of the test to active carcinogens and the negative results 
obtained with pre-carcinogens suggest a specificity of the test response to the active forms of 
the genotoxins. 
4.3 The Ty1 test is positive with carcinogens not detectable in the other short-term 
tests 
Every short-term test has a range of carcinogen’s detection and the usage of batteries of tests 
extends the limits of detection. Nevertheless, a fraction of genotoxins with carcinogenic 
potential proved in long-term experiments did not induce any short-term assay tested up to 
the maximum solubility and the reasons for this are not known (Ramel et al. 1996). We 













Control - 100 25 ± 5 1.0 0.045±0.001 
Carcinogens negative in Salmonella tests 
Acetamide 34 60 172 ± 18 7.82 0.284±0.041 
Thioacet-amide 13 71 182 ± 24 8.23 0.315±0.048 
Dichloro-
methane 
10 58 193 ± 31 8.76 0.421±0.055 
Carcinogens negative in all short-term tests 
Furfuryl alcohol 5 45 110 ± 8 5.0 0.470±0.028 
Tetrahydro-
furan 
5 58 121 ± 12 5.5 0.520±0.055 
tert-butyl-
hydroquinone 
0.05 53 134 ± 16 6.1 1.020±0.099 
Noncarcinogenic mutagens 
5-bromuracil 52 50 33 ± 4 1.5 0.050±0.015 
Benzo(e) 
pyrenea) 
160 61 41 ± 6 1.9 0.068±0.005 
Anthracenea) 34 72 26 ± 7 1.2 0.048±0.010 
Average values ± SD of 5 experiments 
a)Benzo(e)pyrene and anthracene were dissolved in Me2SO and tested in presence of S9 mix of Ty1 test 
did not result from secondary effects of dying cells and the test responds positively to some carcinogens 
not detectable by the other short-term assays. 
Table 3. Wider range of Ty1 test in carcinogen’s detection 
Furfuryl alcohol, tetrahydrofuran and tert-butylhydroquinone which are carcinogens not 
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al., 2011;Pesheva et al. 2005). With increasing the time of exposure (15 to 45 min) the 
frequency of Ty1 transposition steadily increased and reached a plateau suggesting saturation 
of transposition rates. After 30 min exposure to different concentrations, the tester cells 
exhibited a dose response with an increase at higher concentrations of the carcinogens. The 
induction of Ty1 transposition (fold increase >2.0) started before significant cell death become 
apparent. Based on these data, it is concluded that the carcinogen-stimulated positive response 
to some carcinogens not detectable by the other short term assays.  
Negative results in Ty1 test were obtained with 5-bromuracil, anthracene and 
benzo(e)pyrene [B(e)P] which are mutagens without carcinogenic potential (Table 3). The 
positive results in Ty1 test found for a number of carcinogens, the specific test response to 
only metabolically activated carcinogens and the absence of response to noncarcinogenic 
mutagens suggested that Ty1 test may have the ability to differentiate carcinogens from 
mutagens without carcinogenic properties.  
 









H2O - 100 1.0 0.048±0.009 
Me2SO 5% 98 1.1 0.058±0.010 
Carcinogens 
B(a)A 26 57 14.5 2.450±0.205 
CDH 1000 48 16.0 2.851±0.221 
LH 1000 53 22.0 3.446±0.255 
CrVI 5 54 47.3 4.405±0.366 
Noncarcinogenic mutagens 
B(b)A 26 70 1.8 0.068±0.005 
TDH 1000 61 1.8 0.045±0.009 
GDH 1000 80 1.5 0.058±0.010 
CrIII 5 59 1.3 0.031±0.005 
Average values of 6 experiments 
Me2SO – dimettylsulfoxide; B(a)A – benzo(a)anthracene; B(b)A– benzo(b)anthracene; CrVI – hexavalent 
chromium; CrIII – trivalent chromium; CDH – chenodeoxycholic bile acid; LH – lithocholic bile acid; 
TDH - taurodeoxycholic bile acid; GDH- glycodeoxycholic bile acid 
a)CrVI and CrIII were dissolved in water; all the other genotoxins were dissolved in Me2SO and tested in 
the presence of S9 mix 
Table 4. Selective response of Ty1 test to carcinogens 
4.4 Selective response of Ty1 test to carcinogens 
The possibility that Ty1 test may have a selective positive response to carcinogens was 
studied using pairs of genotoxins with close to identical chemical structure: the one being 
strong carcinogen and the second having only mutagenic properties without being a 
carcinogen. One such pair is the well known carcinogen B(a)P and the B(e)P which is a 
noncarcinogenic mutagen. The carcinogenic status of all compounds used in our studies was 
according to YARC (1990) and recent publications in the field (Donkin et al. 2000). As it was 
already shown (Tables 2, 3) B(a)P induces strong positive answer in Ty1 test, while B(e)P 
was without effect on Ty1 transposition rate.  
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Benzo(a)anthracene [B(a)A] and benzo(b)anthracene [B(b)A] represent another pair of 
genotoxins studied in the Ty1 test (Dimitrov et al.,2011; Pesheva et al. 2008). B(a)A is 
assessed as carcinogenic for animals and humans while B(b)A is a non-carcinogenic 
mutagen (Salamone 1981). The study of these genotoxins in the Ty1 test (Table 4) showed a 
strong positive answer for the carcinogenic B(a)A and negative result (fold increase < 2.0) 
for the noncarcinogenic mutagen B(b)A. Table 4 shows results obtained at equimolar 
concentrations and the absence of positive test-response was also found for higher 
concentrations of B(b)A killing up to 70% of tester cells. 
Considerable evidence support the view that free, but not conjugated, bile acids are 
carcinogenic in humans (reviewed in Bernstein et al. 2005). We took advantage from these 
observations to further characterize Ty1 test and studied the effect of the free 
chenodeoxycholic (CDH) and lithocholic (LH) bile acids and the noncarcinogenic 
conjugated taurodeoxycholic (TDH) and glycodeoxycholic (GDH) bile acids (Pesheva et al. 
2008). The results obtained (Table 4) show that the carcinogenic CDH and LH bile acids 
induced positive responses in the Ty1 test, whereas the noncarcinogenic TDH and GDH bile 
acids give values close to the controls. While the two free bile acids increase the frequency of 
Ty1 transposition over a tenfold concentration range, the conjugated acids showed no such 
activity, even though toxicities of up to 60% were produced.  
Although some heavy metals (the so-called trace elements) are essential for the survival of all 
life forms, others can be quite toxic and carcinogenic. In preliminary experiments we studied 
the response of Ty1 test to arsenic (As) classified as confirmed human carcinogen, lead (Pb) 
categorized as probable human carcinogen and zinc (Zn) which is not classifiable with regard 
to human carcinogenicity (Dimitrov et al. 2011). The results obtained were positive for As and 
Pb in concentration and time dependent experiments, while Zn was without effect on Ty1 
transposition. A special interest represents the pair hexavalent chromium (CrVI) and trivalent 
chromium (CrIII). While CrVI is confirmed as strong human carcinogen, the data for CrIII are 
controversial. An extensive recent review (Eastmond et al. 2008) points to many instances of 
conflicting information. Thus, in vitro data suggest that CrIII has the potential to react with 
DNA and to cause DNA damages which however required experimental conditions 
incompatible with cell-life. In vivo evidence suggest that genotoxic effects did not occur in 
human cells or animals exposed to CrIII and the trivalent chromium complexes are widely 
used for decades as nutritional supplements and insulin enhancers in patients with type 2 
diabetes. Although firm data for a carcinogenic effect of CrIII are lacking, there is a growing 
concern (Levina & Lay 2008) over a possible carcinogenicity of CrIII based on the assumption 
that once in the cell, part of CrIII can be oxidized to CrVI which is a confirmed human 
carcinogen. The study of CrVI and CrIII in the Ty1 test confirmed the strong carcinogenic 
effect of CrVI with a fold increase of 47 following  treatment with 5mM CrVI for 30 min (Table 
4). At the same conditions CrIII gave values close to the controls, as did all studied till now 
noncarcinogenic mutagens. Regardless of results that will be obtained in the future in favor of 
presence or absence of carcinogenicity for CrIII, it should be noted that the data obtained with 
CrVI and CrIII evidence that the Ty1 short-term test possesses the characteristic to discriminate 
opposite effects of a heavy metal, determined by changes in its valence. 
5. Response of Ty1 test to environmental pollutants 
Biomonitoring requires accurate, sensitive, easy and fast methods to assay environmental 
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with laboratory genotoxins suggested a verification of the characteristics of the assay in 
environmental studies monitoring pollution. The study was conducted during 2006-2007 
and consisted of monitoring pollution in soil, water and air in regions in Bulgaria (Pesheva 
et al. 2008), using Ty1 test and quantitative chemical analysis of the samples. Processed 
samples were chemically analyzed for presence of mutagens, carcinogens, pesticides, 
polychlorinated biophenols, heavy metals, etc., at a total of 53 substances. In this review 
only short excerpts of the protocols will be presented, and, results obtained for air and water 
samples will be omitted. 
Soil samples were collected from regions with low (odd number) or high (even number 
samples) pollution levels in June 2006 (S1, S2), November 2006 (S3, S4), May 2007 (S5, S6) 
and October 2007 (S8). Samples were processed according to standard procedures and each 
extract of sample was directly analyzed chemically and studied with Ty1 test in presence of 
S9 metabolic activating mix. Such experimental program gives the advantage to directly 
compare results obtained in the short-term test with the amount of genotoxins found in the 
chemically analysis of the samples. Samples collected from clean region showed low toxicity 
and gave negative responses in Ty1 test (Table 5). These results evidence that the Ty1 assay 
does not give false positives with extracts of samples. Samples collected from polluted 
regions showed different toxicities on yeast cells with a higher toxic effect of samples 
containing petrol products (S8). All samples from polluted regions gave positive results in 
Ty1 test with a fold increase ranging 7-12. The positive answers were confirmed in 
concentrations (= sample volume) dependent and kinetics experiments (Pesheva et al. 2008). 
The chemical analysis Table 5 shows that samples from the clean regions did not contain 
any carcinogenic genotoxins, while all samples from polluted regions contain mixtures of 
carcinogens. Only substances found in amounts above the accepted ecological standards are 
shown on (Table 5). Since each sample from polluted regions contained several carcinogenic 
substances, their positive results evidence that the Ty1 test responds positively to mixtures 
of carcinogens, as well. 
Special attention should be given to samples S1 and S3 collected from clean regions which 
showed negative results in the Ty1 test. These samples were polluted with flouranthrene at 
concentrations 0.28 mg/kg and 0.19 mg/kg for S1 and S3, respectively. Given the accepted 
ecological maximum of 0.02 mg/kg, it is clear that although S1 and S3 samples are heavily 
polluted with flouranthrene they show negative results in Ty1 test. It has consistently been 
shown that fluoranthrene proved to be a potent mutagen in bacterial and mammalian in 
vitro test systems, however results from in vivo carcinogenicity studies in rodents evidenced 
it is not carcinogenic (Goldman et all. 2001; Verschueren 2001). Thus the selective response 
of Ty1 test to carcinogens found in studies with laboratory genotoxins is also characteristic 
for the assay used in environmental studies. 
A short excerpt of the chemical analysis of soil samples is given in Table 6. For all mutagens 
and carcinogens that were analyzed but not included in the table, concentrations values 
below the accepted ecological standards were found. The results showed the significant 
pollution of samples collected from polluted regions. The amounts of some carcinogenic 
heavy metals (Pb, As, Cd) were 4-6 fold higher and the samples were polluted with mixtures 
of the carcinogenic genotoxins (B(a)P, B(a)A, benzo(hgi)pyrene, petrol products) and 
different mutagens. 
 






(per 108 cells) 
Ty1 test 
(fold increase)
Mutagens/carcinogens b)  
found in chemical analysis 
Control 
Me2SO 5% 100 18 ± 5 1.0  
Clean Regions 
S1 92 22 ± 6 1.2 fluoranthrene 
S3 90 27 ± 8 1.5 fluoranthrene 
S5 97 31 ± 6 1.7  
Polluted regions 
S2 78 131 ± 16 7.3 As, B(a)P, B(a)A, pyrene, 
crysene, benzo(ghi)perylene, 
Pb, B(e)P, fluoranthrene 
S4 67 127 ± 18 7.1 As, B(a)P, pyrene, crysene, Pb, 
B(e)P, 
S6 79 99 ± 9 5.5 As, B(a)P, pyrene, crysene, Pb, 
fluoranthrene 
S8 42 228 ± 21 12.7 B(a)P, B(a)A, pyrene, crysene, 
petrol products, Pb, B(e)P, 
B(b)A 
a) Average values ± SD from 10 experiments 
b) Carcinogenes are shown in bold 








Pollutants in soil samples (mg/kg) 
Clean regions samples Polluted regions samples 
S1 S3 S5 S2 S4 S6 S8 
Pb 50 31 24 29 364 386 348 287 
As 25 15 9 12 113 93 82 199 
Cd 2 0.4 0.3 0.5 2.2 3.2 1.5 1.8 
Anthracene 0.05 0.00 0.01 0.02 0.04 0.06 0.02 0.09 
Flouranthene 0.02 0.28 0.19 0.03 0.24 0.06 0.13 0.49 
B(e)P 0.02 0.01 0.01 0.00 0.09 0.18 0.00 0.18 
B(a)P 0.02 0.00 0.00 0.00 0.06 0.18 0.00 0.21 
Benzo(ghi)pyrene 0.02 0.00 0.00 0.00 0.09 0.00 0.00 0.01 
Petrol products 50 0.00 0.00 0.00 2 8 25 195 
Pyrene 0.02 0.02 0.02 0.02 0.28 0.05 0.18 0.49 
B(a)A 0.02 0.02 0.02 0.02 0.10 0.03 0.05 0.47 
Chrysene 0.01 0.01 0.00 0.00 0.12 0.07 0.06 0.24 
Table 6. Chemical analysis of soil samples 
The samples collected from clean regions did not contain carcinogens above the ecological 
standards, although some of them (S1, S3) were polluted with flouranthene as already 
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Ty1 test sensitivity in environmental studies. An assay should be sensitive enough to detect 
levels of carcinogens over the accepted standards and to not give false positives with 
carcinogen’s concentration below the ecological standards. The accepted standards for the 
different mutagenic or carcinogenic substances indicate the amounts of genotoxins that are 
not harmful for humans and animals. Table 6 (the three bottom lines) show that samples S1, 
S3, S5 contain pyrene at concentrations of 0.02 mg/kg which is the ecological standard. 
Samples S1 and S3 contain also B(a)A at concentrations close to the ecological standard and 
sample S1 contains 0.01 mg/kg of chrysene which is the accepted standard for this 
carcinogen. All these samples give negative results in Ty1 test (Table 5) evidencing that this 
assay remains negative with concentrations of carcinogens bellow the ecological standards. 
Together, the results obtained in environmental studies evidence that Ty1 test detects 
selectively carcinogenic pollutants only if they are in concentrations above the accepted 
ecological standards.  
6. The molecular mechanism of the selective response to carcinogens 
The positive and selective response to carcinogenic genotoxins requires explanation and two 
observations directed our efforts to clarify the molecular mechanism of the Ty1 test 
response.  
First, we noted that the appearance of rho- mutants among His+ transposants induced by 
carcinogens, is a very rare event. S. cerevisiae rho- cells are mitochondrial mutants 
representing large deletions of mitochondrial DNA (mtDNA), that appear spontaneously 
(Dujon, 1981), or can be induced by treatment with ethidium bromide (Sherman et al. 2001) 
or freezing (Stamenova et al. 2007). Nine out of ten studied carcinogens induced only rho+ 
transposants (with wild type mtDNA) and the percentage of rho- transposants induced by 
tert-butylhydroquinoline was below the spontaneous frequency. This results and the 
observation that treatment with different carcinogens of rho- mutants was without effect on 
Ty1 transposition (Stoycheva et al. 2007; 2008), strongly suggested that the carcinogen 
induced positive response in Ty1 test depends on the function of mitochondria. 
Although the deleted mtDNA fragment spans over different number of genes in rho- 
mutants, the genes for oxidative phosphorylation are deleted in all rho-  isolates irrespective 
of the way they are induced (Dujon 1981). The nuclear gene SCO1 codes for a protein that is 
transported to mitochondria where it participates in formation of oxidative phosphorylation 
complexes (Glerum et al. 1996). Mutations in, or disruption of the SCO1 gene are associated 
with respiratory deficiency, however in contrast to rho- mutants, sco1 mutants lack only 
mitochondrial oxidative phosphorylation in otherwise intact and functional mitochondria. 
We disrupted SCO1 gene in S. cerevisiae 551 tester strain and the study of carcinogen-
induced Ty1 transposition in 551 sco1∆ cells showed absence of Ty1 induction with almost 
equal Ty1 transposition rates in sco1∆, rho- or control cells (Stoycheva et al. 2010). Therefore, 
the Ty1 transposition induced by carcinogens depends on oxidative phosphorylation and 
not on another mitochondrial function.  
The second observation we made came from an extensive survey of the literature showing 
that all carcinogens with positive answer in Ty1 test are powerful generators of reactive 
oxygen species (ROS) in different cells (Bernstein et al. 2007; Toyooka & Ibuki 2007) 
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including S. cerevisiae (Brennan & Schiestl 1998; Herrero et al. 2008). The data for 
noncarcinogenic mutagens, although not abundant, showed absence of, or negligible effect 
on cellular level of ROS (Scandalios 2005; Toyooka & Ibuki 2007). ROS are generated in 
aerobic organisms through both endogenous and exogenous routes. The majority of 
endogenous ROS are produced through leakage of superoxide anions (O2.-) from the 
mitochondrial respiratory chain.  
ROS are generated by one electron reduction of O2 or formed from enzymatic systems 
(Fridovich 1997). Dismutation of O2.- (spontaneously or by superoxide dismutases) produces 
hydrogen peroxide (H2O2) which in the presence of metal ions is partially reduced to 
hydroxyl radical (.OH). To minimize the damaging effects of ROS, aerobic cells evolved 
nonenzymatic and enzymatic antioxidant defenses. At increased levels, however ROS can 
not be detoxified sufficiently and may have deleterious effects on lipids, fatty acids, proteins 
and DNA. A variety of DNA lesions, block of replication and chromosomal loss were 
frequently detected in cells under oxidative stress. 
We studied the possible link between carcinogen-induced Ty1 transposition and ROS level 
by simultaneous determination of Ty1 mobility and O2.- levels following treatment with 
carcinogens. As shown on Tables 2, 3 and 4 (last columns) the treatment with carcinogens 
increased both, Ty1 transposition rate and O2.- in tester cells, while noncarcinogenic 
mutagens (Table 4) have little effect on Ty1 mobility and O2.- level. We used a method for 
quantitative determination of O2.- in live cells only (Stamenova et al. 2008), so that the 
various toxicities of genotoxins can not account for the different amount of O2.- found in 
cells treated with carcinogens or noncarcinogenic mutagens. 
 






(per 108 live cells) 
551 rho- 15 - 72 ± 6 
30 - 16 ± 3 
551 rho+ 15 - 87 ± 7 
30 - 19 ± 6 
551 rho- 15 + 78 ± 8 
30 + 17 ± 4 
551 rho+ 15 + 641 ± 32 
30 + 155 ± 18 
Average values ±SD from 6 experiments 
Table 7. Ty1 transposition at different temperatures 
Another possible reason to fall into error studying the interactions between carcinogen-
induced Ty1 transposition and ROS level would be that the whole process of transposition 
in rho- cells is impeded from unknown yet reason and cells are unable to carry out Ty1 
transposition at all. It has been shown that the rate of spontaneous transposition in cells 
cultivated at temperatures of 15°C increases relative to cells grown at 30°C (Paquin & 
Williamson 1984). We confirmed this result and as shown on Table 7 the number  
of spontaneous His+ transposants in rho- cells at 15°C was significantly higher compared  
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Williamson 1984). We confirmed this result and as shown on Table 7 the number  
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methylmethanesulfonate (MMS) did not enhance Ty1 transposition rates at any of the two 
temperatures. In rho+ cells the increase of spontaneous and MMS-induced Ty1 transpositions 
was evident after cultivation at 15°C and 30°C. Since rho+ and rho- cells increase spontaneous 
transposition rates at 15°C by an equal factor of 5 relative to cultivation at 30°C, the reason 
for absence of carcinogen-induced Ty1 transposition in rho- cells is not a general defect in the 
transposition process and most likely is due to loss of the start signal for the carcinogen 
induced transposition. 
Several lines of evidence confirmed the role of increased ROS levels as inducers of Ty1 
transposition in S. cerevisiae cells treated with carcinogens. 
Although tightly coupled, the two processes in mitochondrial phosphorylation, electron 
transfer and ATP synthesis, can be selectively inhibited: antimycinA inhibits the transfer of 
electrons while carbonyl cyanide-3-chlorophenyl hydrazine (CCCP) blocks ATP synthesis 
(Epstein et al. 2001). Tester 551 cells cultivated in presence of antimycinA showed significant 
higher Ty1 transposition rates (fold increase 30-40) upon treatment with MMS compared 
to cells with not inhibited electron transfer and treated with the same concentration of 
MMS (fold increase 6-8). The block of ATP synthesis with CCCP had little or no effect on 
MMS-induced Ty1 mobility (Stoycheva et al. 2010). The inhibition of electron transfer 
along the respiratory chain is known to increase the leakage of electrons and to enhance in 
this way the production of ROS (Rasmussen et al., 2003). Higher ROS levels are also 
generated in exponential cells and cells growing in high dextrose (2%) media vs. 
stationary cells and cells cultivated in low dextrose (0.2%) media (Barros et al.,; 2004Lin et 
al., 2002). The study of MMS-induced Ty1 transposition showed increased mobility of Ty1 
in exponential cells and cells from high dextrose medium compared to stationary cells and 
cells grown in low dextrose medium. The activation of Ty1 mobility by carcinogens seems 
to depend on accumulation of O2.- generated by the carcinogens since addition of N-
acetylcysteine (NAC), a scavenger of O2.-, resulted in absence of both, the increase in O2.- 
levels and the induction of Ty1 transposition rates (Table 8). The elevation of O2.- level 
with menadione, a superoxide generator, also increases Ty1 mobility without any 
additional treatment with carcinogen. Taken together, these results show that yeast cells 
with functioning oxidative phosphorylation accumulate O2.- upon treatment with 
carcinogens and indicate a key role of enhanced ROS levels in activating the initiation of 
the Ty1 transposition process. 
S. cerevisiae has been shown to have distinct protective responses to superoxides and 
peroxides (Jamieson et al. 1992). The YAP1 gene encodes a transcription factor that activates 
target genes involved in response against H2O2 (Nguyen et al. 2001) and mutants deleted for 
YAP1 gene accumulate H2O2 in the cells. We disrupted the YAP1 gene in 551 tester strain 
and found 551yap1∆ cells to respond upon carcinogen treatment with significantly higher 
induction of Ty1 mobility compared to cells with functioning YAP1 gene. A dose-dependent 
increase of ROS following exposure of cells to exogenously added H2O2 was found in 
numerous studies (Tample et al. 2005 and citations therein). We used this observation to 
supply rho- cells with the missing ROS and studied Ty1 transposition in the 551 rho- strain 
treated with increased concentrations of H2O2. Treatment with 0.5, 1.0 and 3.0mM H2O2 
induced Ty1 transposition with a fold increase of 6, 10 and 25, respectively, relative to the 
nontreated control. 
 















Control (H2O) - - 100 0.045 ± 0.015 1.0 
MMS (3.0) - - 45 0.387 ± 0.115 8.5 
MMS (3.0) + - 78 0.040 ± 0.010 0.9 
As (2.0) - - 51 0.871 ± 0.250 33.5 
As (2.0) + - 82 0.053 ± 0.009 0.8 
CrVI(5.0) - - 54 1.440 ± 0.410 41.3 
CrVI(5.0) + - 75 0.048 ± 0.018 1.7 
- - 2 81 0.788 ± 0.115 4.5 
- - 5 41 2.675 ± 0.550 8.1 
a) N-acetylcysteine added 1h before treatment with carcinogens 
b) Menadione added for 1h 
c) Average of 4 experiments 
Table 8. Response of S. cerevisiae 551 cells to carcinogens depends on ROS level 
In addition to the transposition process, the movement and integration of Ty1 transposon to 
a new location in the genome can also occur by gene conversion (Roeder & Fink 1982). In 
this process a resident Ty1 element without being replicated undergoes homologous 
recombination with a second Ty1 element located on another place in the genome. There are 
data in the literature (Winn 2003) indicating an activation of homologous recombination by 
elevated ROS levels. Given the importance of having an activation of Ty1 mobility in rho- 
cells only after treatment with H2O2, Southern blot experiments were performed to 
differentiate de novo transposition from gene conversion (Figure 2). DNA samples isolated 
from rho+ transposants induced with MMS or H2O2 have dispersed bands in addition to the 
5kb band of the parental insertion. These bands indicated de novo transposition events in 
different locations of the genome. In rho- transposants such additional bands were found 
only after treatment with H2O2 and not with MMS. This result evidenced that the supply of 
ROS by addition of H2O2 to the cell culture activates a process of Ty1 transposition de novo 
and not by gene conversion. In addition these results evidence that the overall enhanced 
level of ROS and not the increased production of a particular oxygen species is involved in 
the induction of Ty1 mobility by carcinogens. 
1            2          3            4             5          6 
  
Lanes 1, 2, 3: DNA from rho+ cells; lanes 4, 5, 6 – DNA from rho- cells. Lanes 1 and 4 – cells treated with 
1mM H2O2 for 30 minutes. Lanes 2 and 5 – cells treated with 3.5mM MMS for 30 minutes. Lanes 3 and 6 
– control cells. DNA was digested with PvuII and probed with HIS3. The 5kb fragment indicates the 
position of parental TymHis3AI insertion while dispersed bands represent de novo transposition events.  
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transposition in S. cerevisiae cells treated with carcinogens. 
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electrons while carbonyl cyanide-3-chlorophenyl hydrazine (CCCP) blocks ATP synthesis 
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along the respiratory chain is known to increase the leakage of electrons and to enhance in 
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generated in exponential cells and cells growing in high dextrose (2%) media vs. 
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Control (H2O) - - 100 0.045 ± 0.015 1.0 
MMS (3.0) - - 45 0.387 ± 0.115 8.5 
MMS (3.0) + - 78 0.040 ± 0.010 0.9 
As (2.0) - - 51 0.871 ± 0.250 33.5 
As (2.0) + - 82 0.053 ± 0.009 0.8 
CrVI(5.0) - - 54 1.440 ± 0.410 41.3 
CrVI(5.0) + - 75 0.048 ± 0.018 1.7 
- - 2 81 0.788 ± 0.115 4.5 
- - 5 41 2.675 ± 0.550 8.1 
a) N-acetylcysteine added 1h before treatment with carcinogens 
b) Menadione added for 1h 
c) Average of 4 experiments 
Table 8. Response of S. cerevisiae 551 cells to carcinogens depends on ROS level 
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1            2          3            4             5          6 
  
Lanes 1, 2, 3: DNA from rho+ cells; lanes 4, 5, 6 – DNA from rho- cells. Lanes 1 and 4 – cells treated with 
1mM H2O2 for 30 minutes. Lanes 2 and 5 – cells treated with 3.5mM MMS for 30 minutes. Lanes 3 and 6 
– control cells. DNA was digested with PvuII and probed with HIS3. The 5kb fragment indicates the 
position of parental TymHis3AI insertion while dispersed bands represent de novo transposition events.  






The accumulated data clarify to some extent the molecular mechanism of the selective Ty1 
test response to carcinogens. The early work of Wilkie & Evans (1982) suggesting that in 
yeast cells carcinogens primarily attack the mitochondria, found nowadays its explanation 
and support in the observation that most, if not all, carcinogenic genotoxins generate high 
levels of ROS. The generated oxidative stress has different after-effects for the cells, 
including DNA damages. The oxidative DNA damages act in concert with the DNA 
damages caused directly by the carcinogens to labilize genome structure, which seems to be 
one of the first step towards neoplastic differentiation of the cell (Bertram 2001; Garfinkel 
2005). Numerous studies (Lesage & Todeschini 2005; Nyswaner et al. 2008; Salmon et al. 
2004; Tucker & Fields 2004) indicated the role of DNA damages, induced directly by the 
carcinogens, in the activation of the Ty1 mobility.  
Some of our data, however, suggest an alternative explanation. When S. cerevisiae cells are 
deficient in production of ROS, the treatment with carcinogens does not activate Ty1 
mobility, although there are no reasons to suppose that direct DNA damages are not 
generated by the genotoxin. Cells with compromised production of ROS (rho-, sco1∆) 
respond with a dose-dependent increase of Ty1 mobility only if the missing ROS are 
supplied to the culture. The use of N-acetylcysteine to scavenge the burst of O2.- following 
treatment with carcinogens also resulted in lack of activation the Ty1 transposition despite 
the appearance of direct DNA damages caused by the carcinogen. Opposite results were 
obtained with menadione, a generator of O2.- for which literature data (Cojocel et al. 2006) 
did not support a direct DNA damaging effect. Menadione increased Ty1 transposition 
without any additional treatment with DNA damaging agent. Finally, cultivation at 
temperatures at 15-20°C instead of 30°C increases Ty1 transposition (Paquin & Williamson 
1986) because of increased ROS production (Zhang et al. 2003) at suboptimal temperatures 
and not because of the appearance of DNA damages. Together, these data evidence that the 
increased ROS level may have an independent key role on the induction of Ty1 
transposition by carcinogens. We suppose that in cells with functioning mitochondrial 
oxidative phosphorylation, the carcinogen-induced burst in ROS production is the major 
initiator of Ty1 transposition. The effect of the direct carcinogen-induced DNA damages is 
later multiplied by the appearance of secondary oxidative DNA damages due to the already 
existing oxidative stress. Cells with compromised mitochondrial oxidative phosphorylation 
can not produce the major initiator in the Ty1 transposition process and the carcinogen 
activated induction of transposition can not take place in such cells. 
Thus, the selective positive answer of Ty1 test to carcinogens is due to activation of Ty1 
transposition by the burst of ROS generated by carcinogenic genotoxins. Noncarcinogenic 
mutagens are not strong ROS generators in S. cerevisiae cells and therefore give negative 
results in the Ty1 test. Both, carcinogens and noncarcinogenic mutagens are DNA damaging 
agents and the discrimination between the two kinds of genotoxins in Ty1 test is based on 
the ROS generating capacity of carcinogens which is not an intrinsic property of 
noncarcinogenic mutagens. These conclusions have been made on the basis of results 
obtained with 48 carcinogenic and 12 noncarcinogenic but mutagenic genotoxins studied till 
now in the Ty1 test. Given a number of genotoxins with carcinogenic and/or mutagenic 
potential of several hundreds, we can well believe that our current interpretation of the 
molecular mechanism underlying the selective positive response of Ty1 test to carcinogens 
may undergo some changes depending on the results obtained in future studies. 
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7. Applicability of Ty1 test: Advantages and shortcomings 
7.1 Advantages 
The Ty1 test is a short-term test based on fast growing yeast cells and results with this assay 
are obtained in 5 days. The test is easy to perform and requires expertise at the level of 
technicians. The usage of only one strain as tester cells makes possible the study of a number 
of samples per day by one person. The characterization of the test required repetitions to 
obtain statistically reliable results, but the presence or absence of carcinogenic activities in 
the studied sample is obvious after the first implementation of the Ty1 test. The 
accomplishment of the test does not require special equipment and can be performed in 
every microbiological laboratory. S. cerevisiae cells have an intrinsic P450/P488 based 
metabolic system which can be activated by a change in cultivation from low to high 
dextrose medium. Although the results in Tables are presented with usage of exogenously 
added S9 mix, very similar values were obtained in almost all experiments using the 
endogenous metabolic system of the tester 551 cells. The utilization of the intrinsic metabolic 
activation system in the tester strain further lowers the anyway low cost of the assay. 
A significant advantage of the Ty1 test is its ability to respond positively to carcinogens and 
negatively to noncarcinogenic mutagens. The advantage of having a selective answer to 
carcinogenic genotoxins becomes evident when the Ty1 test is used at the beginning of a 
battery of tests in mutagenicity/carcinogenicity studies. Most short-term tests in bacteria or 
mammalian cells have been designed primarily for hazard identification of genotoxicity and 
thus represent the starting point in the process of risk assessment. The answer of the 
important question about the carcinogenic or not carcinogenic nature of a substance is 
obtained at the end of the battery and is given by studies of the genotoxin in long-term tests. 
The implementation of Ty1 assay at the beginning of the study will give in 5 days the 
information about presence or absence of carcinogenic potential of the genotoxin and will 
spare time, efforts and costs. Therefore, the Ty1 assays is an indicator test that provides 
evidence of carcinogenicity and is thus an indicator of carcinogenic potential. 
Another important advantage of Ty1 test is its wide range in detection of carcinogens. 
Several carcinogenic genotoxins not detectable by the other short-term tests were tested and 
found to give positive results in Ty1 assay. The following reasons can be considered in 
explanation the wider range of Ty1 test in carcinogen detection.  
First, the tester cells have mutationally increased cellular permeability to genotoxins which 
facilitates the uptake of carcinogens in otherwise low permeable, and therefore low sensitive 
S. cerevisiae cells. Second, the Ty1 test is based on activation the transposition of a Ty1 
transposon which is a typical genetic retroelement with structure, function and cell-cycle 
analogous to the known oncogenic retroviruses. Similarities in regulation of certain steps of 
Ty1 transposition and neoplastic differentiation of cells were detected, which might explain 
to some extent the selective character of Ty1 test response to wider range of carcinogens. 
Finally and probably most importantly, the molecular mechanism of the positive Ty1 test 
response is principally different compared to other assays. Most short-term tests were 
constructed to detect one genetic end-point raised by one, or several (but not all) carcinogens. 
On the opposite, the positive response of Ty1 test is due to induction the initiation step of the 
transposition process. Instead of detecting a DNA-damage as end-product of the effect of 
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due to increased ROS levels generated by the carcinogens, which seems to be a property 
common to most, if not all, carcinogens. We consider such molecular mechanism of 
carcinogen detection as important in explanation the selective Ty1 test response to wider 
range of carcinogens. 
7.2 Shortcomings 
The advantage of Ty1 test to selectively detect carcinogens may be assessed as a 
shortcoming, if the test is used alone in environmental studies. Results obtained with 
laboratory genotoxins and in field studies evidenced a negative response of the test to 
noncarcinogenic mutagens. Thus, environmental samples taken from regions polluted with 
mutagens that are not carcinogenic will remain silent in the test. A way to overcome this 
shortcoming is to use the Ty1 assay for environmental studies together with a short-term 
test detecting mutations, if information about the general pollution of the region is required. 
Another disadvantage of Ty1 test would be that the assay will give positive results with 
substances that are ROS generators in S. cerevisiae, irrespective of their carcinogenic or 
noncarcinogenic nature. The ROS generators represent a small group of chemicals used for 
research only and not found as environmental pollutants. Their carcinogenic potential is not 
well known and remains to be studied in the future. 
A positive result of environmental sample in the Ty1 test means that the region this sample 
was collected from is polluted with carcinogen(s). The test does not show if one or a mixture 
of carcinogens are present in the sample. This feature of the Ty1 test is shared by the other 
short-term tests, as well. 
The Ty1 test is a quantitative assay in the sense that every transposition event of the marked 
Ty1 element activated by the studied genotoxin gives rise to one His+ colony. A 
concentration dependence of the positive answer was found for all studied carcinogens in 
the test, suggesting that higher fold increase of Ty1 transposition means higher 
concentration of the genotoxin in the sample. However, the activation of the Ty1 
transposition process depends on increased ROS generated by the genotoxins. Studies, now 
in progress, indicate that different carcinogens produce various levels of ROS in S. cerevisiae 
and that the fold increase of Ty1 transposition depends on ROS level and not on the 
concentration of the genotoxins. Therefore, the fold increase of transposition reflects the 
ROS generating capacity of carcinogen(s) and not the amount of the genotoxin in the studied 
sample. The property of Ty1 test to give a quantitative measure of carcinogen’s effect has to 
be taken into consideration only when different concentrations of one particular genotoxin 
are studied. 
7.3 Fields of applications 
The Ty1 test can be successfully used in research to study carcinogenicity of chemicals, 
including such applied in agriculture, nutrition and pharmacy. A positive answer of the test 
would be a strong indicator for carcinogenic potential of the studied substance or drug. The 
test can also be applied to study ROS generators and scavengers. Since the increase of Ty1 
transposition depends on the ROS level, a decrease in the rate of transposition caused by an 
added substance indicates scavenging properties of this substance.  
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Another application of the Ty1 test is its usage in control studies of food products. Some 
foods, such as smoked meat, fish, cheese, etc., have to be checked according to the 
requirements of the European Commission for Nutrition, for presence of carcinogens that 
accumulate on the surface during product’s processing. The usage of liquid additives 
instead of wooden smoke does not guarantee a full absence of carcinogens in food products. 
The usage of Ty1 test in environmental studies has been described in order to better 
characterize the assay. In this research environmental samples were studied in Ty1 test and 
chemically analyzed for presence of genotoxins. The results obtained showed a positive 
response of Ty1 test to samples from regions polluted with carcinogens in amounts 
exceeding the accepted ecological standards and negative results with samples from region 
not polluted with carcinogens.  The high sensitivity of the test, its selectivity towards 
carcinogenic pollutants and the absence of false positive responses substantiated the 
inclusion of Ty1 assay in the battery of tests used by the National Executive Environmental 
Agency (Sofia, Bulgaria) to control pollution of environment. 
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1. Introduction  
In general, nucleic acid adducts are formed when harmful chemical compounds react 
covalently with cellular DNA or RNA molecules. With only four natural nucleobases in 
DNA or RNA, identical nucleic acid adducts can theoretically occur at multiple positions 
within the human genome or transcriptome. The frequency of nucleic acid adduction is 
further increased by the reactivity of DNA or RNA to form adducts with many different 
types of chemicals, which include both exogenous compounds that our bodies have been 
exposed and endogenous compounds that are generated through normal metabolic 
activities in our bodies.1,2 Some exogenous compounds may require metabolic activation 
prior to the formation of nucleic acid adducts, whereas others may react directly with 
nucleic acids. If DNA adducts are not effectively removed by the DNA repair mechanism, 
the adducts can directly interfere with DNA replication and transcription.3 Similarly, the 
presence of adducts in RNA molecules can affect their biological functions. From the results 
of many experimental studies, the association of either DNA adducts or RNA adducts to 
cancer have already been well established. In the case of DNA adducts, it is widely 
recognized as the key element for the onset of carcinogenesis. Both DNA adducts and RNA 
adducts are, therefore, important biomarkers for cancer research, which include the 
monitoring of exposure to carcinogens, genetic mutation, DNA repair and so on. Similar to 
the analysis of other cancer biomarkers, both identification and quantification of nucleic acid 
adducts are required. Prior to the detection of nucleic acid adducts, it is important to ensure 
the biological or clinical samples are collected and stored properly. Equally important, the 
isolation of genomic DNA or RNA has to be carried out with high efficiency, which includes 
the yield and purity of selected material, reproducibility and the rate of sample throughput. 
For the detection of nucleic acid adducts, the requirements can be divided into the following 
order: 
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1. Limit of Detection. First and foremost is the ability to detect the presence of the adduct of 
interest. The detection signal that corresponds to a specific adduct should be at least 
two times above the background noise which originates from either the sample matrix 
or electronic components in an analytical instrumentation.  
2. Selectivity. The major analytical challenge for the analysis of nucleic acid adducts is that 
the ratio between unmodified nucleotides and adducts can be as high as 1012 : 1. To 
achieve an accurate measurement, it is very important to be able to select or separate 
the adduct of interest from other nucleotides that have not been modified.  
3. Specificity. For the analysis of nucleic acid adducts, specificity refers to the ability to 
distinguish the target adduct from the other possible adducts, including different 
isomers, that may co-exist in the same sample. In the case of mass spectrometric 
methods, this can be easily achieved by using a mass spectrometer that can provide 
high mass resolution (e.g. Orbitrap from Thermo Scientific).  
4. Quantitation. As mentioned above, it is important to be able to accurately determine the 
amount of target adduct in a biological sample. To achieve absolute quantitation, the 
construction of a calibration graph with the dilutions of a pure standard is required. 
This can be a challenge simply because many pure standards of nucleic acid adducts are 
not available. 
5. Reproducibility. It is important to ensure the method being used to measure a target 
adduct is reproducible which includes both intraday and interday reproducibility. 
6. Sample Throughput. With a wide variety of nucleic acid adducts and their high frequency 
of occurrence in a genome and transcriptome, the number of assays that are required in a 
specific study, especially in a clinical related study, can be relatively high. Thus, it is 
necessary to consider the time which is required to complete every step in the method 
being used as well as how many samples can be processed in parallel at the same time. 
7. Cost. For measuring a relatively high number of samples, the cost of running a 
particular method for each sample can add up to a prohibitive level. In general, the 
higher the sensitivity of the method, the less sample and reagent are required. Also, the 
smaller the number of experimental steps is involved in a selected method, the fewer 
reagents are required.   
To address these challenges for analyzing nucleic acid adducts, a number of different 
methods have been designed and developed.4,5,6,7,8,9 Among those methods, LC-MS is the 
most commonly used analytical technique for carrying out the end point measurements of 
nucleic acid adducts. However, different samples or different adducts often pose their 
unique challenges. In other words, there is no single analytical technique that can be 
considered as a universal technique for detecting nucleic acid adducts. Unlike some of the 
recent publications, in which only the use of one specific analytical technique was discussed, 
this chapter provides an overview of the entire process for analyzing nucleic acid adducts. 
This chapter begins with a section on the introduction and challenges of nucleic acid adduct 
analysis. In the second section, the isolation and initial characterization of genomic DNA or 
specific groups of cellular RNA are discussed. Various analytical methods that have been 
developed for the detection of nucleic acid adducts are discussed in the third and fourth 
section, which also includes the rationale for selecting each detection method. It is, however, 
not our intention to review the analysis of each specific nucleic acid adduct that have been 
reported in the literature.  
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2. Methods 
2.1 Isolation of genomic DNA and specific groups of cellular RNA 
With the advance in the techniques for isolating nucleic acids from cellular samples, the 
analysis of nucleic acids has become an indispensable tool for studying the biological 
processes in different types of living organisms. As shown in Figure 1, sample preparation is 
the most important step preceding any specific type of nucleic acid measurement. For 
instance, the purpose of proper sampling is to ensure that a representative sample is 
collected, whose identity and composition is representative of the true in-situ abundance. 
Equally important, the integrity of DNA and RNA should be preserved to ensure 
trustworthiness and relevance of the data would be obtained in the downstream 
measurements. This section will cover the current methods for isolating cellular DNA or 

















Fig. 1. Schematic diagram of work flow for preparing nucleic acid adduct samples  
Sampling and Sample Storage
Tissue or Cell Disruption 
Isolation of DNA or RNA 
Sample purification
Initial Sample Characterization 
- Quantity 





1. Limit of Detection. First and foremost is the ability to detect the presence of the adduct of 
interest. The detection signal that corresponds to a specific adduct should be at least 
two times above the background noise which originates from either the sample matrix 
or electronic components in an analytical instrumentation.  
2. Selectivity. The major analytical challenge for the analysis of nucleic acid adducts is that 
the ratio between unmodified nucleotides and adducts can be as high as 1012 : 1. To 
achieve an accurate measurement, it is very important to be able to select or separate 
the adduct of interest from other nucleotides that have not been modified.  
3. Specificity. For the analysis of nucleic acid adducts, specificity refers to the ability to 
distinguish the target adduct from the other possible adducts, including different 
isomers, that may co-exist in the same sample. In the case of mass spectrometric 
methods, this can be easily achieved by using a mass spectrometer that can provide 
high mass resolution (e.g. Orbitrap from Thermo Scientific).  
4. Quantitation. As mentioned above, it is important to be able to accurately determine the 
amount of target adduct in a biological sample. To achieve absolute quantitation, the 
construction of a calibration graph with the dilutions of a pure standard is required. 
This can be a challenge simply because many pure standards of nucleic acid adducts are 
not available. 
5. Reproducibility. It is important to ensure the method being used to measure a target 
adduct is reproducible which includes both intraday and interday reproducibility. 
6. Sample Throughput. With a wide variety of nucleic acid adducts and their high frequency 
of occurrence in a genome and transcriptome, the number of assays that are required in a 
specific study, especially in a clinical related study, can be relatively high. Thus, it is 
necessary to consider the time which is required to complete every step in the method 
being used as well as how many samples can be processed in parallel at the same time. 
7. Cost. For measuring a relatively high number of samples, the cost of running a 
particular method for each sample can add up to a prohibitive level. In general, the 
higher the sensitivity of the method, the less sample and reagent are required. Also, the 
smaller the number of experimental steps is involved in a selected method, the fewer 
reagents are required.   
To address these challenges for analyzing nucleic acid adducts, a number of different 
methods have been designed and developed.4,5,6,7,8,9 Among those methods, LC-MS is the 
most commonly used analytical technique for carrying out the end point measurements of 
nucleic acid adducts. However, different samples or different adducts often pose their 
unique challenges. In other words, there is no single analytical technique that can be 
considered as a universal technique for detecting nucleic acid adducts. Unlike some of the 
recent publications, in which only the use of one specific analytical technique was discussed, 
this chapter provides an overview of the entire process for analyzing nucleic acid adducts. 
This chapter begins with a section on the introduction and challenges of nucleic acid adduct 
analysis. In the second section, the isolation and initial characterization of genomic DNA or 
specific groups of cellular RNA are discussed. Various analytical methods that have been 
developed for the detection of nucleic acid adducts are discussed in the third and fourth 
section, which also includes the rationale for selecting each detection method. It is, however, 
not our intention to review the analysis of each specific nucleic acid adduct that have been 
reported in the literature.  
 
Isolation and Detection of Carcinogenic Nucleic Acid Adducts 113 
2. Methods 
2.1 Isolation of genomic DNA and specific groups of cellular RNA 
With the advance in the techniques for isolating nucleic acids from cellular samples, the 
analysis of nucleic acids has become an indispensable tool for studying the biological 
processes in different types of living organisms. As shown in Figure 1, sample preparation is 
the most important step preceding any specific type of nucleic acid measurement. For 
instance, the purpose of proper sampling is to ensure that a representative sample is 
collected, whose identity and composition is representative of the true in-situ abundance. 
Equally important, the integrity of DNA and RNA should be preserved to ensure 
trustworthiness and relevance of the data would be obtained in the downstream 
measurements. This section will cover the current methods for isolating cellular DNA or 

















Fig. 1. Schematic diagram of work flow for preparing nucleic acid adduct samples  
Sampling and Sample Storage
Tissue or Cell Disruption 
Isolation of DNA or RNA 
Sample purification
Initial Sample Characterization 
- Quantity 





In general, the isolation of nucleic acids is dependent on the efficiency on disrupting the 
tissues or cells, the inactivation of nucleases such as deoxyribonuclease (DNase) or 
ribonuclease (RNase), and the removal of any proteins that may be structurally associated 
with nucleic acids. Since the quality of any downstream process including the nucleic acid 
measurements is dependent on the purity of isolated nucleic acids, great care should be 
taken to avoid any contamination. The most common contaminants include cellular 
proteins, carbohydrates, lipids, or the presence of RNA in isolated DNA and vice versa.10 An 
extensive review on the effects of nucleic acid sample preparations on downstream 
applications was recently published by GE Healthcare.11  
The procedures used for sample preparation prior to the isolation of cellular nucleic acids 
are critical for success. Special care should be taken to prevent sample degradation by 
nucleases during and after isolation. For example, the degradation of a DNA or RNA 
biomolecules may hinder a downstream measurement where the nucleic acid is required to 
bind to a complementary probe such as in microarray analysis. Some indicators of nucleic 
acid degradation or contamination may include extra products in PCR reactions, failure or 
reduced success in steps involving nucleic acid modification or restriction using enzymes. A 
classic signature of nuclease contamination in DNA samples is the characteristic ladder like 
separation or smear when the DNA is electrophoresed in an agarose gel. In some 
circumstances, it is necessary to isolate both genomic DNA and RNA from the same sample 
and this is discussed later in the chapter.12 
Many commercial kits for the isolation of nucleic acids have been developed but the 
challenges of sample preparation still remain. These challenges include the availability of 
very small sample sizes, the ability to eliminate all contaminating materials that may 
interfere with downstream measurements and the fact that degradation of nucleic acids 
starts immediately after sample collection. In some cases, samples are difficult to disrupt so 
as to get to the nucleic acids. It is also challenging to isolate both DNA and RNA from the 
same sample, to isolate small RNA that are less than 200 nucleotides long, to detect nucleic 
acids arising from viruses in collected samples, or to detect RNA transcripts which are 
expressed in low abundance.13 
2.2 Sampling and sample storage 
Prior to the isolation of nucleic acids, it is important to determine which is the nucleic acid of 
interest (i.e. DNA or RNA), the type of sample that will be collected, and an estimate of how 
much nucleic acid materials will be required. The limit of detection of the technique to be 
used for downstream measurements, and its tolerance to contamination should also be 
considered. All these information are needed for choosing the most suitable isolation 
method.14 Nucleic acids have been successfully isolated from tissue, cell culture, bacteria, 
yeast, fungi, virus, soil, fecal samples, and biofluids such as blood, serum, plasma, lymph, 
cerebral spinal fluid, ascites, saliva, urine, and amniotic fluid. Following the collection of 
samples, the general guideline is to begin the process of nucleic acid isolation as quickly as 
possible. In this way, the possible degradation of nucleic acids will be kept to the minimum. 
If immediate isolation is not possible, the tissue or cellular samples can be mixed with a 
stabilizing agent (e.g. RNAlater® from Qiagen) or flash frozen the samples in liquid nitrogen 
and stored at  -80°C. In cases where nucleic acids have to be stored at room temperature for 
extended periods of time, commercial products such as the FTA Cards technology 
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developed by Whatman can be used. In brief, the FTA cards contain chemically conditioned 
cellulose fiber matrices whose composition quickly lyse the cells, inactivate proteins and 
immobilize the nucleic acids thereby protecting the samples from degeneration. Once the 
samples have been spotted on the cards, the cards have to be thoroughly dried and can be 
stored at room temperature for long term archiving. For the FTA cards, the cellular debris is 
washed away and the nucleic acids remain bound to the card. Whereas, for the FTA Elute, 
nucleic acids are eluted from the cards using water at 95°C while contaminants remain 
bound on the cellulose matrix.15 Isolated DNA samples are best stored at -20°C in 1X TE 
buffer. If long term storage is required, the isolated nucleic acids should be dissolved in 70% 
ethanol and stored at -80oC. Prior to storing the samples, the stock solution should be 
divided into small aliquots which can avoid the degradation of the sample during the freeze 
and thaw cycles of the stock solution. It is important to make sure that the buffer used to 
store the nucleic acids is compatible with the downstream experiments such as PCR, mass 
spectrometry etc.16 
2.3 Sample disruption and deactivation of nucleases 
DNA is found within the nucleus of the cell, tightly coil around histone proteins and 
together forming the chromatin, while RNA is present both inside and outside the nucleus. 
The cell membrane forms a protective and selectively permeable layer around the cellular 
contents, protecting them from the extracellular environment. In order to isolate nucleic 
acids from collected samples, the DNA or RNA has to be liberated from the cells first by 
breaking down the cell membrane and forms a cell lysate, a process known as sample 
disruption. Cultured cells can be lysed directly. Whereas, solid samples such as tissue 
sections have to be physically disrupted. Sample disruption should be carried out in such a 
manner that the integrity of nucleic acids is preserved. A high degree of cell membrane 
disruption is desired in order to maximize the yield of isolated nucleic acids and prevent 
problems in subsequent steps such as clogging of purification columns. After sample 
disruption and homogenization, there should be no visible particulates unless the sample 
contained non cellular components such as bones or connective tissue. The cell membranes 
can be disrupted and homogenized in a variety of ways. These disruption methods are 
classified as either mechanical or non-mechanical.17 
2.3.1 Mechanical methods of cell disruption 
Mechanical cell lysis methods involve breaking the samples by shearing force under liquid 
nitrogen. The samples are mechanically ground using equipment such as a French press, 
sonicator, bead mill or homogenizer.18  Mechanical disruption methods can lead to complete 
cell disruption but can also cause heating or foaming of the sample. Mechanical methods are 
used for samples such as animal tissues that require great force to disrupt.19 
2.3.2 Non-mechanical methods of cell disruption 
Non-mechanical methods involve physical, chemical or enzymatic processes. These 
methods can be used for samples such as cultured cells that do not require strong disruption 
methods. Physical ways of disrupting samples include decompression, freeze thaw, osmotic 
shock lysis, desiccation, or thermolysis. For example, the freeze thaw technique uses 
 
Carcinogen 114 
In general, the isolation of nucleic acids is dependent on the efficiency on disrupting the 
tissues or cells, the inactivation of nucleases such as deoxyribonuclease (DNase) or 
ribonuclease (RNase), and the removal of any proteins that may be structurally associated 
with nucleic acids. Since the quality of any downstream process including the nucleic acid 
measurements is dependent on the purity of isolated nucleic acids, great care should be 
taken to avoid any contamination. The most common contaminants include cellular 
proteins, carbohydrates, lipids, or the presence of RNA in isolated DNA and vice versa.10 An 
extensive review on the effects of nucleic acid sample preparations on downstream 
applications was recently published by GE Healthcare.11  
The procedures used for sample preparation prior to the isolation of cellular nucleic acids 
are critical for success. Special care should be taken to prevent sample degradation by 
nucleases during and after isolation. For example, the degradation of a DNA or RNA 
biomolecules may hinder a downstream measurement where the nucleic acid is required to 
bind to a complementary probe such as in microarray analysis. Some indicators of nucleic 
acid degradation or contamination may include extra products in PCR reactions, failure or 
reduced success in steps involving nucleic acid modification or restriction using enzymes. A 
classic signature of nuclease contamination in DNA samples is the characteristic ladder like 
separation or smear when the DNA is electrophoresed in an agarose gel. In some 
circumstances, it is necessary to isolate both genomic DNA and RNA from the same sample 
and this is discussed later in the chapter.12 
Many commercial kits for the isolation of nucleic acids have been developed but the 
challenges of sample preparation still remain. These challenges include the availability of 
very small sample sizes, the ability to eliminate all contaminating materials that may 
interfere with downstream measurements and the fact that degradation of nucleic acids 
starts immediately after sample collection. In some cases, samples are difficult to disrupt so 
as to get to the nucleic acids. It is also challenging to isolate both DNA and RNA from the 
same sample, to isolate small RNA that are less than 200 nucleotides long, to detect nucleic 
acids arising from viruses in collected samples, or to detect RNA transcripts which are 
expressed in low abundance.13 
2.2 Sampling and sample storage 
Prior to the isolation of nucleic acids, it is important to determine which is the nucleic acid of 
interest (i.e. DNA or RNA), the type of sample that will be collected, and an estimate of how 
much nucleic acid materials will be required. The limit of detection of the technique to be 
used for downstream measurements, and its tolerance to contamination should also be 
considered. All these information are needed for choosing the most suitable isolation 
method.14 Nucleic acids have been successfully isolated from tissue, cell culture, bacteria, 
yeast, fungi, virus, soil, fecal samples, and biofluids such as blood, serum, plasma, lymph, 
cerebral spinal fluid, ascites, saliva, urine, and amniotic fluid. Following the collection of 
samples, the general guideline is to begin the process of nucleic acid isolation as quickly as 
possible. In this way, the possible degradation of nucleic acids will be kept to the minimum. 
If immediate isolation is not possible, the tissue or cellular samples can be mixed with a 
stabilizing agent (e.g. RNAlater® from Qiagen) or flash frozen the samples in liquid nitrogen 
and stored at  -80°C. In cases where nucleic acids have to be stored at room temperature for 
extended periods of time, commercial products such as the FTA Cards technology 
 
Isolation and Detection of Carcinogenic Nucleic Acid Adducts 115 
developed by Whatman can be used. In brief, the FTA cards contain chemically conditioned 
cellulose fiber matrices whose composition quickly lyse the cells, inactivate proteins and 
immobilize the nucleic acids thereby protecting the samples from degeneration. Once the 
samples have been spotted on the cards, the cards have to be thoroughly dried and can be 
stored at room temperature for long term archiving. For the FTA cards, the cellular debris is 
washed away and the nucleic acids remain bound to the card. Whereas, for the FTA Elute, 
nucleic acids are eluted from the cards using water at 95°C while contaminants remain 
bound on the cellulose matrix.15 Isolated DNA samples are best stored at -20°C in 1X TE 
buffer. If long term storage is required, the isolated nucleic acids should be dissolved in 70% 
ethanol and stored at -80oC. Prior to storing the samples, the stock solution should be 
divided into small aliquots which can avoid the degradation of the sample during the freeze 
and thaw cycles of the stock solution. It is important to make sure that the buffer used to 
store the nucleic acids is compatible with the downstream experiments such as PCR, mass 
spectrometry etc.16 
2.3 Sample disruption and deactivation of nucleases 
DNA is found within the nucleus of the cell, tightly coil around histone proteins and 
together forming the chromatin, while RNA is present both inside and outside the nucleus. 
The cell membrane forms a protective and selectively permeable layer around the cellular 
contents, protecting them from the extracellular environment. In order to isolate nucleic 
acids from collected samples, the DNA or RNA has to be liberated from the cells first by 
breaking down the cell membrane and forms a cell lysate, a process known as sample 
disruption. Cultured cells can be lysed directly. Whereas, solid samples such as tissue 
sections have to be physically disrupted. Sample disruption should be carried out in such a 
manner that the integrity of nucleic acids is preserved. A high degree of cell membrane 
disruption is desired in order to maximize the yield of isolated nucleic acids and prevent 
problems in subsequent steps such as clogging of purification columns. After sample 
disruption and homogenization, there should be no visible particulates unless the sample 
contained non cellular components such as bones or connective tissue. The cell membranes 
can be disrupted and homogenized in a variety of ways. These disruption methods are 
classified as either mechanical or non-mechanical.17 
2.3.1 Mechanical methods of cell disruption 
Mechanical cell lysis methods involve breaking the samples by shearing force under liquid 
nitrogen. The samples are mechanically ground using equipment such as a French press, 
sonicator, bead mill or homogenizer.18  Mechanical disruption methods can lead to complete 
cell disruption but can also cause heating or foaming of the sample. Mechanical methods are 
used for samples such as animal tissues that require great force to disrupt.19 
2.3.2 Non-mechanical methods of cell disruption 
Non-mechanical methods involve physical, chemical or enzymatic processes. These 
methods can be used for samples such as cultured cells that do not require strong disruption 
methods. Physical ways of disrupting samples include decompression, freeze thaw, osmotic 
shock lysis, desiccation, or thermolysis. For example, the freeze thaw technique uses 
 
Carcinogen 116 
repeated freezing and thawing of cells to form sharp ice crystals within the cells to disrupt 
the sample.20 Osmotic shock lysis technique is dependent on the changes of hydrostatic 
pressure created by a change in concentration of solutes between a semipermeable cell 
membrane. The osmotic gradient forces water to flow through the cell membrane, and result 
in breaking the cells apart. Chemical methods use detergents, salts, solvents, or chelating 
agents to disrupt the cells. For chemical disruption, chaotropic salts such as guanidinium 
isothiocyanate disrupt cells by providing a less hydrophobic condition in the sample that in 
return weakens the hydrophobic interactions within the cell membrane, thus breaking the 
cell membrane apart. Chaotropic salts also possess the ability to denature nucleases and 
proteins. Detergent chemical based disruption works by disturbing the hydrophobic 
interactions of phospholipids that are part of the cell membranes. Enzymatic methods utilize 
lysozymes and proteases to break down the cell membranes and are mainly used to disrupt 
cell cultures. Enzymatic treatment is typically followed by sonication, and homogenization 
by overtaxing in a lysing buffer.21 
 
Fig. 2. Summary of sample disruption methods. 
Pathological samples are often formalin-fixed and paraffin embedded (FFPE). If FFPE 
samples have to be used for the isolation of nucleic acids, proper deparafinization using an 
organic solvent like xylene should be done first.22 As a general rule, it is advisable to use the 
mildest disruption method possible to avoid mechanical breakdown of nucleic acids, 
perform the isolation within the shortest period of time by using pre-chilled equipment and 
use nuclease inhibitors. The choice of purification method will depend on the desired 
quality and purity of nucleic acids as well as the yield required for downstream analysis. 
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Disruption of frozen samples is best done in liquid nitrogen rather than letting the samples 
thaw for the same reasons of limiting nuclease activity.23 
Usually one of the most important steps towards achieving high quality of nucleic acids is 
the inactivation of nucleases immediately after the sample is disrupted. Naturally occurring 
nucleases in the sample can degrade nucleic acids and therefore, during lysis, it is advisable 
to add a nuclease inhibitor into the lysing buffer. After sample collection, the samples can be 
flash-frozen using liquid nitrogen or homogenized in the presence of nuclease inactivation 
solution. Placing sample in a lysing buffer such as guanidinium isothiocyanate can 
inactivate nucleases. Chelating agents such as EDTA that sequester Mg2+ ions which are 
required for nuclease activity can also be used to prevent nucleic acid degradation by 
nucleases during storage. Treatment of the sample using proteinase K digests and degrades 
all proteins, including nucleases. The breakdown of proteins reduces the viscosity of 
samples and helps in subsequent steps such as filtration.24 Moreover, nucleases are 
ubiquitous and can be found in glassware as well as on our fingers.  Thus, care should also 
be taken to avoid contaminating the samples with exogenous nucleases. The use of a clean 
nuclease-free working area and wearing gloves should always be part of the experimental 
procedure. Likewise, glassware should be sterilized at 250 °C for two hours.25 
2.4 DNA isolation techniques 
Since the first DNA isolation by the Swiss physician Friedrich Miescher in 1869, numerous 
protocols have been developed. DNA isolation begins with cell membrane disruption, 
removal of histone proteins, cell membrane debris and other biomolecules like RNA, lipids 
and proteins. The common DNA isolation methods are either solution based isolation, silica 
based methods or anion exchange. Solution based isolation methods use organic solvents 
such as phenol-chloroform mixture followed by ethanol precipitation. Silica and anion 
exchange based techniques utilize DNA binding media that is in the form of membranes or 
solid phase such as spin columns. Many commercial DNA isolation kits are available in the 
market. The kits use varying protocols and the time for nucleic acid isolation can range from 
a few minutes to few hours depending on the protocol that has been used in the kit. The kits 
typically contain all the required solvents and buffers.26 Numerous studies have been done 
to compare various kits based on hands-on- time, cost per DNA isolation, ease of use, the 
yield and quality. However, when setting up a new project, it is always advisable to 
evaluate different kits for their suitability for the sample of interest from which DNA is to be 
isolated.16 
2.4.1 Solution based extraction techniques 
The most common solution based extraction technique is the phenol-chloroform based 
method which has been extensively used with great success. The phenol-chloroform 
extraction technique depends on phase separation. The lysed samples are mixed with a 
phenol-chloroform solution where DNA or RNA partitions in the aqueous phase depending 
on the pH and salt concentrations of the solutions. If the solution is neutral or basic, RNA 
partitions in the organic phase or in the interface together with proteins, while DNA 
partitions in the aqueous phase. Centrifugation is done to separate the two phases and 
residual phenol can be removed by extracting the purified sample using chloroform. The 
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organic solvent like xylene should be done first.22 As a general rule, it is advisable to use the 
mildest disruption method possible to avoid mechanical breakdown of nucleic acids, 
perform the isolation within the shortest period of time by using pre-chilled equipment and 
use nuclease inhibitors. The choice of purification method will depend on the desired 
quality and purity of nucleic acids as well as the yield required for downstream analysis. 
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Disruption of frozen samples is best done in liquid nitrogen rather than letting the samples 
thaw for the same reasons of limiting nuclease activity.23 
Usually one of the most important steps towards achieving high quality of nucleic acids is 
the inactivation of nucleases immediately after the sample is disrupted. Naturally occurring 
nucleases in the sample can degrade nucleic acids and therefore, during lysis, it is advisable 
to add a nuclease inhibitor into the lysing buffer. After sample collection, the samples can be 
flash-frozen using liquid nitrogen or homogenized in the presence of nuclease inactivation 
solution. Placing sample in a lysing buffer such as guanidinium isothiocyanate can 
inactivate nucleases. Chelating agents such as EDTA that sequester Mg2+ ions which are 
required for nuclease activity can also be used to prevent nucleic acid degradation by 
nucleases during storage. Treatment of the sample using proteinase K digests and degrades 
all proteins, including nucleases. The breakdown of proteins reduces the viscosity of 
samples and helps in subsequent steps such as filtration.24 Moreover, nucleases are 
ubiquitous and can be found in glassware as well as on our fingers.  Thus, care should also 
be taken to avoid contaminating the samples with exogenous nucleases. The use of a clean 
nuclease-free working area and wearing gloves should always be part of the experimental 
procedure. Likewise, glassware should be sterilized at 250 °C for two hours.25 
2.4 DNA isolation techniques 
Since the first DNA isolation by the Swiss physician Friedrich Miescher in 1869, numerous 
protocols have been developed. DNA isolation begins with cell membrane disruption, 
removal of histone proteins, cell membrane debris and other biomolecules like RNA, lipids 
and proteins. The common DNA isolation methods are either solution based isolation, silica 
based methods or anion exchange. Solution based isolation methods use organic solvents 
such as phenol-chloroform mixture followed by ethanol precipitation. Silica and anion 
exchange based techniques utilize DNA binding media that is in the form of membranes or 
solid phase such as spin columns. Many commercial DNA isolation kits are available in the 
market. The kits use varying protocols and the time for nucleic acid isolation can range from 
a few minutes to few hours depending on the protocol that has been used in the kit. The kits 
typically contain all the required solvents and buffers.26 Numerous studies have been done 
to compare various kits based on hands-on- time, cost per DNA isolation, ease of use, the 
yield and quality. However, when setting up a new project, it is always advisable to 
evaluate different kits for their suitability for the sample of interest from which DNA is to be 
isolated.16 
2.4.1 Solution based extraction techniques 
The most common solution based extraction technique is the phenol-chloroform based 
method which has been extensively used with great success. The phenol-chloroform 
extraction technique depends on phase separation. The lysed samples are mixed with a 
phenol-chloroform solution where DNA or RNA partitions in the aqueous phase depending 
on the pH and salt concentrations of the solutions. If the solution is neutral or basic, RNA 
partitions in the organic phase or in the interface together with proteins, while DNA 
partitions in the aqueous phase. Centrifugation is done to separate the two phases and 
residual phenol can be removed by extracting the purified sample using chloroform. The 
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procedure is completed by precipitating the nucleic acid from the aqueous phase using 
ethanol. This technique is inexpensive, however, it involves the use of phenol which is toxic. 
The presence of residual phenol in the extracted DNA can impact negatively on 
downstream analysis that may involve the use of enzymes. Phenol is neurotoxic and can 
cause severe burns and therefore care must be taken when using it.27 
2.4.2 Silica based extraction techniques 
The silica based techniques that are used by most current methods offer a fast and robust 
method for DNA purification. This technique is dependent on the simple fact that DNA 
adsorbs onto silica surfaces in the presence of high concentrations of chaotropic salts. The 
silica can be in the form of two different formats: particles that are coated on magnetic beads 
or silica columns. Many commercial kits using the silica based technique are available, some 
of which are automated. The buffers used in cell lysis can be chosen in such a manner that 
during adsorption, only DNA adsorbs onto the silica while all other biomolecules such as 
RNA and proteins remain in solution. Cellular debris and other biomolecules are washed 
out using ethanol while the DNA is retained on the silica surface. The DNA is eluted using 
low salt buffer such as Tris-EDTA (TE) or water. Relatively pure DNA can be obtained using 
silica based technique; however, treatment of the purified DNA with RNase to remove 
residual RNA may sometimes be helpful. Care should be taken to wash out all the ethanol 
to make sure that it does not interfere with downstream applications e.g. presence of ethanol 
in DNA samples can cause the sample to “float” out of gel electrophoresis wells causing a 
loss of sample.28 
2.4.3 Anion exchange chromatography 
This purification method relies on the interaction between the negatively charged phosphate 
backbone of DNA and positively charged functional groups found on an anion exchange 
resin. The sample is loaded under low salt concentration to allow DNA to bind. A medium 
strength buffer is used to wash off RNA, proteins and other cellular metabolites. The DNA 
is then eluted using high strength buffer. Additionally, alcohol precipitation can be used for 
desalting as well as concentrating the isolated DNA. Since the DNA is eluted with high salt 
buffer, most downstream applications will require the sample to be desalted. Plasmid DNA 
is routinely precipitated with ethanol; however, ethanol precipitation of genomic DNA 
makes it harder to be redissolved. If desalting or concentration of genomic DNA is required, 
it is best done using isopropanol precipitation or desalting columns.29 
2.5 Characterization of isolated DNA 
Because DNA absorbs at 260nm while protein absorbs at 280 nm, the UV absorbance ratio at 
A260/A280 is generally accepted as a measure of the nucleic acid purity from the 
contamination of any cellular proteins. A ratio of 1.8 and above is considered as good 
quality. Organic compounds and chaotropic salts usually absorb at 230nm and therefore the 
A260/A230 ratio can be used to evaluate the presence of residual contaminants from the 
extraction of DNA. A value of 1.5 and above is considered to be good. A measure of 
turbidity at 320nm can also be used to evaluate presence of contaminants. The quality of 
DNA can be assessed by using gel electrophoresis, which provides valuable information on 
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the integrity of isolated DNA. More vigorous isolation techniques can lead to degradation of 
DNA, which is evident on the gel as a smear of low molecular weight DNA.30 DNA quality 
can also be characterized by using the Agilent 2100 analyzer31 or real time polymerase chain 
reaction (qPCR).32 DNA quantitation is commonly done by UV absorbance. 
Spectrophotometers such as the NanoDrop developed by NanoDrop Technologies are 
capable of utilizing as little as one microliter of sample for absorbance measurements with a 
large dynamic range spanning three orders of magnitude. Usually the conversion factors for 
1 absorbance unit at 260nm are 50µg/mL for double stranded DNA, 33µg/mL for single 
stranded DNA, and 20-30µg/mL for oligonucleotides. Although most quantification work 
on nucleic acids is done using UV absorbance, this method has some sensitivity and 
accuracy limits. A260 measurements can be altered by contaminants such as free nucleotides 
leading to erroneous quantification. Fluorescent dyes that selectively bind DNA have also 
been used for the characterization DNA. In spite of the fact that fluorescent dyes are more 
expensive than using UV absorbance techniques, the benefits of using fluorescent dyes 
outweighs their cost drawback. The dyes have a high affinity for DNA and exhibit increased 
fluorescence enhancement after binding. This enables quantification of very small amounts 
of DNA. The sensitivity can be more than 10,000 times greater than UV absorbance 
measurements. Furthermore, a great advantage of fluorescent dyes over UV is that 
measurements are not affected by the presence of free nucleotides or proteins. Commonly 
used dyes include PicoGreen and OliGreen for DNA.  
2.6 Potential pitfalls of DNA isolation 
Residual cellular RNA can be found in the samples of isolated DNA. This is more common 
when samples are from organs that exhibit more transcriptional activities such as the tissue 
samples of liver or kidney. Since RNA also absorbs UV light at 260 nm, the presence of any 
RNA in DNA samples adversely affect the quantitative UV measurements. The presence of 
RNA in isolated DNA samples also interferes with sequencing and reduces the efficiency of 
amplification. RNA contamination can be eliminated by treating the sample with RNase to 
degrade the RNA. The presence of proteins in isolated DNA samples can be the result of 
incomplete digestion by proteases and interfere with the mobility of DNA during gel 
electrophoresis as well as altering the kinetics of other enzymatic reactions. Residual organic 
solvents such as ethanol, phenol, chloroform etc. will negatively affect most downstream 
procedures while salts will slow down or inhibit enzymatic activity such as restriction 
enzymes. Furthermore, just because a sample contains only DNA is not absolute proof of 
good quality. This is because during isolation, the sample can be contaminated with DNA 
from other sources. Such external DNA will give a false impression during DNA 
quantitation and interfere with amplification procedures.33 
2.7 RNA isolation techniques 
Total RNA can be divided into several groups of RNA which include messenger RNA 
(mRNA), transfer RNA (tRNA), ribosomal RNA (rRNA), mitochondrial RNA (mtRNA) and 
many groups of small RNA such as microRNA (miRNA), and piwi-interacting RNA (piRNA). 
On average, about 80% of total RNA is made up of rRNA while 1-5% is mRNA. Expression of 
mRNA can vary greatly from cell to cell and can range from a few copies per cell to several 
thousand.34 If poly-adenylated mRNA is required, it is preferably isolated from total RNA by 
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procedure is completed by precipitating the nucleic acid from the aqueous phase using 
ethanol. This technique is inexpensive, however, it involves the use of phenol which is toxic. 
The presence of residual phenol in the extracted DNA can impact negatively on 
downstream analysis that may involve the use of enzymes. Phenol is neurotoxic and can 
cause severe burns and therefore care must be taken when using it.27 
2.4.2 Silica based extraction techniques 
The silica based techniques that are used by most current methods offer a fast and robust 
method for DNA purification. This technique is dependent on the simple fact that DNA 
adsorbs onto silica surfaces in the presence of high concentrations of chaotropic salts. The 
silica can be in the form of two different formats: particles that are coated on magnetic beads 
or silica columns. Many commercial kits using the silica based technique are available, some 
of which are automated. The buffers used in cell lysis can be chosen in such a manner that 
during adsorption, only DNA adsorbs onto the silica while all other biomolecules such as 
RNA and proteins remain in solution. Cellular debris and other biomolecules are washed 
out using ethanol while the DNA is retained on the silica surface. The DNA is eluted using 
low salt buffer such as Tris-EDTA (TE) or water. Relatively pure DNA can be obtained using 
silica based technique; however, treatment of the purified DNA with RNase to remove 
residual RNA may sometimes be helpful. Care should be taken to wash out all the ethanol 
to make sure that it does not interfere with downstream applications e.g. presence of ethanol 
in DNA samples can cause the sample to “float” out of gel electrophoresis wells causing a 
loss of sample.28 
2.4.3 Anion exchange chromatography 
This purification method relies on the interaction between the negatively charged phosphate 
backbone of DNA and positively charged functional groups found on an anion exchange 
resin. The sample is loaded under low salt concentration to allow DNA to bind. A medium 
strength buffer is used to wash off RNA, proteins and other cellular metabolites. The DNA 
is then eluted using high strength buffer. Additionally, alcohol precipitation can be used for 
desalting as well as concentrating the isolated DNA. Since the DNA is eluted with high salt 
buffer, most downstream applications will require the sample to be desalted. Plasmid DNA 
is routinely precipitated with ethanol; however, ethanol precipitation of genomic DNA 
makes it harder to be redissolved. If desalting or concentration of genomic DNA is required, 
it is best done using isopropanol precipitation or desalting columns.29 
2.5 Characterization of isolated DNA 
Because DNA absorbs at 260nm while protein absorbs at 280 nm, the UV absorbance ratio at 
A260/A280 is generally accepted as a measure of the nucleic acid purity from the 
contamination of any cellular proteins. A ratio of 1.8 and above is considered as good 
quality. Organic compounds and chaotropic salts usually absorb at 230nm and therefore the 
A260/A230 ratio can be used to evaluate the presence of residual contaminants from the 
extraction of DNA. A value of 1.5 and above is considered to be good. A measure of 
turbidity at 320nm can also be used to evaluate presence of contaminants. The quality of 
DNA can be assessed by using gel electrophoresis, which provides valuable information on 
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the integrity of isolated DNA. More vigorous isolation techniques can lead to degradation of 
DNA, which is evident on the gel as a smear of low molecular weight DNA.30 DNA quality 
can also be characterized by using the Agilent 2100 analyzer31 or real time polymerase chain 
reaction (qPCR).32 DNA quantitation is commonly done by UV absorbance. 
Spectrophotometers such as the NanoDrop developed by NanoDrop Technologies are 
capable of utilizing as little as one microliter of sample for absorbance measurements with a 
large dynamic range spanning three orders of magnitude. Usually the conversion factors for 
1 absorbance unit at 260nm are 50µg/mL for double stranded DNA, 33µg/mL for single 
stranded DNA, and 20-30µg/mL for oligonucleotides. Although most quantification work 
on nucleic acids is done using UV absorbance, this method has some sensitivity and 
accuracy limits. A260 measurements can be altered by contaminants such as free nucleotides 
leading to erroneous quantification. Fluorescent dyes that selectively bind DNA have also 
been used for the characterization DNA. In spite of the fact that fluorescent dyes are more 
expensive than using UV absorbance techniques, the benefits of using fluorescent dyes 
outweighs their cost drawback. The dyes have a high affinity for DNA and exhibit increased 
fluorescence enhancement after binding. This enables quantification of very small amounts 
of DNA. The sensitivity can be more than 10,000 times greater than UV absorbance 
measurements. Furthermore, a great advantage of fluorescent dyes over UV is that 
measurements are not affected by the presence of free nucleotides or proteins. Commonly 
used dyes include PicoGreen and OliGreen for DNA.  
2.6 Potential pitfalls of DNA isolation 
Residual cellular RNA can be found in the samples of isolated DNA. This is more common 
when samples are from organs that exhibit more transcriptional activities such as the tissue 
samples of liver or kidney. Since RNA also absorbs UV light at 260 nm, the presence of any 
RNA in DNA samples adversely affect the quantitative UV measurements. The presence of 
RNA in isolated DNA samples also interferes with sequencing and reduces the efficiency of 
amplification. RNA contamination can be eliminated by treating the sample with RNase to 
degrade the RNA. The presence of proteins in isolated DNA samples can be the result of 
incomplete digestion by proteases and interfere with the mobility of DNA during gel 
electrophoresis as well as altering the kinetics of other enzymatic reactions. Residual organic 
solvents such as ethanol, phenol, chloroform etc. will negatively affect most downstream 
procedures while salts will slow down or inhibit enzymatic activity such as restriction 
enzymes. Furthermore, just because a sample contains only DNA is not absolute proof of 
good quality. This is because during isolation, the sample can be contaminated with DNA 
from other sources. Such external DNA will give a false impression during DNA 
quantitation and interfere with amplification procedures.33 
2.7 RNA isolation techniques 
Total RNA can be divided into several groups of RNA which include messenger RNA 
(mRNA), transfer RNA (tRNA), ribosomal RNA (rRNA), mitochondrial RNA (mtRNA) and 
many groups of small RNA such as microRNA (miRNA), and piwi-interacting RNA (piRNA). 
On average, about 80% of total RNA is made up of rRNA while 1-5% is mRNA. Expression of 
mRNA can vary greatly from cell to cell and can range from a few copies per cell to several 
thousand.34 If poly-adenylated mRNA is required, it is preferably isolated from total RNA by 
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capturing the poly(A) tail onto oligo(dT) primers. The same approach can also be used to 
isolate mRNA directly from the lysate without necessarily isolating the total RNA. Similar to 
the isolation of DNA, the requirements for both quality and quantity of isolated RNA would 
determine the choice of isolation method. For example, RNA isolated for use in microarrays 
and RT-PCR needs to be of high purity and free from contaminants such as salts, phenol, 
ethanol etc. whereas methods such as Northern blotting may be more forgiving for 
contaminants. When purifying RNA, it is very important that it is prevented from degradation 
by both endogenous and exogenous RNases. Many commercial kits for RNA isolation have 
been developed, some of them are designed to isolate specific group of RNA, e.g. mRNA. 
The most common solution based technique for RNA isolation is the guanidinium, phenol-
chloroform ethanol precipitation. This technique was first reported by Chomczynski and 
Sacchi in 1987 and later revisited in 2006 by the same authors.35 Over time, the method has 
been widely used and modified. Basically, it operates on the principle that RNA can be 
separated from DNA if an acidic solution containing sodium acetate, phenol, chloroform 
and guanidinium isothiocyanate is used. Guanidinium isothiocyanate is a very effective 
protein denaturant and when used in buffers, it provides an RNase-free environment. 
Phenol dissociates nucleic acids from proteins while chloroform denatures both proteins 
and lipids. Chloroform also makes nucleic acids less soluble in phenol and maintains the 
separation of the aqueous and the organic layer. Mixing the lysate with the acidic solution 
results in phase separation with the RNA partitioning in the upper aqueous layer while the 
DNA, lipids and protein remain either in the interphase or in the lower organic phenol 
layer. The upper aqueous layer is retrieved and the total RNA recovered through 
precipitation with isopropanol. 
2.7.1 Sequence specific RNA isolation 
To capture RNA whose sequence is known, biotinylated DNA probes consisting of a 
sequence complimentary to the known portion of the RNA to be isolated can be used. The 
probe-RNA complex is then isolated using streptavidin coated magnetic beads through the 
interaction of biotin and streptavidin. The beads are pulled out of solution using a magnet, 
and the supernatant containing cellular debris and contaminants is removed. The captured 
RNA is then eluted from the beads for downstream applications.36 
2.7.2 Isolation of mRNA  
To isolate mRNA, a sample containing total RNA is loaded in an oligo(dT) spin column. In 
high salt conditions, the 3’ poly(dA) tail of mRNA hybridize to oligo(dT) that have been 
immobilized on the column. The contaminants are washed off with a high salt buffer and a 
low salt buffer. The mRNA is then eluted using a low ionic strength buffer. Alternatively, 
magnetic beads coated with poly(dT) beads can be added to total RNA sample. The beads are 
captured with a magnet and the contaminants are removed. The bead complex is then washed 
and mRNA are eluted. This technique is also useful for concentrating mRNA samples.37 
2.7.3 Isolation of Small RNA with <200 nucleotides (nt) 
The most widely used techniques for total RNA isolation are phenol or silica based. These 
methods were designed and optimized for isolation of high molecular weight RNA because 
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small RNA molecules were thought to be unimportant. As such, these traditional methods 
do not retain most of the small RNA fraction and are therefore not suitable for the isolation 
of small RNA (<200nt). Since small RNA only makes up a small fraction of total RNA, the 
use of total RNA as starting material for any detection method can potentially lower its 
sensitivity and/or specificity. Small RNA such as microRNA, siRNA, piwiRNA, rasiRNA 
and others have been shown to perform important biological functions. In order to isolate 
these RNA, the traditional methods have been redesigned or completely new methods have 
been developed. Initially, separation and enrichment of small RNA from total RNA was 
done by size fractionation using size exclusion columns or by using 12-15% denaturing 
polyacrylamide gel electrophoresis. These techniques however only yield minute amounts 
of small RNA. The need to isolate larger amounts of small RNA has led to development of 
the new methods. Commercially available kits for small RNA isolation include PureLink 
from Invitrogen (Carlsbad, CA, USA)38, miRNeasy Mini Kit from Qiagen (Valencia, CA, 
USA)39 and mirVana that is produced and sold by Ambion (Austin, Texas, USA)40 among 
others. The mirVana kit makes use of organic as well as solid phase isolation. RNA is first 
isolated from the lysed sample using acidic phenol-chloroform solution that separates RNA 
from proteins, DNA and other cellular debris. The isolated RNA can be further purified for 
small RNA by immobilizing them onto a glass-fiber filter. A low ionic strength buffer is 
used to wash the filter before small RNA is eluted with a relatively low ethanol 
concentration (25%).41 
2.8 Characterization of isolated RNA  
Similar to the characterization of isolated DNA, the traditional method for the quantification 
of RNA is by using UV absorbance measurements. A diluted sample of RNA is measured at 
260 and 280nm. Using the Beer-Lambert law which assumes that the relationship between 
absorbance and concentration is linear, the concentration of RNA can be calculated. An 
absorbance of 1.0 using A260 measurement translates to an RNA concentration of ~40µg/mL. 
The A260/A280 ratio is used as a measure of RNA purity since proteins absorb at A280. A ratio 
of 1.82:1 is accepted as a measure of highly purified RNA. In the presence of DNA 
contamination, UV measurements can overestimate the RNA concentration because DNA 
also absorbs at 260nm, however, if DNA contamination is suspected, the sample should be 
treated with RNase-free DNase to eliminate the DNA. The quantity of RNA can be 
determined by using fluorescent dyes such as RiboGreen and fluorometric measurements. 
This method is less sensitive to free nucleotides and proteins but can be inaccurate in the 
presence of DNA contamination. The integrity of isolated RNA is often measured by using 
denaturing gel electrophoresis. When total RNA sample is run on a denaturing gel stained 
with ethidium bromide, the 28S and 18S rRNA  show up as intense bands. The 28S and 18S 
rRNA band intensity ratio can be used as a measure of the integrity of RNA. A ratio of 2:1 
(28S:18S) is usually accepted as a measure of intact RNA. Smeared 28S and 18S coupled with 
a ratio below 2:1 is an indication of RNA degradation. Highly degraded RNA samples 
appear as a smear in the region of low molecular weight. For limited amounts of RNA 
samples, other RNA staining dyes that are more sensitive such as SYBR Gold and SYBR 
Green can be used.42 A more recent method is the Agilent 2100 Bioanalyzer that uses a 
microfluidics-based platform in conjunction with capillary electrophoresis and fluorescent 
dyes to perform both qualitative and quantitative measurements. The sample size for the 
2100 Bioanalyzer can be as low as 1µL of 10ng/µL RNA.43 
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capturing the poly(A) tail onto oligo(dT) primers. The same approach can also be used to 
isolate mRNA directly from the lysate without necessarily isolating the total RNA. Similar to 
the isolation of DNA, the requirements for both quality and quantity of isolated RNA would 
determine the choice of isolation method. For example, RNA isolated for use in microarrays 
and RT-PCR needs to be of high purity and free from contaminants such as salts, phenol, 
ethanol etc. whereas methods such as Northern blotting may be more forgiving for 
contaminants. When purifying RNA, it is very important that it is prevented from degradation 
by both endogenous and exogenous RNases. Many commercial kits for RNA isolation have 
been developed, some of them are designed to isolate specific group of RNA, e.g. mRNA. 
The most common solution based technique for RNA isolation is the guanidinium, phenol-
chloroform ethanol precipitation. This technique was first reported by Chomczynski and 
Sacchi in 1987 and later revisited in 2006 by the same authors.35 Over time, the method has 
been widely used and modified. Basically, it operates on the principle that RNA can be 
separated from DNA if an acidic solution containing sodium acetate, phenol, chloroform 
and guanidinium isothiocyanate is used. Guanidinium isothiocyanate is a very effective 
protein denaturant and when used in buffers, it provides an RNase-free environment. 
Phenol dissociates nucleic acids from proteins while chloroform denatures both proteins 
and lipids. Chloroform also makes nucleic acids less soluble in phenol and maintains the 
separation of the aqueous and the organic layer. Mixing the lysate with the acidic solution 
results in phase separation with the RNA partitioning in the upper aqueous layer while the 
DNA, lipids and protein remain either in the interphase or in the lower organic phenol 
layer. The upper aqueous layer is retrieved and the total RNA recovered through 
precipitation with isopropanol. 
2.7.1 Sequence specific RNA isolation 
To capture RNA whose sequence is known, biotinylated DNA probes consisting of a 
sequence complimentary to the known portion of the RNA to be isolated can be used. The 
probe-RNA complex is then isolated using streptavidin coated magnetic beads through the 
interaction of biotin and streptavidin. The beads are pulled out of solution using a magnet, 
and the supernatant containing cellular debris and contaminants is removed. The captured 
RNA is then eluted from the beads for downstream applications.36 
2.7.2 Isolation of mRNA  
To isolate mRNA, a sample containing total RNA is loaded in an oligo(dT) spin column. In 
high salt conditions, the 3’ poly(dA) tail of mRNA hybridize to oligo(dT) that have been 
immobilized on the column. The contaminants are washed off with a high salt buffer and a 
low salt buffer. The mRNA is then eluted using a low ionic strength buffer. Alternatively, 
magnetic beads coated with poly(dT) beads can be added to total RNA sample. The beads are 
captured with a magnet and the contaminants are removed. The bead complex is then washed 
and mRNA are eluted. This technique is also useful for concentrating mRNA samples.37 
2.7.3 Isolation of Small RNA with <200 nucleotides (nt) 
The most widely used techniques for total RNA isolation are phenol or silica based. These 
methods were designed and optimized for isolation of high molecular weight RNA because 
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small RNA molecules were thought to be unimportant. As such, these traditional methods 
do not retain most of the small RNA fraction and are therefore not suitable for the isolation 
of small RNA (<200nt). Since small RNA only makes up a small fraction of total RNA, the 
use of total RNA as starting material for any detection method can potentially lower its 
sensitivity and/or specificity. Small RNA such as microRNA, siRNA, piwiRNA, rasiRNA 
and others have been shown to perform important biological functions. In order to isolate 
these RNA, the traditional methods have been redesigned or completely new methods have 
been developed. Initially, separation and enrichment of small RNA from total RNA was 
done by size fractionation using size exclusion columns or by using 12-15% denaturing 
polyacrylamide gel electrophoresis. These techniques however only yield minute amounts 
of small RNA. The need to isolate larger amounts of small RNA has led to development of 
the new methods. Commercially available kits for small RNA isolation include PureLink 
from Invitrogen (Carlsbad, CA, USA)38, miRNeasy Mini Kit from Qiagen (Valencia, CA, 
USA)39 and mirVana that is produced and sold by Ambion (Austin, Texas, USA)40 among 
others. The mirVana kit makes use of organic as well as solid phase isolation. RNA is first 
isolated from the lysed sample using acidic phenol-chloroform solution that separates RNA 
from proteins, DNA and other cellular debris. The isolated RNA can be further purified for 
small RNA by immobilizing them onto a glass-fiber filter. A low ionic strength buffer is 
used to wash the filter before small RNA is eluted with a relatively low ethanol 
concentration (25%).41 
2.8 Characterization of isolated RNA  
Similar to the characterization of isolated DNA, the traditional method for the quantification 
of RNA is by using UV absorbance measurements. A diluted sample of RNA is measured at 
260 and 280nm. Using the Beer-Lambert law which assumes that the relationship between 
absorbance and concentration is linear, the concentration of RNA can be calculated. An 
absorbance of 1.0 using A260 measurement translates to an RNA concentration of ~40µg/mL. 
The A260/A280 ratio is used as a measure of RNA purity since proteins absorb at A280. A ratio 
of 1.82:1 is accepted as a measure of highly purified RNA. In the presence of DNA 
contamination, UV measurements can overestimate the RNA concentration because DNA 
also absorbs at 260nm, however, if DNA contamination is suspected, the sample should be 
treated with RNase-free DNase to eliminate the DNA. The quantity of RNA can be 
determined by using fluorescent dyes such as RiboGreen and fluorometric measurements. 
This method is less sensitive to free nucleotides and proteins but can be inaccurate in the 
presence of DNA contamination. The integrity of isolated RNA is often measured by using 
denaturing gel electrophoresis. When total RNA sample is run on a denaturing gel stained 
with ethidium bromide, the 28S and 18S rRNA  show up as intense bands. The 28S and 18S 
rRNA band intensity ratio can be used as a measure of the integrity of RNA. A ratio of 2:1 
(28S:18S) is usually accepted as a measure of intact RNA. Smeared 28S and 18S coupled with 
a ratio below 2:1 is an indication of RNA degradation. Highly degraded RNA samples 
appear as a smear in the region of low molecular weight. For limited amounts of RNA 
samples, other RNA staining dyes that are more sensitive such as SYBR Gold and SYBR 
Green can be used.42 A more recent method is the Agilent 2100 Bioanalyzer that uses a 
microfluidics-based platform in conjunction with capillary electrophoresis and fluorescent 
dyes to perform both qualitative and quantitative measurements. The sample size for the 
2100 Bioanalyzer can be as low as 1µL of 10ng/µL RNA.43 
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2.9 Potential pitfalls of RNA isolation 
The presence of RNase causes degradation of RNA and will affect all downstream 
applications that require intact RNA. The presence of polysaccharides especially in liver and 
muscle tissues can affect RNA isolation and lead to low yields. Polysaccharides also inhibit RT-
PCR, though, the mechanism of interference is not known. Residual genomic DNA in isolated 
RNA interferes with RT-PCR, microarrays and even nuclease protection experiments. The 
DNA contaminants can compete for PCR primers or other probes for the detection of RNA 
and lead to false positive signals. DNA is easily removed from the isolated RNA by digesting 
it with DNase. The DNase can be easily removed before downstream experiments are 
performed. Residual EDTA and solvents used to isolate RNA can chelate Mg2+ ions that are 
needed by polymerases in PCR and prevent cDNA synthesis. They can also interfere with 
microarray experiments. Carryover salts from buffers and other solutions slow down reverse 
transcriptase and cDNA synthesis. Alcohol, chloroform and phenol that may be carried over 
during isolation affect most biological experiments by inhibiting enzymatic activity.  
3. Detection and quantificaton of DNA adducts 
Referring to Figure 3, depending upon the type of biological samples, nucleic acid adducts 
can exist at the genomic level (i.e. intact DNA) or individual nucleotide adducts, which 
result from biodegradation and have been excreted into biofluids (e.g. urine).  
For the analysis of genomic DNA, the majority of developed methods require breaking 
down the genomic DNA into monomeric nucleotides or dinucleotides. This can be 
accomplished by either chemical hydrolysis or enzymatic digestion as shown in the 
schematic diagram in Figure 3. With the chemical hydrolysis of genomic DNA, if an acidic 
compound is used, it may induce the depurination of DNA and/or the hydrolysis of DNA 
adducts. Thus, the alternative enzymatic approach is more widely used to digest genomic 
DNA. To ensure a complete digestion of genomic DNA, a combination of different 
nucleases, for instance exonuclease and endonuclease, is often used. Following the digestion 
of genomic DNA, the approach for analyzing DNA adducts is the same for all types of 
biological samples, i.e. DNA adducts are separated from a mixture of nucleotides prior to 
their specific detection.  
The removal of unmodified nucleotides can greatly enhance the specificity of the 
subsequent detection of DNA adducts. This is because, in many studies, the ratio of 
unmodified nucleotides to nucleotide adducts can be as high as 1012 : 1. As indicated in 
Figure 3, the separation of DNA adducts is usually achieved by using one or a combination 
of chromatographic techniques. Often times, this part of an experimental procedure for 
analyzing specific DNA adducts is referred as enrichment of DNA adducts or a solid-phase 
extraction of DNA adducts. After the separation of DNA adducts, there are a number of 
different analytical techniques that have been chosen for carrying out the end point 
measurements of specific DNA adducts as shown in Figure 3. In general, the end point 
measurements can be divided into two groups, namely with or without the use of reporting 
labels. The use of reporting labels, for instance 32P radioactive isotope, can achieve lower 
limit of detection (LOD). On the other hand, the direct adduct measurements, i.e. without 
the use of any reporting labels, can achieve higher specificity and also allow the molecular 
structure of adducts to be determined. The selection of a specific analytical technique is 
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ultimately determined by the physiochemical properties of DNA adduct and its abundance 
in the biological samples. More details on each analytical technique that have been used to 
detect DNA adducts are covered in subsections 3.1.1 to 3.1.5. Readers are advised that the 
aim of this section is to provide an overview of the current methodologies for DNA adduct 
analysis that have been used in the last five years and is not intended to cover all the reports 
in the literature. Several excellent reviews on the detection of specific DNA adducts are 
available in the literature.44,45 
 
Fig. 3. Schematic diagram of different approaches for analyzing DNA adduction. 
It is important to realize that the digestion of genomic DNA into its monomeric nucleotides 
is equivalent to erasing all the DNA sequence information, thus the locations of adduction 
within the genome can no longer be determined. In order to determine the locations of DNA 
adduction, genomic DNA has to be analyzed. There are a number of polymerase chain 
reaction (PCR) based methods that have been developed which allow us to determine the 
locations of adduction. In general, these methodologies rely on using specific enzymatic 
activities or chemical hydrolysis methods to create unique reaction products that 
correspond to each location of DNA adduct. For instance, an adduct-containing DNA 
fragment can be cleaved at or near the adduct by a DNA repair enzyme. The resulting 
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2.9 Potential pitfalls of RNA isolation 
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microarray experiments. Carryover salts from buffers and other solutions slow down reverse 
transcriptase and cDNA synthesis. Alcohol, chloroform and phenol that may be carried over 
during isolation affect most biological experiments by inhibiting enzymatic activity.  
3. Detection and quantificaton of DNA adducts 
Referring to Figure 3, depending upon the type of biological samples, nucleic acid adducts 
can exist at the genomic level (i.e. intact DNA) or individual nucleotide adducts, which 
result from biodegradation and have been excreted into biofluids (e.g. urine).  
For the analysis of genomic DNA, the majority of developed methods require breaking 
down the genomic DNA into monomeric nucleotides or dinucleotides. This can be 
accomplished by either chemical hydrolysis or enzymatic digestion as shown in the 
schematic diagram in Figure 3. With the chemical hydrolysis of genomic DNA, if an acidic 
compound is used, it may induce the depurination of DNA and/or the hydrolysis of DNA 
adducts. Thus, the alternative enzymatic approach is more widely used to digest genomic 
DNA. To ensure a complete digestion of genomic DNA, a combination of different 
nucleases, for instance exonuclease and endonuclease, is often used. Following the digestion 
of genomic DNA, the approach for analyzing DNA adducts is the same for all types of 
biological samples, i.e. DNA adducts are separated from a mixture of nucleotides prior to 
their specific detection.  
The removal of unmodified nucleotides can greatly enhance the specificity of the 
subsequent detection of DNA adducts. This is because, in many studies, the ratio of 
unmodified nucleotides to nucleotide adducts can be as high as 1012 : 1. As indicated in 
Figure 3, the separation of DNA adducts is usually achieved by using one or a combination 
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ultimately determined by the physiochemical properties of DNA adduct and its abundance 
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analysis that have been used in the last five years and is not intended to cover all the reports 
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fragments are amplified by using PCR. By sequencing the PCR amplicons, the locations of 
adduct can then be determined. With the use of PCR, very small amounts of starting 
material are required. However, the drawbacks of this approach include the specificity of 
the methods for breaking down the genomic DNA at or near the location of an adduct, the 
lack of information on the adduct identity, and the inability to determine the location of 
adducts that are close or next to each other. Overall, the PCR-based methods are the only 
approach that can be used to determine the location of adducts but may not be universally 
applicable.  
With a wide variety of DNA adductions, there is no single method that can be used to 
analyze every possible DNA adduct. Before spending time and efforts to develop and/or 
validate a method, the extent of DNA damage can be evaluated by a non-specific method 
called comet assay. As indicated in Figure 3, the starting materials for comet assay are tissue 
or cellular samples. In the comet assay, cells are first embedded in an agarose gel. The cells 
are then lysed under a condition that induces DNA to supercoil and link to the nucleus 
matrix. With the presence of DNA damage, it is easier to electrophoretically pull the DNA 
out from the cell nucleus. By using microscopic fluorometry to monitor the migration of 
DNA, which forms a tail resembling a comet, the extent of cellular DNA damage can be 
evaluated. The higher the fluorescence intensity in the tail, the higher the extent of DNA 
damage. Alternatively, for determining the presence of DNA adducts on a tissue section, the 
approach of immunohistochemistry can be used, providing a specific detection antibody 
against the adduct of interest is available.  
3.1 Accelerated Mass Spectrometry (AMS) 
AMS has generally been regarded as the most sensitive method available in the detection of 
DNA adducts with a limit of detection (LOD) ranging from ~1-10 adducts per 1012 
nucleotides.46 In AMS, the abundance of specific radioisotopes is measured. For measuring 
biological samples, the most relevant isotopes are 14C and 3H. The sensitivity of AMS is high 
enough that even very small amounts of exogenously applied radioisotopes can be detected, 
thereby allowing AMS to be used in human studies.47  The sample preparation protocol 
involves the extraction of cellular DNA which can be either analyzed as intact DNA or 
subjected to enzymatic digestion into nucleotides.  This is followed by the separation with 
HPLC to isolate the adduct of interest.  Sample analysis usually involves combustion into 
elemental carbon or CO2 for 14C or titanium hydride for 3H.  However despite the 
aforementioned advantages, AMS has several disadvantages as well. Before the adduct 
measurements, the subject or host has to be exposed to radioactive isotopic-labeled 
precursors. As such, biomonitoring studies are often prohibited.  Since the chemical 
structure of the adduct is lost due to its decomposition into the elemental components, there 
is a requirement to compare the chromatograms of synthetic adducts (if available) with that 
of the sample, to accurately identify the adduct. Significant emphasis must be placed on 
sample purity to prevent the false positive signals from any radioactive background noise. 
Currently, there are a limited number (5-10) of AMS spectrometers worldwide that are 
specifically setup for biological sample analysis.48  To increase the viability to analyze 
samples from humans in terms of possible exposure to unlabeled carcinogenic/genotoxic 
compounds, postlabeling methods have been developed to derivatize DNA adducts of 
interest with 14C or 3H isotopes.46 
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3.2 32P radioisotope labeling 
The 32P-postlabeling method is useful in analyzing a vast array of DNA adducts (e.g. 
polycyclic aromatic hydrocarbons, aromatic amines, etc.) and is also highly regarded with 
respect to sensitivity (LOD of 1 adduct/1010 nucleotides). Following the isolation of genomic 
DNA, the sample is enzymatically digested into 3’-mononucleotides or less commonly 
dinucleotides.  Enrichment procedures call for the use of either immunoaffinity 
chromatography or n-butanol as a means to extract adduct from unmodified nucleotides. 
The extracted nucleotide adduct is then dephosphorylated using nuclease P1 treatment.  
Phosphorylation (or 32P-postlabeling) is then performed by the specific activity of T-4 
polynucleotide kinases. This produces 3’,5’-bisphosphates which are subsequently separated 
by using a chromatographic technique such as high performance liquid chromatography 
(HPLC), two-dimensional thin layer chromatography (2D-TLC), or gel separation. 
Resolution is greater for HPLC but sensitivity is lower than  
TLC. Thus, for quantitative analysis, TLC is more common. The initial standardization 
protocols for quantitation purposes in the 1990s were found to be only qualitative.  More 
recently, a method that overcame some of the shortcomings of earlier trials was reported.49  
With efficient isolation of DNA adduct and labeling, quantitation of specific adducts is 
possible. A set of standardized protocols are now instituted and allow quantitation of 
several types of DNA adducts (aromatic amines, PAHs, methylating agents).50  
Nevertheless, the required large quantities of radioactive isotopes and the lengthy time 
necessary for completing the labeling procedure are problematic. Also, structural 
characterization of DNA adduct is not possible, thus rigorous co-chromatography against 
synthetic or previously identified adducts is required to identify DNA adducts.     
3.3 Mass spectrometry 
With the advances in mass spectrometry, the applications of mass spectrometry to analyze 
DNA adducts have continued to grow in the recent years. A number of excellent reviews 
have been published.51 Following the isolation and digestion of genomic DNA, the analysis 
of DNA adducts can be carried out by using either gas chromatography-mass spectrometry 
(GC-MS) or liquid chromatography-mass spectrometry (LC-MS). In the case of GC-MS, the 
less volatile adducts have to be derivatized prior to the GC-MS measurements. Also, owing 
to the thermal decomposition, the analysis of adducts are often limited to nucleobases. With 
the development of soft ionization techniques like electrospray ionization (ESI) and matrix-
assisted laser desorption/ionization (MALDI), liquid chromatography has been successfully 
coupled to mass spectrometry. This allows the accurate mass of specific adducts to be 
measured as well as their molecular structure can be determined by using tandem mass 
spectrometry (MS/MS). Specifically, following the elution of an adduct from a LC column 
and the ionization of adduct, the precursor (or parent) ion of the adduct is selected by the 
first mass analyzer. The precursor ion is then fragmented by a process called collision-
induced dissociation (CID). After that, all the fragment ions which originated from the 
selected adduct are separated and detected in the second mass analyzer. The molecular 
structure of selected adduct including the type and position of adduction can be determined 
with high accuracy by analyzing the MS/MS data. The structural information is very 
desirable as it may provide insight into the metabolism of a genotoxic agent before 
adduction. Additionally, small sample sizes are possible with the LC-MS method. This is in 
 
Carcinogen 124 
fragments are amplified by using PCR. By sequencing the PCR amplicons, the locations of 
adduct can then be determined. With the use of PCR, very small amounts of starting 
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the methods for breaking down the genomic DNA at or near the location of an adduct, the 
lack of information on the adduct identity, and the inability to determine the location of 
adducts that are close or next to each other. Overall, the PCR-based methods are the only 
approach that can be used to determine the location of adducts but may not be universally 
applicable.  
With a wide variety of DNA adductions, there is no single method that can be used to 
analyze every possible DNA adduct. Before spending time and efforts to develop and/or 
validate a method, the extent of DNA damage can be evaluated by a non-specific method 
called comet assay. As indicated in Figure 3, the starting materials for comet assay are tissue 
or cellular samples. In the comet assay, cells are first embedded in an agarose gel. The cells 
are then lysed under a condition that induces DNA to supercoil and link to the nucleus 
matrix. With the presence of DNA damage, it is easier to electrophoretically pull the DNA 
out from the cell nucleus. By using microscopic fluorometry to monitor the migration of 
DNA, which forms a tail resembling a comet, the extent of cellular DNA damage can be 
evaluated. The higher the fluorescence intensity in the tail, the higher the extent of DNA 
damage. Alternatively, for determining the presence of DNA adducts on a tissue section, the 
approach of immunohistochemistry can be used, providing a specific detection antibody 
against the adduct of interest is available.  
3.1 Accelerated Mass Spectrometry (AMS) 
AMS has generally been regarded as the most sensitive method available in the detection of 
DNA adducts with a limit of detection (LOD) ranging from ~1-10 adducts per 1012 
nucleotides.46 In AMS, the abundance of specific radioisotopes is measured. For measuring 
biological samples, the most relevant isotopes are 14C and 3H. The sensitivity of AMS is high 
enough that even very small amounts of exogenously applied radioisotopes can be detected, 
thereby allowing AMS to be used in human studies.47  The sample preparation protocol 
involves the extraction of cellular DNA which can be either analyzed as intact DNA or 
subjected to enzymatic digestion into nucleotides.  This is followed by the separation with 
HPLC to isolate the adduct of interest.  Sample analysis usually involves combustion into 
elemental carbon or CO2 for 14C or titanium hydride for 3H.  However despite the 
aforementioned advantages, AMS has several disadvantages as well. Before the adduct 
measurements, the subject or host has to be exposed to radioactive isotopic-labeled 
precursors. As such, biomonitoring studies are often prohibited.  Since the chemical 
structure of the adduct is lost due to its decomposition into the elemental components, there 
is a requirement to compare the chromatograms of synthetic adducts (if available) with that 
of the sample, to accurately identify the adduct. Significant emphasis must be placed on 
sample purity to prevent the false positive signals from any radioactive background noise. 
Currently, there are a limited number (5-10) of AMS spectrometers worldwide that are 
specifically setup for biological sample analysis.48  To increase the viability to analyze 
samples from humans in terms of possible exposure to unlabeled carcinogenic/genotoxic 
compounds, postlabeling methods have been developed to derivatize DNA adducts of 
interest with 14C or 3H isotopes.46 
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3.2 32P radioisotope labeling 
The 32P-postlabeling method is useful in analyzing a vast array of DNA adducts (e.g. 
polycyclic aromatic hydrocarbons, aromatic amines, etc.) and is also highly regarded with 
respect to sensitivity (LOD of 1 adduct/1010 nucleotides). Following the isolation of genomic 
DNA, the sample is enzymatically digested into 3’-mononucleotides or less commonly 
dinucleotides.  Enrichment procedures call for the use of either immunoaffinity 
chromatography or n-butanol as a means to extract adduct from unmodified nucleotides. 
The extracted nucleotide adduct is then dephosphorylated using nuclease P1 treatment.  
Phosphorylation (or 32P-postlabeling) is then performed by the specific activity of T-4 
polynucleotide kinases. This produces 3’,5’-bisphosphates which are subsequently separated 
by using a chromatographic technique such as high performance liquid chromatography 
(HPLC), two-dimensional thin layer chromatography (2D-TLC), or gel separation. 
Resolution is greater for HPLC but sensitivity is lower than  
TLC. Thus, for quantitative analysis, TLC is more common. The initial standardization 
protocols for quantitation purposes in the 1990s were found to be only qualitative.  More 
recently, a method that overcame some of the shortcomings of earlier trials was reported.49  
With efficient isolation of DNA adduct and labeling, quantitation of specific adducts is 
possible. A set of standardized protocols are now instituted and allow quantitation of 
several types of DNA adducts (aromatic amines, PAHs, methylating agents).50  
Nevertheless, the required large quantities of radioactive isotopes and the lengthy time 
necessary for completing the labeling procedure are problematic. Also, structural 
characterization of DNA adduct is not possible, thus rigorous co-chromatography against 
synthetic or previously identified adducts is required to identify DNA adducts.     
3.3 Mass spectrometry 
With the advances in mass spectrometry, the applications of mass spectrometry to analyze 
DNA adducts have continued to grow in the recent years. A number of excellent reviews 
have been published.51 Following the isolation and digestion of genomic DNA, the analysis 
of DNA adducts can be carried out by using either gas chromatography-mass spectrometry 
(GC-MS) or liquid chromatography-mass spectrometry (LC-MS). In the case of GC-MS, the 
less volatile adducts have to be derivatized prior to the GC-MS measurements. Also, owing 
to the thermal decomposition, the analysis of adducts are often limited to nucleobases. With 
the development of soft ionization techniques like electrospray ionization (ESI) and matrix-
assisted laser desorption/ionization (MALDI), liquid chromatography has been successfully 
coupled to mass spectrometry. This allows the accurate mass of specific adducts to be 
measured as well as their molecular structure can be determined by using tandem mass 
spectrometry (MS/MS). Specifically, following the elution of an adduct from a LC column 
and the ionization of adduct, the precursor (or parent) ion of the adduct is selected by the 
first mass analyzer. The precursor ion is then fragmented by a process called collision-
induced dissociation (CID). After that, all the fragment ions which originated from the 
selected adduct are separated and detected in the second mass analyzer. The molecular 
structure of selected adduct including the type and position of adduction can be determined 
with high accuracy by analyzing the MS/MS data. The structural information is very 
desirable as it may provide insight into the metabolism of a genotoxic agent before 
adduction. Additionally, small sample sizes are possible with the LC-MS method. This is in 
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contrast to other methodologies for determining molecular structures, such as nuclear 
magnetic resonance (NMR) spectroscopy which requires larger sample sizes and higher 
concentration of adduct. For the quantitation of adducts, the choice of instrumentation is a 
mass spectrometer that is equipped with a triple quadrupole mass analyzer. To ensure 
sufficient high sensitivity is achieved, nano-electrospray ionization and/or the selected 
reaction monitoring (SRM) mode in a triple quadrupole mass spectrometer are 
recommended. Recently, a two-dimensional linear quadrupole ion trap mass spectrometer 
operating in a constant neutral loss scanning mode with subsequent triple stage MS was 
utilized in the detection and quantitation of five different DNA adducts.52  This technique 
was demonstrated to be capable of screening various carcinogenic adducts at low LOD (~1 
adduct per 108 nucleotides) with small quantities of DNA (~10 μg). This is an order of 
magnitude more sensitive than the best available immunoassays and close to that of 32P-
postlabeling method. Several reports have been published in which ESI MS has been 
coupled to capillary electrophoresis (CE) or nanoLC, thereby providing the capability to 
examine adducts at low levels. For example, an LOD of ~5 adducts per 109nucleosides with 
a linear dynamic range between 70 amol and 70 fmol has recently been reported.53 
3.4 Fluorometric and electrochemical detection  
Following the chromatographic separation of adducts, their detection can be achieved by 
fluorescence, electrochemical (EC), or electron capture detection (ECD) providing the 
adducts have either intrinsic or chemically induced properties to generate the corresponding 
signals. In general, the sensitivity of these techniques are often in the range of 1-10 adducts 
per 108 nucleotides and require ~20-100 µg of genomic sample. If pure standards are 
available, structural characterization as well as the quantitation of adducts are possible. 
However, the number of adducts which have the required intrinsic physiochemical 
properties are limited. Also, the derivatization (or labeling) of adducts which lack the 
intrinsic properties to generate the corresponding signals is labor intensive and the yield is 
usually low. These techniques have been used to detect adducts with inherent fluorescence 
property (e.g. PAH and aflatoxin B1) or electrochemical characteristics (e.g. 8-oxo-7,8-
dihydroguanine). Providing the adduct has a derivatizable group in comparison to 
unmodified DNA, the derivatization of adduct with a volatile ligand, such as 
pentafluorophenyl, would allow the use of GC which is coupled to an electron capture 
detector, whose sensitivity can be as low as zeptomole.54  Similar sensitivity can also be 
achieved by using laser induced fluorescence (LIF) providing the phosphate group of a 
nucleotide containing the adduct has been derivatized with an appropriate fluorophore.  
3.5 Immunoassay 
As mentioned earlier, antibodies can be used to detect DNA adducts in a wide variety of 
tissue samples (immunohistochemistry). The same antibody can be applied to the detection 
of digested or excreted DNA adducts in various biofluids by using an enzyme linked 
immunosorbent assay (ELISA) assay or an equivalent immunoassay. Various antibodies 
against adducts with either high or low molecular weight are available. However, in clinical 
studies, the specificity of antibodies to recognize adducts is relatively poor. This is partly 
due to the fact that DNA adducts are not separated from the other unmodified nucleotides 
or cellular components before being measured by immunoassay. To address this technical 
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issue, trapped in agarose DNA immunostaining (TARDIS) assay has been developed. An 
extensive review of this topic has been discussed.55 In general, monoclonal antibodies are 
preferred over polyclonal antibodies with regards to specificity but polyclonal antibodies 
can provide higher sensitivity (1 adduct per 108 nucleotides). The overall assay sensitivity is 
dependent on the affinity of antibody for the adduct of interest and the detectability of 
reporting label being used.   
4. Detection and quantificaton RNA adducts 
In comparison to the DNA adduct analysis, the number of reports on RNA adduct analysis 
are significantly less. This could be partly due to the fact that, unlike the genomic DNA, 
cellular RNAs are not used as templates to generate any biological molecules. Furthermore, 
there is a natural turnover of cellular RNA, i.e. the gene expression and degradation of RNA 
are continuous processes within the cells. Owing to these reasons, the effects of RNA 
adduction have often been considered to be less important than DNA adduction. 
Nevertheless, RNA adduction has been associated with different diseases which include 
cancer. The same methods that have been used to detect DNA adducts can also be applied 
to the detection and quantification of RNA adducts. To ensure higher specificity is achieved, 
it is important to remove any genomic DNA from cellular RNA samples prior to the RNA 
adduct analysis. As mentioned earlier in this chapter, the most effective approach to remove 
genomic DNA is by carrying out the DNase digestion, and the intact cellular RNA that 
remains in the sample can be easily purified by using one of the standard RNA purification 
methods. After that, cellular RNA is ready to be digested into nucleotides, unless the 
information on the location of RNA adducts is desired. To determine the location of adducts 
within an RNA fragment, the PCR-based methods can be used. For instance, reverse 
transcriptase would prematurely stop the cDNA synthesis at the adduct location and 
produce a template which is unique to the adduct location for the subsequent PCR reaction. 
In general, the PCR-based methods have lower specificity than those methods that have 
been developed to analyze a mixture of nucleotides including RNA adducts.  
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contrast to other methodologies for determining molecular structures, such as nuclear 
magnetic resonance (NMR) spectroscopy which requires larger sample sizes and higher 
concentration of adduct. For the quantitation of adducts, the choice of instrumentation is a 
mass spectrometer that is equipped with a triple quadrupole mass analyzer. To ensure 
sufficient high sensitivity is achieved, nano-electrospray ionization and/or the selected 
reaction monitoring (SRM) mode in a triple quadrupole mass spectrometer are 
recommended. Recently, a two-dimensional linear quadrupole ion trap mass spectrometer 
operating in a constant neutral loss scanning mode with subsequent triple stage MS was 
utilized in the detection and quantitation of five different DNA adducts.52  This technique 
was demonstrated to be capable of screening various carcinogenic adducts at low LOD (~1 
adduct per 108 nucleotides) with small quantities of DNA (~10 μg). This is an order of 
magnitude more sensitive than the best available immunoassays and close to that of 32P-
postlabeling method. Several reports have been published in which ESI MS has been 
coupled to capillary electrophoresis (CE) or nanoLC, thereby providing the capability to 
examine adducts at low levels. For example, an LOD of ~5 adducts per 109nucleosides with 
a linear dynamic range between 70 amol and 70 fmol has recently been reported.53 
3.4 Fluorometric and electrochemical detection  
Following the chromatographic separation of adducts, their detection can be achieved by 
fluorescence, electrochemical (EC), or electron capture detection (ECD) providing the 
adducts have either intrinsic or chemically induced properties to generate the corresponding 
signals. In general, the sensitivity of these techniques are often in the range of 1-10 adducts 
per 108 nucleotides and require ~20-100 µg of genomic sample. If pure standards are 
available, structural characterization as well as the quantitation of adducts are possible. 
However, the number of adducts which have the required intrinsic physiochemical 
properties are limited. Also, the derivatization (or labeling) of adducts which lack the 
intrinsic properties to generate the corresponding signals is labor intensive and the yield is 
usually low. These techniques have been used to detect adducts with inherent fluorescence 
property (e.g. PAH and aflatoxin B1) or electrochemical characteristics (e.g. 8-oxo-7,8-
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of digested or excreted DNA adducts in various biofluids by using an enzyme linked 
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issue, trapped in agarose DNA immunostaining (TARDIS) assay has been developed. An 
extensive review of this topic has been discussed.55 In general, monoclonal antibodies are 
preferred over polyclonal antibodies with regards to specificity but polyclonal antibodies 
can provide higher sensitivity (1 adduct per 108 nucleotides). The overall assay sensitivity is 
dependent on the affinity of antibody for the adduct of interest and the detectability of 
reporting label being used.   
4. Detection and quantificaton RNA adducts 
In comparison to the DNA adduct analysis, the number of reports on RNA adduct analysis 
are significantly less. This could be partly due to the fact that, unlike the genomic DNA, 
cellular RNAs are not used as templates to generate any biological molecules. Furthermore, 
there is a natural turnover of cellular RNA, i.e. the gene expression and degradation of RNA 
are continuous processes within the cells. Owing to these reasons, the effects of RNA 
adduction have often been considered to be less important than DNA adduction. 
Nevertheless, RNA adduction has been associated with different diseases which include 
cancer. The same methods that have been used to detect DNA adducts can also be applied 
to the detection and quantification of RNA adducts. To ensure higher specificity is achieved, 
it is important to remove any genomic DNA from cellular RNA samples prior to the RNA 
adduct analysis. As mentioned earlier in this chapter, the most effective approach to remove 
genomic DNA is by carrying out the DNase digestion, and the intact cellular RNA that 
remains in the sample can be easily purified by using one of the standard RNA purification 
methods. After that, cellular RNA is ready to be digested into nucleotides, unless the 
information on the location of RNA adducts is desired. To determine the location of adducts 
within an RNA fragment, the PCR-based methods can be used. For instance, reverse 
transcriptase would prematurely stop the cDNA synthesis at the adduct location and 
produce a template which is unique to the adduct location for the subsequent PCR reaction. 
In general, the PCR-based methods have lower specificity than those methods that have 
been developed to analyze a mixture of nucleotides including RNA adducts.  
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1. Introduction 
In today’s world health and safety are among the basic human needs. Ensuring food safety 
has been a major focus of international and national action over the last decades. 
Both, microbiological and chemical risks are of concern. The “World Health Organization” 
(WHO) has identified as significant sources of food-borne diseases contamination of food 
and feed by mycotoxins (toxic metabolites of molds) and the contamination of fishery 
products by phycotoxins (toxins produced by algae). 
Despite public health and prevention managers have paid particular attention to 
mycotoxins, in several areas of the world they are still an important food safety issue (Fig 1). 
 
Fig. 1. Notifications for food and feed in 2005 (from EU rapid alert system, by European 
Commission 2006). 
Mycotoxins can cause diseases in humans, crops and animals that have led many Countries 
to establish limits on mycotoxins in food and feed to safeguard people’s health, as well as 
the economical interests of producers and traders. 
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The first limits for mycotoxins were set in the late 1960s for the aflatoxins. Already 
approximately 100 Countries in the world have developed specific limits for mycotoxins in 
foodstuffs and feedstuffs and their number continues to grow (Van Egmond & Jonker, 2004; 
WHO, 2002a). 
1.1 General information on mycotoxins 
The natural fungal flora associated with foods is dominated by four genera: Aspergillus, 
Fusarium, Penicillium and Claviceps. 
The chemical structures of mycotoxins produced by these fungi are very diverse, as are the 
mycotoxicoses they can cause. 
The term mycotoxin was coined in 1962 after an unexplained die-off of about 100,000 turkeys. 
It was then discovered that the mysterious turkey's disease was tied to a feed essentially 
composed of peanuts contaminated by secondary metabolites of Aspergillus flavus or 
aflatoxins (Bennett & Klich, 2003). 
Mycotoxins are invisible, odourless molecules, and cannot be detected by taste (Binder, 2007). 
It is difficult to define mycotoxin in a few words. It is a natural low-molecular-weight 
molecule; it is a secondary metabolite produced by molds that has adverse effects even at 
low concentrations on the health of humans, animals, and crops. Those metabolites 
constitute a toxigenically and chemically heterogeneous class. 
Mycotoxins are classified from the a chemical viewpoint into: cyclopeptides, polycetoacids, 
terpenes, and nitrogenous metabolites, depending on their biological origin and structure 
(Bhat et al., 2010). 
They are mainly produced by the filamentous structure of molds mycelia. They have no 
biochemical significance for the growth and development of the fungus itself. Over 400 
mycotoxins have been isolated and chemically characterized, though research has focused 
on those forms causing significant harm to humans, animals and crops (Hussein & Brasel, 
2001; Zain, 2011). Aflatoxins (AFLs), Ochratoxins A (OTA), trichothecenes as Vomitoxin 
(DON), Zearelenone (ZEA), Fumonisins B1 and B2 (FUMO B1, FUMO B2), tremorgenic 
toxins, and ergot alkaloids are the most important mycotoxins if we consider their effects on 
human health.  
It is very important to note that some molds are capable of producing more than one 
mycotoxin and some mycotoxins are produced by more than one species of mold.  
The presence of mycotoxins in cereals, wine, beef, pork and oil seed and other food products 
has been accepted as natural in many of the EU countries, in the U.S.A, in Canada, Russia, 
and in most of the Asian Countries (Bhat et al., 2010; Van Egmond & Jonker, 2004). 
Mycotoxins are not destroyed by cooking and by normal industrial food processing since 
they all are heat-stable. 
Exposure to mycotoxins may result in a variety of illnesses that fall under the heading of 
mycotoxicosis, from ingestion or in occupational circumstances from dermal and inhalation 
exposure (Jarvis & Miller, 2005; Li et al., 2011; Straus, 2011). 
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Human exposure to mycotoxins may occur at all levels of the food chain: via consumption 
of plant-derived products contaminated with toxins (cereal grains, coffee, oil seeds, spices, 
fruit juices, and beverages as wine and beer), or even from carrying-over of mycotoxins and 
their metabolites (e.g. aflatoxin M1) in milk, meat, and other products of animal origin 
contaminated because of using feeds with mycotoxins (Bhat et al., 2010; CAST, 2003), or by 
exposure to air and dust containing toxins (Jarvis, 2002;). In recent times, in actual fact, 
concerns have been raised about exposures to mycotoxins in indoor environments as a 
damp houses and buildings (Straus, 2011). 
In Ferrante and colleagues study (2007) was carried out a monitoring of wheat samples 
because it is the main ingredient of bread and pasta, basic aliments, and quantitatively 
substantial of Mediterranean diet. Wheat samples, from various areas of East Sicily, was 
analyzed for carcinogenic micotoxins (AFLs, OTA, ZEA). The results show that all samples 
collected do not contained AFLs whereas OTA and ZEA have been found in the samples to 
medium concentrations of 0.01 mg/kg and 0.108 mg/kg, respectively. Instead all samples 
contained OTA and ZEA. So this study confirmed the previous findings of the related 
studies present in literature. 
The main mycotoxins that contaminate food rarely are found in indoor environments. 
Indeed, Penicillium and Aspergillus are the main contaminants of both food and damp 
buildings, though in the latter they produce different mycotoxins. 
The genera found in outdoor air, as Aspergillus and Penicillium, are not associated with 
human or animal toxicosis. 
The molds associated with buildings comprise a narrow group of species that grow thanks 
to the nutrients present in building materials and to the available water (Jarvis & Miller, 
2005; Straus, 2011). 
A. versicolor, that is often encountered in damp buildings, typically produces 
Sterigmatocystin, a class 2B carcinogen (IARC, 1993; Jarvis & Miller, 2005). 
 
Fig. 2. Molecular formula of Sterigmatocystin. 
The most frequent toxigenic fungi in Europe are Aspergillus, Penicillium and Fusarium (Bhat 
et al., 2010; Creppy, 2002), while the prevalence of specific toxins around the world is as 
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ZEA and DON in North America; AFLs , FUMO, OTA, DON and T-2 toxin in South America; 
ZEA and DON in the Eastern European Countries; OTA, ZEA and DON in the Western 
European regions (Bhat et al., 2010; Van Egmond & Jonker, 2004; WHO, 2002a). However, with 
the open global trade these mycotoxins might also be detected in all areas of the world. 
 
Fig. 3. Distibution of mycotoxins around the world. (AFLAs: Aflatoxins; FB: Fumonisins; 
OTA: Ochratoxin A; ZEA: Zearalenone; T-2: T-2 toxin). 
At this stage, in Europe mycotoxins are controlled, but the regulatory policies still need to be 
standardized in the various European Countries.  
Factors contributing to the presence or production of mycotoxins in foods or feeds include 
storage, environmental and ecological conditions, but also farming activities, such as drying, 
handling, packaging and transport, contribute to molds growth and to increase the 
production of mycotoxins when good practices are not followed (Zain, 2011). 
Researchers have found a variety of factors operating interdependently in the production of 
mycotoxins. Those factors have been categorized as physical, chemical, and biological. 
Physical factors include environmental characteristics as temperature, relative humidity, 
and insect infestation. 
Chemical factors include the use of fungicides or fertilizers; biological factors, instead, 
depend on the interactions between the colonizing toxigenic fungi and the substrate, in fact 
some plant species are more susceptible to colonization while environmental conditions 
may increase the vulnerability of others that are more resistant (Zain, 2011).  
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2. Health effects from dietary exposure to mycotoxins 
Concern about mycotoxins is based on well-documented human mycotoxicosis such as 
ergotism in Europe, alimentary toxic aleukia (ATA) in Russia, acute aflatoxicosis in South 
and Est Asia, and human primary liver cancer in Africa and South Est Asia.  
OTA, instead, is suspected to be a causal factor of Balkan Endemic Nephropathy (BEN) in 
Yugoslavia and chronic interstitial nephritis (CIN) in North Africa. 
More epidemics, associated with economic losses and war, have occurred in Russia (1924 
and 1944), Ireland (1929), France (1953) and Ethiopia (1978) (Murphy, 2006). 
The first episodes of lethal disease in humans caused by ATA have been in Russia, followed 
by other Countries.  
This devastating disease, often fatal, is characterized by necrotizing, hemorrhagic and 
central nervous system effects and has been identified as a toxic manifestation of grain 
contamination by mold. 
Retrospectively, it has been proven to be caused by; toxins, a metabolite of Fusarium 
sporotrichioides, the most common fungus isolated from contaminated grains incriminated in 
this russian disease (Richard, 2007; Li et al., 2011). 
Still today, especially in developing Countries, mycotoxicoses represent a serious problem, 
difficult to prevent. 
In Africa, many acute diseases are associated with mycotoxins, like aflatoxic hepatitis in 
Kenya and the vascular ergotism in Ethiopia. From studies carried out on people in Kenya, 
Mozambique and Swaziland, higher levels of AFLAs were found in food and these were 
correlated with levels detected in human fluids as urine and blood (Sibanda et al., 1997). 
It is hard to define mycotoxins, as well as to classify them. The classification schemes tend to 
reflect the training of the categorizing person (Zain, 2011). 
Mycotoxins cause various and powerful deleterious effects on human health, as some of 
them are carcinogenic, mutagenic, teratogenic, estrogenic, hemorrhagic, immunotoxic, 
nefrotoxic, hepatotoxic, dermotoxic and neurotoxic (see Table. 1). 
AFLs are important causal factors of liver cancer while FUMO and OTA are suspected to 
have an important role in the etiology of esophageal cancer and in the famous BEN (Balkan 
Endemic Nephrotoxicity) respectively (Tab. 2.).  
The impact of mycotoxins on health depends on various factors, as the fungus species, the 
daily intake of the mycotoxins consumed and their concentration, the toxicity of the 
compound, their mechanisms of action, the body weight of the individual, the presence of 
other synergic or protective elements present in the food, the metabolism and defense 
mechanisms of the host (Hussein & Brasel, 2001; Stayn, 1995). 
Their toxic effects, however, are mostly proven in experimental models. 
The inaccuracy of extrapolation of results for humans is an important point for research; it 
may be explained by the lack of adequate food consumption data, by the gap of knowledge 
about health risks associated with the actual proposed limits and by the big possibility of 
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Genera Mycotoxins Biological effect 
Aspergillus   
 Aflatoxin B1 Carcinogenic, mutagenic, immunotoxic, 
hepatotoxic 
 Aflatoxin G1 Carcinogenic, mutagenic, immunotoxic, 
hepatotoxic 
 Aflatoxin M1 Carcinogenic, mutagenic, immunotoxic, 
hepatotoxic 
 Ochratoxin A  Carcinogenic, teratogenic, immunotoxic, 
nefrotoxic 
 Sterigmatocystin Carcinogenic , mutagenic, teratogenic 
 Cyclopiazonic acid Mutagenic, neurotoxic 
Penicillium   
 Patulin Genotoxic, mutagenic 
 Ochratoxin A Carcinogenic, teratogenic, immunotoxic, 
nefrotoxic, 
 Citrinin Nefrotoxic 
 Penitrem A Neurotoxic 
 Cyclopiazonic acid Mutagenic, neurotoxic 
Fusarium   
 Vomitoxin Hemorrhagic, dermotoxic 
 Nivalenol Hemorrhagic, dermotoxic 
 Zearalenone Estrogenic, dermotoxic 
 T-2 toxin Hemorrhagic, dermotoxic 
 Diacetoxyscirpenol Hemorrhagic 
 Fumonisins Carcinogenic 
 Moniliformin Hemorrhagic 
 Tenuazonic acid  Hemorrhagic 
Alternaria   
 Alternariol Foetotoxic, teratogenic, hemorrhagic 
 Alternariol methyl 
ether 
Foetotoxic, teratogenic, hemorrhagic 
Claviceps   
 Ergot alkaloids Neurotoxic 
Table 1. Some mycotoxins and their biological effects on human health. 
 







 Reye’s sindrome 
  
Ochratoxin A  Balcan Endemic Nephropathy (BEN) 
 Kidney tumors 
  
Sterigmatocystin  Pulmonary tumours 
 Hepatocarcinogenicity 
 Urinary tract tumors 
 Kidney tumors 
  
Fumonisins Esophageal cancer 
 Hepatocarcinogenicity 
 Pulmonary edema 
 Leukoencephalomalacia 
 Hepatotoxicity  
 Nephrotoxicity 
  
Zearalenone Cervical cancer 
Table 2. List of mycotoxins and relative pathologies.  
2.1 Carcinogenic mycotoxins and their mechanisms of action 
2.1.1 Aflatoxins 
The main aflatoxins include aflatoxins B1, B2, G1 and G2 (see Fig. 4) produced by Aspergillus 
flavus and A. parasiticus that contaminate plants and plant products. 
Among all aflatoxins, the Aflatoxin B1 (AFB1) is the most potent hepatocarcinogenic 
substance known; recently, after a thorough risk evaluation, it has been proven to be also 
genotoxic (Van Egmond & Jonker, 2004; Zain, 2011). 
In 1993, the WHO-International Agency for Research on Cancer (WHO-IARC, 1993 a,b) 
evaluated the carcinogenic potential of Aflatoxins and they were classified as carcinogenic 
for humans (Group 1). In particular, studies have shown that AFB1 may act in synergy with 
hepatitis B virus in human hepatocellular carcinoma. 
For this type of carcinogen, it is generally felt that there is no threshold dose below which no 
tumor formation would occur. In other words, only a zero level of exposure will result in no 
risk. 
Aflatoxins are known to bind DNA and induce mutagenic and carcinogenic effects in rats. 
Especially the AFB1 is bioactivated from its original form to a mutagenic and carcinogenic 
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Fig. 4. Molecular formula of Aflatoxins and their metabolites. 
Aflatoxins have been found also in tissues of children suffering from Kwashiorkor and 
Reye’s syndrome, that has led to the hypothesis that they could also be causal factors for 
these diseases.  
Reye’s syndrome, in particular, is characterized by liver and kidney enlargement and 
cerebral edema (Hussein & Brasel, 2001). 
Aflatoxins M1 (AFM1) and M2 (AFM2) are the hydroxylated metabolites of aflatoxin B1 
(AFB1) and B2 (AFB2) respectively and may be found in milk products obtained from 
livestock that have ingested contaminated feed. 
Aflatoxins can be present in cows milk, pork meat or chicken eggs if those animals were 
exposed to aflatoxins in their feed. The main sources of aflatoxins in feeds are peanuts, meal 
maize and cottonseed meal (Creppy, 2002; McLean & Dutton, 1995; Richard, 2007). 
The concentration of AFB1 in feed can be strongly reduced thanks to good manufacturing 
and storage practices. If those preventive measures fail, however, AFB1 can be reduced in 
feed by blending (or diluition) or by physical or chemical treatments. Physical treatments 
include heat, microwaves, gamma-rays, X-rays and ultra-violet light (Creppy, 2002). 
About 0.3–6.2% of AFB1 from animal feed is transformed into AFM1 in milk. The toxicity of 
AFM1 is about one order of magnitude less than that of AFB1 (Creppy, 2002; Van Egmond 
& Jonker, 2004 ; Voss et al., 2002). 
AFM1 is a possible carcinogenic to humans. 
In literature are not yet known specific exposure biomarkers for aflatoxins. 
The AFM1 intake from milk is calculated to be 6.8 ng/person per day for the European diet, 
3.5 ng/person per day for the Latin American diet, 12 ng/person per day for three son per 
day for the Middle Eastern diet and 0.1 ng/person per day for the African diet (Creppy, 
2002). 
 
Carcinogen Role of Food by Mycotoxins and Knowledge Gap 
 
141 
Aflatoxins have been regulated with limits in many Countries of the world; for more 
detailed information see section 6. 
2.1.2 Ochratoxin A 
OTA or (N-[(3R)-(5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)-carbonyl]-l-
phenylalanin) (Fig. 5), is a mycotoxin produced by several strains of Aspergillus and 
Penicillium species, and it is generally associated with a variety of products, such as cereals, 
coffee beans, cocoa beans, and dried fruit (Abrunhosa et al., 2010; Aragua´s et al., 2005; Juan 
et. al., 2008). 
 
Fig. 5. Chemical structure of OTA. 
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the kidney is the target of OTA toxicity in all animal species exposed to this mycotoxin. 
Dietary human exposure to OTA is been suspected to be involved in BEN, a progressive 
kidney disease associated with an increased risk for the development of urothelial cancers, 
that occur in some rural areas of Bosnia, Bulgaria, Croatia, Romania, and Serbia.  
OTA has a very high affinity to plasma proteins, as 99.9% of the circulating OTA is bound to 
plasma proteins. 
OTA is poorly metabolized and slowly excreted with plasma half-life of 230 hrs in humans 
(Mally & Dekant, 2009). 
Inappropriate farm management practices have been associated with higher OTA amounts. 
It is also known that meat may contain OTA through secondary contamination and carry-
over (Pfohl-Leszkowicz & Manderville, 2007). 
Studies have not completely identified so far the mechanism nor the extent of the 
carcinogenic potential of OTA in humans; therefore, OTA is classified by IARC as possible 
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Some scientist have shown that the DNA lesions (on dG exclusively) induced by OTA in 
vivo exposure were no longer repaired in case of repeated exposure; these lesions could 
then be proposed as a marker of exposure in populations at risk (Creppy, 2002; Abrunhosa 
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Prevention of growth of A. ochraceus consists in application of standard practices as rapidly 
and thoroughly drying the grains and also fumigation, aeration and cooling, sealed storage 
and controlled atmosphere.  
An important preventive factor for correlated pathologies is the diet rich in antioxidants, 
vitamins, amino acids and aspartame. In fact positive and protective effects of aspartame in 
kidney and brain have been reported. Actually aspartame is used for prevention of OTA 
genotoxicity in kidneys (Creppy, 2002). 
Several studies are available on OTA-induced nephrotoxicty and renal tumor formation.  
The OTA mechanisms of action are divided into direct (covalent DNA adduction) and 
indirect (oxidative DNA damage) (Pfohl-Leszkowicz & Manderville, 2007; Mally & Dekant, 
2009; Reddy & Bhoola, 2010). 
Oxidative DNA damage induced by direct oxidation of DNA constituents or through 
oxidative stress has been implicated in renal tumor formation and it represents the most 
accepted theory in current literature (Mally & Dekant, 2009; Abrunhosa et al., 2010). 
However, currently the OTA carcinogenicity pathway is unknown because it has not yet 
been observed sperimentally.  
Several pathways of kidney tumorigenicity by ochratoxin have been proposed by 
scientists: 
 DNA-adduct formation 
 Oxidative stress 
 Cell proliferation 
 Modulation of apoptosis 
 Alteration of gene expression 
(Kamp et al., 2005; Kuan et al., 2008; Mally & Dekant, 2009 ; Reddy & Bhoola, 2010). 
EFSA has recently established a tolerable weekly intake (TWI) of 120 ng/kg of body weight 
for OTA. While the exposure of the general population in Europe is below this TWI, 
additional data regarding OTA-exposure of infants and children are considered necessary to 




c]xanthen-7-one (Fig. 6) is a toxic metabolite closely related to the aflatoxins structure and 
consists of a xanthone nucleus attached to a bifuran structure. The IARC have included the 
sterigmatocystin in group 2B, which means it is a likely carcinogenic to humans. 
Sterigmatocystin is generally produced by the fungi Aspergillus nidulans and A. versicolor 
(Veršilovskis & De Saeger, 2010). 
It has been found in mouldy grain, green coffee beans and cheese although current 
information on its occurrence in foods is again incomplete and poor.  
 




Fig. 6. Chemical structure of Sterigmatocystin 
It appears to occur much less frequently than the aflatoxins perhaps because the analytical 
methods for its determination have not been as sensitive, therefore it is possible that small 
concentrations of Sterigmatocystin in food commodities may at times not have been 
detected. Sterigmatocystin is considered a potent carcinogen, mutagen and teratogen toxin. 
A number of closely related compounds such as o-methyl Sterigmatocystin are known and 
some may occur naturally. 
Effects of chronic exposure that have been reported include induction of hepatomas in rats, 
pulmonary tumours in mice, renal lesions and alterations in the liver and kidneys of African 
monkeys. Rats fed with 5-10 mg/kg of sterigmatocystin for two years showed a 90% 
incidence of liver tumours.  
The acute toxicity, carcinogenicity and metabolism of Sterigmatocystin have been compared 
to those of aflatoxin and several other hepatotoxic mycotoxins. 
Contamination by Sterigmatocystin usually occurs in wheat, maize, animal feed, hard 
cheese, pecan nuts and green coffee beans but also in cereals, grain products, fruits and 
marmalade, dried meat products and grapefruit juice.  
Relatively high levels of sterigmatocystin have been formed in bread, cured ham and salami 
after inoculation with A. versicolor. No country has legislation for sterigmatocystin; however, 
it is important to emphasize that the natural occurrence of this mycotoxin appears to be 
infrequent, though only a limited number of surveys have been carried out (Noda et al., 
1981; Stich & Laishes, 2006; Veršilovskis & De Saeger, 2010). 
2.1.4 Fumonisin 
Fusarium verticillioides, F. moniliforme and F. proliferatum are the fungi that produce 
significant quantities of fumonisins (Fig. 7 and Fig. 8). Today at least 15 related fumonisin 
compounds have been identified but the fumonisin B1 or diester of propane-1,2,3-
tricarboxylic acid (FB1) (Fig. 6) and fumonisin B2 (FB2) (Fig. 7) are the predominant forms. 
The fumonisins are highly water-soluble because they lack an aromatic structure. 
Fumonisins occur in maize and corn and infrequently in foodstuffs such as sorghum, 
asparagus, rice, beer and beans (Creppy, 2002; Murphy, 2006; Zain, 2011). 
The IARC has classified Fumonisins as possible human carcinogens (Class 2B). Consumption 
of fumonisin has been associated with elevated human esophageal cancer incidence in various 
parts of Africa, China, Central America, and among the black population in Charleston, South 
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FB1 is responsible for leukoencephalomalacia (necrotic lesions in the brain) in horses and 
pulmonary edema in swine. Hepatotoxicity and nephrotoxicity effects have also been 
reported in connection with chronic dietary exposure to fumonisin. Fumonisins are also a 
real risk factor in neural tube and related teratogenic defects because they reduce folate 
uptake (Zain, 2011). 
 
Fig. 7. Chemical structure of FMB1 
  
Fig. 8. Chemical structure of FMB2. 
Fumonisins are known to disrupt sphingolipid synthesis and concentrations; thus, the 
altered plasma sphingosine/sphinganine ratios is an important biomarker of fumonisin 
dietary exposure (Murphy et al., 2006). 
Many biochemical pathways have been postulated to explain the induction of illnesses by 
fumonisins. Several hypotheses are proposed and all are related to disruption of lipid 
metabolism as the initial step. 
Some researchers have proposed that the first mechanism involves disruption of 
sphingolipid metabolism through inhibition of ceramide synthase. Glycerophospholipid 
metabolism is also affected (Voss et al., 2002).  
A second theory proposes a biochemical mechanism that involves the fatty acid disruption, 
Glycerophospholipid metabolism, the relative induction of oxidative stress but also an 
incorrect modulation of gene expression. 
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Fumonisin has been unequivocally shown to be genotoxic, in fact DNA adducts of 
fumonisin B1 have been found. 
A provisional maximum of tolerable daily intake (PMTDI) for FB1, FB2 and FB3, 
individually or in combination, is fixed at 2 µg/kg of body weight per day on the basis of 
the NOEL of 0.2 mg/kg of body weight per day and a safety factor of 100 (Creppy, 2002). 
2.1.5 Zearalenone  
Zearalenone (Fig. 9) is a mycotoxin produced by F. graminearum and other Fusarium molds as 
F. culmorum, F. cerealis, F. equiseti, and F. semitectum, using corn, wheat, barley, oats and 
sorghum as substrates. Fusarium infects cereals in the field. Toxin production occurs before 
harvesting, but also post harvest if the crop is not handled and dried properly (see section 6). 
 
Fig. 9. Chemical structure of ZEA 
Among the human population, children are the most affected due to consumption of ZEA-
contaminated foods (mainly cereals and cereal-based food products) (Massart & Saggese, 
2010). This toxin is worldwide distributed and can contaminate most of the cereals like 
barley, maize, oats, sorghum, millet, rice, soybeans but also wheat and bread. ZEA has been 
implicated in several incidents of early puberty, as it is suspected to be the causative agent 
in an epidemic of early puberty changes in young children in Puerto Rico. 
ZEA is a non-steroidal compound that exhibits oestrogen-like activity in some farm animals 
(e.g. cattle, sheep and pigs) and it is a 6-(10-hydroxy-6-oxo-trans-1-undecenyl)-b-resorcylic 
acid l-lactone.  
Altogether ZEA may have a species-dependent carcinogenic effect possibly secondary to the 
hormonal effect (Massart & Saggese, 2010); however, no data about formation of DNA-
adducts in humans are actually available. 
ZEA and some of its metabolites have been shown to competitively bind to oestrogen 
receptors (α-zearalenol and β-zearalenol); all of them have been included by IARC in Group 
3, as not classifiable as carcinogens to humans. 
Human adenocarcinomas and endometrial hyperplasia found in ZEA contaminated women 
are still under investigation (Bhat et al., 2010; Codex Alimentarius Commission, 2000; 
Creppy, 2002; Massart & Saggese, 2010; Zain, 2011). 
No international homogeneous maximum limit exists in foodstuff for ZEA. Eight countries 
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The JECFA has established a provisional maximum tolerable daily intake for ZEA to be 0.5 
μg/kg of body weight (JECFA, 2000).  
The Canadian daily intake of ZEA from maize and maize-based cereals has been estimated 
to be 0.005 - 0.087 μg/kg b.w. for 12 - 19 year-old males, the highest consumption group. An 
additional intake from popcorn was estimated to be 0.001 - 0.023 μg/kg b.w. 
3. Combined toxic effects of mycotoxins 
It has been known for many years that several products derived from plants contaminated 
by fungi during plant growth or during harvest and storage of the food item, can contain 
more types of mycotoxins; as a consequence, food intake results in a simultaneous exposure 
to a mix of mycotoxins; for example, often citrinin and ochratoxin A are found together (see 
Table 3).  
There are several combinations of mycotoxins that frequently occur as verified by specific 
monitoring programs. These combinations are summarized in Table 3.  
 
Mycotoxins References 
OTA and Citrinin Pohland et al., 1992; Vrabcheva et al., 2000; Pfohl-Leszkowicz et 
al. 2007 
OTA and ZEA Halabi et al. 1998 
AFB1 , FB1 and ZEA  Oliveira et al., 2006 
OTA and AFB1 Sedmikova et al., 2001 
FB1 and Moniliformin Gutema et al., 2000 
DON, NIV, T2, HT-2 Eskola et al., 2001 
DON, NIV, T2, HT-2, ZEA Tanaka et al., 2010 
Table 3. Combinations of mycotoxins in food.  
When mycotoxins are of similar structure and of the same species or of the same family, it is 
likely to expect similar mechanism of action, therefore mycotoxins are likely to exert 
additive effects. However, there are relatively poor information on the interaction between 
mycotoxins that occur at the same time and the consequences for animal and human health.  
The available data in literature show that adequate studies to establish antagonistic, additive 
or synergistic effects after combined exposure to mycotoxins are rare and some of them are 
difficult to interpret. 
The few studies conducted on the mycotoxins co-presence have shown that combined 
exposure to several mycotoxins generally results in an additive toxic effect with a few 
exceptions. The synergic capacity is relatively small for NIV, DON, T-2, ZEA and FB1. 
The interaction between NIV and T-2 has been seen as synergistic because the effect of T-2 is 
potentiated in the presence of high levels of NIV (Berthiller et al., 2009; Bouslimi et al., 2008; 
Speijers & Speijers, 2004; Tammer et al., 2007). 
It would be proper for future research to try to understand how mycotoxins can interact and 
thus interfere between them.  
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4. Ghost mycotoxins 
Mycotoxins may also occur in conjugated forms such as:  
 soluble or masked mycotoxins  
 mycotoxins incorporated into/associated with/attached or bound to macromolecules. 
Conjugated mycotoxins can be produced after metabolization by living plants, fungi and 
mammals, after food processing or because of some cooking methods. 
It has been shown that wheat enzymatically produces deoxynivalenol 3-glucoside (D3G) 
from DON to defend itself from the very same toxin attack.  
During storage, on the contrary, the plant product generally has a low metabolic activity 
and its enzymatic protections may not be as active. 
Mycotoxins can be altered by subsequent food processing and most frequently through 
conjugation. The reliable analytical methods, measurement standards and occurrence and 
toxicity for this forms of mycotoxins are still lacking.  
So, the risk assessment from exposure of consumers to mycotoxins should also take into 
account the presence of those forms (Berthiller et al., 2009; Bouslimi et al., 2008; Tammer et 
al., 2007). 
4.1 Fungal conjugates 
Some mycotoxin conjugates can be excreted directly by fungi, although examples are rare. 
This is the case of the well known 3-acetyl deoxynivalenol (3ADON) and 15-acetyl 
deoxynivalenol (15ADON), that can be found in cereals contaminated by Fusarium. Both 
substances are biosynthetic precursors of DON. 
Some strains of F. sambucinum and F. sporotrichoides produce compounds such as 4-
propionyl HT-2 toxin, 8-nhexanoyl neosolaniol, 8-butyryl neosolaniol, 8-isobuturyl 
neosolaniol, and 8-pentenoyl neosolaniol in hydroponics culture. 
Zearalenone 4-sulfate (Z4S) was found to be a natural Fusarium metabolite. 
Similarly, Rhizopus arrhizus is capable of catalysing sulfation of ZEA to Z4S. (Berthiller et al., 
2009; Tammer et al., 2007). 
4.2 Plant conjugates 
Plants protect themselves from xenobiotic compounds like mycotoxins by converting them 
into more polar metabolites. 
It remains unclear, however, whether glycosylated mycotoxins are less toxic than the 
storage forms or they are part of the mechanism of the plant self-protection. 
In wheat and maize cell suspension cultures OTA is transformed into ochratoxin α and 
methylester-ochratoxin A (two isomers of hydroxyochratoxin A) as well as into their 
glucosides and methyl esters. 
Fumonisin conjugates were long believed to occur only after food processing but recently it 
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4. Ghost mycotoxins 
Mycotoxins may also occur in conjugated forms such as:  
 soluble or masked mycotoxins  
 mycotoxins incorporated into/associated with/attached or bound to macromolecules. 
Conjugated mycotoxins can be produced after metabolization by living plants, fungi and 
mammals, after food processing or because of some cooking methods. 
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So, the risk assessment from exposure of consumers to mycotoxins should also take into 
account the presence of those forms (Berthiller et al., 2009; Bouslimi et al., 2008; Tammer et 
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deoxynivalenol (15ADON), that can be found in cereals contaminated by Fusarium. Both 
substances are biosynthetic precursors of DON. 
Some strains of F. sambucinum and F. sporotrichoides produce compounds such as 4-
propionyl HT-2 toxin, 8-nhexanoyl neosolaniol, 8-butyryl neosolaniol, 8-isobuturyl 
neosolaniol, and 8-pentenoyl neosolaniol in hydroponics culture. 
Zearalenone 4-sulfate (Z4S) was found to be a natural Fusarium metabolite. 
Similarly, Rhizopus arrhizus is capable of catalysing sulfation of ZEA to Z4S. (Berthiller et al., 
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4.2 Plant conjugates 
Plants protect themselves from xenobiotic compounds like mycotoxins by converting them 
into more polar metabolites. 
It remains unclear, however, whether glycosylated mycotoxins are less toxic than the 
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glucosides and methyl esters. 
Fumonisin conjugates were long believed to occur only after food processing but recently it 





The exact chemical nature of these naturally occurring hidden forms is still unknown. In 
particular, it has to be understood whether conjugates are formed by the plant from non 
covalent interactions, e.g. with starch or proteins. 
4.3 Food-processing conjugates 
Food processing, especially heating and fermentation, can potentially alter some 
mycotoxins. D3G in fact was detected in malt and beer made from barley naturally 
contaminated with Fusarium, but also DON conjugates with higher masses as diglucosides 
and triglucosides have been detected in beer. Generally, very little is known regarding 
bound mycotoxins. 
Depending on the type of linkage to proteins, starch, pectins, hemicellulose, cellulose and 
lignin, it is possible that at least some of the bound mycotoxins could become bioavailable 
again in the digestive tract of humans and animals. 
Conjugation does not occur only during food processing; an excessive heat can also alter 
mycotoxins structure considerably; in fact, although mycotoxins are very stable, thermal 
degradation products of NIV and DON have been found in food and feed.  
Fumonisins conjugates with sugars, amino acids and proteins are known to occur in food 
and feed. Heating FB1 with reducing sugars can yield N-(carboxymethyl) FB1, even in corn 
products.  
Protected lysine and cysteine methyl esters react with FB1 demonstrating that free groups as 
thiol or amino groups of proteins are likely to react with the mycotoxins. Furthermore, it has 
been proven that thermal food processing influences the chemical structure and toxicity of 
fumonisins (Berthiller et al., 2009; Bouslimi et al., 2008; Speijers & Speijers, 2004; Tammer et 
al., 2007). 
4.4 Mammalian conjugates 
Conjugates that arise from mammalian metabolization unlikely have a role in food or 
feedstuffs and are therefore not regarded as masked mycotoxins. 
Mycotoxins are conjugated by humans and animals during metabolization in the liver and 
are excreted in urine. Serum albumin adducts of AFB1 can be formed by Patulin that has 
been shown to react with cellular nucleophiles such as proteins or glutathione. This is the 
most probable pathway of detoxification in man and animals after dietary exposure to 
patulin-contaminated apples.  
The ability to form glutathione and cysteine conjugates has also been shown for ochratoxin 
A. The most common mycotoxin conjugation products in mammals are glucuronides, as 
found for the Fusarium mycotoxins DON and ZEA. Besides the unchanged mycotoxins, both 
deoxynivalenol glucuronides and zearalenone glucuronide were detected in the urine of 
exposed animals.  
Some DON and ZEA sulfates are formed and excreted by animals too. These conjugates 
might be used as biomarkers; by doing so, also inhalation of mycotoxins (e.g. by grain 
workers or from indoor moulds) and the consumption of all bioavailable forms of 
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mycotoxins (including masked mycotoxins) might be monitored (Berthiller et al., 2009; 
Bouslimi et al., 2008; Speijers & Speijers, 2004; Tammer et al., 2007). 
5. Mycotoxins control strategies, a possible form of prevention 
Good agricultural practices (GAPs), good manufacturing practices (GMPs), HACCP 
(Hazard Analytical Critical Control Point), biological control measures and transgenic 
approaches, are actually the only realistic and possible form of primary prevention for 
mycotoxins flowering. 
A control program for mycotoxins from the field to the table should include the HACCP 
approach, thus requiring an understanding of the interactions of the toxigenic fungi with 
crop plants, of the production and harvest methods for crops, of the production of livestock 
using grains and processed feeds, a thorough knowledge including diagnostic capabilities 
for mycotoxicoses, the development of new practices of foods processing for human 
consumption including storage and delivery (Jard et al., 2011). 
A good protocol for mycotoxins checking is necessary to manage all control points and 
finally for being able to ensure to the consumer a food supply free from mycotoxins (Binder, 
2007 ; Richard, 2007; Abrunhosa et al., 2010). 
The results of HACCP show that the products obtained have an elevated hygienic quality, 
thus lowering the risk of contamination. The dried pasta, for example, is one of the foods 
most commonly consumed by Italians and Italy is leading the world ranking for the 
consumption of pasta. Also, pasta is conquering more and more important positions in the 
dietary habits of various peoples. The study of Ferrante and colleagues (2009) was to assess 
the presence of ZEA and OTA with the aim of identifying the consumer’s risk. 
The results of this study have showed OTA and Zea concentrations below the limit of 
methods in all types of dried pasta tested, also have showed that the HACCP system 
adopted by Italian food industries are adequate for preserve the food quality. This study 
moreover have showed in particular that the products for celiac consumers and the 
products made with whole wheat flour have an elevated hygienic quality. 
The efficient storage systems can be also a good practice for reduction of contamination by 
mycotoxins. 
One of the conservation techniques for food is the lyophilization. Ferrante and colleagues in 
2006 carried out the study for verify presence of : tri-5 gene, ZEA, NIV and DON, in the 
primary products used for the preparation of lyophilized foodstuffs and in their final 
products (prontocrepes and prontocone).  
The study have showed that the Tri-5 gene are always present in prontocrepes and always 
absent in prontocone products. With the air treatment a reduction of DON and NIV in both 
products has been obtained. The nitrogen treatment has had a single influence on the DON 
and in both final products, in which has had a reduction to 50 %. While, the NIV with the 
same treatment has reached the lowest percentage of reduction in both final products. The 
treatments affect relatively on the contamination of processed-foods that, therefore, in this 
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Populations residing in developed Countries are usually considered to be less exposed to 
mycotoxins than those in developing Countries; this might be attributed to various factors:  
 execution and practice of modern food handling/preservation technology 
 successful governmental regulation and commercial control over food quality and 
safety. 
However, even monitoring and exercising of good agricultural and manufacturing practices 
(GAP and GMP) along with an effective HACCP approach might not completely avoid or 
eliminate mycotoxins in the food chain (Bhat, 2010; Jard et al., 2011; Zain, 2011). 
5.1 Biological control 
Various biocontrol strategies are possible for reducing the levels of mycotoxins in the crops, 
such as development of atoxigenic bio-control fungi that can out-compete their closely 
related, toxigenic strains in field environments. 
It has been reported the existence of non-toxigenic strains of A. flavus and A. parasiticus that 
can reduce the post-harvest aflatoxin contamination by 95.9%. 
The competitive use of biological agents such as F. verticillioides strains was observed to 
suppress the growth of fumonisin-producing fungi. 
Control of fumonisins producing fungi by endophytic bacteria has also been reported and 
competitive exclusion was thought to be the mechanism involved. 
It has also been reported that Pichia anomala, Pichia kluyveri and Hanseniaspora uvarum 
can inhibit in vitro OTA.  
Furthermore, fungal strains of Trichoderma have been demonstrated to control pathogenic 
molds through mechanisms such as competition for nutrients and space, fungistasis, 
rhizosphere modification, mycoparasitism, biofertilization and the stimulation of plant-
defense mechanisms (Bhat, 2010; Jard et al., 2011; Zain, 2011). 
5.2 Chemical control 
Appropriate use of pesticides during the production period could help in minimizing fungal 
infections or insect infestation of crops and consequently mycotoxins contamination; 
therefore, Fumonisins contamination could be reduced by application of fungicides that 
have been used for controlling Fusarium, such as prochloraz, propiconazole, epoxyconazole,  
tebuconazole, cyproconazole and azoxystrobin.  
On the other hand, fungicides such as itraconazole and amphotericin B have been shown to 
effectively control the aflatoxin-producing Aspergillus species. However, use of fungicides 
is been discouraged because of economic, environment and severe food safety issues (Bhat, 
2010; Jard et al., 2011; Zain, 2011). 
5.3 Decontamination 
Decontamination of food and feed from mycotoxins could be achieved through 
chemoprotection or enterosorption. 
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Chemoprotection from aflatoxins has been demonstrated with the use of a number of 
chemical compounds like oltipraz and chlorophylin or through dietary interventions based 
on broccoli sprouts and green tea that increase animal’s detoxification processes or prevent 
the production of epoxide, that is known to cause chromosomal anomalies. 
However, this intervention might not be sustainable in the long-term because it is expensive 
and shows some side effects.  
Entersorption is based on the discovery of certain clay minerals, such as Novasil, that can 
selectively adsorb mycotoxins enough to prevent their absorption from the gastrointestinal 
tract . 
There are different adsorption agents but their efficacy in preventing mycotoxicosis varies. 
Calcium montorillonites have proven to be the most highly selective and effective of 
enterosorbents. However, with enterosorption, there is a risk that non-specific adsorption 
agents may prevent uptake of micronutrients from the food (Bhat, 2010; Jard et al., 2011; 
Zain, 2011). 
5.4 Breeding for resistance 
Breeding for resistance is the most promising and encouraged long-term strategy for control 
of mycotoxins contamination in Africa. Sources of resistance to A. flavus and Fusarium spp. 
have been identified, particularly F. verticillioides. 
Zain (2011) states that "Prototypes of genetically engineered crops have been developed that 
a. contain genes for resistance to the phytotoxic effects of certain trichothecenes, thus 
helping reducing fungal virulence or  
b. contain genes encoding fungal growth inhibitors for reducing fungal infection in the 
USA". 
To devise effective strategies to control fungal infections and minimize mycotoxins 
production in host plants, a good knowledge of genetic variability and plants population 
structure is necessary (Kazan et. al., 2011; Jard et al., 2011; Zain, 2011). 
6. Regulation of mycotoxins in foods and feeds 
A series of studies on mycotoxins in food and feed have been carried out around the world 
in order to improve policy making. 
Regulations relating to mycotoxins have been established in many Countries to protect 
consumers from the harmful effects of these compounds. In 2003 about 100 Countries 
(covering approximately 85% of the world’s inhabitants) had already specific regulations or 
detailed guidelines on mycotoxins in food. Regulations concerned AFB1, AFB2, AFG1, 
AFG2 and AFM1, trichothecenes (Vomitoxin, diacetoxyscirpenol, T-2 toxin and HT-2 toxin), 
FB1, FB2, and FB3, agaric acid, ergot alkaloids, OTA, patulin, phomopsins and ZEA, leaving 
out sterigmatocystin. 
Harmonized EU limits now exist for 40 mycotoxin–food combinations. The direct or indirect 
influence of European organizations and programs on the EU mycotoxins regulatory 
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The current maximum limits are more and more based on scientific evidence from 
authoritative agencies such as FAO/WHO, Joint Expert Committee on Food Additives of 
the United Nations (JECFA) and the European Food Safety Authority (EFSA) (Van Egmond 
& Jonker, 2004). 
The FDA has action levels for aflatoxins but the European Community levels are more 
restrictive (Creppy, 2002; Mally & Dekant, 2009). 
Efforts have continued internationally to establish better guidelines to control mycotoxins. 
FAO, for example, has worked with developing Countries (African and East-Asian 
Countries) to mitigate mycotoxins contamination in foods and feeds.  
Many Countries have regulatory or guideline limits for OTA in foods but in the majority of 
cases OTA content limits have been established only for cereals and cereal products (see 
Tab. 5). 
There are still some discussions in those organizations regarding the limit that should be 
established for OTA in some cereal-derived foods, in fact in some Countries there is no limit 
or it is not harmonized with the international level (see Tab. 5) (Araguás et al., 2005).  
 
Limit of AFB1 
on ppb (μg/kg)
Number of countries Limit of AFB1, B2,G1,G2 
on ppb (μg/kg) 
Number of countries 
25 1 35 2 
20 3 30 3 
15 2 20 17 
10 5 15 8 
5 21 10 8 
2 29 5 3 
1 1 4 29 
20 3 3 1 
  1 3 
  0 2 
Table 4. Worlwide limits for AFB1 and sum of AFB1, B2, G1, G2 in food. 
Many Countries, even if industrialized, such as USA and Canada, still today lack of legal 
limit for AFB1, showing how the problem is unfortunately underestimated. 
Furthermore, looking at Table 5, it is also evident that still today in many Countries of the 
world there are no limits for OTA, ZEA and Fumonisins, and that worldwide regulations for 
sterigmatocystin are completely lacking. 
Several Countries, such as Bahamas, Bolivia, Burkina Faso, Cameroon, Ecuador, Ethiopia, 
Iraq, Myanmar, Nicaragua, Pakistan, Panama, Qatar, Trinitad and Tobago, Uganda, United 
Arab Emirates, Yemen, Zambia and Zimbawe, until 2003, hadn’t yet established any 
regulations or limits for any mycotoxins, that means that the carcinogenic risk to which local 
populations are subjected is high. 
 
Carcinogen Role of Food by Mycotoxins and Knowledge Gap 
 
153 




AFB1 EU* 2 Food, peanuts, shell fruits, dried fruits, 
cereals
  5 Unprocessed maize , spices and tea 
  8 Unprocessed peanuts
  0.1 Cereal and other complementary foods for 
infants and small children
  0.1 Dietary foods for special medical purposes 
(specifically for infants)
  2 Maize, cereals
 Algeria 10 Peanuts, nuts, cereals.
 Armenia 5 All foods
 China 20 Maize and maize products, peanut and 
peanut products, peanut oil, irradiated 
peanut
  10 Rice, irradiated rice, edible vegetable oil 
  5 Soya bean sauce, grain paste, vinegar, other 
grains, beans, fermented foods, fermented 
bean products, starch products, fermented 
wine, red rice, butter cake, pastry biscuit and 
bread
 Croatia 5 Cereals, beans, peanuts, coffee, tea 
  30 Spices
 Cuba 5 Cereals, peanuts, cocoa mass
 Egypt 5 Peanuts and cereals
 Honduras 1 Maize
  10 Corn
 Iran 10 Barley
  5 Pistachio nuts, peanuts, walnuts, other nuts, 
edible seeds, dates, dried grapes (raisins and 
sultanas), figs and all dried fruits, maize, 
rice, wheat, legumes
  0.5 Baby food based on cereals with milk 
  1 Baby food based on cereals without milk 
 Israel 5 Nuts, peanuts, maize flour, figs and their 
products and other foods
 Japan 10 All foods
 Jordan 15 Almonds, cereals, maize, peanuts, pistachio 
nuts, pine nuts, rice
 Korea Rep. 10 Grains, soy-bean, peanuts, nuts, wheat and 
the products made from these by simple 
processing
 Malawi 5 Peanuts export
 Moldova Rep. 5 Cereals, legumes, flour, cocoa, nuts, coffee, 
sunflower, tea
 Morocco 10 Wheat bran and all foods
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Limit of AFB1 
on ppb (μg/kg)
Number of countries Limit of AFB1, B2,G1,G2 
on ppb (μg/kg) 
Number of countries 
25 1 35 2 
20 3 30 3 
15 2 20 17 
10 5 15 8 
5 21 10 8 
2 29 5 3 
1 1 4 29 
20 3 3 1 
  1 3 
  0 2 
Table 4. Worlwide limits for AFB1 and sum of AFB1, B2, G1, G2 in food. 
Many Countries, even if industrialized, such as USA and Canada, still today lack of legal 
limit for AFB1, showing how the problem is unfortunately underestimated. 
Furthermore, looking at Table 5, it is also evident that still today in many Countries of the 
world there are no limits for OTA, ZEA and Fumonisins, and that worldwide regulations for 
sterigmatocystin are completely lacking. 
Several Countries, such as Bahamas, Bolivia, Burkina Faso, Cameroon, Ecuador, Ethiopia, 
Iraq, Myanmar, Nicaragua, Pakistan, Panama, Qatar, Trinitad and Tobago, Uganda, United 
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regulations or limits for any mycotoxins, that means that the carcinogenic risk to which local 
populations are subjected is high. 
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AFB1 EU* 2 Food, peanuts, shell fruits, dried fruits, 
cereals
  5 Unprocessed maize , spices and tea 
  8 Unprocessed peanuts
  0.1 Cereal and other complementary foods for 
infants and small children
  0.1 Dietary foods for special medical purposes 
(specifically for infants)
  2 Maize, cereals
 Algeria 10 Peanuts, nuts, cereals.
 Armenia 5 All foods
 China 20 Maize and maize products, peanut and 
peanut products, peanut oil, irradiated 
peanut
  10 Rice, irradiated rice, edible vegetable oil 
  5 Soya bean sauce, grain paste, vinegar, other 
grains, beans, fermented foods, fermented 
bean products, starch products, fermented 
wine, red rice, butter cake, pastry biscuit and 
bread
 Croatia 5 Cereals, beans, peanuts, coffee, tea 
  30 Spices
 Cuba 5 Cereals, peanuts, cocoa mass
 Egypt 5 Peanuts and cereals
 Honduras 1 Maize
  10 Corn
 Iran 10 Barley
  5 Pistachio nuts, peanuts, walnuts, other nuts, 
edible seeds, dates, dried grapes (raisins and 
sultanas), figs and all dried fruits, maize, 
rice, wheat, legumes
  0.5 Baby food based on cereals with milk 
  1 Baby food based on cereals without milk 
 Israel 5 Nuts, peanuts, maize flour, figs and their 
products and other foods
 Japan 10 All foods
 Jordan 15 Almonds, cereals, maize, peanuts, pistachio 
nuts, pine nuts, rice
 Korea Rep. 10 Grains, soy-bean, peanuts, nuts, wheat and 
the products made from these by simple 
processing
 Malawi 5 Peanuts export
 Moldova Rep. 5 Cereals, legumes, flour, cocoa, nuts, coffee, 
sunflower, tea
 Morocco 10 Wheat bran and all foods









  1 Peanuts, pistachio nuts, almonds, vegetable 
oils in pasta, children foods
 Nepal 20 Cereals
 Nigeria 20 Foodstuffs
 Oman 10 Foodstuffs
 Russia 5 All foods
 Senegal 50 Peanut products
  300 Peanut products (feedstuff ingredients) 
 South Africa 5 All foodstuffs
 Switzerland 1 All foods
 Tanzania Rep. 5 Cereals, oil seeds
 Tunisia 2 All foods
Σ (B1, B2, G1, 
G2) 
EU* 4 Peanuts , dried fruits, cereals and related 
products intended for direct human 
consumption
  15 Unprocessed peanuts
  10 Unprocessed shell fruits, dried fruits  
  10 Maize unprocessed, spices and thea. 
 Algeria 20 Peanuts, nuts, cereals.
 Australia§ 15 Peanuts, tree nuts
 Barbados 20 All foods
 Bosnia & 
Herzegovina
1& Cereals
  5 Beans
 Canada 15 Nuts and nut products
 Chile 5 All foods
 Colombia 10 All foods
  20 Maize
 Costa Rica 35 Maize
 Croatia 3 Cocoa beans, almonds, flours, hazelnuts, 
walnuts
 Cuba 5 All foods
 Dominican 
Rep.
0& Maize(products), groundnut, soya, 
tomato(products)
  20 Imported maize
 Egypt 10 Peanuts , cereals
  20 Corn
 Guatemala 20 Maize, kidney beans, rice, sorghum, 
groundnuts, and groundnut butter 
 Honduras 1° All foods
  0.01& Baby food
 India 30 All foods
 Indonesia 20 Peanuts, coco nuts, spices, traditional drugs, 
erbs
 Iran 15 Pistachio nuts, peanuts, walnuts, other nuts, 
edible seeds, dates, dried grapes (raisins and 
sultanas), figs and all dried fruits,wheat 
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 Vietnam 10 Foodstuffs 
AFM1 EU* 0.025 Newborn and baby food 
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 Armenia 0.5 Milk  
 Barbados 0.5 Milk 
 Chile 0.05 Milk 
 China 0.5 Milk and milk products 
 Croatia 0.5 Milk and milk products 
 Honduras 0.05 Milk and milk products 
  0.02 Baby food 
  0.25 Cheese 
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  20 Corn
 Guatemala 20 Maize, kidney beans, rice, sorghum, 
groundnuts, and groundnut butter 
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  0.01& Baby food
 India 30 All foods
 Indonesia 20 Peanuts, coco nuts, spices, traditional drugs, 
erbs
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  10 Legumes 
  50 Barley 
  30 Maize, rice 
 Israel 15 Nuts, peanuts, maize flour, figs and their 
products and other foods 
 Jamaica 20 Food, grains 
 Jordan 30 Almonds, cereals, maize, peanuts, pistachio 
nuts, pine nuts, rice 
 Kenya 20 Peanuts, vegetable oils 
 Kuwait 0.2 Milk and milk products(except dried milk) 
  0.05 Infant and children food 
 Macedonia 1& Wheat, maize, rice and cereals 
  5& Beans 
 Malaysia 35 All foods 
 MERCOSUR+ 20 Peanuts, maize and products thereof 
 Mexico 20 Cereals and products 
  12 Corn flour for tortillas 
 Mozambique 10 Peanut, maize, peanut butter, peanut milk 
 Philippines 20 Nut products 
 Salvador El 20 All foods 
 Saudi Arabia 0.05 Infant and children food 
 Singapore 5 Corn, nuts, and cereal products 
 South Africa 10 All foodstuffs 
 Switzerland 5° All foods 
 Taiwan 15 Peanut, corn, maize 
  10 Rice, sorghum, legumes, nuts, wheat and 
barley, oats, edible oils and fats 
 Tanzania Rep. 10 Cereals, oil seeds 
 Thailand 20 All foods 
 USA 20 All foods 
 Venezuela 20 Corn, corn flour, peanuts, peanut butter 
 Vietnam 10 Foodstuffs 
AFM1 EU* 0.025 Newborn and baby food 
  0.05 Milk and derivates 
 Armenia 0.5 Milk  
 Barbados 0.5 Milk 
 Chile 0.05 Milk 
 China 0.5 Milk and milk products 
 Croatia 0.5 Milk and milk products 
 Honduras 0.05 Milk and milk products 
  0.02 Baby food 
  0.25 Cheese 









 Indonesia 5 Milk, cheese 
 Iran 0.02 Baby food based on cereals with milk 
  0.5 Milk powder
  0.01 Milk powder for babies
  0.2 Cheese
  0.02 Butter, gee
 Israel 0.05 Milk and milk products
 Korea Rep. 0.5 Milk and milk products
 MERCOSUR+ 0.5 Milk
  5 Milk powder
 Moldova Rep. 0.5 Milk, cottage cheese, butter
 Morocco 0.05 Milk and milk products
  0.03 Milk (product) for infants under 3 years 
  0.5 Milk powder
  0.3 Milk powder for infants under 3 years 
 Russia 0.5 Milk and milk products
 Singapore 0.5 Milk, cheese
 South Africa 0.05 Milk
 Switzerland 0.02 Newborn and baby food
  0.05 Milk and milk products
  0.250 Cheese
 Taiwan 0.5 Milk
  5 Milk powder
 USA 0.5 Milk 
 Venezuela 0.5 Milk
  5 Milk powder
OTA EU* 5 Unprocessed cereals 
  3 Cereals and processed cereal-based food 
intended for direct human consumption 
  10 Dried grapes (raisins and sultanas) 
  5 Roasted coffee beans and ground roasted 
coffee, with the exception of instant coffee 
  10 Instant coffee 
  2 Wine (red, white and rosé) and other wine 
and / or other drinks based on grape must. 
Grape juice, based ingredients of grape juice 
  2 Cocoa and chocolate powder 
  0.5 Cereal and other complementary foods for 
infants and dietary foods for special medical 
purposes (specifically for infants)  
  0.5 Chocolate and its derivatives 
  0.2 Beer 
  1 Pork and derivatives 
 Cuba 5 Coffee, cereals 
 Indonesia Not detectable Coffee 
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 Iran 50 Barley, maize 
  20 Legumes 
  10 Dates, dried grapes (raisins and sultanas), 
figs and all dried fruits 
  5 Rice, wheat 
  1 Baby food based on cereals without milk 
 Israel 50 Cereals, cereal products and other foods 
 Morocco 30 Cereals 
 Singapore 2.5 Cereal, raw coffee beans and roasted coffee 
beans 
 Sudan 15 Wheat 
 Switzerland 2 Cereals 
FB1+ FB2 EU* 4000 Unprocessed maize 
  1000 Maize intended for direct human 
consumption, maize-based foods for direct 
human consumption 
  800 Maize-based breakfast cereals and maize-
based snacks 
  200 Processed maize-based foods and baby 
foods for infants and young children 
 Cuba 1000 Maize, rice 
 Switzerland 1000 Maize 
 USA 2000 Unprocessed maize 
ZEA EU* 20 Processed maize-based foods for infants and 
young children 
  100 Unprocessed cereals other than maize 
  350 Unprocessed maize  
  400 Refined maize oil 
  75 Cereals intended for direct human 
consumption, cereal flour, bran and germ. 
  50 Bread pastries, biscuits, cereal snacks and 
breakfast cereals, excluding maize-snacks 
and maize-based breakfast cereals 
  100 Maize intended for direct human 
consumption, maize-based snacks and 
maize-based 
breakfast cereals 
  100 Maize intended for direct human 
consumption 
 Armenia 1000 All foods 
 Chile 200 All foods 
 Indonesia Not detectable Maize 









 Indonesia 5 Milk, cheese 
 Iran 0.02 Baby food based on cereals with milk 
  0.5 Milk powder
  0.01 Milk powder for babies
  0.2 Cheese
  0.02 Butter, gee
 Israel 0.05 Milk and milk products
 Korea Rep. 0.5 Milk and milk products
 MERCOSUR+ 0.5 Milk
  5 Milk powder
 Moldova Rep. 0.5 Milk, cottage cheese, butter
 Morocco 0.05 Milk and milk products
  0.03 Milk (product) for infants under 3 years 
  0.5 Milk powder
  0.3 Milk powder for infants under 3 years 
 Russia 0.5 Milk and milk products
 Singapore 0.5 Milk, cheese
 South Africa 0.05 Milk
 Switzerland 0.02 Newborn and baby food
  0.05 Milk and milk products
  0.250 Cheese
 Taiwan 0.5 Milk
  5 Milk powder
 USA 0.5 Milk 
 Venezuela 0.5 Milk
  5 Milk powder
OTA EU* 5 Unprocessed cereals 
  3 Cereals and processed cereal-based food 
intended for direct human consumption 
  10 Dried grapes (raisins and sultanas) 
  5 Roasted coffee beans and ground roasted 
coffee, with the exception of instant coffee 
  10 Instant coffee 
  2 Wine (red, white and rosé) and other wine 
and / or other drinks based on grape must. 
Grape juice, based ingredients of grape juice 
  2 Cocoa and chocolate powder 
  0.5 Cereal and other complementary foods for 
infants and dietary foods for special medical 
purposes (specifically for infants)  
  0.5 Chocolate and its derivatives 
  0.2 Beer 
  1 Pork and derivatives 
 Cuba 5 Coffee, cereals 
 Indonesia Not detectable Coffee 
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 Iran 50 Barley, maize 
  20 Legumes 
  10 Dates, dried grapes (raisins and sultanas), 
figs and all dried fruits 
  5 Rice, wheat 
  1 Baby food based on cereals without milk 
 Israel 50 Cereals, cereal products and other foods 
 Morocco 30 Cereals 
 Singapore 2.5 Cereal, raw coffee beans and roasted coffee 
beans 
 Sudan 15 Wheat 
 Switzerland 2 Cereals 
FB1+ FB2 EU* 4000 Unprocessed maize 
  1000 Maize intended for direct human 
consumption, maize-based foods for direct 
human consumption 
  800 Maize-based breakfast cereals and maize-
based snacks 
  200 Processed maize-based foods and baby 
foods for infants and young children 
 Cuba 1000 Maize, rice 
 Switzerland 1000 Maize 
 USA 2000 Unprocessed maize 
ZEA EU* 20 Processed maize-based foods for infants and 
young children 
  100 Unprocessed cereals other than maize 
  350 Unprocessed maize  
  400 Refined maize oil 
  75 Cereals intended for direct human 
consumption, cereal flour, bran and germ. 
  50 Bread pastries, biscuits, cereal snacks and 
breakfast cereals, excluding maize-snacks 
and maize-based breakfast cereals 
  100 Maize intended for direct human 
consumption, maize-based snacks and 
maize-based 
breakfast cereals 
  100 Maize intended for direct human 
consumption 
 Armenia 1000 All foods 
 Chile 200 All foods 
 Indonesia Not detectable Maize 









  200 Maize, rice, wheat 
 Moldova Rep. 1000 Wheat , barley, maize and their flour 
 Morocco 200 Cereals and vegetable oils 
 Russia 1000 Cereals and vegetable oils
  
Eu*= 27 countries (Austria, Bulgaria, Cyprus, Czech. Rep., Denmark, Estonia, Finland, France, 
Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, The Netherland, 
Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Great Britain). Norway, Iceland and 
Liechtenstein to follow the limits of the European Union (harmonized standards). 
° = Σ ( B2, G1 and G2). 
&= Σ (B1+G1). 
§= All Australian regulations were harmonized with New Zealand. 
 += MERCOSUR member states: Argentina, Brazil, Paraguay and Uruguay. 
Table 5. Worldwide maximum limit of carcinogenic mycotoxins for food. 
7. Conclusions and future research 
Besides the demonstrated effects of mycotoxins on humans and animals, some important 
aspects of their toxicology and possible control mechanism are still unknown and 
unexplored. The occurrence of mycotoxins in the food chain is therefore an unavoidable and 
serious problem that the world is facing not without efforts nor difficulties. 
The toxic effects of mycotoxins (on liver and kidney, hematopoietic toxicity, immune system 
toxicity, reproductive system toxicity, foetal toxicity and teratogenicity, and moreover 
carcinogenicity) are mostly known in experimental models but the extrapolation for humans 
is often inaccurate. 
The inaccuracy of extrapolation for humans may be explained by the lack of adequate food 
consumption data and/or lack of knowledge about relative health risks associated with 
specifically proposed limits and finally by the gap of knowledge on the possibility of 
synergism with other mycotoxins present in the same food products.  
Wide gaps still exist on the toxicological effects of feeding animals with mycotoxin-
contaminated feeds. 
Further research also needs to be focused on epidemiology of toxic effects, especially in 
humans.  
Development of new genetically modified plants by the application of genetic engineering 
that might be resistant to fungal invasion might also prove today to be a good option for 
preventing growth of toxigenic fungi, though they leave open many question marks in any 
case. 
Development of methods for simple, rapid and economic analysis chemical contaminants 
throughout the food chain. The researchers Ferrante and Oliveri Conti have carried out the 
development of a method for simultaneous determination of 13 mycotoxins and some their 
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metabolites in LC-MS tandem TQD in serum and urine of humans (Article awaiting 
acceptance by journal) after enzyme treatment of samples. 
Even though research papers, reviews, monographs, and government reports are available 
on the contamination of food and feed by fungal toxins, nonetheless most of the information 
are restricted to only one type of mycotoxin (Bhat et al., 2010), and they do not take into 
account ghost mycotoxins. 
Much still needs to be done, both at governmental and scientific level, in order to reach 
higher standards of protection for consumers. It is important to harmonize as soon as 
possible the maximum limits for food taken from Country to Country due to global trade, 
that increases the risks due to mycotoxins ingestion in the population of the importing 
Country. 
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1. Introduction 
One of the major challenges in biomedicine is to find strategies to prevent cancer. It is 
among the top 10 causes of death in middle and high income countries (WHO, 2004) and 
accounts for a major economic expenditure; for instance, £5.86 billion were spend on cancer 
care in 2009-2010 in the UK, which is 5.6% of the UK´s total annual health spending 
(Sullivan et al., 2011). The pathogenesis of this condition involves a series of complex and 
interwoven mechanisms ranging from genetic to environmental and/or behavioral factors. 
Some of the causes and risk factors of cancer are smoking, infection/inflamation, dietary 
factors, sunlight exposure, and pollution (Sugimura, 2002). Radiofrequency electromagnetic 
fields have also been recently classified as “possibly carcinogenic” by the World Health 
Organization’s International Agency for Research on Cancer (IARC) (IARC, 2011). This 
chapter is going to focus mainly on diet as a risk factor for cancer. 
Diet can play an important role in the onset of cancer since apparent harmless meals, to which 
we are exposed daily, can bring mutagens in close proximity to our DNA, certainly a bad 
combination. The formation of the “cooking mutagens” takes place in the framework of the 
Maillard reaction when thermally treating food. These mutagens are products of the reaction 
of common food components such as aminoacids, fatty acids or creatine and have to be 
metabolically activated to acquire the potential to alter DNA. For instance, melanoidins, the 
polymers that give the brownish colour when cooking (Arnoldi et al., 1997; Tehrani et al., 
2002), are other products of the Maillard reaction with which we are more familiar.  
Study in cooking mutagens was pioneered at Lund University, in 1939, where E.M.P 
Widmark reported that organic solvent extracts from grilled horse meat caused tumours in 
mice mammary glands when they were repeatedly applied to mouse skin (Widmark, 1939). 
Some years later, Druckrey and Preussman (Druckrey et al., 1962) reported the presence of 
carcinogenic N-nitrosamines in tobacco smoke, which were identified in food in the 1990s 
(Drabik-Markiewicz et al, 2011; Tricker et al., 1991). The presence of polycyclic aromatic 
hydrocarbons was also found on the crust of well-done charcoal-grilled steaks by Lijinsky 
and Shubick. These compounds were formed from the pyrolysis of fat drippings into flames 
and the adherence of this pyrolysate to the surface of food (Chung, 2011; Lijinsky & Shubick, 
1964). Not long after, a revolutionary assay to quantify mutagenic activity was developed by 
Ames et al. (1975) based on Salmonella typhimurium strains (Ames et al., 1975). This assay 
helped Sugimura and co-workers to find high mutagenic activity in particles of smoke 
produced by cooking proteinaceous foodstuffs and immediately afterwards in charred parts 
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prepared under domestic conditions (Commoner et al., 1978). These findings initiated 
research into heterocyclic amines (HCAs) and since then several series of mutagenic HCAs 
have been identified. Some potential and new HCAs have been recently reported in thermally 
treated food (Busquets et al., 2007, 2008; Turesky et al., 2007). HCAs result from the reaction of 
natural components present in protein rich food at normal cooking conditions. In 2005, the 
U.S. National Toxicology Program listed four HCAs as reasonably anticipated human 
carcinogens, status that has been mantained in the latest report (RoC, 2011). Earlier, in 1993, 
the IARC already listed one HCA as probable human carcinogen (group 2A) and eight HCAs 
as possible human carcinogens (group 2B) and recommended a decrease in their intake (IARC, 
1993). Furan, mainly found in coffee, baby food, beer and canned sauces and soups, was also 
classified as possibly carcinogenic to humans (Group 2B) (IARC, 1995). This compound is 
formed from three major routes beginning with sugars, ascorbic acid or unsaturated fatty acids 
(Al Taki et. al, 2011; Maga, 1979). For a review, see Crews and Castle (Crews & Castle, 2007). 
Recently, acrylamide, listed within the group 2A (IARC, 1994) and formed from the reaction 
between asparagine and glucose (Mottram et al., 2002; Tareke et al., 2002;) has also been found 
in carbohydrate-rich foods. The major exposure to acrylamide mainly appears to come from 
the consumption of French fries, crisps, biscuits or cereals (Bermudo et al., 2006; Tareke et al., 
2002). At present, additional naturally occurring substances such as 5-(hydroxymethyl)-2-
furfual (HMF) and related compounds, which are formed from hexoses in acidic media, are 
being evaluated for their potential human genotoxicity. In particular, high levels of HMF have 
been quantified in honeys, caramel products, plum-derived products, coffee and balsamic 
vinegars (Glatt & Sommer, 2006; Teixidó et al., 2006). Some examples of relatively abundant 
cooking mutagens among the types listed above, are the nitrosamine NMDA (N-
nitrosodimethylamine); the polycyclic aromatic hydrocarbon BPA (benzo[a]pyrene); the 
heterocyclic aromatic amine PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine); HMF; 
furan and acrylamide, shown in Fig. 1.  
 
Fig. 1. Examples of food borne mutagens. 
When somebody is informed about the generation of potential harmful compounds in 
common food items, whom asks who or what is responsible for that exposure. The answer 
to that is our eating preferences and habits, as it will be explained later in this book chapter. 
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food is not healthy”. This is a good start, because it means that research has been 
disseminated and people are aware to some extent of the lack of safety in burnt food. 
However the information received is partly innacurate as potential hazardous compounds 
can also be present in the non overcooked parts of the food. For instance, Fig. 2 shows 
chicken cooked using different methods and the corresponding concentration of mutagenic 
HCAs analysed in these food items. It can be seen that non charred meat can contain 
relatively high levels of cooking mutagens, HCAs in this case. Besides, very different levels 
of HCAs can be found in an item presenting similar degree of doneness and browning that 
has been processed using different cooking methods.  
 
Fig. 2. Level of mutagenic HCAs in chicken cooked in different ways. Each bar corresponds 
to the concentration of HCAs quantified in the respective item displayed. The cooking and 
analysis conditions have been reported elsewhere (Busquets et al., 2004, 2008). 
Finally, despite the effort of scientists to study food borne mutagens, human behaviour is 
complex and, in some occasions, the public reacts saying “I like barbecued meat and I love 
crisps and there is no way I will I stop eating them”. In summary, if in the best case people 
have been warned on the certain risks associated to some food items and they will not make 
an effort to reduce the exposure, who would care about them; are food borne carcinogens a 
dead end? 
2. Exposure to food borne carcinogens. Heterocyclic amines (HCAs), a case 
study 
The formation of HCAs results from the reaction of hexoses, creatine/creatinine and amino 
acids (Jägerstad et al, 1983a, 1983b; Murkovic et al., 1999, 2004) and is highly affected by the 
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cooking mutagens among the types listed above, are the nitrosamine NMDA (N-
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Fig. 1. Examples of food borne mutagens. 
When somebody is informed about the generation of potential harmful compounds in 
common food items, whom asks who or what is responsible for that exposure. The answer 
to that is our eating preferences and habits, as it will be explained later in this book chapter. 
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food is not healthy”. This is a good start, because it means that research has been 
disseminated and people are aware to some extent of the lack of safety in burnt food. 
However the information received is partly innacurate as potential hazardous compounds 
can also be present in the non overcooked parts of the food. For instance, Fig. 2 shows 
chicken cooked using different methods and the corresponding concentration of mutagenic 
HCAs analysed in these food items. It can be seen that non charred meat can contain 
relatively high levels of cooking mutagens, HCAs in this case. Besides, very different levels 
of HCAs can be found in an item presenting similar degree of doneness and browning that 
has been processed using different cooking methods.  
 
Fig. 2. Level of mutagenic HCAs in chicken cooked in different ways. Each bar corresponds 
to the concentration of HCAs quantified in the respective item displayed. The cooking and 
analysis conditions have been reported elsewhere (Busquets et al., 2004, 2008). 
Finally, despite the effort of scientists to study food borne mutagens, human behaviour is 
complex and, in some occasions, the public reacts saying “I like barbecued meat and I love 
crisps and there is no way I will I stop eating them”. In summary, if in the best case people 
have been warned on the certain risks associated to some food items and they will not make 
an effort to reduce the exposure, who would care about them; are food borne carcinogens a 
dead end? 
2. Exposure to food borne carcinogens. Heterocyclic amines (HCAs), a case 
study 
The formation of HCAs results from the reaction of hexoses, creatine/creatinine and amino 
acids (Jägerstad et al, 1983a, 1983b; Murkovic et al., 1999, 2004) and is highly affected by the 






































chemical and physical parameters during the cooking process as well as the composition of 
the raw food. It is important to understand the effect of such parameters on exposure to 
HCAs, as an example of food borne mutagens, to understand, to some extent, the absence of 
legislation, and subsequently the low interest of the companies to monitor or reduce the 
level of HCAs in food items. The proposed route for the formation of HCAs (quinolines and 
quinoxalines) is shown in Fig 3 and the proposed mechanism for the formation of pyridinic 
HCAs is given in Fig. 4. 
 
 
Fig. 3. Proposed pathway for the formation of quinoline (IQ, MeIQ) and quinoxale type 
(MeIQx, 4,8-DiMeIQx and 7,8-DiMeIQx) of HCAs. Adapted from Jägerstad et al. (Jägerstad 
et al., 1983b). 
A study using precursors of PhIP (structure shown in Fig. 1) labelled with 13C was key to 
clarify the reaction mechanism involved in the formation of this amine, which is the most 
abundant mutagenic HCA in cooked meat and fish. Phenylalanine labelled with 13C at three 
non-aromatic positions (C-1, C-2 and C-3) (see Fig. 4) provided important information. 
When labelling the carbon atom of the carboxylic acid of phenylalanine (C-1), there was no 
incorporation of 13C, probably due to fast decarboxylation. When labelling the C-2 of the 
amino acid, two different signals were detected in 13C-NMR (C-5 and C-7 in PhIP); and 
when labelling at C-3, just one position of PhIP incorporated the 13C (C-3 in PhIP). From 
these experiments, Murkovic et al. proposed the mechanism of formation of PhIP that is 
reproduced in Figure 4 (Murkovic et al., 1999). C-1 of phenylacetaldeyde (2), i.e. Strecker 
degradation product of phenylalanine (1), undergoes aldol condensation with creatine (3) to 
form (A), which suffers dehydration to form (B). A and B intermediates were isolated from 
model systems and from heated meat in Dr. Murkovic’s research group (Zöchling et al., 
2002). Experiments with 15N-labelled phenylalanine, carried out to identify the origin of the 
nitrogen forming the pyridine moiety of PhIP, revealed that this amino acid was not the 
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Fig. 4. Formation of PhIP. The marked carbon atoms correspond to the labelled positions in 
the experiments. Intermediate reaction products are signalled. Adapted from Murkovic et al. 
(Murkovic et al., 1999; Murkovic, 2004). 
2.1 Parameters affecting the yield of HCAs 
Among the different parameters affecting the formation of HCAs, temperature is the most 
important. The levels of HCAs are highly dependent on the temperature of the cooking 
process. In general, the amounts of HCAs increase at high temperature (Knize et al., 1994; Skog 
et al., 1995, 1997). Thus, HCAs form primarily in the crust of the cooked products and to a 
lesser extent in the inner part, which is where the temperature is lower (Skog et al., 1995). 
Heat and mass transfer are variables that affect the formation of HCAs in cooking processes. 
Heating of meat produces protein denaturation, losses of fat and moisture and changes in 
the shrinkage and porosity of the meat or fish matrix. When heat is applied to the surface of 
the meat, it is transferred to the centre, creating a temperature gradient between the surface 
and the centre. As the temperature at the surface increases, the partial pressure of water 
increases at the surface, which causes a vapour flow towards the centre, where it condenses 
and releases heat. The increase of water content at the centre produces a flow of water towards 
the surface, even out of the meat (Persson et al., 2002). This water transport brings precursors 
of HCAs to the surface of the meat and to the drippings. In consequence, heat from the hot 
source favours the reaction between precursors of HCAs, and therefore HCAs can be found in 
drippings, even at higher amounts than in the food itself (Skog et al., 1997; Pais et al., 1999). 
Mechanisms controlling heat and mass transfer during thermal processing of beefburgers were 
studied by Bea. Kovácsné in a doctoral thesis at Lund University (B. Kovácsné, 2004). Cooking 
methods involve different heat and mass flows. Roasting entails transference of heat by 
convection through the air and radiation through the walls. In cooking methods where liquid 
surrounds the meat, such as stewing, boiling or deep-frying, heat is transferred by convection. 
Pan-frying produces heat transference to the meat by conduction and convection through a 
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not rise above 100ºC as long as water is present, and from the crust to a certain depth there is 
an evaporation zone. When crust is formed, heat flow towards the inside of the meat slows 
down because the crust insulates to some extent. Likewise, coating foods can reduce the 
formation of HCAs due to the insulating effect of the coating, and conductive heat transfer 
dominates inside the meat (Busquets et al., 2008; Persson et al., 2002; Skog et al., 2003). In 
general, roasting, boiling, stir-frying and stewing are the cooking methods in which lower 
amount of HCAs are formed; whereas griddling, pan-frying, barbecuing and deep-frying are 
the methods that lead to higher levels of HCAs, due to greater heat transfer (Busquets et al., 
2004, 2008; Sinha et al., 1998a, 1998b; Skog et al., 1998). An example of the profile of 
temperatures when frying meat is shown in Fig. 5. Chicken breasts fillets, 1 cm in thickness, 
were fried in an aluminium frying pan, without adding fat, at 220 ºC for 5 minutes each site. K-
type thermocouples were inserted in different sites of the fillet; 2 in the centre of the fillet (T 
centre 1, 2); two were fixed at 1 mm below the upper and the lower surface (T surface 1,2), and 
one thermocouple was placed between the pan surface and the fillet to measure the 
temperature (Frying T), which was recorded every 10 seconds. The temperature profile 
measured was found highly reproducible when frying different fillets evidencing that the heat 
and mass transfer mechanisms taking place during the cooking process are reproducible. The 
temperature in the centre of the fillet did not go over 100 ºC and the temperature at 1 mm 
below the surface never reached the frying temperature. 
 
 
Fig. 5. Temperature profiles during pan-frying of a chicken fillet (1cm thick). Each side of 
the fillet was in contact with the hot surface for 5 minutes. The temperature of the pan was 
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Knowledge on the physical mechanisms affecting the formation of HCAs has led researchers 
to look for ways to decrease the formation of these mutagens. Changing cooking practices to 
minimize weight loss resulted in less formation of HCAs because of the alteration of the 
mass transfer of HCA precursors. The addition of NaCl, sodium tryphosphate or 
carbohydrates with water-holding capacity to meat prior to cooking was an efficient and 
simple way to reduce the subsequent formation of HCAs, explained by a reduction in the 
transport of water-soluble precursors towards the crust (Persson et al., 2003, 2004). Based on 
the same principle, microwaving beef patties before frying caused a reduction in 
mutagenicity possibly due to the loss of water and HCA precursors during the pre-
treatment (Felton et al., 1994). Flipping the food frequently reduced the formation of HCAs 
because the meat has spent less time in contact with the hot surface (Salmon et al., 2000; 
Tran et al., 2002); and shortening cooking time or lowering cooking temperature also 
resulted in lower heat and mass transfer. As a result of the above-mentioned studies, easy-
to-adopt cooking practices that reduce exposure to HCAs can be recommended. 
Alternatively, solutions can also be found interfering in the chemical reactions leading to the 
formation of HCAs. For instance, one of the most effective methods reported for the 
inhibition of the formation of PhIP has been marinating the meat with red wine previous to 
the cooking process involving heat, effect that was markedly different to control marinades 
containing water and ethanol (Busquets et al., 2006). An example of the reduction of PhIP in 






























Fig. 6. Effect of marinating time on the reduction of PhIP in fried chicken. The marinating 
media was red wine. The wine characterisation and experimental conditions are as reported 
in Busquets et al. 2006. 
One way to interfere in the formation of HCAs is using antioxidants, which may affect 
radical reactions involved in the formation of HCAs by scavenging free radicals (Kikugawa, 
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One way to interfere in the formation of HCAs is using antioxidants, which may affect 
radical reactions involved in the formation of HCAs by scavenging free radicals (Kikugawa, 





depending on their concentration and type. For instance, Johansson and Jägerstad studied 
the effect of several antioxidants, at different concentrations, on the formation of HCAs in 
model systems. The results showed that, surprisingly, most antioxidants increased the 
formation of HCAs and that the rate of the effect depended on the concentration. Likewise, a 
lack of correlation was found between the concentration of the antioxidant and the effect 
observed (Johansson & Jägerstad, 1996). In summary, the formation of the heterocyclic 
amines which mechanism of formation may involve radical reactions can be enhanced or 
reduced depending on the particular cooking conditions used. Therefore, the effect of 
antioxidants on the formation of HCAs is not clear yet (Balogh et al., 2000; Britt et al., 1998; 
Melo 2008; Murkovic et al., 1998; Oguri et al., 1998; Shin et al., 2002; Tai et al., 2001; Tsen et 
al., 2006).  
2.2 Levels of HCAs in food  
Nowadays it is accepted that the main source of exposure to HCAs is the intake of cooked 
meat and fish. In order to know the type and amounts of HCAs to which humans are 
exposed, the content of HCAs has been determined in a high number of food items and the 
reported amounts are compiled periodically (Felton et al. 2000; Layton et al., 1995; Skog et 
al., 1998). To date about 20 mutagenic HCAs have been identified in cooked proteinaceous 
food and new ones may be identified in the future; species which structure is close to HCAs, 
if not HCAs, have been detected recently (Busquets et al., 2008). The most commonly found 
HCAs in thermally treated proteinaceous food are shown in Fig. 7. 
To have an overview on the amount of HCAs in commonly consumed food items, the 
concentration of HCAs in over 20 publications have been summarized in Fig. 8 (Ahn et al 
2005; Bermudo et al., 2005 ; Borgen et al., 2004; Busquets et al., 2004, 2006, 2008; Casal et al., 
2004; Cheng et al., 2007; Gerbl et al., 2004; Khan et al., 2008; Lan et al., 2004; Melo et al., 2008; 
Ni et al., 2008; Oz et al., 2007; Persson et al., 2004; Ristic et al. 2004; Salmon et al., 2006; 
Toribio et al., 2007; Tsen et al., 2006; Warzecha et al., 2004; Wong et al, 2005). The average 
concentrations of several HCAs in meats cooked using different methods shows that chicken 
presents the highest concentration of HCAs, and in particular of the amines called DMIP 
and PhIP, which are structurally related, and the comutagens and neurotoxic amines 
harman and norharman, which were also found at relative high concentrations in venison. 
For a review on the latter ones, see Pfau & Skog (2004). The higher abundance of PhIP and 
DMIP in chicken can be due to the higher amount of some free amino acids such as 
phenylalanine mainly but also tyrosine, leucine, isoleucine or threonine, whereas the lower 
content identified in other meats can be due to the lower content of sugars or 
creatine/creatinine (Bjeldanes et al., 1982; Jägerstad et al., 1983a, 1983b ; Khan et al., 2009). 
Cooking methods also play an important role in the formation of PhIP because low amounts 
of this usually abundant amine have also been quantified in fried chicken breast cooked in 
the Chinese style (Wong et al., 2005; Salmon et al., 2006). Interestingly, low content of PhIP, 
below 2 ng/g, was found in turkey cooked by a prolonged frying process (15 min/side at 
190-200ºC) (Warzecha et al., 2004). Pork showed the highest content of the HCAs named IQ, 
MeIQx, 4,8-DiMeIQx, Trp-P-2 and Trp-P-1, and any HCA stand out in beef samples in terms 
of concentration level. The median concentration of HCAs in beef was below 3 ng/g; and 
even lower amounts were quantified in fish. Compared with previous data (Layton et al., 
1995; Skog et al., 1998; Felton et al., 2000), the amounts of HCAs determined in fish for the 
 
Food Borne Carcinogens: A Dead End? 
 
171 
studied period are low. The cause of this low occurrence may be the oriental recipies used, 
which use ingredients with antioxidant properties and cooking methods with low heat 
transfer (Wong et al., 2005; Salmon et al., 2006). The data in the papers included in Fig. 8 
corroborates that the cooking methods involving higher heat transfer (barbecuing, frying, 
griddling and grilling) are related to higher levels of HCAs, whereas the processes with 
lower heat transfer (stewing, stir-frying, roasting, coated-frying and boiling) are related to 




























































Fig. 7. Chemical structure of HCAs commonly found in cooked protein rich food. 
2.3 Assessment of the exposure to HCAs 
The toxicological effect of the habitual exposure of HCAs on humans is still unknown. There 
are two main approaches to quantifying exposure to HCAs; the first one evaluates the 
correlation between the intake of HCAs and increased risk of different types of human 
cancer; the second, searches for biomarkers of exposure to HCAs in biological fluids that 
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are two main approaches to quantifying exposure to HCAs; the first one evaluates the 
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for the analysis of such biomarkers under a normal exposure to HCAs is at its initial stages 
(Busquets et al., 2009; Frandsen et al., 2002, 2007, 2008); a few biomarker of exposure have 
been proposed so far but their analysis and correlation with cancer incidence in large 




















































































Fig. 8. Concentration of HCAs, identified by their acronym, reported in chicken, pork, 
venison, beef and fish items cooked in various ways. 
Epidemiological studies relate the content of specific HCAs in food and the incidence of 
particular types of cancer. Several epidemiological studies have found a positive correlation 
between the intake of some HCAs and different types of human cancer (Butler et al., 2003; 
Cross A.J et at., 2011; Destefani et al., 1997, 1998; Martinez et al., 2007; Sinha et al., 2001) 
whereas other studies have found no such correlation (Augustsson et al., 1999; Gunter et al., 
2005; Sonestedt et al., 2008). Numerous factors hinder reaching conclusions on the 
association of HCAs and human cancer by means of dietary calculations. Problems still to be 
surmounted are: the difficulty in getting accurate information on eating habits; bias, 
inconsistent reporting or misclassification; the fact that different cooking methods and 
degrees of doneness cause very different HCA content, as discussed earlier in this chapter; 
difficulty in quantifying cooking doneness using questionnaires; difficulty in considering 
variations in day-to-day diet; the existence of multiple HCAs and possibly some other 
factors that have not yet been identified. The representativity of the food analysed and the 
accuracy of HCA quantification must also be taken into account. For instance, several 
studies have related the occurrence of MeIQx or 4,8-DiMeIQx with cancer but these amines 
occur at low concentration, usually <2 ng/g cooked food, as it is shown in Figure 8, and 
their determination is difficult and possibly it is carried out with low accuracy. In addition, 
the whole amount of the HCAs ingested is not bioavailable, in part due to other components 
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of the meal, but epidemiologic studies can not take these unknown parameters into 
consideration. Furthermore, only a fraction of the bioavailable HCAs are activated to the 
ultimate electrophilic intermediate that causes the genetic damage and this activation can be 
more or less effective depending on the phenotypes of the enzymes involved in the 
activation pathways and on lifestyle factors (Le Marchand et al., 2001). Moreover, there are 
mechanisms in the human body that repair mutations and, in addition, the mutations that 
initiate cancer processes may be caused by environmental factors other than HCAs in diet. 
Another factor, not unique to HCAs, is that the delay between the evaluation of the 
exposure and disease outcome (Alexander et al., 2002). These factors show that there is a big 
gap between the estimation of HCA exposure and the identification of the origin of cancer 
processes by means of epidemiologic studies.  
Regardless of all the existing limitations and approximations necessary to asses the exposure 
to HCAs, the individual daily exposure to HCAs has been quantified in several countries. 
For Asian populations: 50 ng in China (Wong et al., 2005) and 72 ng in Japan (Kobayashi et 
al., 2002) were estimated. In general, higher values have been found for European 
populations: 69 ng in Germany (Rohrmann et al., 2007); 160 ng (Augustsson et al., 1997), 690 
ng (Ericson et al. 2007) and 520 ng (Sonestedt et al., 2008) in Sweden; 330 ng in Switzerland 
(Zimmerli et al., 2001); and 286 ng (Busquets et al., 2008) and 606 ng in Spain (Busquets et 
al., 2004). Several studied performed in the United States studies found high values: 1.690 ng 
(Layton et al., 1995), 455 ng (Keating & Bogen, 2001), 585 ng (Bogen & Keating, 2001) and 
715-1.293 ng (Keating & Bogen, 2004). The quoted intakes were calculated for an average 
body mass of 65 Kg. The levels of exposure estimated from food frequency questionnaires 
and analysis of HCAs in food may be useful in toxicological studies to define the impact of 
HCAs on health and to make risk-based recommendations about reducing exposure to 
HCAs. However, the reported values have to be used in full awareness of the intrinsic 
limitations of exposure assessment by means of food frequency questionnaires and 
determination of HCAs in a limited number of cooked foods. 
The intake of HCAs is not directly related with mutations in the DNA. Only a part of the 
total amount of HCAs present in heated proteinaceous food will be absorbed. To the best of 
our knowledge, few studies have focused on the bioavailable or effective dose of HCAs, 
although this is key to assessing the effective dose of the dietary intake of HCAs. To 
understand the influence of digestion parameters on the release of HCAs, Kulp and 
coworkers used a model system to test the effect of several enzymes (amylase, pepsin and 
pancreatin) on the digestion of well-done chicken (Kulp et al., 2003) and pancreatin was the 
only enzyme that favoured the bioavailability of HCAs. In addition, HCAs differed greatly 
from each other in ways that affected their bioavailability; PhIP, which is less polar than the 
other amines studied, was 50% present in each fraction, which implies that PhIP is less 
accessible than more polar HCAs. Very important also was the finding that the higher the 
degree of doneness, the lower the bioavailability of HCAs was (Kulp et al., 2003). Another 
factor that may affect the bioavailability of HCAs is the presence of fibre in the meal. 
Experiments carried out in rats revealed that dietary fibre, 95% of which is contributed by 
whole plant cell walls, may protect by adsorbing carcinogens, thus lowering their effective 
concentration in the alimentary tract, and by carrying the carcinogens out of the body in 
faeces (Ferguson & Harris, 1996). However, not all types of fibre had adsorptive abilities. 
The most hydrophobic plant cell wall preparations containing the polymer suberin, which 





for the analysis of such biomarkers under a normal exposure to HCAs is at its initial stages 
(Busquets et al., 2009; Frandsen et al., 2002, 2007, 2008); a few biomarker of exposure have 
been proposed so far but their analysis and correlation with cancer incidence in large 




















































































Fig. 8. Concentration of HCAs, identified by their acronym, reported in chicken, pork, 
venison, beef and fish items cooked in various ways. 
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HCAs among the fibre examined and preparations with lignin showed intermediate 
adsorptive abilities. The adsorption of HCAs to the plant cell walls increased with 
increasing hydrophobicity of the HCA (Ferguson et al., 1995; Ferguson & Harris, 1996; 
Harris et al., 1996; Hayatsu et al., 1993b). Similarly, chlorophyllin, intestinal microflora and 
certain bacterial strains contained in fermented foods may decrease the bioavailability of 
HCAs by direct binding of HCAs to their structure (Hayatsu et al., 1993a; Kassie et al., 2001, 
2004; Knasmüller et al., 2001; Orrhage et al., 1994; 2002). 
Once the HCAs are bioavailable, they require metabolic activation to damage DNA. Most 
HCAs are oxidized in the body and just a small portion is excreted unchanged. The first step 
to activate HCAs is catalyzed by cytochrome P450 enzymes (CYP). 57 CYP genes have been 
identified in human genome, half of which are involved in xenobiotic metabolism (Glatt, 
2006). Among the different CYPs, those of family 1 have been found to participate in the 
metabolism of HCAs. CYP1A2 shows the highest activity for N-hydroxylation or activation 
of the HCAs to the ultimate mutagenic specie (Boobis et al., 1994; Glatt, 2006; Rich et al., 
1992; Zhao et al., 1994). CYP1A2 activity may vary from person to person and can be 
activated by lifestyle factors such as smoking or eating habits (Lang et al., 1994). N-
hydroxylated HCAs undergo O-acetylation and O-sulphatation catalyzed by N-
acetyltransferases and sulphotransferases, respectively. These esters are hydrolyzed to 
produce highly electrophilic arylnitrenium ions, considered to be the final genotoxicants, 
which react with some sites of the DNA. The reactive nitrenium ion also reacts with proteins 
(Buonarati et al., 1990; Turesky et al., 1992; Turesky et al., 2004). Detoxification involves 
converting the toxicants to polar molecules that can be excreted or transported to 
extrahepatic tissues. Various detoxification pathways, such as ring hydroxylation, catalyzed 
by CYPs, or glucoronidation, catalyzed by UDP-glucoronosyltransferases, compete with the 
activation routes. Understanding the metabolic pathways of HCAs and developing 
analytical methodology capable of determining metabolites from HCAs in biological fluids 
with high accuracy, despite their low concentration and complexity of the matrices, is 
providing the tools to identify species that could be proved to be biomarkers of exposure. 
The analysis of species proved to be biomakers of exposure to HCAs in large cohorts and its 
relation with cancer incidence will be ultimate evidence to relate HCAs with human cancer. 
3. Conclusion 
Heat treatments applied during cooking processes cause the formation of mutagenic 
compounds from the reaction of natural precursors present in raw food. Although the 
exposure to such toxicants seems unavoidable, it can be highly reduced by just applying 
minor changes in cooking and eating habits. The exposure to HCAs is currently being 
estimated with methods comprising many approximations. Different types and levels of 
food borne mutagens are present in frequently eaten food items. The bioavailability of these 
cooking mutagens, their metabolic activation and DNA repair mechanism are also variable. 
The pathogenesis can also be caused by other factors, and it appears with a delay on time 
with respect to the causes that induced the genetic damage. For these reasons, the link 
between food borne mutagens and cancer has not been well established in humans although 
the effect of high concentrations of the mutagens in animals has shown to cause tumours. 
The mortality rate of cancer, the economical burden that the disease represents, and the 
evidences on the exposure to food borne mutagens discussed in this chapter, claim major 
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attention from the legislative bodies, which should establish maximum concentration limits 
for these species in commercial food products and recommend guidelines for “good cooking 
practices”. Legislation on this topic would encourage the food industry to monitor, control 
and ultimately reduce the exposure food borne mutagens. Besides, the public health 
institutions and scientist should inform the population about the existence of the food borne 
mutagens and ways to minimise their formation. A change towards healthier 
eating/cooking habits in terms of exposure to cooking toxicants may be fomented with the 
approach used when disseminating the information. If the exposure is presented as 
something unavoidable, the consummers will resing themselves and do nothing. However, 
the attitude from the public may be more active if they receive information in a positive 
way; there is exposure to hazardous compounds but it can be reduced easily by using 
certain practices such as cooking methods with low heat transfer (boiling, stewing, coating, 
flipping the food frequently); lowering cooking time and temperature or using ingredients 
that interfer in the Maillard reaction. Once individuals are aware of the problem and willing 
to solve it, these generates a commercial opportunity, and for the first time companies 
would invest in products for a diet with low in food borne toxicants without being pushed 
to it. In summary, food borne carcinogens are not a dead end; individuals, food companies 
and public bodies have health or business interest in them. 
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During the last decades, cancer diseases have increased all over the world. The low 
quality of food and strong pollution of environment are the main prerequisites for 
carcinogenesis. The main problem for scientists is to find strategy for prevention 
of cancer diseases. Therefore, the information about the models for studying 
carcinogenesis and mutagens which appear during cooking, environmental pollutants, 
and tests for specific detection of carcinogens is particularly important. The book 
“Carcinogen” is intended for biologists, researchers, students in medical sciences and 
professionals interested in associated areas.




I  7 - - 1-7010 5
